5/CD reaction/NN Allergic/JJ
5/CD reaction/NN
fluorouracil/JJ infusion/NN reaction/NN Allergic/JJ
fluorouracil/JJ infusion/NN reaction/NN
cisplatin/VBN occurred/VBN patient/NN carcinoma/NN cavity/NN cirrhosis/NNS
5/CD infusion/NN occurred/VBN induced/VBN impaired/JJ
5/CD infusion/NN occurred/VBN function/NN renal/JJ
5/CD infusion/NN occurred/VBN function/NN
fluorouracil/RB occurred/VBN induced/VBN impaired/JJ
fluorouracil/RB occurred/VBN function/NN renal/JJ
fluorouracil/RB occurred/VBN function/NN
5/CD infusion/NN occurred/VBN reaction/NN allergic/JJ
5/CD infusion/NN occurred/VBN reaction/NN
fluorouracil/RB occurred/VBN reaction/NN allergic/JJ
fluorouracil/RB occurred/VBN reaction/NN
cisplatin/VBN occurred/VBN induced/VBN impaired/JJ
cisplatin/VBN occurred/VBN function/NN renal/JJ
cisplatin/VBN occurred/VBN function/NN
cisplatin/VBN occurred/VBN patient/NN carcinoma/NN
cisplatin/VBN occurred/VBN patient/NN carcinoma/NN cavity/NN of/IN
cisplatin/VBN occurred/VBN patient/NN carcinoma/NN cavity/NN the/DT
cisplatin/VBN occurred/VBN patient/NN carcinoma/NN cavity/NN oral/JJ
cisplatin/VBN occurred/VBN patient/NN carcinoma/NN cavity/NN
cisplatin/VBN occurred/VBN reaction/NN allergic/JJ
cisplatin/VBN occurred/VBN reaction/NN
5/CD infusion/NN occurred/VBN patient/NN carcinoma/NN
5/CD infusion/NN occurred/VBN patient/NN carcinoma/NN cavity/NN of/IN
5/CD infusion/NN occurred/VBN patient/NN carcinoma/NN cavity/NN the/DT
5/CD infusion/NN occurred/VBN patient/NN carcinoma/NN cavity/NN oral/JJ
5/CD infusion/NN occurred/VBN patient/NN carcinoma/NN cavity/NN
fluorouracil/RB occurred/VBN patient/NN carcinoma/NN
fluorouracil/RB occurred/VBN patient/NN carcinoma/NN cavity/NN of/IN
fluorouracil/RB occurred/VBN patient/NN carcinoma/NN cavity/NN the/DT
fluorouracil/RB occurred/VBN patient/NN carcinoma/NN cavity/NN oral/JJ
fluorouracil/RB occurred/VBN patient/NN carcinoma/NN cavity/NN
5/CD infusion/NN occurred/VBN patient/NN carcinoma/NN cavity/NN cirrhosis/NNS
fluorouracil/RB occurred/VBN patient/NN carcinoma/NN cavity/NN cirrhosis/NNS
cisplatin/VBN occurred/VBN reaction/NN consisting/VBG edema/NN angioneurotic/JJ
cisplatin/VBN occurred/VBN reaction/NN consisting/VBG edema/NN
diphenhydramine/JJ Oral/NNP ineffective/JJ preventing/VBG recurrence/NN reaction/NN allergic/JJ
diphenhydramine/JJ Oral/NNP ineffective/JJ preventing/VBG recurrence/NN reaction/NN
prednisone/JJ diphenhydramine/JJ Oral/NNP ineffective/JJ preventing/VBG recurrence/NN reaction/NN allergic/JJ
prednisone/JJ diphenhydramine/JJ Oral/NNP ineffective/JJ preventing/VBG recurrence/NN reaction/NN
testosterone/NN patients/NNS referred/VBN dysfunction/NN erectile/JJ
testosterone/NN patients/NNS referred/VBN dysfunction/NN
testosterone/NN screened/VBN basis/NN desire/NN gynecomastia/NN
testosterone/NN gynecomastia/NN
testosterone/JJ heptylate/NN consisted/VBD hyperprolactinemia/NN
heptylate/NN consisted/VBD hyperprolactinemia/NN
bromocriptine/NN hypogonadism/NN
bromocriptine/NN hypogonadism/NN consisted/VBD hyperprolactinemia/NN
testosterone/JJ heptylate/NN consisted/VBD hypogonadism/NN
heptylate/NN consisted/VBD hypogonadism/NN
testosterone/JJ determination/NN discovered/VBN tumors/NNS pituitary/JJ
testosterone/JJ determination/NN discovered/VBN tumors/NNS
testosterone/NN levels/NNS Most/JJS seemed/VBD result/VB luteinizing/VBG dysfunction/NN hypothalamic/JJ
testosterone/NN levels/NNS Most/JJS seemed/VBD result/VB luteinizing/VBG dysfunction/NN
testosterone/NN levels/NNS Most/JJS seemed/VBD result/VB have/VB role/NN dysfunction/NN erectile/JJ
testosterone/NN levels/NNS Most/JJS seemed/VBD result/VB have/VB role/NN dysfunction/NN
testosterone/JJ prolactin/NN cannot/NN erectile/JJ
testosterone/JJ prolactin/NN cannot/NN dysfunction/NN
testosterone/NN desire/NN gynecomastia/NN
vasopressin/NN gene/NN expression/NN Upregulation/NNP insipidus/NNS diabetes/NN
vasopressin/NN gene/NN expression/NN Upregulation/NNP insipidus/NNS
lithium/NN nuclei/NNS gene/NN expression/NN Upregulation/NNP insipidus/NNS diabetes/NN
lithium/NN nuclei/NNS gene/NN expression/NN Upregulation/NNP insipidus/NNS
lithium/NN polyuria/NN
Li/NNP lithium/NN polyuria/NN
arginine/JJ gene/NN expression/NN investigated/VBN lithium/NN polyuria/NN
vasopressin/NN gene/NN expression/NN investigated/VBN lithium/NN polyuria/NN
AVP/NNP gene/NN expression/NN investigated/VBN lithium/NN polyuria/NN
AVP/NNP elevation/NN contribute/VB dehydration/VBN
AVP/NNP expression/NN upregulation/NN elevation/NN contribute/VB dehydration/VBN
Li/NNP SON/NNP expression/NN upregulation/NN elevation/NN contribute/VB dehydration/VBN induced/VBN rat/VB insipidus/NNS diabetes/NN
Li/NNP SON/NNP expression/NN upregulation/NN elevation/NN contribute/VB dehydration/VBN induced/VBN rat/VB insipidus/NNS
AVP/NNP elevation/NN contribute/VB dehydration/VBN induced/VBN rat/VB insipidus/NNS diabetes/NN
AVP/NNP elevation/NN contribute/VB dehydration/VBN induced/VBN rat/VB insipidus/NNS
AVP/NNP expression/NN upregulation/NN elevation/NN contribute/VB dehydration/VBN induced/VBN rat/VB insipidus/NNS diabetes/NN
AVP/NNP expression/NN upregulation/NN elevation/NN contribute/VB dehydration/VBN induced/VBN rat/VB insipidus/NNS
Li/NNP SON/NNP expression/NN upregulation/NN elevation/NN contribute/VB dehydration/VBN
lidocaine/NNP man/NN bolus/NNS resulted/VBN depression/NN
lidocaine/VB represented/VBD had/VBD conditions/NNS predisposed/VBN development/NN bradyarrhythmias/NNS
UM/NNP administered/VBN tachycardias/NNS ventricular/NN
UM/NNP administered/VBN tachycardias/NNS
272/NNP administered/VBN tachycardias/NNS ventricular/NN
272/NNP administered/VBN tachycardias/NNS
N/NNP 272/NNP administered/VBN tachycardias/NNS ventricular/NN
N/NNP 272/NNP administered/VBN tachycardias/NNS
N/NNP N/NNP 272/NNP administered/VBN tachycardias/NNS ventricular/NN
N/NNP N/NNP 272/NNP administered/VBN tachycardias/NNS
dimethylpropranolol/NN N/NNP 272/NNP administered/VBN tachycardias/NNS ventricular/NN
dimethylpropranolol/NN N/NNP 272/NNP administered/VBN tachycardias/NNS
UM/NNP converted/VBD tachycardia/NN ventricular/NN
UM/NNP converted/VBD tachycardia/NN
272/NNP converted/VBD tachycardia/NN ventricular/NN
272/NNP converted/VBD tachycardia/NN
oxygen/NN therapy/NN cystitis/NNS hemorrhagic/JJ
oxygen/NN therapy/NN cystitis/NNS
cyclophosphamide/NN control/NN therapy/NN cystitis/NNS hemorrhagic/JJ
cyclophosphamide/NN control/NN therapy/NN cystitis/NNS
cyclophosphamide/VB therapy/NN granulomatosis/NNS Wegener/NNP
cyclophosphamide/VB therapy/NN granulomatosis/NNS Wegener/NNP '/POS
cyclophosphamide/VB therapy/NN granulomatosis/NNS s/JJ
cyclophosphamide/VB therapy/NN granulomatosis/NNS
cyclophosphamide/VB due/JJ case/NN cystitis/NNS hemorrhagic/JJ
cyclophosphamide/VB due/JJ case/NN cystitis/NNS
prostaglandin/NN F/NN irrigation/NN treatment/NN failed/VBD control/VB hemorrhage/NN
F/NN irrigation/NN treatment/NN failed/VBD control/VB hemorrhage/NN
2/CD alpha/NN F/NN irrigation/NN treatment/NN failed/VBD control/VB hemorrhage/NN
alpha/NN F/NN irrigation/NN treatment/NN failed/VBD control/VB hemorrhage/NN
cyclophosphamide/NN treatment/NN alternative/NN offer/VB cystitis/NNS hemorrhagic/JJ
cyclophosphamide/NN treatment/NN alternative/NN offer/VB cystitis/NNS
steroids/NNS efficacy/NN seizures/NNS
steroids/NNS demonstrate/VBP actions/NNS relevance/VBN host/NN disorders/NNS neurological/JJ
steroids/NNS demonstrate/VBP actions/NNS relevance/VBN host/NN disorders/NNS neurological/JJ and/CC
steroids/NNS demonstrate/VBP actions/NNS relevance/VBN host/NN disorders/NNS neurological/JJ psychiatric/JJ
steroids/NNS demonstrate/VBP actions/NNS relevance/VBN host/NN disorders/NNS
steroid/VBD modulate/VBP effects/NNS cocaine/NN engendered/VBN administration/NN kindling/NN seizure/NN
gamma/NN modulate/VBP effects/NNS cocaine/NN engendered/VBN administration/NN kindling/NN seizure/NN
aminobutyric/JJ acid/NN gamma/NN modulate/VBP effects/NNS cocaine/NN engendered/VBN administration/NN kindling/NN seizure/NN
acid/NN gamma/NN modulate/VBP effects/NNS cocaine/NN engendered/VBN administration/NN kindling/NN seizure/NN
GABA/NNP receptor/NN acid/NN gamma/NN modulate/VBP effects/NNS cocaine/NN engendered/VBN administration/NN kindling/NN seizure/NN
Allopregnanolone/VB tested/VBN ability/NN suppress/VB expression/NN development/NN seizures/NNS
3/CD alpha/CD Allopregnanolone/VB tested/VBN ability/NN suppress/VB expression/NN development/NN seizures/NNS
alpha/CD Allopregnanolone/VB tested/VBN ability/NN suppress/VB expression/NN development/NN seizures/NNS
hydroxy/NN alpha/CD Allopregnanolone/VB tested/VBN ability/NN suppress/VB expression/NN development/NN seizures/NNS
5/CD alpha/NNS hydroxy/NN alpha/CD Allopregnanolone/VB tested/VBN ability/NN suppress/VB expression/NN development/NN seizures/NNS
alpha/NNS hydroxy/NN alpha/CD Allopregnanolone/VB tested/VBN ability/NN suppress/VB expression/NN development/NN seizures/NNS
pregnan/NN alpha/NNS hydroxy/NN alpha/CD Allopregnanolone/VB tested/VBN ability/NN suppress/VB expression/NN development/NN seizures/NNS
20/CD one/CD hydroxy/NN alpha/CD Allopregnanolone/VB tested/VBN ability/NN suppress/VB expression/NN development/NN seizures/NNS
one/CD hydroxy/NN alpha/CD Allopregnanolone/VB tested/VBN ability/NN suppress/VB expression/NN development/NN seizures/NNS
pregnanolone/VB Allopregnanolone/VB tested/VBN ability/NN suppress/VB expression/NN development/NN seizures/NNS
3/CD alpha/CD pregnanolone/VB Allopregnanolone/VB tested/VBN ability/NN suppress/VB expression/NN development/NN seizures/NNS
alpha/CD pregnanolone/VB Allopregnanolone/VB tested/VBN ability/NN suppress/VB expression/NN development/NN seizures/NNS
hydroxy/NN alpha/CD pregnanolone/VB Allopregnanolone/VB tested/VBN ability/NN suppress/VB expression/NN development/NN seizures/NNS
5/CD beta/NN hydroxy/NN alpha/CD pregnanolone/VB Allopregnanolone/VB tested/VBN ability/NN suppress/VB expression/NN development/NN seizures/NNS
beta/NN hydroxy/NN alpha/CD pregnanolone/VB Allopregnanolone/VB tested/VBN ability/NN suppress/VB expression/NN development/NN seizures/NNS
pregnan/NN beta/NN hydroxy/NN alpha/CD pregnanolone/VB Allopregnanolone/VB tested/VBN ability/NN suppress/VB expression/NN development/NN seizures/NNS
20/CD one/CD hydroxy/NN alpha/CD pregnanolone/VB Allopregnanolone/VB tested/VBN ability/NN suppress/VB expression/NN development/NN seizures/NNS
one/CD hydroxy/NN alpha/CD pregnanolone/VB Allopregnanolone/VB tested/VBN ability/NN suppress/VB expression/NN development/NN seizures/NNS
allopregnanolone/NN alpha/NNP derivative/NN ganaxolone/VB Allopregnanolone/VB tested/VBN ability/NN suppress/VB expression/NN development/NN seizures/NNS
ganaxolone/VB Allopregnanolone/VB tested/VBN ability/NN suppress/VB expression/NN development/NN seizures/NNS
3/CD alpha/NNP derivative/NN ganaxolone/VB Allopregnanolone/VB tested/VBN ability/NN suppress/VB expression/NN development/NN seizures/NNS
alpha/NNP derivative/NN ganaxolone/VB Allopregnanolone/VB tested/VBN ability/NN suppress/VB expression/NN development/NN seizures/NNS
hydroxy/NN alpha/NNP derivative/NN ganaxolone/VB Allopregnanolone/VB tested/VBN ability/NN suppress/VB expression/NN development/NN seizures/NNS
3/CD beta/NN alpha/NNP derivative/NN ganaxolone/VB Allopregnanolone/VB tested/VBN ability/NN suppress/VB expression/NN development/NN seizures/NNS
beta/NN alpha/NNP derivative/NN ganaxolone/VB Allopregnanolone/VB tested/VBN ability/NN suppress/VB expression/NN development/NN seizures/NNS
methyl/NN alpha/NNP derivative/NN ganaxolone/VB Allopregnanolone/VB tested/VBN ability/NN suppress/VB expression/NN development/NN seizures/NNS
5/CD alpha/NNS alpha/NNP derivative/NN ganaxolone/VB Allopregnanolone/VB tested/VBN ability/NN suppress/VB expression/NN development/NN seizures/NNS
alpha/NNS alpha/NNP derivative/NN ganaxolone/VB Allopregnanolone/VB tested/VBN ability/NN suppress/VB expression/NN development/NN seizures/NNS
pregnan/NN alpha/NNP derivative/NN ganaxolone/VB Allopregnanolone/VB tested/VBN ability/NN suppress/VB expression/NN development/NN seizures/NNS
20/CD alpha/NNP derivative/NN ganaxolone/VB Allopregnanolone/VB tested/VBN ability/NN suppress/VB expression/NN development/NN seizures/NNS
one/CD alpha/NNP derivative/NN ganaxolone/VB Allopregnanolone/VB tested/VBN ability/NN suppress/VB expression/NN development/NN seizures/NNS
allopregnanolone/JJ suppressed/VBN expression/NN seizures/NNS
GABA/NNP modulators/NNS suppressed/VBN expression/NN seizures/NNS
ganaxolone/JJ allopregnanolone/JJ suppressed/VBN expression/NN seizures/NNS
prazosin/NN taking/VBG change/VB resolve/VB incontinence/NN
Bradykinin/JJ antagonists/NNS inhibitors/VBZ vincristine/NN induced/VBN hyperalgesia/NN model/NN chemotherapy/JJ diabetic/JJ
Bradykinin/JJ antagonists/NNS inhibitors/VBZ vincristine/NN induced/VBN hyperalgesia/NN model/NN neuropathy/JJ
Bradykinin/JJ antagonists/NNS inhibitors/VBZ vincristine/NN induced/VBN hyperalgesia/NN
nitric/JJ synthase/NN antagonists/NNS inhibitors/VBZ vincristine/NN induced/VBN hyperalgesia/NN model/NN chemotherapy/JJ diabetic/JJ
nitric/JJ synthase/NN antagonists/NNS inhibitors/VBZ vincristine/NN induced/VBN hyperalgesia/NN model/NN neuropathy/JJ
oxide/NN synthase/NN antagonists/NNS inhibitors/VBZ vincristine/NN induced/VBN hyperalgesia/NN model/NN chemotherapy/JJ diabetic/JJ
oxide/NN synthase/NN antagonists/NNS inhibitors/VBZ vincristine/NN induced/VBN hyperalgesia/NN model/NN neuropathy/JJ
nitric/JJ synthase/NN antagonists/NNS inhibitors/VBZ vincristine/NN induced/VBN hyperalgesia/NN
oxide/NN synthase/NN antagonists/NNS inhibitors/VBZ vincristine/NN induced/VBN hyperalgesia/NN
vincristine/NN induced/VBN hyperalgesia/NN model/NN chemotherapy/JJ diabetic/JJ
vincristine/NN induced/VBN hyperalgesia/NN model/NN neuropathy/JJ
HOE/NNP bradykinin/NN antagonists/NNS action/NN influence/NN model/NN diabetic/NN
HOE/NNP bradykinin/NN antagonists/NNS action/NN influence/NN model/NN diabetic/NN streptozotocin/NN
HOE/NNP bradykinin/NN antagonists/NNS action/NN influence/NN model/NN diabetic/NN streptozotocin/NN induced/NNP
HOE/NNP bradykinin/NN antagonists/NNS action/NN influence/NN model/NN diabetic/NN and/CC
HOE/NNP bradykinin/NN antagonists/NNS action/NN influence/NN model/NN diabetic/NN neuropathy/NN toxic/JJ
HOE/NNP bradykinin/NN antagonists/NNS action/NN influence/NN model/NN diabetic/NN neuropathy/NN vincristine/NN
HOE/NNP bradykinin/NN antagonists/NNS action/NN influence/NN model/NN diabetic/NN neuropathy/NN vincristine/NN induced/NNP
HOE/NNP bradykinin/NN antagonists/NNS action/NN influence/NN model/NN diabetic/NN neuropathy/NN
140/CD HOE/NNP bradykinin/NN antagonists/NNS action/NN influence/NN model/NN diabetic/NN
140/CD HOE/NNP bradykinin/NN antagonists/NNS action/NN influence/NN model/NN diabetic/NN streptozotocin/NN
140/CD HOE/NNP bradykinin/NN antagonists/NNS action/NN influence/NN model/NN diabetic/NN streptozotocin/NN induced/NNP
140/CD HOE/NNP bradykinin/NN antagonists/NNS action/NN influence/NN model/NN diabetic/NN and/CC
140/CD HOE/NNP bradykinin/NN antagonists/NNS action/NN influence/NN model/NN diabetic/NN neuropathy/NN toxic/JJ
140/CD HOE/NNP bradykinin/NN antagonists/NNS action/NN influence/NN model/NN diabetic/NN neuropathy/NN vincristine/NN
140/CD HOE/NNP bradykinin/NN antagonists/NNS action/NN influence/NN model/NN diabetic/NN neuropathy/NN vincristine/NN induced/NNP
140/CD HOE/NNP bradykinin/NN antagonists/NNS action/NN influence/NN model/NN diabetic/NN neuropathy/NN
des/NNP HOE/NNP action/NN influence/NN model/NN diabetic/NN
des/NNP HOE/NNP action/NN influence/NN model/NN diabetic/NN streptozotocin/NN
des/NNP HOE/NNP action/NN influence/NN model/NN diabetic/NN streptozotocin/NN induced/NNP
des/NNP HOE/NNP action/NN influence/NN model/NN diabetic/NN and/CC
des/NNP HOE/NNP action/NN influence/NN model/NN diabetic/NN neuropathy/NN toxic/JJ
des/NNP HOE/NNP action/NN influence/NN model/NN diabetic/NN neuropathy/NN vincristine/NN
des/NNP HOE/NNP action/NN influence/NN model/NN diabetic/NN neuropathy/NN vincristine/NN induced/NNP
des/NNP HOE/NNP action/NN influence/NN model/NN diabetic/NN neuropathy/NN
Arg/NNP HOE/NNP action/NN influence/NN model/NN diabetic/NN
Arg/NNP HOE/NNP action/NN influence/NN model/NN diabetic/NN streptozotocin/NN
Arg/NNP HOE/NNP action/NN influence/NN model/NN diabetic/NN streptozotocin/NN induced/NNP
Arg/NNP HOE/NNP action/NN influence/NN model/NN diabetic/NN and/CC
Arg/NNP HOE/NNP action/NN influence/NN model/NN diabetic/NN neuropathy/NN toxic/JJ
Arg/NNP HOE/NNP action/NN influence/NN model/NN diabetic/NN neuropathy/NN vincristine/NN
Arg/NNP HOE/NNP action/NN influence/NN model/NN diabetic/NN neuropathy/NN vincristine/NN induced/NNP
Arg/NNP HOE/NNP action/NN influence/NN model/NN diabetic/NN neuropathy/NN
10/CD HOE/NNP action/NN influence/NN model/NN diabetic/NN
10/CD HOE/NNP action/NN influence/NN model/NN diabetic/NN streptozotocin/NN
10/CD HOE/NNP action/NN influence/NN model/NN diabetic/NN streptozotocin/NN induced/NNP
10/CD HOE/NNP action/NN influence/NN model/NN diabetic/NN and/CC
10/CD HOE/NNP action/NN influence/NN model/NN diabetic/NN neuropathy/NN toxic/JJ
10/CD HOE/NNP action/NN influence/NN model/NN diabetic/NN neuropathy/NN vincristine/NN
10/CD HOE/NNP action/NN influence/NN model/NN diabetic/NN neuropathy/NN vincristine/NN induced/NNP
10/CD HOE/NNP action/NN influence/NN model/NN diabetic/NN neuropathy/NN
HOE/NNP action/NN influence/NN model/NN diabetic/NN
HOE/NNP action/NN influence/NN model/NN diabetic/NN streptozotocin/NN
HOE/NNP action/NN influence/NN model/NN diabetic/NN streptozotocin/NN induced/NNP
HOE/NNP action/NN influence/NN model/NN diabetic/NN and/CC
HOE/NNP action/NN influence/NN model/NN diabetic/NN neuropathy/NN toxic/JJ
HOE/NNP action/NN influence/NN model/NN diabetic/NN neuropathy/NN vincristine/NN
HOE/NNP action/NN influence/NN model/NN diabetic/NN neuropathy/NN vincristine/NN induced/NNP
HOE/NNP action/NN influence/NN model/NN diabetic/NN neuropathy/NN
140/VBN HOE/NNP action/NN influence/NN model/NN diabetic/NN
140/VBN HOE/NNP action/NN influence/NN model/NN diabetic/NN streptozotocin/NN
140/VBN HOE/NNP action/NN influence/NN model/NN diabetic/NN streptozotocin/NN induced/NNP
140/VBN HOE/NNP action/NN influence/NN model/NN diabetic/NN and/CC
140/VBN HOE/NNP action/NN influence/NN model/NN diabetic/NN neuropathy/NN toxic/JJ
140/VBN HOE/NNP action/NN influence/NN model/NN diabetic/NN neuropathy/NN vincristine/NN
140/VBN HOE/NNP action/NN influence/NN model/NN diabetic/NN neuropathy/NN vincristine/NN induced/NNP
140/VBN HOE/NNP action/NN influence/NN model/NN diabetic/NN neuropathy/NN
NO/DT synthase/NN constitutive/NN inhibitor/NN influence/NN model/NN diabetic/NN
NO/DT synthase/NN constitutive/NN inhibitor/NN influence/NN model/NN diabetic/NN streptozotocin/NN
NO/DT synthase/NN constitutive/NN inhibitor/NN influence/NN model/NN diabetic/NN streptozotocin/NN induced/NNP
NO/DT synthase/NN constitutive/NN inhibitor/NN influence/NN model/NN diabetic/NN and/CC
NO/DT synthase/NN constitutive/NN inhibitor/NN influence/NN model/NN diabetic/NN neuropathy/NN toxic/JJ
NO/DT synthase/NN constitutive/NN inhibitor/NN influence/NN model/NN diabetic/NN neuropathy/NN vincristine/NN
NO/DT synthase/NN constitutive/NN inhibitor/NN influence/NN model/NN diabetic/NN neuropathy/NN vincristine/NN induced/NNP
NO/DT synthase/NN constitutive/NN inhibitor/NN influence/NN model/NN diabetic/NN neuropathy/NN
NO/DT synthase/NN inhibitor/NN constitutive/NN inhibitor/NN influence/NN model/NN diabetic/NN
NO/DT synthase/NN inhibitor/NN constitutive/NN inhibitor/NN influence/NN model/NN diabetic/NN streptozotocin/NN
NO/DT synthase/NN inhibitor/NN constitutive/NN inhibitor/NN influence/NN model/NN diabetic/NN streptozotocin/NN induced/NNP
NO/DT synthase/NN inhibitor/NN constitutive/NN inhibitor/NN influence/NN model/NN diabetic/NN and/CC
NO/DT synthase/NN inhibitor/NN constitutive/NN inhibitor/NN influence/NN model/NN diabetic/NN neuropathy/NN toxic/JJ
NO/DT synthase/NN inhibitor/NN constitutive/NN inhibitor/NN influence/NN model/NN diabetic/NN neuropathy/NN vincristine/NN
NO/DT synthase/NN inhibitor/NN constitutive/NN inhibitor/NN influence/NN model/NN diabetic/NN neuropathy/NN vincristine/NN induced/NNP
NO/DT synthase/NN inhibitor/NN constitutive/NN inhibitor/NN influence/NN model/NN diabetic/NN neuropathy/NN
NO/DT synthase/NN inhibitor/NN constitutive/NN inhibitor/NN influence/NN model/NN diabetic/NN
NO/DT synthase/NN inhibitor/NN constitutive/NN inhibitor/NN influence/NN model/NN diabetic/NN streptozotocin/NN
NO/DT synthase/NN inhibitor/NN constitutive/NN inhibitor/NN influence/NN model/NN diabetic/NN streptozotocin/NN induced/NNP
NO/DT synthase/NN inhibitor/NN constitutive/NN inhibitor/NN influence/NN model/NN diabetic/NN and/CC
NO/DT synthase/NN inhibitor/NN constitutive/NN inhibitor/NN influence/NN model/NN diabetic/NN neuropathy/NN toxic/JJ
NO/DT synthase/NN inhibitor/NN constitutive/NN inhibitor/NN influence/NN model/NN diabetic/NN neuropathy/NN vincristine/NN
NO/DT synthase/NN inhibitor/NN constitutive/NN inhibitor/NN influence/NN model/NN diabetic/NN neuropathy/NN vincristine/NN induced/NNP
NO/DT synthase/NN inhibitor/NN constitutive/NN inhibitor/NN influence/NN model/NN diabetic/NN neuropathy/NN
bradykinin/NN antagonists/NNS action/NN influence/NN model/NN diabetic/NN
bradykinin/NN antagonists/NNS action/NN influence/NN model/NN diabetic/NN streptozotocin/NN
bradykinin/NN antagonists/NNS action/NN influence/NN model/NN diabetic/NN streptozotocin/NN induced/NNP
bradykinin/NN antagonists/NNS action/NN influence/NN model/NN diabetic/NN and/CC
bradykinin/NN antagonists/NNS action/NN influence/NN model/NN diabetic/NN neuropathy/NN toxic/JJ
bradykinin/NN antagonists/NNS action/NN influence/NN model/NN diabetic/NN neuropathy/NN vincristine/NN
bradykinin/NN antagonists/NNS action/NN influence/NN model/NN diabetic/NN neuropathy/NN vincristine/NN induced/NNP
bradykinin/NN antagonists/NNS action/NN influence/NN model/NN diabetic/NN neuropathy/NN
bradykinin/NN receptors/NNS inhibition/NN confirm/VB paper/NN results/NNS RESULTS/NNS reduces/VBZ hyperalgesia/NN diabetic/JJ
bradykinin/NN receptors/NNS inhibition/NN confirm/VB paper/NN results/NNS RESULTS/NNS reduces/VBZ hyperalgesia/NN
NO/DT synthase/NN inducible/VB confirm/VB paper/NN results/NNS RESULTS/NNS reduces/VBZ hyperalgesia/NN diabetic/JJ
NO/DT synthase/NN inducible/VB confirm/VB paper/NN results/NNS RESULTS/NNS reduces/VBZ hyperalgesia/NN
NO/DT activity/NN neuronal/VB inducible/VB confirm/VB paper/NN results/NNS RESULTS/NNS reduces/VBZ hyperalgesia/NN diabetic/JJ
NO/DT activity/NN neuronal/VB inducible/VB confirm/VB paper/NN results/NNS RESULTS/NNS reduces/VBZ hyperalgesia/NN
bradykinin/NN inducible/NN products/NNS involved/VBN hyperalgesia/NN
NO/DT activation/NN inducible/NN products/NNS involved/VBN hyperalgesia/NN
NO/JJ activation/NN inducible/NN products/NNS involved/VBN hyperalgesia/NN
des/FW HOE/NNP activity/NN L/NNP 140/NNP neuropathy/NN toxic/JJ
des/FW HOE/NNP activity/NN L/NNP 140/NNP neuropathy/NN
Arg/NNP 140/NNP neuropathy/NN toxic/JJ
Arg/NNP 140/NNP neuropathy/NN
10/CD 140/NNP neuropathy/NN toxic/JJ
10/CD 140/NNP neuropathy/NN
HOE/NNP 140/NNP neuropathy/NN toxic/JJ
HOE/NNP 140/NNP neuropathy/NN
140/NNP neuropathy/NN toxic/JJ
140/NNP neuropathy/NN
HOE/NNP activity/NN L/NNP 140/NNP neuropathy/NN toxic/JJ
HOE/NNP activity/NN L/NNP 140/NNP neuropathy/NN
140/CD HOE/NNP activity/NN L/NNP 140/NNP neuropathy/NN toxic/JJ
140/CD HOE/NNP activity/NN L/NNP 140/NNP neuropathy/NN
bradykinin/NN activity/NN participates/VBZ streptozotocin/NN induced/VBN hyperalgesia/NN
bradykinin/NN activity/NN participates/VBZ seemed/VBD bradykinin/NN hyperalgesia/NN
bradykinin/NN seemed/VBD participates/VBZ streptozotocin/NN induced/VBN hyperalgesia/NN
bradykinin/NN hyperalgesia/NN
NO/DT synthase/NN participates/VBZ streptozotocin/NN induced/VBN hyperalgesia/NN
NO/DT synthase/NN participates/VBZ seemed/VBD bradykinin/NN hyperalgesia/NN
NO/DT pathway/NN neuronal/VB seemed/VBD participates/VBZ streptozotocin/NN induced/VBN hyperalgesia/NN
NO/DT pathway/NN neuronal/VB seemed/VBD bradykinin/NN hyperalgesia/NN
NO/DT inhibitors/NNS antagonists/NNS doses/NNS administration/NN effective/JJ alleviation/NN pain/NN neuropathic/JJ
NO/DT inhibitors/NNS antagonists/NNS doses/NNS administration/NN effective/JJ alleviation/NN pain/NN
bradykinin/JJ antagonists/NNS doses/NNS administration/NN effective/JJ alleviation/NN pain/NN neuropathic/JJ
bradykinin/JJ antagonists/NNS doses/NNS administration/NN effective/JJ alleviation/NN pain/NN
caffeine/NN migraine/NN
ergotamine/NN mg/NN comparison/NN caffeine/NN migraine/NN
rizatriptan/NN mg/NN comparison/NN caffeine/NN migraine/NN
5/CD selective/JJ agonist/NN onset/NN action/NN treatment/NN migraine/NN
-/NNP agonist/NN onset/NN action/NN treatment/NN migraine/NN
HT/NNP agonist/NN onset/NN action/NN treatment/NN migraine/NN
Rizatriptan/NNP agonist/NN onset/NN action/NN treatment/NN migraine/NN
caffeine/VB tablets/NNS patients/NNS treating/VBG attack/NN migraine/NN
ergotamine/JJ assessed/VBD caffeine/VB tablets/NNS patients/NNS treating/VBG attack/NN migraine/NN
rizatriptan/NN tablet/NN assessed/VBD caffeine/VB tablets/NNS patients/NNS treating/VBG attack/NN migraine/NN
rizatriptan/NN %/NN Faster/NNP reason/NN relief/NN headache/NN
caffeine/NN ergotamine/NN preferred/VBD %/NN Faster/NNP reason/NN relief/NN headache/NN
ergotamine/NN preferred/VBD %/NN Faster/NNP reason/NN relief/NN headache/NN
rizatriptan/NN favor/NN co/NN endpoint/NN free/JJ pain/RB
ergotamine/JJ caffeine/NN treated/VBN %/NN Forty/NNP pain/NN
caffeine/NN treated/VBN %/NN Forty/NNP pain/NN
rizatriptan/NN pain/NN
rizatriptan/VBN caffeine/NN treated/VBN %/NN Forty/NNP pain/NN
rizatriptan/CD %/NN relief/NN Headache/JJ
rizatriptan/NN caffeine/NN superior/JJ relief/NN Headache/JJ
caffeine/NN superior/JJ relief/NN Headache/JJ
caffeine/VBZ relief/NN Headache/JJ
ergotamine/NN %/NN relief/NN Headache/JJ
ergotamine/VB superior/JJ relief/NN Headache/JJ
ergotamine/JJ caffeine/NN patients/NNS %/NN free/JJ pain/RB
caffeine/NN patients/NNS %/NN free/JJ pain/RB
rizatriptan/NN taking/VBG patients/NNS %/NN free/JJ pain/RB
Rizatriptan/NNP superior/JJ ergotamine/VB proportions/NNS patients/NNS nausea/NN phonophobia/NN
caffeine/NN ergotamine/VB proportions/NNS patients/NNS nausea/NN phonophobia/NN
ergotamine/VB proportions/NNS patients/NNS nausea/NN phonophobia/NN
Rizatriptan/NNP superior/JJ ergotamine/VB proportions/NNS patients/NNS nausea/NN vomiting/NN
caffeine/NN ergotamine/VB proportions/NNS patients/NNS nausea/NN
ergotamine/VB proportions/NNS patients/NNS nausea/NN photophobia/NN
ergotamine/VB proportions/NNS patients/NNS nausea/NN vomiting/NN
Rizatriptan/NNP superior/JJ ergotamine/VB proportions/NNS patients/NNS nausea/NN photophobia/NN
caffeine/NN ergotamine/VB proportions/NNS patients/NNS nausea/NN vomiting/NN
caffeine/NN ergotamine/VB proportions/NNS patients/NNS nausea/NN photophobia/NN
ergotamine/VB proportions/NNS patients/NNS nausea/NN
caffeine/NN events/NNS dizziness/NN 6/CD nausea/NN
caffeine/NN events/NNS dizziness/NN 6/CD somnolence/NN
caffeine/NN events/NNS dizziness/NN
ergotamine/NN rizatriptan/NN caffeine/NN events/NNS dizziness/NN
ergotamine/NN rizatriptan/NN caffeine/NN events/NNS dizziness/NN 6/CD somnolence/NN
ergotamine/NN rizatriptan/NN caffeine/NN events/NNS dizziness/NN 6/CD nausea/NN
rizatriptan/NN caffeine/NN events/NNS dizziness/NN 6/CD somnolence/NN
rifampin/NN therapy/NN tuberculosis/NNP pulmonary/JJ
rifampin/NN therapy/NN tuberculosis/NNP
isoniazid/NN rifampin/NN regimen/NN 10/CD underwent/VBD discovered/VBN developed/VBN signs/NNS failure/NN renal/JJ
isoniazid/NN rifampin/NN regimen/NN 10/CD underwent/VBD discovered/VBN developed/VBN signs/NNS failure/NN
rifampin/NN regimen/NN 10/CD underwent/VBD tuberculosis/NNP pulmonary/JJ
rifampin/NN regimen/NN 10/CD underwent/VBD tuberculosis/NNP
isoniazid/NN rifampin/NN regimen/NN 10/CD underwent/VBD tuberculosis/NNP pulmonary/JJ
isoniazid/NN rifampin/NN regimen/NN 10/CD underwent/VBD tuberculosis/NNP
lithium/NNP anticonvulsants/NN use/NN type/NN diagnosis/NN structured/VBN Patients/NNS experienced/VBD compared/VBN switch/NN manic/JJ
lithium/NNP anticonvulsants/NN use/NN type/NN diagnosis/NN structured/VBN Patients/NNS experienced/VBD compared/VBN switch/NN manic/JJ hypomanic/JJ
lithium/NNP anticonvulsants/NN use/NN type/NN diagnosis/NN II/NNP vs/NN DSM/SYM
lithium/NNP anticonvulsants/NN use/NN type/NN diagnosis/NN II/NNP vs/NN IV/NNP
lithium/NNP anticonvulsants/NN use/NN type/NN diagnosis/NN II/NNP vs/NN bipolar/NNP
lithium/NNP anticonvulsants/NN use/NN type/NN diagnosis/NN II/NNP vs/NN I/NN
lithium/NNP anticonvulsants/NN use/NN type/NN diagnosis/NN II/NNP bipolar/NNP
lithium/NNP anticonvulsants/NN use/NN type/NN diagnosis/NN II/NNP
lithium/NNP anticonvulsants/NN use/NN type/NN diagnosis/NN number/NN episodes/NNS manic/JJ
amsacrine/JJ CI/NN study/NN 921/CD non/NN
amsacrine/JJ CI/NN study/NN cell/NN small/JJ
amsacrine/JJ CI/NN study/NN cell/NN
amsacrine/JJ CI/NN study/NN cell/NN cancer/NN lung/NN
amsacrine/JJ CI/NN study/NN cell/NN cancer/NN
CI/NN study/NN 921/CD non/NN
CI/NN study/NN cell/NN small/JJ
CI/NN study/NN cell/NN
CI/NN study/NN cell/NN cancer/NN lung/NN
CI/NN study/NN cell/NN cancer/NN
921/CD non/NN
921/CD study/NN cell/NN small/JJ
921/CD study/NN cell/NN
921/CD study/NN cell/NN cancer/NN lung/NN
921/CD study/NN cell/NN cancer/NN
NSC/NNP 921/CD non/NN
NSC/NNP 921/CD study/NN cell/NN small/JJ
NSC/NNP 921/CD study/NN cell/NN
NSC/NNP 921/CD study/NN cell/NN cancer/NN lung/NN
NSC/NNP 921/CD study/NN cell/NN cancer/NN
343499/CD NSC/NNP 921/CD non/NN
343499/CD NSC/NNP 921/CD study/NN cell/NN small/JJ
343499/CD NSC/NNP 921/CD study/NN cell/NN
343499/CD NSC/NNP 921/CD study/NN cell/NN cancer/NN lung/NN
343499/CD NSC/NNP 921/CD study/NN cell/NN cancer/NN
suxamethonium/NN dose/NN spasm/NN threatening/VBG developed/VBD primigravida/NN year/NN case/NN congenita/NN myotonia/NN
suxamethonium/NN dose/NN spasm/NN threatening/VBG developed/VBD primigravida/NN year/NN case/NN congenita/NN
Pethidine/NNP associated/VBN pethidine/NN control/NN postoperative/JJ
Pethidine/NNP associated/VBN pethidine/NN control/NN pain/NN
pethidine/NN control/NN postoperative/JJ
pethidine/NN control/NN pain/NN
pethidine/NN doses/NNS received/VBN male/NN year/NN controlled/VBD pump/VBP management/NN control/NN postoperative/JJ
pethidine/NN doses/NNS received/VBN male/NN year/NN controlled/VBD pump/VBP management/NN control/NN pain/NN
DFU/NNP Comparison/NNP toxicity/NN
piroxicam/NN study/NN DFU/NNP Comparison/NNP toxicity/NN
DFU/NNP COX/NN piroxicam/NN toxicity/NN
5/CD DFU/NNP COX/NN piroxicam/NN toxicity/NN
5/CD 5/CD DFU/NNP COX/NN piroxicam/NN toxicity/NN
dimethyl/NN 5/CD DFU/NNP COX/NN piroxicam/NN toxicity/NN
3/CD dimethyl/NN 5/CD DFU/NNP COX/NN piroxicam/NN toxicity/NN
3/CD dimethyl/NN 5/CD DFU/NNP COX/NN piroxicam/NN toxicity/NN
fluorophenyl/NN 3/CD dimethyl/NN 5/CD DFU/NNP COX/NN piroxicam/NN toxicity/NN
4/CD 5/CD DFU/NNP COX/NN piroxicam/NN toxicity/NN
4/CD phenyl/NNS 4/CD 5/CD DFU/NNP COX/NN piroxicam/NN toxicity/NN
methylsulphonyl/NN 4/CD phenyl/NNS 4/CD 5/CD DFU/NNP COX/NN piroxicam/NN toxicity/NN
phenyl/NNS 4/CD 5/CD DFU/NNP COX/NN piroxicam/NN toxicity/NN
2/CD 5/CD DFU/NNP COX/NN piroxicam/NN toxicity/NN
5/CD H/CD 2/CD 5/CD DFU/NNP COX/NN piroxicam/NN toxicity/NN
H/CD 2/CD 5/CD DFU/NNP COX/NN piroxicam/NN toxicity/NN
furanon/NN 2/CD 5/CD DFU/NNP COX/NN piroxicam/NN toxicity/NN
piroxicam/NN toxicity/NN
piroxicam/NN septal/VB analysis/NN ventricular/NN
piroxicam/NN septal/VB
piroxicam/NN septal/VB VSD/NNP
piroxicam/NN septal/VB and/CC
piroxicam/NN septal/VB midline/VB
piroxicam/NN septal/VB MD/NNP
piroxicam/NN septal/VB defects/NNS
piroxicam/NN dose/NN treated/VBN rats/NNS found/VBN toxicity/NNP
DFU/NNP toxicity/NN
5/CD Fluoropyrimidines/NNP fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN
5/CD Fluoropyrimidines/NNP fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN breast/NN
5/CD Fluoropyrimidines/NNP fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN and/CC
5/CD Fluoropyrimidines/NNP fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN head/NN
5/CD Fluoropyrimidines/NNP fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN and/CC
5/CD Fluoropyrimidines/NNP fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN cancers/NNS neck/NN
5/CD Fluoropyrimidines/NNP fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN cancers/NNS
fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN
fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN breast/NN
fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN and/CC
fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN head/NN
fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN and/CC
fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN cancers/NNS neck/NN
fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN cancers/NNS
5/CD fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN
5/CD fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN breast/NN
5/CD fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN and/CC
5/CD fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN head/NN
5/CD fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN and/CC
5/CD fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN cancers/NNS neck/NN
5/CD fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN cancers/NNS
FU/NNP 5/CD fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN
FU/NNP 5/CD fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN breast/NN
FU/NNP 5/CD fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN and/CC
FU/NNP 5/CD fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN head/NN
FU/NNP 5/CD fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN and/CC
FU/NNP 5/CD fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN cancers/NNS neck/NN
FU/NNP 5/CD fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN cancers/NNS
Fluoropyrimidines/NNP fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN tumors/NNS
Fluoropyrimidines/NNP fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN
Fluoropyrimidines/NNP fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN breast/NN
Fluoropyrimidines/NNP fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN and/CC
Fluoropyrimidines/NNP fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN head/NN
Fluoropyrimidines/NNP fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN and/CC
Fluoropyrimidines/NNP fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN cancers/NNS neck/NN
Fluoropyrimidines/NNP fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN colorectal/NN cancers/NNS
5/CD Fluoropyrimidines/NNP fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN tumors/NNS
fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN tumors/NNS
5/CD fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN tumors/NNS
FU/NNP 5/CD fluorouracil/NN IMPORTANCE/NNP mainstay/NN treatment/NN tumors/NNS
capecitabine/NN safety/NN gain/VB populations/NNS patients/NNS disease/NN age/NN renal/JJ
capecitabine/NN safety/NN gain/VB populations/NNS patients/NNS disease/NN age/NN and/CC
capecitabine/NN safety/NN gain/VB populations/NNS patients/NNS disease/NN age/NN kidney/NN
capecitabine/NN safety/NN gain/VB populations/NNS patients/NNS disease/NN
Capecitabine/NNP has/VBZ given/VBN patients/NNS dysfunctions/NNS age/NN hepatic/JJ
Capecitabine/NNP has/VBZ given/VBN patients/NNS dysfunctions/NNS age/NN and/CC
Capecitabine/NNP has/VBZ given/VBN patients/NNS dysfunctions/NNS age/NN renal/JJ
Capecitabine/NNP has/VBZ given/VBN patients/NNS dysfunctions/NNS
metocurine/NN abolished/VBN rigidity/NN
antidepressant/JJ fluoxetine/NN exposure/NN disease/NN patients/NNS disability/NN motor/NN
antidepressant/JJ fluoxetine/NN exposure/NN disease/NN patients/NNS disability/NN
antidepressant/JJ fluoxetine/NN exposure/NN disease/NN Parkinson/NNP idiopathic/JJ
antidepressant/JJ fluoxetine/NN exposure/NN disease/NN Parkinson/NNP
antidepressant/JJ fluoxetine/NN exposure/NN disease/NN Parkinson/NNP '/POS
antidepressant/JJ fluoxetine/NN exposure/NN disease/NN s/JJ
antidepressant/JJ fluoxetine/NN exposure/NN disease/NN
fluoxetine/NN exposure/NN disease/NN Parkinson/NNP idiopathic/JJ
fluoxetine/NN exposure/NN disease/NN Parkinson/NNP
fluoxetine/NN exposure/NN disease/NN Parkinson/NNP '/POS
fluoxetine/NN exposure/NN disease/NN s/JJ
fluoxetine/NN exposure/NN disease/NN
dopamine/NN capacity/NN fluoxetine/NN patients/NNS Parkinson/NNP
dopamine/NN capacity/NN fluoxetine/NN patients/NNS Parkinson/NNP '/POS
dopamine/NN capacity/NN fluoxetine/NN patients/NNS s/JJ
dopamine/NN capacity/NN fluoxetine/NN patients/NNS disease/NN
fluoxetine/NN patients/NNS Parkinson/NNP
fluoxetine/NN patients/NNS Parkinson/NNP '/POS
fluoxetine/NN patients/NNS s/JJ
fluoxetine/NN patients/NNS disease/NN
gentamicin/NN regimen/NN Nephrotoxicity/NNP
cephalothin/NN Nephrotoxicity/NNP
gentamicin/NN therapy/NN sodium/NN combination/NN receiving/VBG necrosis/NNS characterized/VBN clinically/RB failure/NN oliguric/JJ
gentamicin/NN therapy/NN sodium/NN combination/NN receiving/VBG necrosis/NNS characterized/VBN clinically/RB failure/NN renal/JJ
gentamicin/NN therapy/NN sodium/NN combination/NN receiving/VBG necrosis/NNS characterized/VBN clinically/RB failure/NN
sulfate/NN therapy/NN sodium/NN combination/NN receiving/VBG necrosis/NNS characterized/VBN clinically/RB failure/NN oliguric/JJ
sulfate/NN therapy/NN sodium/NN combination/NN receiving/VBG necrosis/NNS characterized/VBN clinically/RB failure/NN renal/JJ
sulfate/NN therapy/NN sodium/NN combination/NN receiving/VBG necrosis/NNS characterized/VBN clinically/RB failure/NN
cephalothin/JJ sodium/NN combination/NN receiving/VBG necrosis/NNS characterized/VBN clinically/RB failure/NN oliguric/JJ
cephalothin/JJ sodium/NN combination/NN receiving/VBG necrosis/NNS characterized/VBN clinically/RB failure/NN renal/JJ
cephalothin/JJ sodium/NN combination/NN receiving/VBG necrosis/NNS characterized/VBN clinically/RB failure/NN
sodium/NN combination/NN receiving/VBG necrosis/NNS characterized/VBN clinically/RB failure/NN oliguric/JJ
sodium/NN combination/NN receiving/VBG necrosis/NNS characterized/VBN clinically/RB failure/NN renal/JJ
sodium/NN combination/NN receiving/VBG necrosis/NNS characterized/VBN clinically/RB failure/NN
Thiopentone/NNP pretreatment/VBP pain/NN
lidocaine/NN reduces/VBZ incidence/NN pain/NN
thiopentone/NN reduces/VBZ reduces/VBZ incidence/NN pain/NN
amantadine/JJ activity/NN depressed/JJ
amines/NNS results/NNS suggest/VBP decrease/NN account/VB depression/NN behavioral/JJ
amines/NNS results/NNS suggest/VBP decrease/NN account/VB depression/NN
catecholamine/JJ rate/NN decrease/NN account/VB depression/NN behavioral/JJ
catecholamine/JJ rate/NN decrease/NN account/VB depression/NN
norepinephrine/NN methylation/NN rate/NN decrease/NN account/VB depression/NN behavioral/JJ
norepinephrine/NN methylation/NN rate/NN decrease/NN account/VB depression/NN
Nicotine/NNP appear/VB enhance/VB thrombosis/NNS
Papaverine/NNP hydrochloride/NNP direct/JJ vasodilator/NN used/VBN manage/VB vasospasm/NN
hydrochloride/NNP direct/JJ vasodilator/NN used/VBN manage/VB vasospasm/NN
papaverine/NN cases/NNS described/VBN dysfunction/NNS cranial/JJ
papaverine/NN cases/NNS described/VBN dysfunction/NNS nerve/NN
papaverine/NN cases/NNS described/VBN dysfunction/NNS
papaverine/NN received/VBD vasospasm/NN
papaverine/NN used/VBN manage/VB vasospasm/NN
papaverine/NNP treatment/NN vasospasm/NN
papaverine/NN avoid/VB deficits/NNS cranial/JJ
papaverine/NN avoid/VB deficits/NNS nerve/NN
papaverine/NN avoid/VB deficits/NNS
ibuprofen/NN use/NN associated/VBN described/VBN child/NN developed/VBD syndrome/NN vanishing/JJ
ibuprofen/NN use/NN associated/VBN described/VBN child/NN developed/VBD syndrome/NN bile/NN
ibuprofen/NN use/NN associated/VBN described/VBN child/NN developed/VBD syndrome/NN duct/NN
ibuprofen/NN use/NN associated/VBN described/VBN child/NN developed/VBD syndrome/NN
ursodeoxycholic/JJ acid/NN therapy/NN unrelenting/JJ disease/NN cholestatic/JJ
ursodeoxycholic/JJ acid/NN therapy/NN unrelenting/JJ disease/NN
acid/NN therapy/NN unrelenting/JJ disease/NN cholestatic/JJ
acid/NN therapy/NN unrelenting/JJ disease/NN
tacrolimus/NNS acid/NN therapy/NN unrelenting/JJ cirrhosis/NNS
prednisone/NN acid/NN therapy/NN unrelenting/JJ cirrhosis/NNS
prednisone/NN acid/NN therapy/NN unrelenting/JJ disease/NN cholestatic/JJ
prednisone/NN acid/NN therapy/NN unrelenting/JJ disease/NN
ursodeoxycholic/JJ acid/NN therapy/NN unrelenting/JJ cirrhosis/NNS
acid/NN therapy/NN unrelenting/JJ cirrhosis/NNS
tacrolimus/NNS acid/NN therapy/NN unrelenting/JJ disease/NN cholestatic/JJ
tacrolimus/NNS acid/NN therapy/NN unrelenting/JJ disease/NN
atorvastatin/NN effects/NNS Anti/NNP hypertension/NN
superoxide/JJ production/NN increased/VBD deficiency/VBZ Dexamethasone/NNP characterized/VBN hypertension/NN
O/NNP superoxide/JJ production/NN increased/VBD deficiency/VBZ Dexamethasone/NNP characterized/VBN hypertension/NN
2/CD -/CD O/NNP superoxide/JJ production/NN increased/VBD deficiency/VBZ Dexamethasone/NNP characterized/VBN hypertension/NN
-/CD O/NNP superoxide/JJ production/NN increased/VBD deficiency/VBZ Dexamethasone/NNP characterized/VBN hypertension/NN
nitric/JJ oxide/NN associated/VBN dysfunction/NN characterized/VBN hypertension/NN
oxide/NN associated/VBN dysfunction/NN characterized/VBN hypertension/NN
NO/RB oxide/NN associated/VBN dysfunction/NN characterized/VBN hypertension/NN
Atorvastatin/NNP possesses/VBZ reduced/VBD O/NNP production/NN forms/NNS hypertension/NN
Ato/NNP possesses/VBZ reduced/VBD O/NNP production/NN forms/NNS hypertension/NN
O/NNP production/NN forms/NNS hypertension/NN
2/CD O/NNP production/NN forms/NNS hypertension/NN
NO/RB availability/NN improve/VB reported/VBN properties/NNS possesses/VBZ reduced/VBD O/NNP production/NN forms/NNS hypertension/NN
clozapine/NN commencement/NN developed/VBD year/NN schizophrenia/NN
clozapine/NN remains/VBZ standard/NN treatment/NN psychosis/NNS
alcohol/NN consumption/NN patients/NNS failure/NN Acute/JJ
alcohol/NN consumption/NN patients/NNS failure/NN liver/NN
alcohol/NN consumption/NN patients/NNS failure/NN
paracetamol/NNP ingesting/VBG failure/NN Acute/JJ
paracetamol/NNP ingesting/VBG failure/NN liver/NN
paracetamol/NNP ingesting/VBG failure/NN
alcohol/NN development/NN hepatotoxicity/NN
alcohol/NN consumers/NNS developed/VBD failure/NN liver/NN
alcohol/NN consumers/NNS developed/VBD failure/NN
alcohol/NN consumption/NN days/NNS paracetamol/NNP 3/CD developed/VBD failure/NN liver/NN
alcohol/NN consumption/NN days/NNS paracetamol/NNP 3/CD developed/VBD failure/NN
alcohol/NN consumption/NN g/NNP factors/NNS patients/NNS possible/JJ failure/NN liver/NN
alcohol/NN consumption/NN g/NNP factors/NNS patients/NNS possible/JJ failure/NN
scopolamine/NN caused/VBN amnesia/NN
L/NNP glyceryl/NN Effect/NN phosphorylcholine/NN amnesia/NN
alpha/NN glyceryl/NN Effect/NN phosphorylcholine/NN amnesia/NN
glyceryl/NN Effect/NN phosphorylcholine/NN amnesia/NN
phosphorylcholine/NN amnesia/NN
L/NNP effects/NNS alpha/NN glycerylphosphorylcholine/NN impairment/NN memory/NN
L/NNP effects/NNS alpha/NN glycerylphosphorylcholine/NN impairment/NN
alpha/NN glycerylphosphorylcholine/NN impairment/NN memory/NN
alpha/NN glycerylphosphorylcholine/NN impairment/NN
glycerylphosphorylcholine/NN impairment/NN memory/NN
glycerylphosphorylcholine/NN impairment/NN
L/NNP glycerylphosphorylcholine/NN impairment/NN memory/NN
L/NNP glycerylphosphorylcholine/NN impairment/NN
alpha/NNP L/NNP glycerylphosphorylcholine/NN impairment/NN memory/NN
alpha/NNP L/NNP glycerylphosphorylcholine/NN impairment/NN
GFC/NNP L/NNP glycerylphosphorylcholine/NN impairment/NN memory/NN
GFC/NNP L/NNP glycerylphosphorylcholine/NN impairment/NN
beta/NN reactions/NNS allergic/JJ
beta/NN reactions/NNS
lactam/NN antibiotics/NNS evaluated/VBN group/NN patients/NNS reactions/NNS allergic/JJ
lactam/NN antibiotics/NNS evaluated/VBN group/NN patients/NNS reactions/NNS
penicillin/NN derivatives/NNS reacting/VBG allergic/VBP
penicillin/NN derivatives/NNS reacting/VBG allergic/VBP had/VBD responses/NNS allergic/JJ
beta/NN allergic/VBP
lactam/NN antibiotics/NNS had/VBD allergic/VBP
beta/NN allergic/VBP had/VBD responses/NNS allergic/JJ
lactam/NN antibiotics/NNS had/VBD responses/NNS allergic/JJ
beta/NN diagnosed/VBN allergic/NNP
lactam/NN antibiotics/VBZ diagnosed/VBN allergic/NNP
PG/NNP tolerance/NN selected/VBD cases/NNS allergy/NN
BPO/NNP negative/JJ test/NN negative/JJ MDM/NNP
PG/NNP negative/JJ MDM/NNP
PG/NNP reported/VBD tolerated/VBN patients/NNS allergic/JJ
azathioprine/NN agents/NNS associated/VBN have/VBP risk/NN development/NN leukemia/NN acute/JJ
azathioprine/NN agents/NNS associated/VBN have/VBP risk/NN development/NN leukemia/NN nonlymphocytic/JJ
azathioprine/NN agents/NNS associated/VBN have/VBP risk/NN development/NN leukemia/NN
Cyclophosphamide/JJ therapy/NN increases/VBZ risk/NN carcinoma/NN
Cyclophosphamide/JJ therapy/NN increases/VBZ risk/NN carcinoma/NN bladder/NN of/IN
Cyclophosphamide/JJ therapy/NN increases/VBZ risk/NN carcinoma/NN bladder/NN the/DT
Cyclophosphamide/JJ therapy/NN increases/VBZ risk/NN carcinoma/NN bladder/NN
cyclophosphamide/NN azathioprine/NN treated/VBN arthritis/NN rheumatoid/JJ
cyclophosphamide/NN azathioprine/NN treated/VBN arthritis/NN
cyclophosphamide/NN azathioprine/NN treated/VBN arthritis/NN patients/NNS incidence/NN most/JJS cancers/NNS
azathioprine/NN treated/VBN arthritis/NN rheumatoid/JJ
azathioprine/NN treated/VBN arthritis/NN
azathioprine/NN treated/VBN arthritis/NN patients/NNS incidence/NN most/JJS cancers/NNS
alkylating/JJ agents/NNS drugs/NNS use/NN reserved/VBN collected/VBN Data/NNP risk/NN malignancy/NN arthritis/NN rheumatoid/JJ
alkylating/JJ agents/NNS drugs/NNS use/NN reserved/VBN collected/VBN Data/NNP risk/NN malignancy/NN arthritis/NN
agents/NNS drugs/NNS use/NN reserved/VBN collected/VBN Data/NNP risk/NN malignancy/NN arthritis/NN rheumatoid/JJ
agents/NNS drugs/NNS use/NN reserved/VBN collected/VBN Data/NNP risk/NN malignancy/NN arthritis/NN
alkylating/JJ agents/NNS drugs/NNS use/NN treatment/NN arthritis/NN rheumatoid/JJ
alkylating/JJ agents/NNS drugs/NNS use/NN treatment/NN arthritis/NN
agents/NNS drugs/NNS use/NN treatment/NN arthritis/NN rheumatoid/JJ
agents/NNS drugs/NNS use/NN treatment/NN arthritis/NN
alkylating/JJ agents/NNS drugs/NNS use/NN reserved/VBN collected/VBN Data/NNP risk/NN malignancy/NN
agents/NNS drugs/NNS use/NN reserved/VBN collected/VBN Data/NNP risk/NN malignancy/NN
Ifosfamide/JJ encephalopathy/NN presenting/VBG asterixis/NNS
ifosfamide/NN infusion/NN developed/VBD plasmacytoma/NN
ifosfamide/NN administration/NN discontinued/VBN resolved/VBD asterixis/NNS
ifosfamide/JJ findings/NNS infusion/NN asterixis/NNS
IFX/NNP use/NN associated/VBN suggest/VBP presence/NN asterixis/NNS
Methamphetamine/NNP induced/VBN neurotoxicity/RB
DA/NNP neurons/NNS neurodegeneration/NN
DA/NNP system/NN models/NNS neurotoxicity/NN
DA/NNP system/NN selective/JJ hypothesized/VBZ plays/VBZ role/NN induced/VBN neurotoxicity/RB
METH/NNP caused/VBN damage/NN selective/JJ system/NN models/NNS neurotoxicity/NN
METH/NNP caused/VBN damage/NN selective/JJ hypothesized/VBZ plays/VBZ role/NN induced/VBN neurotoxicity/RB
METH/NNP role/NN plays/VBZ hypothesized/VBZ selective/JJ system/NN models/NNS neurotoxicity/NN
METH/NNP role/NN induced/VBN neurotoxicity/RB
MPTP/NNP METH/NNP caused/VBN damage/NN selective/JJ system/NN models/NNS neurotoxicity/NN
MPTP/NNP METH/NNP caused/VBN damage/NN selective/JJ hypothesized/VBZ plays/VBZ role/NN induced/VBN neurotoxicity/RB
DA/NNP system/NN selective/JJ damage/NN CNS/NNP
DA/NNP system/NN selective/JJ damage/NN
METH/NNP treated/VBN examined/VBN neurotoxicity/NN
METH/VB activation/NN neurotoxicity/JJ
bupivacaine/NN prilocaine/NN incidence/NN symptoms/NNS Transient/JJ
bupivacaine/NN prilocaine/NN incidence/NN symptoms/NNS neurologic/JJ
bupivacaine/NN prilocaine/NN incidence/NN symptoms/NNS
bupivacaine/NN infrequent/JJ follow/VBP symptoms/NNS transient/JJ
bupivacaine/NN infrequent/JJ follow/VBP symptoms/NNS neurologic/JJ
bupivacaine/NN infrequent/JJ follow/VBP symptoms/NNS
bupivacaine/NN infrequent/JJ follow/VBP symptoms/NNS TNSs/NNP
bupivacaine/NN lidocaine/NN prilocaine/JJ compares/VBZ duration/NN risk/NN TNSs/NNP
bupivacaine/NN receiving/VBG patients/NNS none/NN Nine/CD patients/NNS receiving/VBG TNSs/NNS
bupivacaine/NN receiving/VBG patients/NNS none/NN Nine/CD RESULTS/NNS had/VBD TNSs/NNS
gemcitabine/JJ chemotherapy/NN approach/NN carcinoma/NN nonsmall/JJ
gemcitabine/JJ chemotherapy/NN approach/NN carcinoma/NN cell/NN
gemcitabine/JJ chemotherapy/NN approach/NN carcinoma/NN lung/NN
gemcitabine/JJ chemotherapy/NN approach/NN carcinoma/NN
cisplatin/NN Paclitaxel/NNP chemotherapy/NN approach/NN carcinoma/NN nonsmall/JJ
cisplatin/NN Paclitaxel/NNP chemotherapy/NN approach/NN carcinoma/NN cell/NN
cisplatin/NN Paclitaxel/NNP chemotherapy/NN approach/NN carcinoma/NN lung/NN
cisplatin/NN Paclitaxel/NNP chemotherapy/NN approach/NN carcinoma/NN
Paclitaxel/NNP chemotherapy/NN approach/NN carcinoma/NN nonsmall/JJ
Paclitaxel/NNP chemotherapy/NN approach/NN carcinoma/NN cell/NN
Paclitaxel/NNP chemotherapy/NN approach/NN carcinoma/NN lung/NN
Paclitaxel/NNP chemotherapy/NN approach/NN carcinoma/NN
Cisplatin/NNP BACKGROUND/NNP based/VBN improve/VB quality/NN life/NN carcinoma/NN nonsmall/JJ
Cisplatin/NNP BACKGROUND/NNP based/VBN improve/VB quality/NN life/NN carcinoma/NN cell/NN
Cisplatin/NNP BACKGROUND/NNP based/VBN improve/VB quality/NN life/NN carcinoma/NN lung/NN
Cisplatin/NNP BACKGROUND/NNP based/VBN improve/VB quality/NN life/NN carcinoma/NN
Cisplatin/NNP BACKGROUND/NNP based/VBN improve/VB quality/NN life/NN NSCLC/NNP
gemcitabine/JJ combination/NN paclitaxel/NN toxicity/NN
gemcitabine/JJ combination/NN paclitaxel/NN toxicity/NN feasibility/NN determine/VB treat/VB NSCLC/NN
cisplatin/NN paclitaxel/NN toxicity/NN
cisplatin/NN paclitaxel/NN toxicity/NN feasibility/NN determine/VB treat/VB NSCLC/NN
paclitaxel/NN toxicity/NN feasibility/NN determine/VB treat/VB NSCLC/NN
paclitaxel/NN toxicity/NN
gemcitabine/NN 1/CD cisplatin/VBN Day/NNP treated/VBN chemotherapy/NN patients/NNS NSCLC/NNP
cisplatin/VBN Day/NNP treated/VBN chemotherapy/NN patients/NNS NSCLC/NNP
paclitaxel/NN combination/NN treated/VBN chemotherapy/NN patients/NNS NSCLC/NNP
gemcitabine/NN paclitaxel/NN tolerated/JJ shows/VBZ NSCLC/NN
cisplatin/NN paclitaxel/NN tolerated/JJ shows/VBZ NSCLC/NN
paclitaxel/NN tolerated/JJ shows/VBZ NSCLC/NN
metronidazole/JJ treat/VB infection/NN
salbutamol/NN doses/NNS administration/NN assessed/VBD patients/NNS disease/NN obstructive/JJ
salbutamol/NN doses/NNS administration/NN assessed/VBD patients/NNS disease/NN lung/NN
salbutamol/NN doses/NNS administration/NN assessed/VBD patients/NNS disease/NN
4/CD bolus/VBZ done/VBN tumors/NNS
'/POS 4/CD bolus/VBZ done/VBN tumors/NNS
0/CD tetrahydropyranyladriamycin/CD done/VBN tumors/NNS
tetrahydropyranyladriamycin/CD done/VBN tumors/NNS
Pirarubicin/NNP tetrahydropyranyladriamycin/CD done/VBN tumors/NNS
carbamazepine/VB presenting/VBG reaction/NN eosinophilia/NN
carbamazepine/VB presented/VBN erythroderma/NN eosinophilia/NN
dopamine/JJ neurotransmission/NN dysfunction/NN associated/VBN Schizophrenia/NNP
N/NNP D/NNP antagonists/NNS produce/VBP schizophrenic/JJ
methyl/NN D/NNP antagonists/NNS produce/VBP schizophrenic/JJ
D/NNP antagonists/NNS produce/VBP schizophrenic/JJ
aspartate/JJ receptor/NN D/NNP antagonists/NNS produce/VBP schizophrenic/JJ
NMDA/NNP receptor/NN D/NNP antagonists/NNS produce/VBP schizophrenic/JJ
NMDA/NNP receptor/NN system/NN dysfunctioning/NN idea/NN led/VBN observation/NN produce/VBP schizophrenic/JJ
glutamate/NNP D/NNP antagonists/NNS produce/VBP schizophrenic/JJ
NMDA/NNP Nr/NNP challenge/NN models/NNS hyperactivity/NN
SSR/NNP properties/NNS investigating/VBG focus/NN models/NNS hyperactivity/NN
103800/CD SSR/NNP properties/NNS investigating/VBG focus/NN models/NNS hyperactivity/NN
NMDA/NN antagonist/NN hyperactivity/NN
NMDA/NN antagonist/NN hyperactivity/NN 801/CD hyperactivity/NN
NMDA/NNP Nr/NNP hyperactivity/NN 801/CD hyperactivity/NN
NMDA/NNP Nr/NNP hyperactivity/NN
SSR/NNP blocked/VBD hyperactivity/NN
103800/CD SSR/NNP blocked/VBD hyperactivity/NN
SSR/NNP blocked/VBD hyperactivity/NN 801/CD hyperactivity/NN
103800/CD SSR/NNP blocked/VBD hyperactivity/NN 801/CD hyperactivity/NN
dopamine/JJ transporter/NN observed/JJ induced/VBN hyperactivity/RB
SSR/NNP 103800/NNP failed/VBD affect/VB induced/VBN hyperactivity/RB
103800/NNP failed/VBD affect/VB induced/VBN hyperactivity/RB
aripiprazole/NN clozapine/NN olanzapine/NN atypical/JJ antipsychotics/NNS classical/JJ effective/JJ models/NNS hyperactivity/NN
haloperidol/JJ classical/JJ effective/JJ models/NNS hyperactivity/NN
olanzapine/NN atypical/JJ antipsychotics/NNS classical/JJ effective/JJ models/NNS hyperactivity/NN
clozapine/NN olanzapine/NN atypical/JJ antipsychotics/NNS classical/JJ effective/JJ models/NNS hyperactivity/NN
SSR/NNP 103800/NNP produce/VB catalepsy/NN
103800/NNP produce/VB catalepsy/NN
tyrosine/JJ phosphatase/NN nephrosis/NNS
PAN/NNP injection/NN days/NNS as/RB include/VB phase/NN proteinuria/NN associated/VBN effacement/NN phase/NN proteinuria/NN associated/VBN glomerulosclerosis/NNS
Valproate/NNP syndrome/NN manifest/VB individuals/NNS epileptic/JJ
Nitro/NNP ester/NN protector/NN ototoxicity/NN
L/NNP Nitro/NNP ester/NN protector/NN ototoxicity/NN
arginine/JJ ester/NN protector/NN ototoxicity/NN
methyl/NN ester/NN protector/NN ototoxicity/NN
ester/NN protector/NN ototoxicity/NN
gentamicin/NN ototoxicity/NN
gentamicin/NN caused/VBN loss/NN high/JJ
gentamicin/NN caused/VBN loss/NN frequency/NN
gentamicin/NN caused/VBN loss/NN hearing/NN
gentamicin/NN caused/VBN loss/NN
nitro/NN act/VB high/JJ
nitro/NN act/VB high/JJ loss/NN frequency/NN
nitro/NN act/VB high/JJ loss/NN hearing/NN
nitro/NN act/VB high/JJ loss/NN
L/NNP nitro/NN act/VB high/JJ
L/NNP nitro/NN act/VB high/JJ loss/NN frequency/NN
L/NNP nitro/NN act/VB high/JJ loss/NN hearing/NN
L/NNP nitro/NN act/VB high/JJ loss/NN
arginine/JJ ester/NN act/VB high/JJ
arginine/JJ ester/NN act/VB high/JJ loss/NN frequency/NN
arginine/JJ ester/NN act/VB high/JJ loss/NN hearing/NN
arginine/JJ ester/NN act/VB high/JJ loss/NN
methyl/NN ester/NN act/VB high/JJ
methyl/NN ester/NN act/VB high/JJ loss/NN frequency/NN
methyl/NN ester/NN act/VB high/JJ loss/NN hearing/NN
methyl/NN ester/NN act/VB high/JJ loss/NN
ester/NN act/VB high/JJ
ester/NN act/VB high/JJ loss/NN frequency/NN
ester/NN act/VB high/JJ loss/NN hearing/NN
ester/NN act/VB high/JJ loss/NN
L/NNP ester/NN act/VB high/JJ
L/NNP ester/NN act/VB high/JJ loss/NN frequency/NN
L/NNP ester/NN act/VB high/JJ loss/NN hearing/NN
L/NNP ester/NN act/VB high/JJ loss/NN
NAME/NNP L/NNP ester/NN act/VB high/JJ
NAME/NNP L/NNP ester/NN act/VB high/JJ loss/NN frequency/NN
NAME/NNP L/NNP ester/NN act/VB high/JJ loss/NN hearing/NN
NAME/NNP L/NNP ester/NN act/VB high/JJ loss/NN
nitric/JJ oxide/NN inhibitor/VBP nitro/NN act/VB high/JJ
nitric/JJ oxide/NN inhibitor/VBP nitro/NN act/VB high/JJ loss/NN frequency/NN
nitric/JJ oxide/NN inhibitor/VBP nitro/NN act/VB high/JJ loss/NN hearing/NN
nitric/JJ oxide/NN inhibitor/VBP nitro/NN act/VB high/JJ loss/NN
oxide/NN inhibitor/VBP nitro/NN act/VB high/JJ
oxide/NN inhibitor/VBP nitro/NN act/VB high/JJ loss/NN frequency/NN
oxide/NN inhibitor/VBP nitro/NN act/VB high/JJ loss/NN hearing/NN
oxide/NN inhibitor/VBP nitro/NN act/VB high/JJ loss/NN
NO/RB oxide/NN inhibitor/VBP nitro/NN act/VB high/JJ
NO/RB oxide/NN inhibitor/VBP nitro/NN act/VB high/JJ loss/NN frequency/NN
NO/RB oxide/NN inhibitor/VBP nitro/NN act/VB high/JJ loss/NN hearing/NN
NO/RB oxide/NN inhibitor/VBP nitro/NN act/VB high/JJ loss/NN
Aminoglycoside/NNP antibiotics/NNS used/VBN inhibitor/VBP nitro/NN act/VB high/JJ
Aminoglycoside/NNP antibiotics/NNS used/VBN inhibitor/VBP nitro/NN act/VB high/JJ loss/NN frequency/NN
Aminoglycoside/NNP antibiotics/NNS used/VBN inhibitor/VBP nitro/NN act/VB high/JJ loss/NN hearing/NN
Aminoglycoside/NNP antibiotics/NNS used/VBN inhibitor/VBP nitro/NN act/VB high/JJ loss/NN
NO/RB production/NN involves/VBZ need/VBP problem/NN ototoxicity/NN
NO/RB production/NN involves/VBZ mechanism/NN ototoxic/JJ
NO/DT inhibitors/NNS use/NN assess/VB need/VBP problem/NN ototoxicity/NN
NO/DT inhibitors/NNS use/NN assess/VB need/VBP involves/VBZ mechanism/NN ototoxic/JJ
aminoglycoside/NN prevention/NN assess/VB need/VBP problem/NN ototoxicity/NN
aminoglycoside/NN prevention/NN assess/VB need/VBP involves/VBZ mechanism/NN ototoxic/JJ
NO/RB production/NN involves/VBZ need/VBP assess/VB prevention/NN loss/NN sensorineural/JJ
NO/RB production/NN involves/VBZ need/VBP assess/VB prevention/NN loss/NN hearing/NN
NO/RB production/NN involves/VBZ need/VBP assess/VB prevention/NN loss/NN
NO/DT inhibitors/NNS use/NN assess/VB prevention/NN loss/NN sensorineural/JJ
NO/DT inhibitors/NNS use/NN assess/VB prevention/NN loss/NN hearing/NN
NO/DT inhibitors/NNS use/NN assess/VB prevention/NN loss/NN
aminoglycoside/NN prevention/NN loss/NN sensorineural/JJ
aminoglycoside/NN prevention/NN loss/NN hearing/NN
aminoglycoside/NN prevention/NN loss/NN
L/NNP induced/VBD loss/NN hearing/NN
L/NNP induced/VBD loss/NN
NAME/JJ gentamicin/NN L/NNP induced/VBD loss/NN hearing/NN
NAME/JJ gentamicin/NN L/NNP induced/VBD loss/NN
cimetidine/NN mg/JJ continuous/JJ hour/NN receiving/VBG developed/VBD year/NN man/NN leukemia/NN
cimetidine/NN mg/JJ continuous/JJ hour/NN receiving/VBG developed/VBD year/NN history/NN disease/NN cardiac/JJ
cimetidine/NN mg/JJ continuous/JJ hour/NN receiving/VBG developed/VBD year/NN history/NN disease/NN
cimetidine/VB related/VBN arrhythmias/NNS
ranitidine/JJ treatment/NN recur/VB related/VBN arrhythmias/NNS
methyl/NN dopa/NN treated/VBN histories/NNS psychiatric/JJ
dopa/NN treated/VBN histories/NNS psychiatric/JJ
gemfibrozil/NN cyclosporin/NN treated/VBN patients/NNS lovastatin/NN reported/VBN associated/VBN myoglobinuria/NN
lovastatin/NN reported/VBN Myopathy/RB
niacin/NN cyclosporin/NN treated/VBN patients/NNS lovastatin/NN reported/VBN associated/VBN myoglobinuria/NN
cyclosporin/NN treated/VBN patients/NNS lovastatin/NN reported/VBN associated/VBN failure/NN renal/JJ
cyclosporin/NN treated/VBN patients/NNS lovastatin/NN reported/VBN associated/VBN failure/NN
niacin/NN cyclosporin/NN treated/VBN patients/NNS lovastatin/NN reported/VBN associated/VBN failure/NN renal/JJ
niacin/NN cyclosporin/NN treated/VBN patients/NNS lovastatin/NN reported/VBN associated/VBN failure/NN
cyclosporin/NN treated/VBN patients/NNS lovastatin/NN reported/VBN associated/VBN myoglobinuria/NN
gemfibrozil/NN cyclosporin/NN treated/VBN patients/NNS lovastatin/NN reported/VBN associated/VBN failure/NN renal/JJ
gemfibrozil/NN cyclosporin/NN treated/VBN patients/NNS lovastatin/NN reported/VBN associated/VBN failure/NN
sodium/NN nitroprusside/NN than/IN greater/JJR hemorrhage/NN
nitroprusside/NN than/IN greater/JJR hemorrhage/NN
sodium/NN nitroprusside/NN infusion/NN decreased/VBN' decreased/VBN decreased/VBN'' hemorrhage/NN
nitroprusside/NN infusion/NN decreased/VBN' decreased/VBN decreased/VBN'' hemorrhage/NN
sodium/NN nitroprusside/NN infusion/NN decreased/VBN' decreased/VBN decreased/VBN'' hemorrhage/NN HEM/NNP
nitroprusside/NN infusion/NN decreased/VBN' decreased/VBN decreased/VBN'' hemorrhage/NN HEM/NNP
SNP/NNP nitroprusside/NN infusion/NN decreased/VBN' decreased/VBN decreased/VBN'' hemorrhage/NN
SNP/NNP nitroprusside/NN infusion/NN decreased/VBN' decreased/VBN decreased/VBN'' hemorrhage/NN HEM/NNP
SNP/NNP group/NN that/DT lower/JJR hypotension/NN HEM/NNP
SNP/NNP group/NN Hg/NNP //NNS Hg/NNP group/NN HEM/NNP
SNP/NNP HEM/NNP
scopolamine/NN induced/VBN Components/NNP dementia/NN
s/PRP effects/NNS dementia/NN
limonene/VBD anti/NN effects/NNS dementia/NN
s/VBZ limonene/VBD anti/NN effects/NNS dementia/NN
perillyl/JJ alcohol/NN observed/VBN limonene/VBD anti/NN effects/NNS dementia/NN
alcohol/NN observed/VBN limonene/VBD anti/NN effects/NNS dementia/NN
s/PRP associative/VBD showed/VBD improve/VB memory/NN
s/PRP associative/VBD showed/VBD improve/VB memory/NN impaired/VBN
perillyl/JJ alcohol/NN relieved/VBD s/PRP associative/VBD showed/VBD improve/VB memory/NN
perillyl/JJ alcohol/NN relieved/VBD s/PRP associative/VBD showed/VBD improve/VB memory/NN impaired/VBN
alcohol/NN relieved/VBD s/PRP associative/VBD showed/VBD improve/VB memory/NN
alcohol/NN relieved/VBD s/PRP associative/VBD showed/VBD improve/VB memory/NN impaired/VBN
s/PRP relieved/VBD deficit/NN
s/PRP relieved/VBD deficit/NN memory/NN of/IN
s/PRP relieved/VBD deficit/NN memory/NN associative/JJ
s/PRP relieved/VBD deficit/NN memory/NN
perillyl/JJ alcohol/NN relieved/VBD deficit/NN
perillyl/JJ alcohol/NN relieved/VBD deficit/NN memory/NN of/IN
perillyl/JJ alcohol/NN relieved/VBD deficit/NN memory/NN associative/JJ
perillyl/JJ alcohol/NN relieved/VBD deficit/NN memory/NN
alcohol/NN relieved/VBD deficit/NN
alcohol/NN relieved/VBD deficit/NN memory/NN of/IN
alcohol/NN relieved/VBD deficit/NN memory/NN associative/JJ
alcohol/NN relieved/VBD deficit/NN memory/NN
aminoglycosides/JJ dose/NN appeared/VBD Ototoxicity/NNP
aminoglycosides/JJ dose/NN drugs/NNS ototoxic/JJ
furosemide/JJ aminoglycosides/JJ dose/NN appeared/VBD Ototoxicity/NNP
furosemide/JJ aminoglycosides/JJ dose/NN drugs/NNS ototoxic/JJ
carmofur/NN result/VB syndrome/NN organic/JJ
carmofur/NN result/VB syndrome/NN personality/NN
carmofur/NN result/VB syndrome/NN
Raloxifene/NNP Evaluation/NNP Outcomes/NNP METHODS/NNS enrolled/VBD 7/CD women/NNS osteoporosis/NN
Raloxifene/NNP increase/VB 9/CD 7/CD 2/CD 3/CD %/NN %/NN CI/NNP cancer/NN endometrial/JJ
Raloxifene/NNP increase/VB 9/CD 7/CD 2/CD 3/CD %/NN %/NN CI/NNP cancer/NN
Raloxifene/NNP increase/VB 9/CD 7/CD 2/CD 3/CD %/NN %/NN CI/NNP hyperplasia/NN endometrial/JJ
Raloxifene/NNP increase/VB 9/CD 7/CD 2/CD 3/CD %/NN %/NN CI/NNP hyperplasia/NN
Raloxifene/NNP increase/VB 9/CD 7/CD 2/CD 3/CD %/NN %/NN CI/NNP disease/NN gallbladder/NN
Raloxifene/NNP increase/VB 9/CD 7/CD 2/CD 3/CD %/NN %/NN CI/NNP disease/NN
Raloxifene/NNP increase/VB cataracts/NNS
Raloxifene/NNP associated/VBN was/VBD risk/NN cataracts/NNS cancer/NN endometrial/JJ
Raloxifene/NNP associated/VBN was/VBD risk/NN cataracts/NNS cancer/NN
Raloxifene/NNP associated/VBN was/VBD risk/NN cataracts/NNS hyperplasia/NN endometrial/JJ
Raloxifene/NNP associated/VBN was/VBD risk/NN cataracts/NNS hyperplasia/NN
Raloxifene/NNP associated/VBN was/VBD risk/NN cataracts/NNS disease/NN gallbladder/NN
Raloxifene/NNP associated/VBN was/VBD risk/NN cataracts/NNS disease/NN
Raloxifene/NNP associated/VBN was/VBD risk/NN cataracts/NNS
calcium/NN blockers/NNS administration/NN levels/NNS reduction/NN led/VBD relief/NN pain/NN
cyclosporine/NN effect/NN Syndrome/NNP CIPS/NNP
tacrolimus/NNS cyclosporine/NN effect/NN Syndrome/NNP CIPS/NNP
angiotensin/NN inhibitor/NN Effects/NNPS converting/VBG coagulation/NN intravascular/NN
angiotensin/NN inhibitor/NN Effects/NNPS converting/VBG coagulation/NN
Captopril/NNP enzyme/NN converting/VBG coagulation/NN intravascular/NN
Captopril/NNP enzyme/NN converting/VBG coagulation/NN
Captopril/NNP enzyme/NN insufficiency/NN pulmonary/JJ
Captopril/NNP enzyme/NN insufficiency/NN pulmonary/JJ and/CC
Captopril/NNP enzyme/NN insufficiency/NN pulmonary/JJ renal/JJ
Captopril/NNP enzyme/NN insufficiency/NN
angiotensin/NN inhibitor/NN Effects/NNPS converting/VBG enzyme/NN insufficiency/NN pulmonary/JJ
angiotensin/NN inhibitor/NN Effects/NNPS converting/VBG enzyme/NN insufficiency/NN pulmonary/JJ and/CC
angiotensin/NN inhibitor/NN Effects/NNPS converting/VBG enzyme/NN insufficiency/NN pulmonary/JJ renal/JJ
angiotensin/NN inhibitor/NN Effects/NNPS converting/VBG enzyme/NN insufficiency/NN
tranexamic/JJ thrombin/JJ acid/NN injection/NN fibrinolysis/NNS coagulation/NN Induction/NNP gives/VBZ resembling/NNS pulmonary/JJ
tranexamic/JJ thrombin/JJ acid/NN injection/NN fibrinolysis/NNS coagulation/NN Induction/NNP gives/VBZ resembling/NNS pulmonary/JJ and/CC
tranexamic/JJ thrombin/JJ acid/NN injection/NN fibrinolysis/NNS coagulation/NN Induction/NNP gives/VBZ resembling/NNS pulmonary/JJ renal/JJ
tranexamic/JJ thrombin/JJ acid/NN injection/NN fibrinolysis/NNS coagulation/NN Induction/NNP gives/VBZ resembling/NNS insufficiency/NN
acid/NN injection/NN fibrinolysis/NNS coagulation/NN Induction/NNP gives/VBZ resembling/NNS pulmonary/JJ
acid/NN injection/NN fibrinolysis/NNS coagulation/NN Induction/NNP gives/VBZ resembling/NNS pulmonary/JJ and/CC
acid/NN injection/NN fibrinolysis/NNS coagulation/NN Induction/NNP gives/VBZ resembling/NNS pulmonary/JJ renal/JJ
acid/NN injection/NN fibrinolysis/NNS coagulation/NN Induction/NNP gives/VBZ resembling/NNS insufficiency/NN
AMCA/NNP acid/NN injection/NN fibrinolysis/NNS coagulation/NN Induction/NNP gives/VBZ resembling/NNS pulmonary/JJ
AMCA/NNP acid/NN injection/NN fibrinolysis/NNS coagulation/NN Induction/NNP gives/VBZ resembling/NNS pulmonary/JJ and/CC
AMCA/NNP acid/NN injection/NN fibrinolysis/NNS coagulation/NN Induction/NNP gives/VBZ resembling/NNS pulmonary/JJ renal/JJ
AMCA/NNP acid/NN injection/NN fibrinolysis/NNS coagulation/NN Induction/NNP gives/VBZ resembling/NNS insufficiency/NN
tranexamic/JJ thrombin/JJ acid/NN injection/NN fibrinolysis/NNS coagulation/NN Induction/NNP gives/VBZ resembling/NNS occurring/VBG trauma/NN
acid/NN injection/NN fibrinolysis/NNS coagulation/NN Induction/NNP gives/VBZ resembling/NNS occurring/VBG trauma/NN
AMCA/NNP acid/NN injection/NN fibrinolysis/NNS coagulation/NN Induction/NNP gives/VBZ resembling/NNS occurring/VBG trauma/NN
tranexamic/JJ thrombin/JJ acid/NN injection/NN fibrinolysis/NNS coagulation/NN Induction/NNP gives/VBZ resembling/NNS occurring/VBG trauma/NN sepsis/NN
acid/NN injection/NN fibrinolysis/NNS coagulation/NN Induction/NNP gives/VBZ resembling/NNS occurring/VBG trauma/NN sepsis/NN
AMCA/NNP acid/NN injection/NN fibrinolysis/NNS coagulation/NN Induction/NNP gives/VBZ resembling/NNS occurring/VBG trauma/NN sepsis/NN
Captopril/NNP Injection/NNP reduced/VBD insufficiency/NN pulmonary/JJ
Captopril/NNP Injection/NNP reduced/VBD insufficiency/NN pulmonary/JJ and/CC
Captopril/NNP Injection/NNP reduced/VBD insufficiency/NN pulmonary/JJ renal/JJ
Captopril/NNP Injection/NNP reduced/VBD insufficiency/NN
angiotensin/NN inhibitor/NN converting/VBG reduced/VBD insufficiency/NN pulmonary/JJ
angiotensin/NN inhibitor/NN converting/VBG reduced/VBD insufficiency/NN pulmonary/JJ and/CC
angiotensin/NN inhibitor/NN converting/VBG reduced/VBD insufficiency/NN pulmonary/JJ renal/JJ
angiotensin/NN inhibitor/NN converting/VBG reduced/VBD insufficiency/NN
Captopril/NNP prevented/VBN damage/NN Renal/JJ
Captopril/NNP prevented/VBN damage/NN
urea/NN increase/NN reflected/VBN damage/NN Renal/JJ
urea/NN increase/NN reflected/VBN damage/NN
Captopril/NNP reduce/VB produced/VBN damage/NN kidney/NN
Captopril/NNP reduce/VB produced/VBN damage/NN
verapamil/NN effect/NN ulcers/NNS
verapamil/NN effect/NN rats/NNS atherosclerotic/JJ
verapamil/NN effect/NN ulcers/NNS gastric/JJ
verapamil/NN effect/NN ulcers/NNS hemorrhagic/JJ
histamine/NN release/NN diffusion/NN generation/NN modulating/VBG rats/NNS atherosclerosis/NNS
histamine/NN release/NN diffusion/NN generation/NN modulating/VBG hemorrhage/NN ulcer/NN
histamine/NN release/NN diffusion/NN generation/NN modulating/VBG hemorrhage/NN gastric/JJ
histamine/NN release/NN diffusion/NN generation/NN modulating/VBG hemorrhage/NN
verapamil/NN model/NN ulcer/NN
histamine/JJ concentration/NN diffusion/NN areas/NNS ulcer/NN
luminal/JJ content/NN diffusion/NN areas/NNS ulcer/NN
calcium/NN concentration/NN parameters/NNS atherosclerotic/JJ
calcium/NN concentration/NN parameters/NNS obtained/VBN rats/NNS atherosclerotic/JJ
histamine/JJ release/NN diffusion/NN observed/VBN accompanied/VBN ulcers/NNS
luminal/JJ content/NN diffusion/NN observed/VBN accompanied/VBN ulcers/NNS
histamine/NN correlation/NN found/VBN rats/NNS atherosclerotic/JJ
histamine/NN histamine/NN' ulcer/NN
histamine/NN hemorrhage/NN gastric/JJ
histamine/NN hemorrhage/NN
verapamil/NN dose/JJ ulcer/NN
verapamil/NN dose/JJ ulcer/NN hemorrhagic/JJ
verapamil/NN ameliorated/VBN release/NN diffusion/NN ulcer/NN
verapamil/NN ameliorated/VBN release/NN diffusion/NN ulcer/NN produce/VB Atherosclerosis/NNS
histamine/JJ release/NN diffusion/NN ulcer/NN produce/VB Atherosclerosis/NNS
histamine/JJ release/NN diffusion/NN ulcer/NN
verapamil/NN ameliorated/VBN release/NN diffusion/NN ulcer/NN gastric/JJ
verapamil/NN ameliorated/VBN release/NN diffusion/NN ulcer/NN hemorrhagic/JJ
histamine/JJ release/NN diffusion/NN ulcer/NN gastric/JJ
histamine/JJ release/NN diffusion/NN ulcer/NN hemorrhagic/JJ
cephalosporins/NNS associated/VBN defects/NNS birth/NN
cephalosporins/NNS associated/VBN defects/NNS
erythromycins/VBZ associated/VBN defects/NNS birth/NN
erythromycins/VBZ associated/VBN defects/NNS
penicillins/NNS Reassuringly/NNP erythromycins/VBZ associated/VBN defects/NNS birth/NN
penicillins/NNS Reassuringly/NNP erythromycins/VBZ associated/VBN defects/NNS
carboplatin/NN injection/NN Severe/VB toxicity/NN ocular/NN
carboplatin/NN injection/NN Severe/VB toxicity/NN ocular/NN and/CC
carboplatin/NN injection/NN Severe/VB toxicity/NN ocular/NN orbital/NN
carboplatin/NN injection/NN Severe/VB toxicity/NN
carboplatin/NN glioblastomas/NNS
carboplatin/NN said/VBN have/VB effects/NNS cisplatin/NN known/VBN toxicity/NN ocular/JJ
carboplatin/NN said/VBN have/VB effects/NNS cisplatin/NN known/VBN toxicity/NN ocular/JJ and/CC
carboplatin/NN said/VBN have/VB effects/NNS cisplatin/NN known/VBN toxicity/NN ocular/JJ orbital/JJ
carboplatin/NN said/VBN have/VB effects/NNS cisplatin/NN known/VBN toxicity/NN
cisplatin/NN known/VBN toxicity/NN ocular/JJ
cisplatin/NN known/VBN toxicity/NN ocular/JJ and/CC
cisplatin/NN known/VBN toxicity/NN ocular/JJ orbital/JJ
cisplatin/NN known/VBN toxicity/NN
carboplatin/NN injection/NN experienced/VBD case/NN ocular/NN
carboplatin/NN injection/NN experienced/VBD case/NN ocular/NN and/CC
carboplatin/NN injection/NN experienced/VBD case/NN ocular/NN toxicity/NN orbital/NN
carboplatin/NN injection/NN experienced/VBD case/NN ocular/NN toxicity/NN
carboplatin/NN injection/NN received/VBN glioblastomas/NNS
carboplatin/NN toxicity/NN
carboplatin/NN injection/NN performing/VBG aware/JJ toxicity/NN ocular/NN
carboplatin/NN injection/NN performing/VBG aware/JJ toxicity/NN
xanthine/JJ oxidase/NN Role/NNP hypertension/NN
nitric/JJ oxide/NN associated/VBN hypertension/NN
oxide/NN associated/VBN hypertension/NN
nitric/JJ oxide/NN associated/VBN hypertension/NN GC/NNP HT/NNP
oxide/NN associated/VBN hypertension/NN GC/NNP HT/NNP
xanthine/JJ oxidase/NN role/NN studied/VBD dexamethasone/NN hypertension/NN
xanthine/JJ oxidase/NN role/NN studied/VBD dexamethasone/NN hypertension/NN dex/NN HT/NNP
Allopurinol/NNP prevent/VB HT/VBP
allopurinol/NN failed/VBD prevent/VB hormone/NN induced/VBN hypertension/NN
allopurinol/NN failed/VBD together/RB suggests/VBZ determinant/NN HT/NNP
estradiol/JJ -/NNS therapy/NN estrogen/NN women/NNS atherosclerosis/NNS
-/NNS therapy/NN estrogen/NN women/NNS atherosclerosis/NNS
and/CC -/NNS therapy/NN estrogen/NN women/NNS atherosclerosis/NNS
testosterone/JJ esters/NNS -/NNS therapy/NN estrogen/NN women/NNS atherosclerosis/NNS
esters/NNS -/NNS therapy/NN estrogen/NN women/NNS atherosclerosis/NNS
estrogen/NN women/NNS atherosclerosis/NNS
alcohol/NN use/NN diabetes/NN
cholesterol/NN level/NN diabetes/NN
apomorphine/JJ induced/VBN catalepsy/JJ
amphetamine/NN behavior/NN climbing/VBG induced/VBN designed/VBN induced/VBN catalepsy/JJ
histamine/NNP H/NNP effect/NN study/VB designed/VBN induced/VBN catalepsy/JJ
apomorphine/NN used/VBN induced/VBN Catalepsy/NNP
amphetamine/NN apomorphine/NN used/VBN induced/VBN Catalepsy/NNP
R/NN cause/VB catalepsy/RB
alpha/NN R/NN cause/VB catalepsy/RB
methylhistamine/JJ R/NN cause/VB catalepsy/RB
RAMH/NNP methylhistamine/JJ R/NN cause/VB catalepsy/RB
THP/NNP reduced/VBD amphetamine/NN induced/VBN hyperactivity/RB
THP/NNP exhibited/VBD antipsychotic/NN like/VB induced/VBN hyperactivity/RB
apomorphine/NN reducing/VBG induced/VBN like/VB induced/VBN catalepsy/RB
amphetamine/NN reducing/VBG like/VB induced/VBN catalepsy/RB
haloperidol/NN potentiating/VBG like/VB induced/VBN hyperactivity/RB
apomorphine/NN reducing/VBG induced/VBN hyperactivity/RB
oxygen/NN level/NN correlated/VBD NIN/NNP
topiramate/NN prevention/NN impairments/NNS memory/NN
topiramate/NN prevention/NN impairments/NNS memory/NN and/CC
topiramate/NN prevention/NN impairments/NNS memory/NN learning/NN
topiramate/NN prevention/NN impairments/NNS
Cocaine/NNP causes/VBZ impairments/NNS memory/NN
Cocaine/NNP causes/VBZ impairments/NNS memory/NN and/CC
Cocaine/NNP causes/VBZ impairments/NNS memory/NN learning/NN
Cocaine/NNP causes/VBZ impairments/NNS
cocaine/NN toxicity/NN
cocaine/NN brain/NN induced/NN status/NN association/NN stress/NN increase/NN toxicity/NN
cocaine/NN administration/NN model/NN evaluated/VBN activity/NN stress/NN activity/NN effect/NN topiramate/NN therapy/NN addiction/NN cocaine/NN
cocaine/NN administration/NN model/NN evaluated/VBN activity/NN stress/NN activity/NN effect/NN topiramate/NN therapy/NN addiction/NN
nitric/JJ synthase/NN stress/NN activity/NN effect/NN topiramate/NN therapy/NN addiction/NN cocaine/NN
nitric/JJ synthase/NN stress/NN activity/NN effect/NN topiramate/NN therapy/NN addiction/NN
oxide/NN synthase/NN stress/NN activity/NN effect/NN topiramate/NN therapy/NN addiction/NN cocaine/NN
oxide/NN synthase/NN stress/NN activity/NN effect/NN topiramate/NN therapy/NN addiction/NN
topiramate/NN therapy/NN addiction/NN cocaine/NN
topiramate/NN therapy/NN addiction/NN
folate/NN concentrations/NNS efficacy/NN toxicity/NN
carbamazepine/NN treatment/NN efficacy/NN toxicity/NN
propylene/NN glycol/NN vehicle/NN found/VBN exhibit/VB seizures/NNS
glycol/NN vehicle/NN found/VBN exhibit/VB seizures/NNS
propylene/NN glycol/NN vehicle/NN found/VBN inhibited/VBD gain/NN weight/NN
propylene/NN glycol/NN vehicle/NN found/VBN inhibited/VBD gain/NN
glycol/NN vehicle/NN found/VBN inhibited/VBD gain/NN weight/NN
glycol/NN vehicle/NN found/VBN inhibited/VBD gain/NN
CBZ/NNP measure/NN found/VBN Seizures/NNS
CBZ/NNP measure/NN found/VBN seizures/NNS
CBZ/NNP administration/NN h/VBP dose/NN induced/VBN seizures/NNS
CBZ/NNP administration/NN h/VBP toxic/JJ measured/VBN gain/NN weight/NN
CBZ/NNP administration/NN h/VBP toxic/JJ measured/VBN gain/NN
HFDE/NNP protective/JJ induced/VBN dose/NN h/VBP toxic/JJ measured/VBN gain/NN weight/NN
HFDE/NNP protective/JJ induced/VBN dose/NN h/VBP toxic/JJ measured/VBN gain/NN
calcitonin/NN injections/NNS induced/VBN hyperactivity/RB
Methamphetamine/NNP stimulant/NN increases/VBZ produce/VB effects/NNS dysrhythmias/NNS hallucinations/NNS
Methamphetamine/NNP stimulant/NN increases/VBZ produce/VB effects/NNS dysrhythmias/NNS behavior/NN violent/JJ
Methamphetamine/NNP stimulant/NN increases/VBZ produce/VB effects/NNS dysrhythmias/NNS behavior/NN
Methamphetamine/NNP stimulant/NN increases/VBZ produce/VB effects/NNS dysrhythmias/NNS cardiac/JJ
Methamphetamine/NNP stimulant/NN increases/VBZ produce/VB effects/NNS dysrhythmias/NNS
Methamphetamine/NNP stimulant/NN increases/VBZ produce/VB effects/NNS dysrhythmias/NNS hypertension/NN
methamphetamine/NN abusing/VBG patients/NNS present/VB hygiene/NN caries/NNS mouth/NN meth/NN
methamphetamine/NN abusing/VBG patients/NNS present/VB hygiene/NN caries/NNS mouth/NN
methamphetamine/NN abusing/VBG patients/NNS present/VB wear/VBP tooth/NN
methamphetamine/NN abusing/VBG patients/NNS present/VB wear/VBP
methamphetamine/NN abusing/VBG patients/NNS present/VB hygiene/NN caries/NNS xerostomia/JJ
methamphetamines/NNS abusing/VBG patients/NNS manage/VB recognize/VB help/VB presented/VBN case/NN showing/VBG manifestations/NNS mouth/NN meth/JJ
methamphetamines/NNS abusing/VBG patients/NNS manage/VB recognize/VB help/VB presented/VBN case/NN showing/VBG manifestations/NNS mouth/NN
Pyrrolidine/JJ dithiocarbamate/NN protects/VBZ cortex/NN model/NN status/NN
Pyrrolidine/JJ dithiocarbamate/NN protects/VBZ cortex/NN model/NN epilepticus/NNS
dithiocarbamate/NN protects/VBZ cortex/NN model/NN status/NN
dithiocarbamate/NN protects/VBZ cortex/NN model/NN epilepticus/NNS
oxygen/NN species/NNS production/NN activation/NN implicated/VBN damage/NN neuronal/JJ
oxygen/NN species/NNS production/NN activation/NN implicated/VBN damage/NN
PDTC/NNP epilepticus/NNS status/NN
PDTC/NNP epilepticus/NNS
PDTC/JJ epilepticus/NNS status/NN
PDTC/JJ epilepticus/NNS
PDTC/NNP exert/VB development/NN epilepticus/NNS status/NN
PDTC/NNP exert/VB development/NN epilepticus/NNS
PDTC/NNP vehicle/NN treated/VBN rats/NNS epilepticus/NNS status/NN
PDTC/NNP vehicle/NN treated/VBN rats/NNS epilepticus/NNS
PDTC/NN inhibitor/NN NF/NNP protected/VBD affect/VB loss/NN neuronal/JJ
PDTC/NN inhibitor/NN NF/NNP protected/VBD affect/VB loss/NN
oxygen/NN species/NNS generation/NN plays/VBZ role/NN seizure/NN
oxygen/NN species/NNS generation/NN associated/VBN damage/NN neuronal/JJ
oxygen/NN species/NNS generation/NN associated/VBN damage/NN
Flestolol/NNP produced/VBD induced/VBN tachycardia/NN
Flestolol/NNP reduced/VBD tachyarrhythmia/NN supraventricular/JJ
Flestolol/NNP reduced/VBD tachyarrhythmia/NN
flestolol/JJ infusion/NN found/VBN safe/JJ pain/NN chest/NN
flestolol/JJ infusion/NN found/VBN safe/JJ pain/NN
flestolol/JJ infusion/NN found/VBN patients/NNS angina/NN unstable/JJ
flestolol/JJ infusion/NN found/VBN patients/NNS angina/NN
green/JJ tea/NN Effect/NN induced/VBN infarction/NN myocardial/JJ
green/JJ tea/NN Effect/NN induced/VBN infarction/NN
tea/NN Effect/NN induced/VBN infarction/NN myocardial/JJ
tea/NN Effect/NN induced/VBN infarction/NN
vitamin/NN combination/NN tea/NN Effect/NN induced/VBN infarction/NN myocardial/JJ
vitamin/NN combination/NN tea/NN Effect/NN induced/VBN infarction/NN
E/NN combination/NN tea/NN Effect/NN induced/VBN infarction/NN myocardial/JJ
E/NN combination/NN tea/NN Effect/NN induced/VBN infarction/NN
green/JJ tea/NN effects/NNS ATPases/NNS infarction/NN myocardial/JJ
green/JJ tea/NN effects/NNS ATPases/NNS infarction/NN
tea/NN effects/NNS ATPases/NNS infarction/NN myocardial/JJ
tea/NN effects/NNS ATPases/NNS infarction/NN
vitamin/NN E/NN tea/NN effects/NNS ATPases/NNS infarction/NN myocardial/JJ
vitamin/NN E/NN tea/NN effects/NNS ATPases/NNS infarction/NN
E/NN tea/NN effects/NNS ATPases/NNS infarction/NN myocardial/JJ
E/NN tea/NN effects/NNS ATPases/NNS infarction/NN
green/JJ tea/NN effect/NN indicate/VBP ISO/NNP induced/VBN infarction/NN myocardial/JJ
green/JJ tea/NN effect/NN indicate/VBP ISO/NNP induced/VBN infarction/NN
tea/NN effect/NN indicate/VBP ISO/NNP induced/VBN infarction/NN myocardial/JJ
tea/NN effect/NN indicate/VBP ISO/NNP induced/VBN infarction/NN
vitamin/NN E/NN tea/NN effect/NN indicate/VBP ISO/NNP induced/VBN infarction/NN myocardial/JJ
vitamin/NN E/NN tea/NN effect/NN indicate/VBP ISO/NNP induced/VBN infarction/NN
E/NN tea/NN effect/NN indicate/VBP ISO/NNP induced/VBN infarction/NN myocardial/JJ
E/NN tea/NN effect/NN indicate/VBP ISO/NNP induced/VBN infarction/NN
dacarbazine/JJ therapy/NN melanoma/NN
DTIC/NNP therapy/NN melanoma/NN
dacarbazine/JJ therapy/NN melanoma/NN
DTIC/NNP therapy/NN melanoma/NN
paracetamol/NNP cause/VB cancer/NN necrosis/NNS renal/JJ
paracetamol/NNP cause/VB cancer/NN necrosis/NNS papillary/NN
paracetamol/NNP cause/VB cancer/NN necrosis/NNS
paracetamol/NNP cause/VB cancer/NN urothelial/JJ
paracetamol/NNP cause/VB cancer/NN
paracetamol/NNP phenacetin/NN consumption/NN associated/VBN cancer/NN
paracetamol/NNP phenacetin/NN consumption/NN associated/VBN cancer/NN pelvis/NNS of/IN
paracetamol/NNP phenacetin/NN consumption/NN associated/VBN cancer/NN pelvis/NNS the/DT
paracetamol/NNP phenacetin/NN consumption/NN associated/VBN cancer/NN pelvis/NNS renal/JJ
paracetamol/NNP phenacetin/NN consumption/NN associated/VBN cancer/NN pelvis/NNS
paracetamol/NNP phenacetin/NN consumption/NN associated/VBN cancer/NN pelvis/NNS ureter/NN
paracetamol/NNP phenacetin/NN consumption/NN associated/VBN cancer/NN pelvis/NNS or/CC
paracetamol/NNP phenacetin/NN consumption/NN associated/VBN cancer/NN pelvis/NNS bladder/NN
paracetamol/NNP phenacetin/NN consumption/NN associated/VBN cancer/NN necrosis/NNS renal/JJ
paracetamol/NNP phenacetin/NN consumption/NN associated/VBN cancer/NN necrosis/NNS papillary/NN
paracetamol/NNP phenacetin/NN consumption/NN associated/VBN cancer/NN necrosis/NNS
phenacetin/NN consumption/NN associated/VBN cancer/NN
phenacetin/NN consumption/NN associated/VBN cancer/NN pelvis/NNS of/IN
phenacetin/NN consumption/NN associated/VBN cancer/NN pelvis/NNS the/DT
phenacetin/NN consumption/NN associated/VBN cancer/NN pelvis/NNS renal/JJ
phenacetin/NN consumption/NN associated/VBN cancer/NN pelvis/NNS
phenacetin/NN consumption/NN associated/VBN cancer/NN pelvis/NNS ureter/NN
phenacetin/NN consumption/NN associated/VBN cancer/NN pelvis/NNS or/CC
phenacetin/NN consumption/NN associated/VBN cancer/NN pelvis/NNS bladder/NN
phenacetin/NN increased/VBD cancer/NN
phenacetin/NN increased/VBD cancer/NN pelvis/NNS of/IN
phenacetin/NN increased/VBD cancer/NN pelvis/NNS the/DT
phenacetin/NN increased/VBD cancer/NN pelvis/NNS renal/JJ
phenacetin/NN increased/VBD cancer/NN pelvis/NNS
phenacetin/NN increased/VBD cancer/NN pelvis/NNS and/CC
phenacetin/NN increased/VBD cancer/NN pelvis/NNS bladder/NN
phenacetin/NN increased/VBD increased/VBD' cancer/NN ureteric/JJ
phenacetin/NN increased/VBD increased/VBD' cancer/NN
paracetamol/JJ consumption/NN necrosis/NNS renal/JJ
paracetamol/JJ consumption/NN necrosis/NNS papillary/NN
paracetamol/JJ consumption/NN necrosis/NNS
paracetamol/JJ consumption/NN any/DT cancers/NNS
paracetamol/JJ consumption/NN substantiate/VB was/VBD suggestion/NN association/NN cancer/NN
paracetamol/JJ consumption/NN substantiate/VB was/VBD suggestion/NN association/NN cancer/NN ureter/NN of/IN
paracetamol/JJ consumption/NN substantiate/VB was/VBD suggestion/NN association/NN cancer/NN ureter/NN the/DT
paracetamol/JJ consumption/NN substantiate/VB was/VBD suggestion/NN association/NN cancer/NN ureter/NN
lignocaine/NN instillation/NN tinnitus/NNS
lidocaine/VBD Treatment/NNP tinnitus/NNS
lignocaine/NN instillation/NN treating/VBG IST/NNP
lidocaine/NN lignocaine/NN instillation/NN treating/VBG IST/NNP
isosorbide/JJ dinitrate/NN administration/NN wall/NN infarction/NN suffered/VBD old/JJ necrosis/NNS
dinitrate/NN administration/NN wall/NN infarction/NN suffered/VBD old/JJ necrosis/NNS
Simvastatin/NNP ezetimibe/NN failure/NN hepatic/JJ
Simvastatin/NNP ezetimibe/NN failure/NN
ezetimibe/NN failure/NN hepatic/JJ
ezetimibe/NN failure/NN
ezetimibe/NN published/VBN events/NNS hepatotoxic/JJ
simvastatin/NN mg/NN necessitating/VBG developed/VBD failure/NN fulminant/JJ
simvastatin/NN mg/NN necessitating/VBG developed/VBD failure/NN hepatic/JJ
simvastatin/NN mg/NN necessitating/VBG developed/VBD failure/NN
simvastatin/NN maintained/VBN evidence/NN hepatotoxicity/NN
escitalopram/NN Simvastatinezetimibe/NN taking/VBG depression/NN
Simvastatinezetimibe/NN taking/VBG depression/NN
escitalopram/NN Simvastatinezetimibe/NN discontinued/VBN excluded/VBN causes/NNS hepatotoxicity/NN
uridine/JJ glucoronosyltransferases/NNS undergoes/VBZ inhibited/VBD glucuronidation/NN resulting/VBG exposure/NN hepatotoxicity/NN
diphosphate/NN glucoronosyltransferases/NNS undergoes/VBZ inhibited/VBD glucuronidation/NN resulting/VBG exposure/NN hepatotoxicity/NN
simvastatin/NN exposure/NN hepatotoxicity/NN
Ezetimibe/NNP undergoes/VBZ inhibited/VBD glucuronidation/NN resulting/VBG exposure/NN hepatotoxicity/NN
simvastatin/JJ acid/NN glucuronidation/NN resulting/VBG exposure/NN hepatotoxicity/NN
hydroxy/JJ acid/NN glucuronidation/NN resulting/VBG exposure/NN hepatotoxicity/NN
acid/NN glucuronidation/NN resulting/VBG exposure/NN hepatotoxicity/NN
simvastatin/NN report/NN ezetimibe/JJ failure/NN liver/NN
simvastatin/NN report/NN ezetimibe/JJ failure/NN
ezetimibe/JJ failure/NN liver/NN
ezetimibe/JJ failure/NN
simvastatin/NN exposure/NN mechanism/NN simvastatinezetimibe/NN induced/VBN hepatotoxicity/RB
ezetimibe/JJ inhibition/NN exposure/NN mechanism/NN simvastatinezetimibe/NN induced/VBN hepatotoxicity/RB
methotrexate/NN toxicity/NN high/JJ posterior/NN syndrome/NN leukoencephalopathy/NN
methotrexate/NN toxicity/NN high/JJ posterior/NN stroke/NN
methotrexate/NN toxicity/NN high/JJ posterior/NN syndrome/NN secretion/NN inappropriate/JJ
methotrexate/NN toxicity/NN high/JJ posterior/NN syndrome/NN secretion/NN antidiuretic/JJ
methotrexate/NN toxicity/NN high/JJ posterior/NN syndrome/NN secretion/NN hormone/NN
methotrexate/NN toxicity/NN high/JJ posterior/NN syndrome/NN secretion/NN
methotrexate/NN toxicity/NN high/JJ posterior/NN stroke/NN epilepsy/NN temporal/JJ
methotrexate/NN toxicity/NN high/JJ posterior/NN stroke/NN epilepsy/NN lobe/NN
methotrexate/NN toxicity/NN high/JJ posterior/NN stroke/NN epilepsy/NN
methotrexate/NN toxicity/NN
serotonin/NN secondary/JJ inhibitors/NNS incontinence/JJ
cyclophosphamide/NN high/JJ based/VBN cancer/NN breast/NN
cyclophosphamide/NN high/JJ based/VBN cancer/NN
cyclophosphamide/NN high/JJ observed/VBD toxicity/NNP Cardiac/NNP
cyclophosphamide/NN high/JJ observed/VBD toxicity/NNP
melphalan/JJ paclitaxel/JJ combined/VBN We/PRP DESIGN/NNP regimen/NN patients/NNS cancer/NN breast/NN
melphalan/JJ paclitaxel/JJ combined/VBN We/PRP DESIGN/NNP regimen/NN patients/NNS cancer/NN
carboplatin/NN cyclophosphamide/NN DESIGN/NNP regimen/NN patients/NNS cancer/NN breast/NN
carboplatin/NN cyclophosphamide/NN DESIGN/NNP regimen/NN patients/NNS cancer/NN
cyclophosphamide/NN DESIGN/NNP regimen/NN patients/NNS cancer/NN breast/NN
cyclophosphamide/NN DESIGN/NNP regimen/NN patients/NNS cancer/NN
paclitaxel/JJ combined/VBN We/PRP DESIGN/NNP regimen/NN patients/NNS cancer/NN breast/NN
paclitaxel/JJ combined/VBN We/PRP DESIGN/NNP regimen/NN patients/NNS cancer/NN
thiotepa/NN cyclophosphamide/NN DESIGN/NNP regimen/NN patients/NNS cancer/NN breast/NN
thiotepa/NN cyclophosphamide/NN DESIGN/NNP regimen/NN patients/NNS cancer/NN
anthracyclines/NNS use/NN age/NN women/NNS cancer/NN breast/NN
anthracyclines/NNS use/NN age/NN women/NNS cancer/NN
anthracyclines/NNS use/NN age/NN hypertension/NN
anthracyclines/NNS use/NN age/NN mellitus/NNS diabetes/NN
anthracyclines/NNS use/NN age/NN mellitus/NNS
cyclophosphamide/NN women/NNS age/NN hypertension/NN
cyclophosphamide/NN women/NNS age/NN mellitus/NNS diabetes/NN
cyclophosphamide/NN women/NNS age/NN mellitus/NNS
cyclophosphamide/NN women/NNS cancer/NN breast/NN
cyclophosphamide/NN women/NNS cancer/NN
anthracyclines/NNS use/NN age/NN women/NNS cyclophosphamide/NN high/JJ regimen/NN failure/NN congestive/JJ
anthracyclines/NNS use/NN age/NN women/NNS cyclophosphamide/NN high/JJ regimen/NN failure/NN heart/NN
anthracyclines/NNS use/NN age/NN women/NNS cyclophosphamide/NN high/JJ regimen/NN failure/NN
anthracyclines/NNS use/NN age/NN women/NNS cyclophosphamide/NN high/JJ regimen/NN failure/NN CHF/NNP
cyclophosphamide/NN toxicity/NN cardiac/JJ
cyclophosphamide/NN toxicity/NN
steroids/NNS resolved/VBN angioedema/NN
diphenhydramine/JJ hydrochloride/NN steroids/NNS resolved/VBN angioedema/NN
Octreotide/NNP induced/VBN hypertension/NN hypoxemia/NN
octreotide/RB developed/VBD enhance/VB resolution/NN fistula/NN
nitroprusside/NN discontinuation/NN observed/VBN hypertension/NN
Cyproterone/NNP acetate/NNP licensed/VBN treatment/NN women/NNS acne/NN hirsutism/NN
acetate/NNP licensed/VBN treatment/NN women/NNS acne/NN hirsutism/NN
CPA/NNP EE/NNP acetate/NNP licensed/VBN treatment/NN women/NNS acne/NN hirsutism/NN
Cyproterone/NNP acetate/NNP licensed/VBN treatment/NN women/NNS acne/NN
acetate/NNP licensed/VBN treatment/NN women/NNS acne/NN
CPA/NNP EE/NNP acetate/NNP licensed/VBN treatment/NN women/NNS acne/NN
Cyproterone/NNP acetate/NNP licensed/VBN option/NN syndrome/NN polycystic/JJ
Cyproterone/NNP acetate/NNP licensed/VBN option/NN syndrome/NN ovary/NN
Cyproterone/NNP acetate/NNP licensed/VBN option/NN syndrome/NN
acetate/NNP licensed/VBN option/NN syndrome/NN polycystic/JJ
acetate/NNP licensed/VBN option/NN syndrome/NN ovary/NN
acetate/NNP licensed/VBN option/NN syndrome/NN
Cyproterone/NNP acetate/NNP licensed/VBN option/NN syndrome/NN PCOS/NNP
acetate/NNP licensed/VBN option/NN syndrome/NN PCOS/NNP
CPA/NNP EE/NNP acetate/NNP licensed/VBN option/NN syndrome/NN polycystic/JJ
CPA/NNP EE/NNP acetate/NNP licensed/VBN option/NN syndrome/NN ovary/NN
CPA/NNP EE/NNP acetate/NNP licensed/VBN option/NN syndrome/NN
CPA/NNP EE/NNP acetate/NNP licensed/VBN option/NN syndrome/NN PCOS/NNP
ethinyl/JJ estradiol/NN combined/VBN acetate/NNP licensed/VBN treatment/NN women/NNS acne/NN hirsutism/NN
estradiol/NN combined/VBN acetate/NNP licensed/VBN treatment/NN women/NNS acne/NN hirsutism/NN
EE/NNP acetate/NNP licensed/VBN treatment/NN women/NNS acne/NN hirsutism/NN
ethinyl/JJ estradiol/NN combined/VBN acetate/NNP licensed/VBN treatment/NN women/NNS acne/NN
estradiol/NN combined/VBN acetate/NNP licensed/VBN treatment/NN women/NNS acne/NN
EE/NNP acetate/NNP licensed/VBN treatment/NN women/NNS acne/NN
ethinyl/JJ estradiol/NN combined/VBN acetate/NNP licensed/VBN option/NN syndrome/NN polycystic/JJ
ethinyl/JJ estradiol/NN combined/VBN acetate/NNP licensed/VBN option/NN syndrome/NN ovary/NN
ethinyl/JJ estradiol/NN combined/VBN acetate/NNP licensed/VBN option/NN syndrome/NN
estradiol/NN combined/VBN acetate/NNP licensed/VBN option/NN syndrome/NN polycystic/JJ
estradiol/NN combined/VBN acetate/NNP licensed/VBN option/NN syndrome/NN ovary/NN
estradiol/NN combined/VBN acetate/NNP licensed/VBN option/NN syndrome/NN
ethinyl/JJ estradiol/NN combined/VBN acetate/NNP licensed/VBN option/NN syndrome/NN PCOS/NNP
estradiol/NN combined/VBN acetate/NNP licensed/VBN option/NN syndrome/NN PCOS/NNP
EE/NNP acetate/NNP licensed/VBN option/NN syndrome/NN polycystic/JJ
EE/NNP acetate/NNP licensed/VBN option/NN syndrome/NN ovary/NN
EE/NNP acetate/NNP licensed/VBN option/NN syndrome/NN
EE/NNP acetate/NNP licensed/VBN option/NN syndrome/NN PCOS/NNP
oral/JJ contraceptives/NNS associated/VBN thromboembolism/NN venous/JJ
oral/JJ contraceptives/NNS associated/VBN thromboembolism/NN
contraceptives/NNS associated/VBN thromboembolism/NN venous/JJ
contraceptives/NNS associated/VBN thromboembolism/NN
oral/JJ contraceptives/NNS associated/VBN thromboembolism/NN VTE/NNP
contraceptives/NNS associated/VBN thromboembolism/NN VTE/NNP
CPA/NNP EE/NNP associated/VBN VTE/NNP risk/NN estimate/VB aged/VBN years/NNS acne/NN hirsutism/NN
CPA/NNP EE/NNP associated/VBN VTE/NNP risk/NN estimate/VB aged/VBN years/NNS acne/NN
CPA/NNP EE/NNP associated/VBN VTE/NNP risk/NN estimate/VB aged/VBN years/NNS acne/NN PCOS/NNS
EE/NNP associated/VBN VTE/NNP risk/NN estimate/VB aged/VBN years/NNS acne/NN hirsutism/NN
EE/NNP associated/VBN VTE/NNP risk/NN estimate/VB aged/VBN years/NNS acne/NN
EE/NNP associated/VBN VTE/NNP risk/NN estimate/VB aged/VBN years/NNS acne/NN PCOS/NNS
CPA/NNP EE/NNP women/NNS acne/NN hirsutism/NN
CPA/NNP EE/NNP women/NNS acne/NN
CPA/NNP EE/NNP women/NNS acne/NN PCOS/NNS
EE/NNP women/NNS acne/NN hirsutism/NN
EE/NNP women/NNS acne/NN
EE/NNP women/NNS acne/NN PCOS/NNS
5/CD patients/NNS supervision/NN discontinued/VBN observed/JJ pain/NN tachyarrhythmia/NN
FU/NNP treatment/NN supervision/NN discontinued/VBN observed/JJ pain/NN tachyarrhythmia/NN
fentanyl/JJ administration/NN effects/NNS include/VBP rigidity/NN chest/NN
fentanyl/JJ administration/NN effects/NNS include/VBP rigidity/NN wall/NN
fentanyl/JJ administration/NN effects/NNS include/VBP rigidity/NN
fentanyl/NN infusion/NN result/NN mimicking/VBG hydronephrosis/NNS
LEV/NNP treated/VBN FINDINGS/NNS 28/CD year/NN man/NN suffering/VBG epilepsy/NN idiopathic/JJ
LEV/NNP treated/VBN FINDINGS/NNS 28/CD year/NN man/NN suffering/VBG epilepsy/NN
LEV/NNP treated/VBN FINDINGS/NNS 28/CD year/NN man/NN suffering/VBG seizures/NNS
valproate/NN added/VBN LEV/NNP treated/VBN FINDINGS/NNS 28/CD year/NN man/NN suffering/VBG seizures/NNS
VPA/NNP valproate/NN added/VBN LEV/NNP treated/VBN FINDINGS/NNS 28/CD year/NN man/NN suffering/VBG seizures/NNS
valproate/NN added/VBN LEV/NNP treated/VBN FINDINGS/NNS 28/CD year/NN man/NN suffering/VBG epilepsy/NN idiopathic/JJ
valproate/NN added/VBN LEV/NNP treated/VBN FINDINGS/NNS 28/CD year/NN man/NN suffering/VBG epilepsy/NN
VPA/NNP valproate/NN added/VBN LEV/NNP treated/VBN FINDINGS/NNS 28/CD year/NN man/NN suffering/VBG epilepsy/NN idiopathic/JJ
VPA/NNP valproate/NN added/VBN LEV/NNP treated/VBN FINDINGS/NNS 28/CD year/NN man/NN suffering/VBG epilepsy/NN
LEV/NNP discontinuation/NN improved/VBD decreased/VBD frequency/NN seizure/NN
ifosfamide/JJ toxicity/NN children/NNS treated/VBN tumors/NNS malignant/JJ
ifosfamide/JJ toxicity/NN children/NNS treated/VBN tumors/NNS mesenchymal/JJ
ifosfamide/JJ toxicity/NN children/NNS treated/VBN tumors/NNS
ifosfamide/JJ protocol/NN received/VBN children/NNS tumors/NNS malignant/JJ
ifosfamide/JJ protocol/NN received/VBN children/NNS tumors/NNS mesenchymal/JJ
ifosfamide/JJ protocol/NN received/VBN children/NNS tumors/NNS
ifosfamide/JJ protocol/NN Society/NNP -RSB-/NNS Malignant/NNP
ifosfamide/JJ protocol/NN Society/NNP -RSB-/NNS Mesenchymal/NNP
ifosfamide/JJ protocol/NN Society/NNP -RSB-/NNS Tumor/NNP
creatinine/JJ clearance/NN electrolytes/NNS proteinuria/NN
phosphate/JJ reabsorption/NN electrolytes/NNS proteinuria/NN
phosphate/JJ reabsorption/NN electrolytes/NNS glucosuria/NN
creatinine/JJ clearance/NN electrolytes/NNS glucosuria/NN
phosphate/JJ reabsorption/NN electrolytes/NNS aminoaciduria/NN
creatinine/JJ clearance/NN electrolytes/NNS aminoaciduria/NN
phosphate/NN reabsorption/NN microglobulinuria/NN included/VBD identified/VBN included/VBD patients/NNS developed/VBD toxicity/NN resulting/VBG syndrome/NN Fanconi/NNP
phosphate/NN reabsorption/NN microglobulinuria/NN included/VBD identified/VBN included/VBD patients/NNS developed/VBD toxicity/NN resulting/VBG syndrome/NN Fanconi/NNP '/POS
phosphate/NN reabsorption/NN microglobulinuria/NN included/VBD identified/VBN included/VBD patients/NNS developed/VBD toxicity/NN resulting/VBG syndrome/NN s/JJ
phosphate/NN reabsorption/NN microglobulinuria/NN included/VBD identified/VBN included/VBD patients/NNS developed/VBD toxicity/NN resulting/VBG syndrome/NN
phosphate/NN reabsorption/NN microglobulinuria/NN included/VBD identified/VBN included/VBD patients/NNS developed/VBD toxicity/NN resulting/VBG syndrome/NN TDFS/NNP
phosphate/NN reabsorption/NN microglobulinuria/NN included/VBD identified/VBN included/VBD patients/NNS developed/VBD toxicity/NN
ifosfamide/NN predominance/NN involvement/NN tumor/NN
ifosfamide/NN 2/CD correlated/VBN toxicity/NNP
ifosfamide/NN efficacy/NN evaluated/VBN treatment/NN tumors/NNS mesenchymal/JJ
ifosfamide/NN efficacy/NN evaluated/VBN treatment/NN tumors/NNS
MZ/NNP dose/NN age/NN myocardiopathy/NN
MZ/NNP dose/NN age/NN myocardiopathy/NN MP/NNP
MZ/NNP dose/NN age/NN myocardiopathy/NN duration/NN test/NN regurgitation/NN mitral/JJ
MZ/NNP dose/NN age/NN myocardiopathy/NN duration/NN test/NN regurgitation/NN
MZ/NNP dose/NN age/NN myocardiopathy/NN duration/NN test/NN regurgitation/NN MR/NNP
MZ/NNP dose/NN age/NN stroke/NN
MZ/NNP use/NN caused/VBN hypoxia/NN presented/VBD hypoxia/NN due/JJ obstruction/NN airway/NN
MZ/NNP use/NN caused/VBN hypoxia/NN presented/VBD hypoxia/NN due/JJ obstruction/NN
MZ/NNP doses/NNS MR/NN MP/NNP
MZ/NNP doses/NNS MR/NN
methyldopa/NN related/VBN disease/NN liver/NN
methyldopa/NN related/VBN disease/NN
methyldopa/NN taking/VBG another/DT showed/VBD died/VBD presented/VBN failure/NN hepatic/JJ
methyldopa/NN taking/VBG another/DT showed/VBD died/VBD presented/VBN failure/NN
methyldopa/NN episode/NN recommenced/VBN developed/VBD hepatitis/NN fulminant/JJ
methyldopa/NN episode/NN recommenced/VBN developed/VBD hepatitis/NN
methyldopa/NN hepatic/JJ
methyldopa/NN dysfunction/NN
streptomycin/NN effects/NNS neurotoxic/JJ
lidocaine/NN relieved/VBN spasm/NN
sodium/NN pentothal/NN infused/VBN minimize/VB ischaemia/NN cerebral/JJ
sodium/NN pentothal/NN infused/VBN minimize/VB ischaemia/NN
pentothal/NN infused/VBN minimize/VB ischaemia/NN cerebral/JJ
pentothal/NN infused/VBN minimize/VB ischaemia/NN
lidocaine/NN given/VBN counteract/VB vasospasm/NN
caffeine/NN toxicity/NN
acetaminophen/NN Reduction/NN toxicity/NN
caffeine/NN effects/NNS augment/VB reported/VBN focused/VBN reduced/VBD toxicity/NN
caffeine/NN toxicity/NN
acetaminophen/NN presence/NN reduced/VBD toxicity/NN
acetaminophen/NN increased/VBN interval/NN administration/NN onset/NN convulsions/NNS
acetaminophen/NN pretreatment/NN pretreatment/NN acetaminophen/NN reduced/VBN incidence/NN seizures/NNS
acetaminophen/NN pretreatment/NN pretreatment/NN acetaminophen/NN increased/VBN interval/NN administration/NN onset/NN convulsions/NNS
acetaminophen/NN reduced/VBN incidence/NN seizures/NNS
acetaminophen/NN reduced/VBN caffeine/NN 5/CD seizures/NNS
acetaminophen/NN modify/VB seizures/NNS
Bupropion/NNP toxicity/VBZ
Zyban/NNP Bupropion/NNP toxicity/VBZ
diazepam/NN treated/VBN treated/VBN tachycardia/NN
adenosine/NN treated/VBN tachycardia/NN
adenosine/NN treated/VBN treated/VBN seizures/NNS
diazepam/NN treated/VBN seizures/NNS
Zyban/NNP caused/VBD overdose/NN
Zyban/NNP caused/VBD neurological/JJ
Zyban/NNP caused/VBD neurological/JJ and/CC
Zyban/NNP caused/VBD neurological/JJ toxicity/NNS cardiovascular/JJ
Zyban/NNP caused/VBD neurological/JJ toxicity/NNS
cimetidine/JJ was/VBD liver/NN
cimetidine/JJ was/VBD liver/NN or/CC
cimetidine/JJ was/VBD liver/NN disease/NN kidney/NN
cimetidine/JJ was/VBD liver/NN disease/NN
cimetidine/JJ levels/NNS had/VBD disease/NN liver/NN
cimetidine/JJ levels/NNS had/VBD disease/NN liver/NN or/CC
cimetidine/JJ levels/NNS had/VBD disease/NN kidney/NN
cimetidine/JJ levels/NNS had/VBD disease/NN
terbutaline/JJ treatment/NN labor/NN preterm/NN
terbutaline/JJ treatment/NN labor/NN
terbutaline/NN labor/NN preterm/NN
terbutaline/NN labor/NN
cisplatin/NN study/NN therapy/NN cancers/NNS head/NN
cisplatin/NN study/NN therapy/NN cancers/NNS head/NN and/CC
cisplatin/NN study/NN therapy/NN cancers/NNS head/NN neck/NN
cisplatin/NN study/NN therapy/NN cancers/NNS
paclitaxel/JJ cisplatin/NN study/NN therapy/NN cancers/NNS head/NN
paclitaxel/JJ cisplatin/NN study/NN therapy/NN cancers/NNS head/NN and/CC
paclitaxel/JJ cisplatin/NN study/NN therapy/NN cancers/NNS head/NN neck/NN
paclitaxel/JJ cisplatin/NN study/NN therapy/NN cancers/NNS
cisplatin/NN combination/NN used/VBN reported/VBD cancer/NN head/NN
cisplatin/NN combination/NN used/VBN reported/VBD cancer/NN head/NN and/CC
cisplatin/NN combination/NN used/VBN reported/VBD cancer/NN head/NN neck/NN
cisplatin/NN combination/NN used/VBN reported/VBD cancer/NN
cisplatin/NN combination/NN used/VBN improved/VBN duration/NN patients/NNS ovarian/JJ
cisplatin/NN combination/NN used/VBN improved/VBN duration/NN patients/NNS cancer/NN
paclitaxel/NN reported/VBD used/VBN improved/VBN duration/NN patients/NNS ovarian/JJ
paclitaxel/NN reported/VBD used/VBN improved/VBN duration/NN patients/NNS cancer/NN
Taxol/NNP Bristol/NNP paclitaxel/NN reported/VBD used/VBN improved/VBN duration/NN patients/NNS ovarian/JJ
Taxol/NNP Bristol/NNP paclitaxel/NN reported/VBD used/VBN improved/VBN duration/NN patients/NNS cancer/NN
paclitaxel/JJ combination/NN used/VBN improved/VBN duration/NN patients/NNS ovarian/JJ
paclitaxel/JJ combination/NN used/VBN improved/VBN duration/NN patients/NNS cancer/NN
paclitaxel/NN reported/VBD cancer/NN head/NN
paclitaxel/NN reported/VBD cancer/NN head/NN and/CC
paclitaxel/NN reported/VBD cancer/NN head/NN neck/NN
paclitaxel/NN reported/VBD cancer/NN
Taxol/NNP Bristol/NNP paclitaxel/NN reported/VBD cancer/NN head/NN
Taxol/NNP Bristol/NNP paclitaxel/NN reported/VBD cancer/NN head/NN and/CC
Taxol/NNP Bristol/NNP paclitaxel/NN reported/VBD cancer/NN head/NN neck/NN
Taxol/NNP Bristol/NNP paclitaxel/NN reported/VBD cancer/NN
paclitaxel/JJ combination/NN used/VBN reported/VBD cancer/NN head/NN
paclitaxel/JJ combination/NN used/VBN reported/VBD cancer/NN head/NN and/CC
paclitaxel/JJ combination/NN used/VBN reported/VBD cancer/NN head/NN neck/NN
paclitaxel/JJ combination/NN used/VBN reported/VBD cancer/NN
cisplatin/NN escalating/VBG response/NN determine/VB trial/NNP initiated/VBD stimulating/VBG untreated/VBG head/NN
cisplatin/NN escalating/VBG response/NN determine/VB trial/NNP initiated/VBD stimulating/VBG untreated/VBG head/NN and/CC
cisplatin/NN escalating/VBG response/NN determine/VB trial/NNP initiated/VBD stimulating/VBG untreated/VBG head/NN carcinoma/NNS neck/NN
cisplatin/NN escalating/VBG response/NN determine/VB trial/NNP initiated/VBD stimulating/VBG untreated/VBG head/NN carcinoma/NNS
cisplatin/NN escalating/VBG response/NN toxicity/NN
paclitaxel/JJ doses/NNS escalating/VBG response/NN toxicity/NN
paclitaxel/JJ doses/NNS escalating/VBG response/NN determine/VB trial/NNP initiated/VBD stimulating/VBG untreated/VBG head/NN
paclitaxel/JJ doses/NNS escalating/VBG response/NN determine/VB trial/NNP initiated/VBD stimulating/VBG untreated/VBG head/NN and/CC
paclitaxel/JJ doses/NNS escalating/VBG response/NN determine/VB trial/NNP initiated/VBD stimulating/VBG untreated/VBG head/NN carcinoma/NNS neck/NN
paclitaxel/JJ doses/NNS escalating/VBG response/NN determine/VB trial/NNP initiated/VBD stimulating/VBG untreated/VBG head/NN carcinoma/NNS
paclitaxel/JJ doses/NNS escalating/VBG incorporate/VB permitted/VBN permits/VBZ toxicity/NN
cisplatin/NN first/JJ advanced/VBD head/NN
cisplatin/NN first/JJ advanced/VBD head/NN and/CC
cisplatin/NN first/JJ advanced/VBD head/NN neck/NN
cisplatin/NN first/JJ advanced/VBD cancer/NN
Paclitaxel/JJ cisplatin/NN first/JJ advanced/VBD head/NN
Paclitaxel/JJ cisplatin/NN first/JJ advanced/VBD head/NN and/CC
Paclitaxel/JJ cisplatin/NN first/JJ advanced/VBD head/NN neck/NN
Paclitaxel/JJ cisplatin/NN first/JJ advanced/VBD cancer/NN
desferrioxamine/NN receiving/VBG toxicity/NN Ocular/NN
desferrioxamine/NN receiving/VBG toxicity/NN Ocular/NN and/CC
desferrioxamine/NN receiving/VBG toxicity/NN Ocular/NN auditory/NN
desferrioxamine/NN receiving/VBG toxicity/NN
desferrioxamine/NN receiving/VBG period/NN monitored/VBN detection/NN toxicity/NN audiovisual/JJ
desferrioxamine/NN receiving/VBG period/NN monitored/VBN detection/NN toxicity/NN
dyschromatopsy/NN
dyschromatopsy/NN characterized/VBN pigmentary/VB
dyschromatopsy/NN characterized/VBN pigmentary/VB deposits/NNS retinal/JJ
dyschromatopsy/NN characterized/VBN pigmentary/VB deposits/NNS
dyschromatopsy/NN characterized/VBN origin/NN toxicity/NN Visual/JJ
dyschromatopsy/NN characterized/VBN origin/NN toxicity/NN
dyschromatopsy/NN characterized/VBN associated/JJ loss/NN a/DT
dyschromatopsy/NN characterized/VBN associated/JJ loss/NN
dyschromatopsy/NN characterized/VBN associated/JJ loss/NN acuity/NN of/IN
dyschromatopsy/NN characterized/VBN associated/JJ loss/NN acuity/NN visual/JJ
dyschromatopsy/NN characterized/VBN associated/JJ loss/NN acuity/NN
Desferrioxamine/JJ withdrawal/NN resulted/VBD patient/JJ reversal/NN loss/NN hearing/NN
Desferrioxamine/JJ withdrawal/NN resulted/VBD patient/JJ reversal/NN loss/NN
aluminium/NN
desferrioxamine/NN doses/NNS receiving/VBG patients/NNS appeared/VBD coincided/VBD normalization/NN levels/NNS ferritin/NN aluminium/NN
aluminium/NN ferritin/NN levels/NNS normalization/NN coincided/VBD appeared/VBD toxicity/NN
desferrioxamine/NN doses/NNS receiving/VBG patients/NNS appeared/VBD toxicity/NN
desferrioxamine/NN receiving/VBG patients/NNS complication/NN toxicity/NN audiovisual/JJ
desferrioxamine/NN receiving/VBG patients/NNS complication/NN toxicity/NN
Ginsenoside/NNP Rg/NNP restores/VBZ impairment/NN
Ginsenoside/NNP Rg/NNP restores/VBZ impairment/NN learning/VBG of/IN
Ginsenoside/NNP Rg/NNP restores/VBZ impairment/NN learning/VBG
Rg/NNP restores/VBZ impairment/NN
Rg/NNP restores/VBZ impairment/NN learning/VBG of/IN
Rg/NNP restores/VBZ impairment/NN learning/VBG
1/CD Rg/NNP restores/VBZ impairment/NN
1/CD Rg/NNP restores/VBZ impairment/NN learning/VBG of/IN
1/CD Rg/NNP restores/VBZ impairment/NN learning/VBG
Rg/NNP ameliorate/VB impairment/NN learning/NN
Rg/NNP ameliorate/VB impairment/NN
1/CD Rg/NNP ameliorate/VB impairment/NN learning/NN
1/CD Rg/NNP ameliorate/VB impairment/NN
ginsenoside/NN extracted/VBD Rg/NNP ameliorate/VB impairment/NN learning/NN
ginsenoside/NN extracted/VBD Rg/NNP ameliorate/VB impairment/NN
Rg/NNP effect/NN investigate/VB learning/VBG
Rg/NNP effect/NN investigate/VB learning/VBG impairment/NN
1/CD Rg/NNP effect/NN investigate/VB learning/VBG
1/CD Rg/NNP effect/NN investigate/VB learning/VBG impairment/NN
deferoxamine/JJ therapy/NN receiving/VBG studies/NNS neurotoxicity/NN auditory/JJ
deferoxamine/JJ therapy/NN receiving/VBG studies/NNS neurotoxicity/NN
iron/NN therapy/NN receiving/VBG anemia/NN
deferoxamine/VBP documented/VBN Visual/NN
deferoxamine/VBP documented/VBN Visual/NN and/CC
deferoxamine/VBP documented/VBN Visual/NN auditory/NN
deferoxamine/VBP documented/VBN neurotoxicity/RB
deferoxamine/VBP anemia/NN
iron/NN therapy/NN receiving/VBG anemia/NN deferoxamine/VBP documented/VBN Visual/NN
iron/NN therapy/NN receiving/VBG anemia/NN deferoxamine/VBP documented/VBN Visual/NN and/CC
iron/NN therapy/NN receiving/VBG anemia/NN deferoxamine/VBP documented/VBN Visual/NN auditory/NN
iron/NN therapy/NN receiving/VBG anemia/NN deferoxamine/VBP documented/VBN neurotoxicity/RB
deferoxamine/JJ doses/NNS receiving/VBG recommended/VBD mg/NN kg/VBN degree/NN abnormality/NN auditory/JJ
deferoxamine/JJ doses/NNS receiving/VBG recommended/VBD mg/NN kg/VBN degree/NN abnormality/NN
deferoxamine/JJ doses/NNS receiving/VBG recommended/VBD demonstrated/VBN toxicity/NN
deferoxamine/NN receiving/VBG receiving/VBG demonstrated/VBN deterioration/NN provided/VBD convincing/VBG cause/NN administration/NN ototoxicity/NN
deferoxamine/NN relation/NN cause/NN administration/NN ototoxicity/NN
pyridoxine/JJ responsive/JJ convulsions/NNS
isoniazid/JJ mg/NN infant/NN day/NN 17/CD kg/VBP admitted/VBN tuberculosis/NNP
pyridoxine/NN hours/NNS ceased/VBD fits/NNS
pyridoxine/JJ deficiency/NN aetiology/NN suggesting/VBG ceased/VBD fits/NNS
zidovudine/JJ individuals/NNS use/NN toxicity/NN didanosine/NN antibody/NN HIV/NN
zidovudine/JJ individuals/NNS use/NN toxicity/NN didanosine/NN antibody/NN
zidovudine/JJ individuals/NNS positive/JJ
AZT/NNP zidovudine/JJ individuals/NNS use/NN toxicity/NN didanosine/NN antibody/NN HIV/NN
AZT/NNP zidovudine/JJ individuals/NNS use/NN toxicity/NN didanosine/NN antibody/NN
AZT/NNP zidovudine/JJ individuals/NNS positive/JJ
didanosine/NN toxicity/NN
ddI/NN didanosine/NN toxicity/NN
zidovudine/JJ individuals/NNS use/NN toxicity/NN
AZT/NNP zidovudine/JJ individuals/NNS use/NN toxicity/NN
didanosine/NN antibody/NN HIV/NN
didanosine/NN antibody/NN
didanosine/NN toxicity/NN use/NN individuals/NNS positive/JJ
ddI/NN didanosine/NN antibody/NN HIV/NN
ddI/NN didanosine/NN antibody/NN
ddI/NN didanosine/NN toxicity/NN use/NN individuals/NNS positive/JJ
didanosine/NN normal/JJ returned/VBD mild/JJ developed/VBD characteristic/NN diabetes/NN
p/VBP shown/VBN factor/NN digluconate/NN associated/VBN cystitis/NNS
choloroaniline/NN factor/NN digluconate/NN associated/VBN cystitis/NNS
Picloxydine/JJ irrigations/NNS appeared/VBD have/VB incidence/NN cystitis/NNS
doxorubicin/NN model/NN damage/NN diagnosis/NN investigated/VBD examined/VBD development/NN disorders/NNS cardiac/JJ
doxorubicin/NN model/NN damage/NN diagnosis/NN investigated/VBD examined/VBD development/NN disorders/NNS
DOX/NNP doxorubicin/NN model/NN damage/NN diagnosis/NN investigated/VBD examined/VBD development/NN disorders/NNS cardiac/JJ
DOX/NNP doxorubicin/NN model/NN damage/NN diagnosis/NN investigated/VBD examined/VBD development/NN disorders/NNS
DOX/NNP rats/NNS Eighteen/CD died/VBN toxicity/NN
DOX/NNP given/VBN rats/NNS hearts/NNS evaluation/NN revealed/VBD degrees/NNS fibrosis/NN
DOX/NNP injury/NN ischemic/JJ
DOX/NNP injury/NN
DOX/NNP was/VBD is/VBZ induced/VBN cardiotoxicity/RB
DOX/NNP indicates/VBZ rats/NNS cTnT/NN induced/VBN cardiotoxicity/RB
docetaxel/JJ cancer/NN prostate/NN
docetaxel/JJ cancer/NN
thalidomide/JJ docetaxel/JJ cancer/NN prostate/NN
thalidomide/JJ docetaxel/JJ cancer/NN
docetaxel/NN treated/VBN cancer/NN prostate/NN
docetaxel/NN treated/VBN cancer/NN
thalidomide/NN treated/VBN cancer/NN prostate/NN
thalidomide/NN treated/VBN cancer/NN
docetaxel/VB treatment/NN cancer/NN prostate/NN
docetaxel/VB treatment/NN cancer/NN
thalidomide/NN addition/NN docetaxel/VB treatment/NN cancer/NN prostate/NN
thalidomide/NN addition/NN docetaxel/VB treatment/NN cancer/NN
cocaine/NN abusers/NNS hospitalized/VBN evidence/NN injury/NN myocardial/JJ
cocaine/NN abusers/NNS hospitalized/VBN evidence/NN injury/NN
cocaine/NN electrocardiograms/NNS compared/VBN ECGs/NNPS controls/NNS schizophrenic/JJ
cocaine/NN abusers/NNS Eleven/CD had/VBD evidence/NN injury/NN defined/VBN infarction/NN ischemia/NN
cocaine/NN abusers/NNS Eleven/CD had/VBD evidence/NN injury/NN myocardial/JJ
cocaine/NN abusers/NNS Eleven/CD had/VBD evidence/NN injury/NN
telithromycin/NN mg/NN PO/VBP treat/VB infection/NN upper/JJ
telithromycin/NN mg/NN PO/VBP treat/VB infection/NN respiratory/JJ
telithromycin/NN mg/NN PO/VBP treat/VB infection/NN tract/NN
telithromycin/NN mg/NN PO/VBP treat/VB infection/NN
telithromycin/NN cause/NN score/NN 8/CD scale/NN adverse/JJ
telithromycin/NN cause/NN score/NN 8/CD scale/NN drug/NN
telithromycin/NN cause/NN score/NN 8/CD scale/NN reaction/NN
tacrolimus/NNS mapping/NN imaging/NNP neurotoxicity/NN
tacrolimus/NNS developed/VBD complications/NNS neurologic/JJ
tacrolimus/NNS developed/VBD complications/NNS
tacrolimus/NNS lesions/NNS outcomes/NNS predicting/VBG useful/JJ Diffusion/NNP induced/VBN neurotoxicity/RB
dexamethasone/JJ given/VBN rats/NNS had/VBD glomeruli/NNS glomerulosclerosis/NNS
dexamethasone/NN shows/VBZ results/NNS reduction/NN number/NN glomerulosclerosis/NNS
methamphetamine/NN Attenuation/NNP neurotoxicity/NN
lipopolysaccharide/JJ pretreatment/NN mice/NNS neurotoxicity/NN
methamphetamine/NN induced/VBN damage/NN dopaminergic/JJ
methamphetamine/NN induced/VBN damage/NN terminal/NN
methamphetamine/NN induced/VBN damage/NN
dopamine/NN induced/VBN modulating/VBG neurotoxicity/NN
methamphetamine/NN modulating/VBG neurotoxicity/NN
lipopolysaccharide/NN roles/NNS neurotoxicity/NN
Lipopolysaccharide/JJ pretreatment/NN affect/VB temperature/NN hyperthermia/NN
dopamine/VBP neurotoxicity/RB
methamphetamine/NN exerting/VBG concluded/VBD dopamine/VBP neurotoxicity/RB
lipopolysaccharide/NN pretreatment/NN concluded/VBD dopamine/VBP neurotoxicity/RB
dyazide/JJ therapy/NN complicating/VBG nephrolithiasis/VBZ
hydrochlorothiazide/NN years/NNS reported/VBN case/NN nephrolithiasis/NNS
triamterene/JJ therapy/NN years/NNS reported/VBN case/NN nephrolithiasis/NNS
triamterene/JJ nephrolithiasis/NNS case/NN reported/VBN years/NNS therapy/NN hypertension/NN
hydrochlorothiazide/NN years/NNS therapy/NN hypertension/NN
triamterene/JJ therapy/NN hypertension/NN
Curcumin/NNP ameliorates/VBZ dysfunction/NN cognitive/JJ
Curcumin/NNP ameliorates/VBZ dysfunction/NN
curcumin/NN administration/NN effect/NN investigate/VB impairment/NN cognitive/JJ
curcumin/NN administration/NN effect/NN investigate/VB impairment/NN
curcumin/NN administration/NN prevented/VBD impairment/NN cognitive/JJ
curcumin/NN administration/NN prevented/VBD impairment/NN
curcumin/NN has/VBZ effect/NN mitigating/VBG deterioration/NN
curcumin/NN has/VBZ effect/NN mitigating/VBG deterioration/NN functions/NNS of/IN
curcumin/NN has/VBZ effect/NN mitigating/VBG deterioration/NN functions/NNS cognitive/JJ
curcumin/NN has/VBZ effect/NN mitigating/VBG deterioration/NN functions/NNS
curcumin/NN considered/VBN phenobarbitone/VB preventing/VBG impairment/NN cognitive/JJ
curcumin/NN considered/VBN phenobarbitone/VB preventing/VBG impairment/NN
CsA/NNP treated/VBN group/NN worst/JJS showed/VBD analysis/NN grade/NN fibrosis/NN
SRL/NNP CsA/NNP treated/VBN group/NN worst/JJS showed/VBD analysis/NN grade/NN fibrosis/NN
FK/NNP 506/NNP showed/VBD degree/NN fibrosis/NN
506/NNP showed/VBD degree/NN fibrosis/NN
SRL/NNP combination/NN 506/NNP showed/VBD degree/NN fibrosis/NN
ritodrine/NN labor/NN preterm/NN
ritodrine/NN labor/NN
ritodrine/NN effects/NNS interactions/NNS risk/VB patients/NNS receiving/VBG ritodrine/NN labor/NN preterm/NN
ritodrine/NN effects/NNS interactions/NNS risk/VB patients/NNS receiving/VBG ritodrine/NN labor/NN
ritodrine/NN infusion/NN cessation/NN result/VB complications/NNS cardiovascular/JJ
ritodrine/NN infusion/NN cessation/NN result/VB complications/NNS
phenylephrine/NN treat/VB tachycardia/NN
phenylephrine/NN treat/VB patients/NNS hypotensive/JJ
Ro/NNP 4368554/NNP restores/VBZ models/NNS deficiency/NN memory/NN
Ro/NNP 4368554/NNP restores/VBZ models/NNS deficiency/NN
4368554/NNP restores/VBZ models/NNS deficiency/NN memory/NN
4368554/NNP restores/VBZ models/NNS deficiency/NN
metrifonate/NN i/FW kg/NN reversed/VBD induced/VBN deficits/NNS memory/NN
metrifonate/NN i/FW kg/NN reversed/VBD induced/VBN deficits/NNS
TRP/NN scopolamine/NN depletion/NN induced/VBN deficits/NNS memory/NN
TRP/NN scopolamine/NN depletion/NN induced/VBN deficits/NNS
Ro/NNP reversed/VBD induced/VBN deficits/NNS memory/NN
Ro/NNP reversed/VBD induced/VBN deficits/NNS
4368554/CD Ro/NNP reversed/VBD induced/VBN deficits/NNS memory/NN
4368554/CD Ro/NNP reversed/VBD induced/VBN deficits/NNS
Ro/NNP 4368554/NNP improve/VB reversed/VBD cholinergic/NN deficit/NN memory/NN
Ro/NNP 4368554/NNP improve/VB reversed/VBD cholinergic/NN deficit/NN
4368554/NNP improve/VB reversed/VBD cholinergic/NN deficit/NN memory/NN
4368554/NNP improve/VB reversed/VBD cholinergic/NN deficit/NN
Ro/NNP memory/NN facilitation/NN involved/VBN suggesting/VBG reversed/VBD cholinergic/NN deficit/NN memory/NN
Ro/NNP memory/NN facilitation/NN involved/VBN suggesting/VBG reversed/VBD cholinergic/NN deficit/NN
4368554/CD Ro/NNP memory/NN facilitation/NN involved/VBN suggesting/VBG reversed/VBD cholinergic/NN deficit/NN memory/NN
4368554/CD Ro/NNP memory/NN facilitation/NN involved/VBN suggesting/VBG reversed/VBD cholinergic/NN deficit/NN
5/CD involved/VBN suggesting/VBG reversed/VBD cholinergic/NN deficit/NN memory/NN
5/CD involved/VBN suggesting/VBG reversed/VBD cholinergic/NN deficit/NN
HT/NNP 5/CD involved/VBN suggesting/VBG reversed/VBD cholinergic/NN deficit/NN memory/NN
HT/NNP 5/CD involved/VBN suggesting/VBG reversed/VBD cholinergic/NN deficit/NN
Estradiol/NNP reduces/VBZ seizure/NN
Estradiol/NNP reduces/VBZ seizure/NN induced/VBN injury/NN hippocampal/JJ
Estradiol/NNP reduces/VBZ seizure/NN induced/VBN injury/NN
kainic/JJ acid/NN induced/VBN injury/NN hippocampal/JJ
kainic/JJ acid/NN induced/VBN injury/NN
acid/NN induced/VBN injury/NN hippocampal/JJ
acid/NN induced/VBN injury/NN
kainic/JJ acid/NN induced/VBN injury/NN epilepticus/NNS status/NN
kainic/JJ acid/NN induced/VBN injury/NN epilepticus/NNS
acid/NN induced/VBN injury/NN epilepticus/NNS status/NN
acid/NN induced/VBN injury/NN epilepticus/NNS
kainic/JJ acid/NN induced/VBN injury/NN epilepticus/NNS SE/NNP
acid/NN induced/VBN injury/NN epilepticus/NNS SE/NNP
17/CD beta/NN effects/NNS pilocarpine/NN SE/NNP
beta/NN effects/NNS pilocarpine/NN SE/NNP
estradiol/JJ effects/NNS pilocarpine/NN SE/NNP
17/CD beta/NN alter/VB extent/NN CA/NNS evaluated/VBN SE/NNP
beta/NN alter/VB extent/NN CA/NNS evaluated/VBN SE/NNP
Estradiol/NNP alter/VB extent/NN CA/NNS evaluated/VBN SE/NNP
silver/NN extent/NN CA/NNS evaluated/VBN SE/NNP
estradiol/NN threshold/NN seizure/NN
ciprofloxacin/NN suspect/NN infection/NN urinary/JJ
ciprofloxacin/NN suspect/NN infection/NN tract/NN
ciprofloxacin/NN suspect/NN infection/NN
dopamine/NN formation/NN dopa/NN Mediation/NNP bradycardia/NN
L/NNP bradycardia/NN
dopa/NN Mediation/NNP bradycardia/NN
DL/NNP dopa/NN Threo/NNP enhanced/VBN bradycardia/NN
Threo/NNP enhanced/VBN bradycardia/NN
dihydroxyphenylserine/NN had/VBD enhanced/VBN bradycardia/NN
L/NNP Threo/NNP enhanced/VBN bradycardia/NN
dopa/NN Threo/NNP enhanced/VBN bradycardia/NN
dopamine/NN 63/CD beta/NNP have/VB effect/NN hypotension/NN
dopamine/NN 63/CD beta/NNP have/VB effect/NN hypotension/NN bradycardia/NN
L/NNP effect/NN dopa/NN hypotension/NN
dopa/NN hypotension/NN
FLA/NNP beta/NNP have/VB effect/NN hypotension/NN bradycardia/NN
63/CD beta/NNP have/VB effect/NN hypotension/NN bradycardia/NN
L/NNP effect/NN dopa/NN hypotension/NN bradycardia/NN
dopa/NN hypotension/NN bradycardia/NN
FLA/NNP beta/NNP have/VB effect/NN hypotension/NN
63/CD beta/NNP have/VB effect/NN hypotension/NN
L/NNP restored/VBD bradycardia/NN
dopa/NN L/NNP restored/VBD bradycardia/NN
5/CD decreased/VBD decreased/VBD bradycardia/NN
HTP/NNP decreased/VBD decreased/VBD bradycardia/NN
L/JJ stimulation/NN enhances/VBZ bradycardia/NN
dopa/NN enhances/VBZ bradycardia/NN
isoflurane/JJ anaesthesia/NN fusion/NN postero/NN underwent/VBD patients/NNS using/VBG measured/VBN evaluate/VB effect/NN E/NN trimethaphan/NN induced/VBN hypotension/NN
tobramycin/NN nephrotoxicity/NN
gentamicin/NN tobramycin/NN nephrotoxicity/NN
tobramycin/NN sulfate/NNS sulfate/NN continue/VBP demonstrate/VB ototoxicity/NN nephrotoxicity/NN
sulfate/NNS sulfate/NN continue/VBP demonstrate/VB ototoxicity/NN nephrotoxicity/NN
Gentamicin/NN sulfate/NN continue/VBP demonstrate/VB ototoxicity/NN
sulfate/NN continue/VBP demonstrate/VB ototoxicity/NN
tobramycin/NN sulfate/NNS sulfate/NN continue/VBP demonstrate/VB ototoxicity/NN
sulfate/NNS sulfate/NN continue/VBP demonstrate/VB ototoxicity/NN
Gentamicin/NN sulfate/NN continue/VBP demonstrate/VB ototoxicity/NN nephrotoxicity/NN
sulfate/NN continue/VBP demonstrate/VB ototoxicity/NN nephrotoxicity/NN
aminoglycoside/NN development/NN followed/VBN failure/NN renal/JJ
aminoglycoside/NN development/NN followed/VBN failure/NN
gamma/NN effects/NNS induced/NNP seizures/NNS
hexachlorocyclohexane/NN effects/NNS induced/NNP seizures/NNS
lindane/NN hexachlorocyclohexane/NN effects/NNS induced/NNP seizures/NNS
Gamma/NNP shown/VBN decrease/VB threshold/NN seizure/NN
hexachlorocyclohexane/NN shown/VBN decrease/VB threshold/NN seizure/NN
Gamma/NNP shown/VBN decrease/VB pentylenetrazol/NN h/NN seizures/NNS
hexachlorocyclohexane/NN shown/VBN decrease/VB pentylenetrazol/NN h/NN seizures/NNS
gamma/NN hexachlorocyclohexane/NN shown/VBN decrease/VB threshold/NN seizure/NN
HCH/NNP gamma/NN hexachlorocyclohexane/NN shown/VBN decrease/VB threshold/NN seizure/NN
gamma/NN hexachlorocyclohexane/NN shown/VBN decrease/VB pentylenetrazol/NN h/NN seizures/NNS
HCH/NNP gamma/NN hexachlorocyclohexane/NN shown/VBN decrease/VB pentylenetrazol/NN h/NN seizures/NNS
lindane/NN ingredient/NN hexachlorocyclohexane/NN shown/VBN decrease/VB threshold/NN seizure/NN
lindane/NN ingredient/NN hexachlorocyclohexane/NN shown/VBN decrease/VB pentylenetrazol/NN h/NN seizures/NNS
gamma/NN exposure/NN h/NN pentylenetrazol/NN decrease/VB threshold/NN seizure/NN
HCH/NN threshold/NN h/NN pentylenetrazol/NN decrease/VB threshold/NN seizure/NN
gamma/NN exposure/NN h/NN seizures/NNS
HCH/NN threshold/NN h/NN seizures/NNS
gamma/NN exposure/NN h/NN seizures/NNS h/NN pentylenetrazol/NN decrease/VB threshold/NN seizure/NN
HCH/NNP h/NN pentylenetrazol/NN decrease/VB threshold/NN seizure/NN
gamma/NN exposure/NN h/NN seizures/NNS
HCH/NNP h/NN seizures/NNS
gamma/NN kg/VBP severity/NN response/NN seizure/NN
HCH/NNP gamma/NN kg/VBP severity/NN response/NN seizure/NN
gamma/NN administration/NN activity/NN seizure/NN
HCH/NNP administration/NN activity/NN seizure/NN
gamma/NN h/NN observed/JJ increased/VBN hour/NN inducing/VBG administration/NN activity/NN seizure/NN
HCH/NNP gamma/NN h/NN observed/JJ increased/VBN hour/NN inducing/VBG administration/NN activity/NN seizure/NN
gamma/NN PTX/VB occur/VB activity/NN seizure/NN
HCH/NNP decreased/VBN suggest/VBP occur/VB activity/NN seizure/NN
gamma/NN PTX/VB occur/VB suggest/VBP decreased/VBN HCH/NNP response/NN seizure/NNS
HCH/NNP response/NN seizure/NNS
gamma/NN linked/VBD h/VBP site/NN responsible/JJ decrease/NN activity/NN seizure/NN
HCH/NNP GABA/NNP gamma/NN linked/VBD h/VBP site/NN responsible/JJ decrease/NN activity/NN seizure/NN
GABA/NNP gamma/NN linked/VBD h/VBP site/NN responsible/JJ decrease/NN activity/NN seizure/NN
Alpha/NNP prevents/VBZ damage/NN mitochondrial/JJ
Alpha/NNP prevents/VBZ damage/NN
lipoic/JJ acid/NN prevents/VBZ damage/NN mitochondrial/JJ
lipoic/JJ acid/NN prevents/VBZ damage/NN
acid/NN prevents/VBZ damage/NN mitochondrial/JJ
acid/NN prevents/VBZ damage/NN
Alpha/NNP prevents/VBZ damage/NN neurotoxicity/NN
lipoic/JJ acid/NN prevents/VBZ damage/NN neurotoxicity/NN
acid/NN prevents/VBZ damage/NN neurotoxicity/NN
Alpha/NNP prevents/VBZ neuropathy/NN
lipoic/JJ acid/NN prevents/VBZ neuropathy/NN
acid/NN prevents/VBZ neuropathy/NN
alpha/NN neuroprotective/JJ chemotherapy/NN induced/VBN plays/VBZ damage/NN mitochondrial/JJ
alpha/NN neuroprotective/JJ chemotherapy/NN induced/VBN plays/VBZ damage/NN
lipoic/JJ acid/NN neuroprotective/JJ chemotherapy/NN induced/VBN plays/VBZ damage/NN mitochondrial/JJ
lipoic/JJ acid/NN neuroprotective/JJ chemotherapy/NN induced/VBN plays/VBZ damage/NN
acid/NN neuroprotective/JJ chemotherapy/NN induced/VBN plays/VBZ damage/NN mitochondrial/JJ
acid/NN neuroprotective/JJ chemotherapy/NN induced/VBN plays/VBZ damage/NN
alpha/NNP effects/NNS neuroprotective/VBP plays/VBZ damage/NN mitochondrial/JJ
alpha/NNP effects/NNS neuroprotective/VBP plays/VBZ damage/NN
lipoic/JJ acid/NN alpha/NN neuroprotective/JJ chemotherapy/NN induced/VBN plays/VBZ damage/NN mitochondrial/JJ
lipoic/JJ acid/NN alpha/NN neuroprotective/JJ chemotherapy/NN induced/VBN plays/VBZ damage/NN
acid/NN alpha/NN neuroprotective/JJ chemotherapy/NN induced/VBN plays/VBZ damage/NN mitochondrial/JJ
acid/NN alpha/NN neuroprotective/JJ chemotherapy/NN induced/VBN plays/VBZ damage/NN
alpha/NN neuroprotective/JJ chemotherapy/NN induced/VBN neurotoxicity/RB
lipoic/JJ acid/NN neuroprotective/JJ chemotherapy/NN induced/VBN neurotoxicity/RB
acid/NN neuroprotective/JJ chemotherapy/NN induced/VBN neurotoxicity/RB
alpha/NNP effects/NNS neuroprotective/VBP plays/VBZ induced/VBN neurotoxicity/RB
lipoic/JJ acid/NN alpha/NN neuroprotective/JJ chemotherapy/NN induced/VBN neurotoxicity/RB
acid/NN alpha/NN neuroprotective/JJ chemotherapy/NN induced/VBN neurotoxicity/RB
alpha/NN neuroprotective/JJ chemotherapy/NN induced/VBN plays/VBZ role/NN cascade/NN toxic/JJ
alpha/NN neuroprotective/JJ chemotherapy/NN induced/VBN plays/VBZ role/NN cascade/NN neurodegenerative/NN
alpha/NN neuroprotective/JJ chemotherapy/NN induced/VBN plays/VBZ role/NN cascade/NN
lipoic/JJ acid/NN neuroprotective/JJ chemotherapy/NN induced/VBN plays/VBZ role/NN cascade/NN toxic/JJ
lipoic/JJ acid/NN neuroprotective/JJ chemotherapy/NN induced/VBN plays/VBZ role/NN cascade/NN neurodegenerative/NN
lipoic/JJ acid/NN neuroprotective/JJ chemotherapy/NN induced/VBN plays/VBZ role/NN cascade/NN
acid/NN neuroprotective/JJ chemotherapy/NN induced/VBN plays/VBZ role/NN cascade/NN toxic/JJ
acid/NN neuroprotective/JJ chemotherapy/NN induced/VBN plays/VBZ role/NN cascade/NN neurodegenerative/NN
acid/NN neuroprotective/JJ chemotherapy/NN induced/VBN plays/VBZ role/NN cascade/NN
alpha/NNP effects/NNS neuroprotective/VBP plays/VBZ role/NN cascade/NN toxic/JJ
alpha/NNP effects/NNS neuroprotective/VBP plays/VBZ role/NN cascade/NN neurodegenerative/NN
alpha/NNP effects/NNS neuroprotective/VBP plays/VBZ role/NN cascade/NN
lipoic/JJ acid/NN alpha/NN neuroprotective/JJ chemotherapy/NN induced/VBN plays/VBZ role/NN cascade/NN toxic/JJ
lipoic/JJ acid/NN alpha/NN neuroprotective/JJ chemotherapy/NN induced/VBN plays/VBZ role/NN cascade/NN neurodegenerative/NN
lipoic/JJ acid/NN alpha/NN neuroprotective/JJ chemotherapy/NN induced/VBN plays/VBZ role/NN cascade/NN
acid/NN alpha/NN neuroprotective/JJ chemotherapy/NN induced/VBN plays/VBZ role/NN cascade/NN toxic/JJ
acid/NN alpha/NN neuroprotective/JJ chemotherapy/NN induced/VBN plays/VBZ role/NN cascade/NN neurodegenerative/NN
acid/NN alpha/NN neuroprotective/JJ chemotherapy/NN induced/VBN plays/VBZ role/NN cascade/NN
alpha/NN acid/NN preventing/VBG damage/NN axonal/JJ
alpha/NN acid/NN preventing/VBG damage/NN
lipoic/JJ acid/NN preventing/VBG damage/NN axonal/JJ
lipoic/JJ acid/NN preventing/VBG damage/NN
acid/NN preventing/VBG damage/NN axonal/JJ
acid/NN preventing/VBG damage/NN
alpha/NN preventing/VBG damage/NN axonal/JJ
alpha/NN preventing/VBG damage/NN
lipoic/JJ acid/NN alpha/NN acid/NN preventing/VBG damage/NN axonal/JJ
lipoic/JJ acid/NN alpha/NN acid/NN preventing/VBG damage/NN
acid/NN alpha/NN acid/NN preventing/VBG damage/NN axonal/JJ
acid/NN alpha/NN acid/NN preventing/VBG damage/NN
paclitaxel/NN cisplatin/NN cause/VBP impairment/NN mitochondrial/JJ
paclitaxel/NN cisplatin/NN cause/VBP impairment/NN
cisplatin/NN cause/VBP impairment/NN mitochondrial/JJ
cisplatin/NN cause/VBP impairment/NN
Alpha/NNP exerts/VBZ rescues/VBZ toxicity/NN mitochondrial/JJ
Alpha/NNP exerts/VBZ rescues/VBZ toxicity/NN
lipoic/JJ acid/NN exerts/VBZ rescues/VBZ toxicity/NN mitochondrial/JJ
lipoic/JJ acid/NN exerts/VBZ rescues/VBZ toxicity/NN
acid/NN exerts/VBZ rescues/VBZ toxicity/NN mitochondrial/JJ
acid/NN exerts/VBZ rescues/VBZ toxicity/NN
Alpha/NNP exerts/VBZ chemotherapy/NN induced/VBN neurotoxicity/RB
lipoic/JJ acid/NN exerts/VBZ chemotherapy/NN induced/VBN neurotoxicity/RB
acid/NN exerts/VBZ chemotherapy/NN induced/VBN neurotoxicity/RB
paclitaxel/NN event/NN toxicity/NN mitochondrial/JJ
paclitaxel/NN event/NN toxicity/NN
paclitaxel/NN induced/VBN neurotoxicity/RB
cisplatin/NN paclitaxel/NN induced/VBN neurotoxicity/RB
cisplatin/NN paclitaxel/NN event/NN toxicity/NN mitochondrial/JJ
cisplatin/NN paclitaxel/NN event/NN toxicity/NN
alpha/NN suggest/VBP reduce/VB risk/NN developing/VBG toxicity/NN peripheral/JJ
alpha/NN suggest/VBP reduce/VB risk/NN developing/VBG toxicity/NN nerve/NN
alpha/NN suggest/VBP reduce/VB risk/NN developing/VBG toxicity/NN
lipoic/JJ acid/NN reduce/VB risk/NN developing/VBG toxicity/NN peripheral/JJ
lipoic/JJ acid/NN reduce/VB risk/NN developing/VBG toxicity/NN nerve/NN
lipoic/JJ acid/NN reduce/VB risk/NN developing/VBG toxicity/NN
acid/NN reduce/VB risk/NN developing/VBG toxicity/NN peripheral/JJ
acid/NN reduce/VB risk/NN developing/VBG toxicity/NN nerve/NN
acid/NN reduce/VB risk/NN developing/VBG toxicity/NN
prostaglandin/NN E/NNP effects/NNS hypotension/NN haemodilution/NN
E/NNP effects/NNS hypotension/NN haemodilution/NN
1/CD E/NNP effects/NNS hypotension/NN haemodilution/NN
prostaglandin/NN E/NN hypotension/NN haemodilution/NN
E/NN hypotension/NN haemodilution/NN
1/CD E/NN hypotension/NN haemodilution/NN
PGE/NNP 1/CD E/NN hypotension/NN haemodilution/NN
1/CD PGE/NNP 1/CD E/NN hypotension/NN haemodilution/NN
dextran/NN solution/NN amount/NN replacing/VBG withdrawing/VBG produced/VBN Haemodilution/NNP
bilirubin/NN SGOT/NNP showed/VBD showed/VBD decrease/NN decrease/NN'' min/NN start/NN hypotension/NN
PGE/NNP min/NN hypotension/NN haemodilution/NN
1/CD PGE/NNP min/NN hypotension/NN haemodilution/NN
Simvastatin/NNP induced/VBN syndrome/NN myonecrosis/NNS
Simvastatin/NNP induced/VBN syndrome/NN myonecrosis/NNS associated/VBN hypothyroidism/NN
simvastatin/NN thyroxine/NN presented/VBN syndrome/NN myonecrosis/NNS
simvastatin/NN thyroxine/NN taking/VBG male/NN hypothyroid/JJ
thyroxine/NN taking/VBG male/NN hypothyroid/JJ
thyroxine/NN presented/VBN syndrome/NN myonecrosis/NNS
thyroxine/NN presented/VBN syndrome/NN compartment/NN
thyroxine/NN presented/VBN syndrome/NN
fucoidan/NN treatment/NN Effect/NN hemorrhage/NN intracerebral/JJ
fucoidan/NN treatment/NN Effect/NN hemorrhage/NN
fucoidan/NN reported/VBN reduce/VB damage/NN brain/NN
fucoidan/NN reported/VBN reduce/VB damage/NN
fucoidan/NN reported/VBN model/NN hemorrhage/NN intracerebral/JJ
fucoidan/NN reported/VBN model/NN hemorrhage/NN
Fucoidan/NNP treated/VBN exhibited/VBD tended/VBD have/VB inflammation/NN
Fucoidan/NNP treated/VBN exhibited/VBD had/VBD hematomas/NNS
Fucoidan/NNP treated/VBN exhibited/VBD tended/VBD have/VB inflammation/NN vicinity/NN hematoma/NN
oxygen/NN species/NNS implicated/VBN induced/VBN antioxidants/NNS reducing/VBG proteinuria/NN
oxygen/NN species/NNS implicated/VBN induced/VBN nephropathy/RB
haloperidol/NN behaviors/NNS disease/NN Alzheimer/NNP
haloperidol/NN behaviors/NNS disease/NN Alzheimer/NNP '/POS
haloperidol/NN behaviors/NNS disease/NN s/JJ
haloperidol/NN behaviors/NNS disease/NN
haloperidol/NN behaviors/NNS psychosis/JJ disruptive/JJ
haloperidol/NN behaviors/NNS
haloperidol/NN behaviors/NNS psychosis/JJ
haloperidol/NN doses/NNS effects/NNS compare/VB patients/NNS disease/NN Alzheimer/NNP
haloperidol/NN doses/NNS effects/NNS compare/VB patients/NNS disease/NN Alzheimer/NNP '/POS
haloperidol/NN doses/NNS effects/NNS compare/VB patients/NNS disease/NN s/JJ
haloperidol/NN doses/NNS effects/NNS compare/VB patients/NNS disease/NN
haloperidol/NN doses/NNS effects/NNS compare/VB treatment/NN behaviors/NNS psychosis/JJ disruptive/JJ
haloperidol/NN doses/NNS effects/NNS compare/VB treatment/NN behaviors/NNS
haloperidol/NN doses/NNS effects/NNS compare/VB treatment/NN behaviors/NNS psychosis/JJ
haloperidol/RB 2/CD trial/NN 6/CD //VBD compared/VBN outpatients/NNS disease/NN Alzheimer/NNP
haloperidol/RB 2/CD trial/NN 6/CD //VBD compared/VBN outpatients/NNS disease/NN Alzheimer/NNP '/POS
haloperidol/RB 2/CD trial/NN 6/CD //VBD compared/VBN outpatients/NNS disease/NN s/JJ
haloperidol/RB 2/CD trial/NN 6/CD //VBD compared/VBN outpatients/NNS disease/NN
haloperidol/NN 6/CD //VBD compared/VBN outpatients/NNS disease/NN Alzheimer/NNP
haloperidol/NN 6/CD //VBD compared/VBN outpatients/NNS disease/NN Alzheimer/NNP '/POS
haloperidol/NN 6/CD //VBD compared/VBN outpatients/NNS disease/NN s/JJ
haloperidol/NN 6/CD //VBD compared/VBN outpatients/NNS disease/NN
haloperidol/NN efficacious/JJ efficacious/JJ' agitation/NN psychomotor/NN
haloperidol/NN efficacious/JJ efficacious/JJ' agitation/NN
haloperidol/NN low/JJ factor/NN efficacious/JJ efficacious/JJ' agitation/NN psychomotor/NN
haloperidol/NN low/JJ factor/NN efficacious/JJ efficacious/JJ' agitation/NN
haloperidol/NN efficacious/JJ factor/NN psychosis/NN
haloperidol/NN low/JJ factor/NN psychosis/NN
haloperidol/NN observed/VBN window/NN apply/VB neuroleptics/NNS used/VBN patients/NNS Alzheimer/NNP
haloperidol/NN observed/VBN window/NN apply/VB neuroleptics/NNS used/VBN patients/NNS Alzheimer/NNP '/POS
haloperidol/NN observed/VBN window/NN apply/VB neuroleptics/NNS used/VBN patients/NNS s/JJ
haloperidol/NN observed/VBN window/NN apply/VB neuroleptics/NNS used/VBN patients/NNS disease/NN
haloperidol/NN observed/VBN window/NN apply/VB neuroleptics/NNS used/VBN behaviors/NNS psychosis/JJ disruptive/JJ
haloperidol/NN observed/VBN window/NN apply/VB neuroleptics/NNS used/VBN behaviors/NNS
haloperidol/NN observed/VBN window/NN apply/VB neuroleptics/NNS used/VBN behaviors/NNS psychosis/JJ
PG/NNP test/NN passive/NN prevented/VBD amnesia/NN
9/CD prevented/VBD amnesia/NN
PG/NNP induced/VBN amnesia/NN
9/CD able/JJ PG/NNP induced/VBN amnesia/NN
Selegiline/NNP hypotension/NN disease/NN Parkinson/NNP
Selegiline/NNP hypotension/NN disease/NN Parkinson/NNP '/POS
Selegiline/NNP hypotension/NN disease/NN s/JJ
Selegiline/NNP hypotension/NN disease/NN
L/NNP day/NN selegiline/NN receive/VB randomized/VBN patients/NNS mortality/NN found/VBN trial/NN Parkinson/NNP
L/NNP day/NN selegiline/NN receive/VB randomized/VBN patients/NNS mortality/NN found/VBN trial/NN Parkinson/NNP '/POS
L/NNP day/NN selegiline/NN receive/VB randomized/VBN patients/NNS mortality/NN found/VBN trial/NN s/NNP
L/NNP day/NN selegiline/NN receive/VB randomized/VBN patients/NNS mortality/NN found/VBN trial/NN Disease/NNP
dopa/NN OBJECTIVES/NNS trial/NN Parkinson/NNP
dopa/NN OBJECTIVES/NNS trial/NN Parkinson/NNP '/POS
dopa/NN OBJECTIVES/NNS trial/NN s/NNP
dopa/NN OBJECTIVES/NNS trial/NN Disease/NNP
L/NNP day/NN selegiline/NN receive/VB randomized/VBN patients/NNS disease/NN Parkinson/NNP
L/NNP day/NN selegiline/NN receive/VB randomized/VBN patients/NNS disease/NN Parkinson/NNP '/POS
L/NNP day/NN selegiline/NN receive/VB randomized/VBN patients/NNS disease/NN s/JJ
L/NNP day/NN selegiline/NN receive/VB randomized/VBN patients/NNS disease/NN
dopa/NN OBJECTIVES/NNS trial/NN found/VBN mortality/NN patients/NNS disease/NN Parkinson/NNP
dopa/NN OBJECTIVES/NNS trial/NN found/VBN mortality/NN patients/NNS disease/NN Parkinson/NNP '/POS
dopa/NN OBJECTIVES/NNS trial/NN found/VBN mortality/NN patients/NNS disease/NN s/JJ
dopa/NN OBJECTIVES/NNS trial/NN found/VBN mortality/NN patients/NNS disease/NN
L/NNP day/NN selegiline/NN receive/VB randomized/VBN patients/NNS disease/NN PD/NNP
dopa/NN OBJECTIVES/NNS trial/NN found/VBN mortality/NN patients/NNS disease/NN PD/NNP
L/NNP taking/VBG those/DT dopa/NN OBJECTIVES/NNS trial/NN Parkinson/NNP
L/NNP taking/VBG those/DT dopa/NN OBJECTIVES/NNS trial/NN Parkinson/NNP '/POS
L/NNP taking/VBG those/DT dopa/NN OBJECTIVES/NNS trial/NN s/NNP
L/NNP taking/VBG those/DT dopa/NN OBJECTIVES/NNS trial/NN Disease/NNP
dopa/NN L/NNP taking/VBG those/DT dopa/NN OBJECTIVES/NNS trial/NN Parkinson/NNP
dopa/NN L/NNP taking/VBG those/DT dopa/NN OBJECTIVES/NNS trial/NN Parkinson/NNP '/POS
dopa/NN L/NNP taking/VBG those/DT dopa/NN OBJECTIVES/NNS trial/NN s/NNP
dopa/NN L/NNP taking/VBG those/DT dopa/NN OBJECTIVES/NNS trial/NN Disease/NNP
L/NNP taking/VBG those/DT dopa/NN OBJECTIVES/NNS trial/NN found/VBN mortality/NN patients/NNS disease/NN Parkinson/NNP
L/NNP taking/VBG those/DT dopa/NN OBJECTIVES/NNS trial/NN found/VBN mortality/NN patients/NNS disease/NN Parkinson/NNP '/POS
L/NNP taking/VBG those/DT dopa/NN OBJECTIVES/NNS trial/NN found/VBN mortality/NN patients/NNS disease/NN s/JJ
L/NNP taking/VBG those/DT dopa/NN OBJECTIVES/NNS trial/NN found/VBN mortality/NN patients/NNS disease/NN
dopa/NN L/NNP taking/VBG those/DT dopa/NN OBJECTIVES/NNS trial/NN found/VBN mortality/NN patients/NNS disease/NN Parkinson/NNP
dopa/NN L/NNP taking/VBG those/DT dopa/NN OBJECTIVES/NNS trial/NN found/VBN mortality/NN patients/NNS disease/NN Parkinson/NNP '/POS
dopa/NN L/NNP taking/VBG those/DT dopa/NN OBJECTIVES/NNS trial/NN found/VBN mortality/NN patients/NNS disease/NN s/JJ
dopa/NN L/NNP taking/VBG those/DT dopa/NN OBJECTIVES/NNS trial/NN found/VBN mortality/NN patients/NNS disease/NN
L/NNP taking/VBG those/DT dopa/NN OBJECTIVES/NNS trial/NN found/VBN mortality/NN patients/NNS disease/NN PD/NNP
dopa/NN L/NNP taking/VBG those/DT dopa/NN OBJECTIVES/NNS trial/NN found/VBN mortality/NN patients/NNS disease/NN PD/NNP
selegiline/NN receive/VB randomized/VBN patients/NNS mortality/NN found/VBN trial/NN Parkinson/NNP
selegiline/NN receive/VB randomized/VBN patients/NNS mortality/NN found/VBN trial/NN Parkinson/NNP '/POS
selegiline/NN receive/VB randomized/VBN patients/NNS mortality/NN found/VBN trial/NN s/NNP
selegiline/NN receive/VB randomized/VBN patients/NNS mortality/NN found/VBN trial/NN Disease/NNP
selegiline/NN receive/VB randomized/VBN patients/NNS disease/NN Parkinson/NNP
selegiline/NN receive/VB randomized/VBN patients/NNS disease/NN Parkinson/NNP '/POS
selegiline/NN receive/VB randomized/VBN patients/NNS disease/NN s/JJ
selegiline/NN receive/VB randomized/VBN patients/NNS disease/NN
selegiline/NN receive/VB randomized/VBN patients/NNS disease/NN PD/NNP
L/NNP selegiline/NNP therapy/NN associated/VBN hypotension/NN systolic/JJ
L/NNP selegiline/NNP therapy/NN associated/VBN hypotension/NN orthostatic/JJ
L/NNP selegiline/NNP therapy/NN associated/VBN hypotension/NN
dopa/NN associated/VBN hypotension/NN systolic/JJ
dopa/NN associated/VBN hypotension/NN orthostatic/JJ
dopa/NN associated/VBN hypotension/NN
selegiline/NN receiving/VBG patients/NNS PD/NNP
selegiline/NN marked/VBN six/CD patients/NNS PD/NNP
L/NNP selegiline/VBP finding/NN confirms/VBZ associated/VBN hypotension/NN orthostatic/JJ
L/NNP selegiline/VBP finding/NN confirms/VBZ associated/VBN hypotension/NN
dopa/NN associated/VBN hypotension/NN orthostatic/JJ
dopa/NN associated/VBN hypotension/NN
mexiletine/NN I/NNP Report/NNP findings/NNS arrhythmia/NN
mexiletine/NN form/NN effects/NNS evaluated/VBN infarction/NNS myocardial/JJ
mexiletine/NN form/NN effects/NNS evaluated/VBN infarction/NNS
Mexitil/NNP effects/NNS evaluated/VBN infarction/NNS myocardial/JJ
Mexitil/NNP effects/NNS evaluated/VBN infarction/NNS
Perlongets/NNP Mexitil/NNP effects/NNS evaluated/VBN infarction/NNS myocardial/JJ
Perlongets/NNP Mexitil/NNP effects/NNS evaluated/VBN infarction/NNS
mexiletine/JJ group/NN deaths/NNS
E/NN terfenadine/NN compounds/NNS known/VBN increase/VB cause/VB investigated/VBN TDP/NNP
4031/CD terfenadine/NN compounds/NNS known/VBN increase/VB cause/VB investigated/VBN TDP/NNP
cefazedone/NN cefonicid/NN effects/NNS model/NN hematotoxicity/NN
cefonicid/NN effects/NNS model/NN hematotoxicity/NN
cephalosporin/NN hematotoxicity/NN
Cephalosporin/NN antibiotics/NNS cause/VBP variety/NN disturbances/NNS hematologic/JJ
Cephalosporin/NN antibiotics/NNS cause/VBP variety/NN disturbances/NNS
cefazedone/JJ beagle/JJ cefonicid/JJ dogs/NNS administration/NN caused/VBD studies/NNS toxicity/NN
cefonicid/JJ dogs/NNS administration/NN caused/VBD studies/NNS toxicity/NN
cefazedone/JJ kg/VBN mg/NN receiving/VBG dogs/NNS %/NN occurred/VBD compromising/NN cytopenias/NNS
cefonicid/NN mg/NN receiving/VBG dogs/NNS %/NN occurred/VBD compromising/NN cytopenias/NNS
cefazedone/NN cefonicid/VBN tested/VBN dogs/NNS reproduced/VBN syndrome/NN hematologic/JJ
cefazedone/NN cefonicid/VBN tested/VBN dogs/NNS reproduced/VBN syndrome/NN
cefonicid/VBN tested/VBN dogs/NNS reproduced/VBN syndrome/NN hematologic/JJ
cefonicid/VBN tested/VBN dogs/NNS reproduced/VBN syndrome/NN
cephalosporin/NN rechallenge/NN reproduced/VBN syndrome/NN hematologic/JJ
cephalosporin/NN rechallenge/NN reproduced/VBN syndrome/NN
cefazedone/NN cefonicid/NN doses/NNS administration/NN induce/VB similar/JJ hematotoxicity/RB
cefazedone/NN cefonicid/NN doses/NNS administration/NN induce/VB conclude/VBP described/VBD dyscrasias/NNS blood/NN
cefazedone/NN cefonicid/NN doses/NNS administration/NN induce/VB conclude/VBP described/VBD dyscrasias/NNS
cefonicid/NN doses/NNS administration/NN induce/VB similar/JJ hematotoxicity/RB
cefonicid/NN doses/NNS administration/NN induce/VB conclude/VBP described/VBD dyscrasias/NNS blood/NN
cefonicid/NN doses/NNS administration/NN induce/VB conclude/VBP described/VBD dyscrasias/NNS
cephalosporin/NN similar/JJ hematotoxicity/RB
cephalosporin/NN similar/JJ induce/VB conclude/VBP described/VBD dyscrasias/NNS blood/NN
cephalosporin/NN similar/JJ induce/VB conclude/VBP described/VBD dyscrasias/NNS
tincture/NN effect/NN infarction/NN myocardial/JJ
tincture/NN effect/NN infarction/NN
of/IN Crataegus/NNP tincture/NN effect/NN infarction/NN myocardial/JJ
of/IN Crataegus/NNP tincture/NN effect/NN infarction/NN
Crataegus/NNP tincture/NN effect/NN infarction/NN myocardial/JJ
Crataegus/NNP tincture/NN effect/NN infarction/NN
TCR/NNP effect/NN investigate/VB induced/VBG infarction/NN myocardial/JJ
TCR/NNP effect/NN investigate/VB induced/VBG infarction/NN
ethinyl/JJ treatment/NN cholestasis/NNS extrahepatic/JJ
ethinyl/JJ treatment/NN cholestasis/NNS
estradiol/JJ treatment/NN cholestasis/NNS extrahepatic/JJ
estradiol/JJ treatment/NN cholestasis/NNS
EE/NNP treatment/NN cholestasis/NNS extrahepatic/JJ
EE/NNP treatment/NN cholestasis/NNS
pyridoxine/NN disorder/NN behavioral/JJ
pyridoxine/NN disorder/NN
isoniazid/NN administration/NN difficulties/NNS hyperkinesis/NNS irritability/NN
isoniazid/NN administration/NN difficulties/NNS sleeping/VBG
isoniazid/NN administration/NN difficulties/NNS
pyridoxine/NN withdrawal/NN associated/VBN return/NN hyperkinesis/NNS
halogenated/VBD hydroxyquinolines/NNS Neurotoxicity/NNP
hydroxyquinolines/NNS Neurotoxicity/NNP
halogenated/VBD hydroxyquinolines/NNS presented/VBN cases/NNS reactions/NNS neurotoxic/JJ
hydroxyquinolines/NNS presented/VBN cases/NNS reactions/NNS neurotoxic/JJ
clioquinol/NN dose/NN ingestion/NN related/VBN encephalopathy/NN consisted/VBD disturbance/NN neurological/JJ
clioquinol/NN dose/NN ingestion/NN related/VBN encephalopathy/NN consisted/VBD disturbance/NN
clioquinol/JJ received/VBN enteropathica/NN acrodermatitis/JJ
clioquinol/JJ received/VBN enteropathica/NN
levodopa/NN stimulation/NN dyskinesias/NNS disease/NN Parkinson/NNP
levodopa/NN stimulation/NN dyskinesias/NNS disease/NN Parkinson/NNP '/POS
levodopa/NN stimulation/NN dyskinesias/NNS disease/NN s/JJ
levodopa/NN stimulation/NN dyskinesias/NNS disease/NN
ursodeoxycholic/JJ acid/NN response/NN Composition/NNP stones/NNS gall/NN
ursodeoxycholic/JJ acid/NN response/NN Composition/NNP stones/NNS bladder/NN
ursodeoxycholic/JJ acid/NN response/NN Composition/NNP stones/NNS
acid/NN response/NN Composition/NNP stones/NNS gall/NN
acid/NN response/NN Composition/NNP stones/NNS bladder/NN
acid/NN response/NN Composition/NNP stones/NNS
Octreotide/NNP treatment/NN acromegaly/NN
octreotide/NN treated/VBN patients/NNS acromegalic/JJ
cholesterol/NN contained/VBD showed/VBD analysis/NN stones/NNS gall/NN
cholesterol/NN contained/VBD showed/VBD analysis/NN stones/NNS
cholesterol/RB rich/JJ suggesting/VBG partial/JJ dissolution/NN gall/NN
cholesterol/RB rich/JJ suggesting/VBG partial/JJ dissolution/NN stone/NN
cholesterol/RB rich/JJ small/JJ stones/NNS gall/NN
cholesterol/RB rich/JJ small/JJ stones/NNS
cholesterol/RB rich/JJ small/JJ have/VB common/JJ disease/NN gall/NN
cholesterol/RB rich/JJ small/JJ have/VB common/JJ disease/NN stone/NN
cholesterol/RB rich/JJ small/JJ have/VB common/JJ disease/NN
cholesterol/RB rich/JJ small/JJ have/VB duct/NN stones/NNS gall/NN
cholesterol/RB rich/JJ small/JJ have/VB duct/NN stones/NNS
calcium/NN containing/VBG stones/NNS duct/NN have/VB small/JJ stones/NNS gall/NN
calcium/NN containing/VBG stones/NNS duct/NN have/VB small/JJ stones/NNS
calcium/NN containing/VBG stones/NNS duct/NN have/VB common/JJ disease/NN gall/NN
calcium/NN containing/VBG stones/NNS duct/NN have/VB common/JJ disease/NN stone/NN
calcium/NN containing/VBG stones/NNS duct/NN have/VB common/JJ disease/NN
calcium/NN containing/VBG stones/NNS gall/NN
calcium/NN containing/VBG stones/NNS
metoclopramide/NN took/VBD disorder/NN gastrointestinal/JJ
metoclopramide/NN took/VBD disorder/NN
Cocaine/NNP induced/VBN disorder/NN rates/NNS symptoms/NNS psychiatric/JJ
cocaine/NN induced/VBN disorder/NN rates/NNS symptoms/NNS psychiatric/JJ
cocaine/NN induced/VBN disorder/NN CIMD/NNP
cocaine/NN outpatients/NNS cocaine/NN induced/VBN disorder/NN CIMD/NNP
cocaine/NN compared/VBN measures/NNS symptoms/NNS psychiatric/JJ
cocaine/NN outpatients/NNS cocaine/NN compared/VBN measures/NNS symptoms/NNS psychiatric/JJ
Caffeine/NNP induced/VBN arrhythmia/NN cardiac/JJ
Caffeine/NNP induced/VBN arrhythmia/NN
caffeine/NN concentration/NN containing/VBG consuming/VBG developed/VBD describe/VBP 25/CD prolapse/NN mitral/JJ
caffeine/NN concentration/NN containing/VBG consuming/VBG developed/VBD describe/VBP 25/CD prolapse/NN valve/NN
caffeine/NN concentration/NN containing/VBG consuming/VBG developed/VBD describe/VBP 25/CD prolapse/NN
acetylcholine/JJ subunits/NNS alpha/NN necessary/JJ induced/VBN seizures/NNS
nicotine/NN necessary/JJ induced/VBN hypolocomotion/JJ
acetylcholine/JJ subunits/NNS alpha/NN necessary/JJ induced/VBN hypolocomotion/JJ
acetylcholine/NN receptors/NNS Binding/VBG series/NN behaviors/NNS go/VBP seizures/NNS
acetylcholine/NN receptors/NNS Binding/VBG series/NN behaviors/NNS go/VBP exploration/NN tremors/NNS
nicotine/NN Binding/VBG series/NN behaviors/NNS go/VBP seizures/NNS death/NN
acetylcholine/NN receptors/NNS Binding/VBG series/NN behaviors/NNS go/VBP seizures/NNS death/NN
nicotine/NN Binding/VBG series/NN behaviors/NNS go/VBP exploration/NN tremors/NNS
nicotine/NN examined/VBD homozygous/VBZ seizures/NNS hypolocomotion/NNS
nicotine/NN mediators/NNS induced/VBN hypolocomotion/JJ
dopamine/NN explored/VBD success/NN risk/NN defects/NNS visual/JJ
dopamine/NN explored/VBD success/NN risk/NN defects/NNS field/NN
dopamine/NN explored/VBD success/NN risk/NN defects/NNS
dopamine/NN explored/VBD success/NN risk/NN defects/NNS VFD/NNP
DA/NNP dopamine/NN explored/VBD success/NN risk/NN defects/NNS visual/JJ
DA/NNP dopamine/NN explored/VBD success/NN risk/NN defects/NNS field/NN
DA/NNP dopamine/NN explored/VBD success/NN risk/NN defects/NNS
DA/NNP dopamine/NN explored/VBD success/NN risk/NN defects/NNS VFD/NNP
dopamine/NN explored/VBD success/NN treating/VBG abuse/NN substance/NN
dopamine/NN explored/VBD success/NN treating/VBG abuse/NN
DA/NNP dopamine/NN explored/VBD success/NN treating/VBG abuse/NN substance/NN
DA/NNP dopamine/NN explored/VBD success/NN treating/VBG abuse/NN
GVG/NN effects/NNS dopamine/NN explored/VBD success/NN treating/VBG abuse/NN substance/NN
GVG/NN effects/NNS dopamine/NN explored/VBD success/NN treating/VBG abuse/NN
cocaine/NN GVG/NN effects/NNS dopamine/NN explored/VBD success/NN treating/VBG abuse/NN substance/NN
cocaine/NN GVG/NN effects/NNS dopamine/NN explored/VBD success/NN treating/VBG abuse/NN
cocaine/NN GVG/NN effects/NNS dopamine/NN explored/VBD success/NN risk/NN defects/NNS visual/JJ
cocaine/NN GVG/NN effects/NNS dopamine/NN explored/VBD success/NN risk/NN defects/NNS field/NN
cocaine/NN GVG/NN effects/NNS dopamine/NN explored/VBD success/NN risk/NN defects/NNS
cocaine/NN GVG/NN effects/NNS dopamine/NN explored/VBD success/NN risk/NN defects/NNS VFD/NNP
calcium/NN blockers/NNS exposed/VBN fetuses/NNS alterations/VBZ Cardiovascular/NNP
calcium/NN blockers/NNS exposed/VBN fetuses/NNS alterations/VBZ
calcium/NN blocker/NN induced/VBN alterations/NNS cardiovascular/JJ
calcium/NN blocker/NN induced/VBN alterations/NNS
calcium/NN blockers/NNS induce/VB malformations/NNS cardiovascular/JJ
calcium/NN blockers/NNS induce/VB malformations/NNS
calcium/NN blockers/NN one/CD administered/VBN examined/VBD malformations/NNS cardiovascular/JJ
calcium/NN blockers/NN one/CD administered/VBN examined/VBD malformations/NNS
calcium/NN blockers/NNS each/DT observed/VBN incidence/NN malformations/NNS cardiovascular/JJ
calcium/NN blockers/NNS each/DT observed/VBN incidence/NN malformations/NNS
procainamide/NN administered/VBN treatment/NN contractions/NNS flutter/NN atrial/JJ
procainamide/NN administered/VBN treatment/NN contractions/NNS flutter/NN
procainamide/NN administered/VBN treatment/NN contractions/NNS premature/JJ
procainamide/NN administered/VBN treatment/NN contractions/NNS ventricular/NN
procainamide/NN administered/VBN treatment/NN contractions/NNS
procainamide/NN produce/VB Q/NN prolonged/VBN
procainamide/NN produce/VB Q/NN
procainamide/NN produce/VB Q/NN syndrome/NN T/NNP
procainamide/NN produce/VB Q/NN syndrome/NN
steroid/JJ injection/NN syndrome/NN Cauda/NNP
steroid/JJ injection/NN syndrome/NN equina/NN
steroid/JJ injection/NN syndrome/NN
steroid/JJ injections/NNS therapy/NN methods/NNS radiculopathy/NN
triamcinolone/NN injection/NN caused/VBN syndrome/NN cauda/NN
triamcinolone/NN injection/NN caused/VBN syndrome/NN equina/NN
triamcinolone/NN injection/NN caused/VBN syndrome/NN
steroid/JJ injection/NN scheduled/VBN woman/NN back/NN low/JJ
steroid/JJ injection/NN scheduled/VBN woman/NN back/NN
steroid/JJ injection/NN scheduled/VBN woman/NN back/NN and/CC
steroid/JJ injection/NN scheduled/VBN woman/NN back/NN pain/NN right/NN
steroid/JJ injection/NN scheduled/VBN woman/NN back/NN pain/NN leg/NN
steroid/JJ injection/NN scheduled/VBN woman/NN back/NN pain/NN
steroid/JJ injections/NNS vigilance/NN deterioration/NN neurologic/JJ
steroid/JJ injections/NNS vigilance/NN deterioration/NN
dopamine/VB produce/VB induce/VB hypothermia/NN
dopamine/JJ agonist/NN Apomorphine/NNP selected/VBN effects/NNS ability/NN induce/VB hypothermia/NN
agonist/NN Apomorphine/NNP selected/VBN effects/NNS ability/NN induce/VB hypothermia/NN
haloperidol/NN efficacy/NN studies/NNS model/NN disease/NN Parkinson/NNP
haloperidol/NN efficacy/NN studies/NNS model/NN disease/NN Parkinson/NNP '/POS
haloperidol/NN efficacy/NN studies/NNS model/NN disease/NN s/JJ
haloperidol/NN efficacy/NN studies/NNS model/NN disease/NN
risperidone/NN reduction/NN syndrome/NN Withdrawal/NNP
risperidone/NN reduction/NN syndrome/NN emergent/JJ
risperidone/NN reduction/NN syndrome/NN rabbit/NN
risperidone/NN reduction/NN syndrome/NN
dopamine/JJ antagonist/NN serotonin/NN mechanism/NN withdrawal/NN
dopamine/JJ antagonist/NN serotonin/NN mechanism/NN related/VBN RS/NNP emergent/NNP
dopamine/JJ antagonist/NN serotonin/NN mechanism/NN related/VBN RS/NNP
dopamine/JJ antagonist/NN serotonin/NN mechanism/NN development/NN RS/NNP
risperidone/NN profile/NN related/VBN mechanism/NN withdrawal/NN
risperidone/NN profile/NN related/VBN RS/NNP emergent/NNP
risperidone/NN profile/NN related/VBN RS/NNP
serotonin/NN mechanism/NN withdrawal/NN
serotonin/NN mechanism/NN related/VBN RS/NNP emergent/NNP
serotonin/NN mechanism/NN related/VBN RS/NNP
serotonin/NN system/NN influence/NN suggesting/VBG mechanism/NN withdrawal/NN
serotonin/NN system/NN influence/NN suggesting/VBG mechanism/NN related/VBN RS/NNP emergent/NNP
serotonin/NN system/NN influence/NN suggesting/VBG mechanism/NN related/VBN RS/NNP
serotonin/NN mechanism/NN development/NN RS/NNP
serotonin/NN system/NN influence/NN suggesting/VBG mechanism/NN development/NN RS/NNP
cocaine/NN intoxications/NNS abnormalities/NNS movement/NN
cocaine/NN intoxications/NNS abnormalities/NNS
cocaine/NN intoxications/NNS abnormalities/NNS known/VBN hyperkinesias/NNS Choreatiform/JJ
cocaine/NN intoxications/NNS abnormalities/NNS known/VBN hyperkinesias/NNS
heroine/NN abusing/VBG methadone/VBP report/NN movements/NNS euphoria/NN choreoathetoid/NN
heroine/NN abusing/VBG methadone/VBP report/NN movements/NNS
cocaine/NN life/NN short/JJ occur/VB some/DT seizures/NNS strokes/NNS
cocaine/NN characterized/VBN resulted/VBN death/NN
cocaine/NN characterized/VBN prolonged/JJ resulted/VBD death/NN
BE/NNP induced/VBN those/DT prolonged/JJ characterized/VBN resulted/VBN death/NN
BE/NNP induced/VBN those/DT prolonged/JJ resulted/VBD death/NN
mazindol/NN dystrophy/NN Duchenne/NNP
mazindol/NN dystrophy/NN
mazindol/NN trial/NN controlled/VBN boys/NNS dystrophy/NN Duchenne/NNP
mazindol/NN trial/NN controlled/VBN boys/NNS dystrophy/NN
Mazindol/NNP doses/VBZ slow/VB progression/NN weakness/NN
Mazindol/NNP doses/VBZ slow/VB dystrophy/NN Duchenne/NNP
Mazindol/NNP doses/VBZ slow/VB dystrophy/NN
NRA/NNP hyperactivity/NN
0160/CD NRA/NNP hyperactivity/NN
clozapine/JJ hyperactivity/NN
amiloride/NN syndrome/NN Attenuation/NNP diabetes/NNP
amiloride/NN syndrome/NN Attenuation/NNP diabetes/NNP insipidus/NNS
amiloride/NN syndrome/NN like/JJ
amiloride/NN syndrome/NN
lithium/NN effect/NN polydipsia/JJ polyuria/JJ
lithium/NN concentration/NN polydipsia/JJ polyuria/JJ
lithium/NN effect/NN polydipsia/JJ
lithium/NN concentration/NN polydipsia/JJ
LiCl/NNP treated/VBN chronically/NNP rats/NNS investigated/VBN effect/NN polydipsia/JJ polyuria/JJ
LiCl/NNP treated/VBN chronically/NNP rats/NNS investigated/VBN effect/NN polydipsia/JJ
amiloride/NN effect/NN polydipsia/JJ polyuria/JJ
amiloride/NN effect/NN polydipsia/JJ
amiloride/NN attenuation/NN diabetes/NNP
amiloride/NN attenuation/NN insipidus/NNS
amiloride/NN attenuation/NN syndrome/NN like/IN
amiloride/NN attenuation/NN syndrome/NN
potassium/NN level/NN elevation/NN ratio/NN reduction/NN accompanied/VBN attenuation/NN diabetes/NNP
potassium/NN level/NN elevation/NN ratio/NN reduction/NN accompanied/VBN attenuation/NN insipidus/NNS
potassium/NN level/NN elevation/NN ratio/NN reduction/NN accompanied/VBN attenuation/NN syndrome/NN like/IN
potassium/NN level/NN elevation/NN ratio/NN reduction/NN accompanied/VBN attenuation/NN syndrome/NN
lithium/NN concluded/VBN relieve/VB patients/NNS suffering/VBG polydipsia/NN polyuria/NN
lithium/NN levels/NNS result/VB relieve/VB patients/NNS suffering/VBG polydipsia/NN polyuria/NN
lithium/NN concluded/VBN relieve/VB patients/NNS suffering/VBG polydipsia/NN
lithium/NN levels/NNS result/VB relieve/VB patients/NNS suffering/VBG polydipsia/NN
amiloride/JJ administration/NN concluded/VBN relieve/VB patients/NNS suffering/VBG polydipsia/NN polyuria/NN
amiloride/NN supplementation/NN result/VB relieve/VB patients/NNS suffering/VBG polydipsia/NN polyuria/NN
amiloride/JJ administration/NN concluded/VBN relieve/VB patients/NNS suffering/VBG polydipsia/NN
amiloride/NN supplementation/NN result/VB relieve/VB patients/NNS suffering/VBG polydipsia/NN
epinephrine/NN treatment/NN priapism/NN
N/NNP effects/NNS seizure/NN
2/CD urea/NNS effects/NNS seizure/NN
propylpentanoyl/NN 2/CD urea/NNS effects/NNS seizure/NN
urea/NNS effects/NNS seizure/NN
amino/JJ neurotransmitters/NNS urea/NNS effects/NNS seizure/NN
acid/JJ neurotransmitters/NNS urea/NNS effects/NNS seizure/NN
VPU/NNP exhibiting/VBG kg/VBN protecting/VBG rats/NNS seizure/NN
VPA/NNP exhibiting/VBG kg/VBN protecting/VBG rats/NNS seizure/NN
VPA/NNP value/NN mg/CD seizure/NN
glutamate/NN reduction/NN offset/VBN suggested/VBN finding/NN seizure/NN
VPU/NNP protect/VB finding/NN seizure/NN
aspartate/NN glutamate/NN reduction/NN offset/VBN suggested/VBN finding/NN seizure/NN
VPA/NNP VPU/NNP protect/VB finding/NN seizure/NN
amino/JJ neurotransmitters/NNS reduction/NN minor/JJ suggested/VBN finding/NN seizure/NN
acid/NN neurotransmitters/NNS reduction/NN minor/JJ suggested/VBN finding/NN seizure/NN
glutamate/NN increases/NNS account/VB induced/VBN finding/NN induced/VBN seizure/NN
VPU/NNP reduce/VB finding/NN induced/VBN seizure/NN
aspartate/NN glutamate/NN increases/NNS account/VB induced/VBN finding/NN induced/VBN seizure/NN
VPA/NNP induced/VBN seizure/NN
antidepressant/JJ use/NN syndrome/NN Rabbit/JJ
antidepressant/JJ use/NN syndrome/NN
desipramine/JJ toxicity/NN
desipramine/JJ toxicity/NN
quinine/NN available/JJ banned/VBD cramps/NNS nocturnal/JJ
quinine/NN available/JJ banned/VBD cramps/NNS leg/NN
quinine/NN available/JJ banned/VBD cramps/NNS
quinine/NN containing/VBG products/NNS produce/VB complications/NNS neurological/JJ
quinine/NN containing/VBG products/NNS produce/VB complications/NNS
cortisol/NN humans/NNS transport/NN L/NNP induced/VBN hypertension/NN
L/NNP induced/VBN hypertension/NN
arginine/JJ transport/NN L/NNP induced/VBN hypertension/NN
cortisol/NN implicated/VBN arginine/VB induced/VBN hypertension/NN
L/NNP arginine/VB induced/VBN hypertension/NN
arginine/VB induced/VBN hypertension/NN
nitric/JJ system/NN implicated/VBN arginine/VB induced/VBN hypertension/NN
oxide/NN system/NN implicated/VBN arginine/VB induced/VBN hypertension/NN
cortisol/NN conclude/VBP associated/VBN increases/NNS
cortisol/NN conclude/VBP associated/VBN increases/NNS pressure/NN in/IN
cortisol/NN conclude/VBP associated/VBN increases/NNS pressure/NN blood/NN
cortisol/NN conclude/VBP associated/VBN increases/NNS pressure/NN
l/NN abnormalities/NNS associated/VBN increases/NNS
l/NN abnormalities/NNS associated/VBN increases/NNS pressure/NN in/IN
l/NN abnormalities/NNS associated/VBN increases/NNS pressure/NN blood/NN
l/NN abnormalities/NNS associated/VBN increases/NNS pressure/NN
arginine/JJ system/NN l/NN abnormalities/NNS associated/VBN increases/NNS
arginine/JJ system/NN l/NN abnormalities/NNS associated/VBN increases/NNS pressure/NN in/IN
arginine/JJ system/NN l/NN abnormalities/NNS associated/VBN increases/NNS pressure/NN blood/NN
arginine/JJ system/NN l/NN abnormalities/NNS associated/VBN increases/NNS pressure/NN
thienodiazepine/JJ derivative/NN clotiazepam/NN administration/NN onset/NN developed/VBD hepatitis/NN
thienodiazepine/JJ derivative/NN clotiazepam/NN administration/NN onset/NN developed/VBD necrosis/NNS extensive/JJ
thienodiazepine/JJ derivative/NN clotiazepam/NN administration/NN onset/NN developed/VBD necrosis/NNS hepatocellular/NN
thienodiazepine/JJ derivative/NN clotiazepam/NN administration/NN onset/NN developed/VBD necrosis/NNS
clotiazepam/NN administration/NN onset/NN developed/VBD necrosis/NNS extensive/JJ
clotiazepam/NN administration/NN onset/NN developed/VBD necrosis/NNS hepatocellular/NN
clotiazepam/NN administration/NN onset/NN developed/VBD necrosis/NNS
benzodiazepines/NNS administration/NN interfere/VB induce/VB relapse/NN hepatitis/NN
benzodiazepines/NNS hepatotoxicity/NN is/VBZ suggests/VBZ shows/VBZ induce/VB hepatitis/NN
benzodiazepines/NNS hepatotoxicity/NN
Statins/NNS cause/VB myopathy/NN hyperCKaemia/NN
Warfarin/NNP induced/VBN hemorrhage/NN
warfarin/NN therapy/NN man/NN 28/CD case/NN sustained/VBD developed/VBD pain/NN
warfarin/NN therapy/NN man/NN 28/CD case/NN sustained/VBD developed/VBD pain/NN contracture/NN
warfarin/NN form/NN represents/VBZ induced/VBN Anticoagulant/NNP induced/VBN characterized/VBN pain/NN
warfarin/NN form/NN represents/VBZ induced/VBN Anticoagulant/NNP induced/VBN characterized/VBN region/NN degrees/NNS contracture/NN
warfarin/NN form/NN represents/VBZ induced/VBN Anticoagulant/NNP induced/VBN neuropathy/NN peripheral/JJ
warfarin/NN form/NN represents/VBZ induced/VBN Anticoagulant/NNP induced/VBN neuropathy/NN
warfarin/NN form/NN represents/VBZ induced/VBN Anticoagulant/NNP induced/VBN characterized/VBN region/NN degrees/NNS impairment/NN motor/NN
warfarin/NN form/NN represents/VBZ induced/VBN Anticoagulant/NNP induced/VBN characterized/VBN region/NN degrees/NNS impairment/NN motor/NN and/CC
warfarin/NN form/NN represents/VBZ induced/VBN Anticoagulant/NNP induced/VBN characterized/VBN region/NN degrees/NNS impairment/NN motor/NN sensory/JJ
warfarin/NN form/NN represents/VBZ induced/VBN Anticoagulant/NNP induced/VBN characterized/VBN region/NN degrees/NNS impairment/NN
diethylstilbestrol/NN associated/VBN Angiosarcoma/NNP
diethylstilbestrol/NN associated/VBN Angiosarcoma/NNP liver/NN of/IN
diethylstilbestrol/NN associated/VBN Angiosarcoma/NNP liver/NN the/DT
diethylstilbestrol/NN associated/VBN Angiosarcoma/NNP liver/NN
diethylstilbestrol/NN differentiated/VBD adenocarcinoma/NN
diethylstilbestrol/NN differentiated/VBD adenocarcinoma/NN liver/NN of/IN
diethylstilbestrol/NN differentiated/VBD adenocarcinoma/NN liver/NN the/DT
diethylstilbestrol/NN differentiated/VBD adenocarcinoma/NN liver/NN
diethylstilbestrol/NN differentiated/VBD occurred/VBD Angiosarcoma/NNP
diethylstilbestrol/NN differentiated/VBD occurred/VBD Angiosarcoma/NNP liver/NN of/IN
diethylstilbestrol/NN differentiated/VBD occurred/VBD Angiosarcoma/NNP liver/NN the/DT
diethylstilbestrol/NN differentiated/VBD occurred/VBD Angiosarcoma/NNP liver/NN
glutamate/NN uptake/VB dyskinesia/NN orofacial/JJ
glutamate/NN uptake/VB dyskinesia/NN
glutamate/JJ uptake/NN decrease/NN correlates/VBZ increase/NN incidence/NN diskinesia/NN orofacial/JJ
glutamate/JJ uptake/NN decrease/NN correlates/VBZ increase/NN incidence/NN diskinesia/NN
warfarin/NN contributed/VBN haemorrhage/NN
warfarin/NN contributed/VBN considered/VBN complication/NN bleeding/NN
warfarin/NN patients/NNS 24/CD haemorrhage/NN
warfarin/NN patients/NNS 24/CD haemorrhage/NN contributed/VBN considered/VBN complication/NN bleeding/NN
morphine/JJ therapy/NN patients/NNS cancer/NN
ketamine/NN patients/NNS cancer/NN
morphine/NN responsive/JJ Pain/NNP
N/NNP aspartate/VBP effective/JJ improving/VBG analgesia/NN pain/NN neuropathic/JJ
N/NNP aspartate/VBP effective/JJ improving/VBG analgesia/NN pain/NN
methyl/NN N/NNP aspartate/VBP effective/JJ improving/VBG analgesia/NN pain/NN neuropathic/JJ
methyl/NN N/NNP aspartate/VBP effective/JJ improving/VBG analgesia/NN pain/NN
D/NNP methyl/NN N/NNP aspartate/VBP effective/JJ improving/VBG analgesia/NN pain/NN neuropathic/JJ
D/NNP methyl/NN N/NNP aspartate/VBP effective/JJ improving/VBG analgesia/NN pain/NN
aspartate/VBP effective/JJ improving/VBG analgesia/NN pain/NN neuropathic/JJ
aspartate/VBP effective/JJ improving/VBG analgesia/NN pain/NN
NMDA/NNP antagonists/NNS effective/JJ improving/VBG analgesia/NN pain/NN neuropathic/JJ
NMDA/NNP antagonists/NNS effective/JJ improving/VBG analgesia/NN pain/NN
ketamine/NN antagonists/NNS effective/JJ improving/VBG analgesia/NN syndromes/NNS pain/NN
ketamine/NN antagonists/NNS effective/JJ improving/VBG analgesia/NN pain/NN neuropathic/JJ
ketamine/NN antagonists/NNS effective/JJ improving/VBG analgesia/NN pain/NN
N/NNP aspartate/VBP effective/JJ improving/VBG analgesia/NN syndromes/NNS pain/NN
methyl/NN N/NNP aspartate/VBP effective/JJ improving/VBG analgesia/NN syndromes/NNS pain/NN
D/NNP methyl/NN N/NNP aspartate/VBP effective/JJ improving/VBG analgesia/NN syndromes/NNS pain/NN
aspartate/VBP effective/JJ improving/VBG analgesia/NN syndromes/NNS pain/NN
NMDA/NNP antagonists/NNS effective/JJ improving/VBG analgesia/NN syndromes/NNS pain/NN
ketamine/NN doses/NNS bolus/NNS given/VBN patients/NNS unrelieved/VBN pain/NNS
morphine/JJ study/NN unrelieved/VBN patients/NNS cancer/NN
morphine/JJ study/NN unrelieved/VBN pain/NNS
ketamine/NN doses/NNS bolus/NNS given/VBN patients/NNS cancer/NN
Ketamine/NNP reduced/VBD intensity/NN pain/NN
morphine/JJ analgesia/NN pain/NN neuropathic/JJ
morphine/JJ analgesia/NN pain/NN
Ketamine/NNP improve/VB analgesia/NN syndromes/NNS pain/NN
Ketamine/NNP improve/VB analgesia/NN pain/NN neuropathic/JJ
Ketamine/NNP improve/VB analgesia/NN pain/NN
morphine/JJ analgesia/NN syndromes/NNS pain/NN
tacrolimus/NNS cyclosporine/NN toxicity/NN
cyclosporine/NN toxicity/NN
amiodarone/NN administration/NN tachycardia/NN supraventricular/JJ
amiodarone/NN administration/NN tachycardia/NN
amiodarone/NN administration/NN Wolff/NNP
amiodarone/NN administration/NN Parkinson/NNP
amiodarone/NN administration/NN syndrome/NN White/NNP
amiodarone/NN administration/NN syndrome/NN
amiodarone/NN administration/NN boy/NN cardiomyopathy/NN primary/JJ
amiodarone/NN administration/NN boy/NN cardiomyopathy/NN
amiodarone/NN dosage/NN Reduction/NN resulted/VBD disappearance/NN persistence/NN bradycardia/NN sinus/NNS
amiodarone/NN dosage/NN Reduction/NN resulted/VBD disappearance/NN persistence/NN bradycardia/NN
GR/NNP accumbens/VBZ shell/NN induced/VBN hyperactivity/NN locomotor/NN
GR/NNP accumbens/VBZ shell/NN induced/VBN hyperactivity/NN
55562/CD GR/NNP accumbens/VBZ shell/NN induced/VBN hyperactivity/NN locomotor/NN
55562/CD GR/NNP accumbens/VBZ shell/NN induced/VBN hyperactivity/NN
GR/NNP antagonist/NN effects/NNS consisting/VBG modification/NN core/NN shell/NN microinjected/VBD indicate/VBP modified/VBN hyperlocomotion/NN
55562/CD GR/NNP antagonist/NN effects/NNS consisting/VBG modification/NN core/NN shell/NN microinjected/VBD indicate/VBP modified/VBN hyperlocomotion/NN
ampicillin/NN treated/VBN septicemia/NN
gentamicin/NN ampicillin/NN treated/VBN septicemia/NN
penicillins/NNS allergy/NN
penicillins/NNS allergy/NN manifestation/NN myocarditis/NNS Hypersensitivity/NNP
penicillins/NNS allergy/NN manifestation/NN myocarditis/NNS
Tamoxifen/NNP drug/NN prescribed/VBN chemotherapy/NN cancer/NN breast/NN
Tamoxifen/NNP drug/NN prescribed/VBN chemotherapy/NN cancer/NN
TAM/NNP Tamoxifen/NNP drug/NN prescribed/VBN chemotherapy/NN cancer/NN breast/NN
TAM/NNP Tamoxifen/NNP drug/NN prescribed/VBN chemotherapy/NN cancer/NN
alpha/NNP concentrations/NNS prevented/VBN effect/NN hemolytic/JJ
tocopherol/JJ acetate/NN indicating/VBG prevented/VBN effect/NN hemolytic/JJ
alpha/NNP concentrations/NNS prevented/VBN indicating/VBG related/VBN TAM/NNP hemolysis/NNS
tocopherol/JJ acetate/NN indicating/VBG related/VBN TAM/NNP hemolysis/NNS
alpha/NNP tocopherol/JJ acetate/NN indicating/VBG prevented/VBN effect/NN hemolytic/JJ
T/NNP alpha/NNP tocopherol/JJ acetate/NN indicating/VBG prevented/VBN effect/NN hemolytic/JJ
alpha/NNP tocopherol/JJ acetate/NN indicating/VBG related/VBN TAM/NNP hemolysis/NNS
T/NNP alpha/NNP tocopherol/JJ acetate/NN indicating/VBG related/VBN TAM/NNP hemolysis/NNS
alpha/NN tocopherol/JJ acetate/NN indicating/VBG prevented/VBN effect/NN hemolytic/JJ
tocopherol/JJ acetate/NN indicating/VBG prevented/VBN effect/NN hemolytic/JJ
acetate/NN indicating/VBG prevented/VBN effect/NN hemolytic/JJ
alpha/NN tocopherol/JJ acetate/NN indicating/VBG related/VBN TAM/NNP hemolysis/NNS
tocopherol/JJ acetate/NN indicating/VBG related/VBN TAM/NNP hemolysis/NNS
acetate/NN indicating/VBG related/VBN TAM/NNP hemolysis/NNS
alpha/NNP acetate/NN indicating/VBG prevented/VBN effect/NN hemolytic/JJ
TAc/NNP alpha/NNP acetate/NN indicating/VBG prevented/VBN effect/NN hemolytic/JJ
alpha/NNP acetate/NN indicating/VBG related/VBN TAM/NNP hemolysis/NNS
TAc/NNP alpha/NNP acetate/NN indicating/VBG related/VBN TAM/NNP hemolysis/NNS
hydroxyl/NN acetate/NN indicating/VBG prevented/VBN effect/NN hemolytic/JJ
hydroxyl/NN acetate/NN indicating/VBG related/VBN TAM/NNP hemolysis/NNS
oxygen/NN consumption/NN hemolysis/NNS
K/NNP leakage/NN preceded/VBN Hemolysis/NNS
K/NNP leakage/NN preceded/VBN excluding/VBG colloid/NN mechanism/NN hemolysis/NNS
tocopherols/NNS hemolysis/NNS
disulfiram/NN developed/VBD syndrome/NN tachycardia/NN hypotension/NN arterial/NN
disulfiram/NN developed/VBD syndrome/NN tachycardia/NN hypotension/NN
disulfiram/NN developed/VBD syndrome/NN tachycardia/NN flushing/NN
disulfiram/NN developed/VBD syndrome/NN tachycardia/NN
doxorubicin/NN cardiotoxicity/VBP
adriamycin/NN use/NN limits/VBZ complication/NN toxicity/NNP Cardiac/NNP
adriamycin/NN use/NN limits/VBZ complication/NN toxicity/NNP
clozapine/NN treated/VBN inpatients/NNS psychiatric/JJ
L/NNP complications/NNS arise/VBP patients/NNS Parkinson/NNP
L/NNP complications/NNS arise/VBP patients/NNS Parkinson/NNP '/POS
L/NNP complications/NNS arise/VBP patients/NNS s/JJ
L/NNP complications/NNS arise/VBP patients/NNS disease/NN
DOPA/NNP L/NNP complications/NNS arise/VBP patients/NNS Parkinson/NNP
DOPA/NNP L/NNP complications/NNS arise/VBP patients/NNS Parkinson/NNP '/POS
DOPA/NNP L/NNP complications/NNS arise/VBP patients/NNS s/JJ
DOPA/NNP L/NNP complications/NNS arise/VBP patients/NNS disease/NN
L/NNP complications/NNS arise/VBP patients/NNS PD/NNP
DOPA/NNP L/NNP complications/NNS arise/VBP patients/NNS PD/NNP
L/NNP treatment/NN arise/VBP patients/NNS Parkinson/NNP
L/NNP treatment/NN arise/VBP patients/NNS Parkinson/NNP '/POS
L/NNP treatment/NN arise/VBP patients/NNS s/JJ
L/NNP treatment/NN arise/VBP patients/NNS disease/NN
DOPA/NNP arise/VBP patients/NNS Parkinson/NNP
DOPA/NNP arise/VBP patients/NNS Parkinson/NNP '/POS
DOPA/NNP arise/VBP patients/NNS s/JJ
DOPA/NNP arise/VBP patients/NNS disease/NN
L/NNP treatment/NN arise/VBP patients/NNS PD/NNP
DOPA/NNP arise/VBP patients/NNS PD/NNP
bromocriptine/NN DOPA/NN changes/NNS model/NN PD/NNP
L/NNP saline/NN treated/VBN PD/NNP
DOPA/NN changes/NNS model/NN PD/NNP
6/CD obtained/VBN samples/NNS level/NN occurring/VBG changes/NNS model/NN PD/NNP
hydroxydopamine/JJ occurring/VBG changes/NNS model/NN PD/NNP
clozapine/NN threshold/NN lowered/VBD have/VBP risk/NN EPS/NNP
clozapine/VB agranulocytosis/NNS threshold/NN lowered/VBD have/VBP risk/NN EPS/NNP
clozapine/NN threshold/NN lowered/VBD have/VBP associated/VBN degrees/NNS sedation/NN dysfunction/NN sexual/JJ
clozapine/NN threshold/NN lowered/VBD have/VBP associated/VBN degrees/NNS sedation/NN dysfunction/NN
clozapine/VB agranulocytosis/NNS threshold/NN lowered/VBD have/VBP associated/VBN degrees/NNS sedation/NN dysfunction/NN sexual/JJ
clozapine/VB agranulocytosis/NNS threshold/NN lowered/VBD have/VBP associated/VBN degrees/NNS sedation/NN dysfunction/NN
clozapine/NN threshold/NN seizure/NN
clozapine/VB agranulocytosis/NNS threshold/NN seizure/NN
clozapine/NN threshold/NN lowered/VBD have/VBP associated/VBN degrees/NNS sedation/NN gain/NN weight/NN
clozapine/NN threshold/NN lowered/VBD have/VBP associated/VBN degrees/NNS sedation/NN gain/NN
clozapine/VB agranulocytosis/NNS threshold/NN lowered/VBD have/VBP associated/VBN degrees/NNS sedation/NN gain/NN weight/NN
clozapine/VB agranulocytosis/NNS threshold/NN lowered/VBD have/VBP associated/VBN degrees/NNS sedation/NN gain/NN
MK/NNP catalepsy/NN
801/CD haloperidol/NN catalepsy/NN
serotonin/NN release/NN correlation/NN concentration/NN related/VBN attack/NN migraine/NN
NO/VBG attack/NN migraine/NN
calcitonin/NN gene/NN increase/NN attack/NN migraine/NN
gene/NN increase/NN attack/NN migraine/NN
related/VBN attack/NN migraine/NN
peptide/JJ concentration/NN related/VBN attack/NN migraine/NN
CGRP/NNP concentration/NN related/VBN attack/NN migraine/NN
serotonin/NNS concentration/NN content/JJ headache/NN attack/NN migraine/NN
5/CD concentration/NN content/JJ headache/NN attack/NN migraine/NN
hydroxytriptamine/NN 5/CD concentration/NN content/JJ headache/NN attack/NN migraine/NN
5/CD 5/CD concentration/NN content/JJ headache/NN attack/NN migraine/NN
HT/NNP 5/CD 5/CD concentration/NN content/JJ headache/NN attack/NN migraine/NN
serotonin/NNS concentration/NN content/JJ headache/NN
5/CD concentration/NN content/JJ headache/NN
hydroxytriptamine/NN 5/CD concentration/NN content/JJ headache/NN
5/CD 5/CD concentration/NN content/JJ headache/NN
HT/NNP 5/CD 5/CD concentration/NN content/JJ headache/NN
nitroglycerin/NN provoked/VBD concentration/NN content/JJ headache/NN attack/NN migraine/NN
nitroglycerin/NN provoked/VBD concentration/NN content/JJ headache/NN
calcitonin/NN gene/NN investigate/VB was/VBD provoked/VBD concentration/NN content/JJ headache/NN
gene/NN investigate/VB was/VBD provoked/VBD concentration/NN content/JJ headache/NN
related/JJ concentration/NN content/JJ headache/NN
peptide/JJ concentration/NN content/JJ headache/NN
CGRP/NNP concentration/NN content/JJ headache/NN
calcitonin/NN gene/NN investigate/VB was/VBD provoked/VBD concentration/NN content/JJ headache/NN attack/NN migraine/NN
gene/NN investigate/VB was/VBD provoked/VBD concentration/NN content/JJ headache/NN attack/NN migraine/NN
related/JJ concentration/NN content/JJ headache/NN attack/NN migraine/NN
peptide/JJ concentration/NN content/JJ headache/NN attack/NN migraine/NN
CGRP/NNP concentration/NN content/JJ headache/NN attack/NN migraine/NN
nitroglycerin/NN application/NN collected/VBN' collected/VBN min/VBP beginning/NN attack/NN migraine/JJ
CGRP/NNP concentration/NN increased/VBD attack/NN migraine/JJ
CGRP/NNP concentration/NN increased/VBD returned/VBD cessation/NN migraine/NN
CGRP/NNP concentrations/NNS failed/VBD change/VB headache/NN
CGRP/NNP concentrations/NNS failed/VBD change/VB change/VB' subjects/NNS attack/NN migraine/JJ
5/CD higher/JJR tended/VBD lower/JJR subjects/NNS experienced/VBD attack/NN migraine/JJ
HT/NNP content/NN tended/VBD lower/JJR subjects/NNS experienced/VBD attack/NN migraine/JJ
CGRP/NNP concentration/NN higher/JJR tended/VBD lower/JJR subjects/NNS experienced/VBD attack/NN migraine/JJ
serotonin/NN content/NN decreased/VBD significantly/RB observed/VBN nitroglycerin/NN subjects/NNS attack/NN migraine/JJ
serotonin/NN content/NN decreased/VBD significantly/RB observed/VBN patients/NNS attack/NN migraine/JJ
nitroglycerin/NN subjects/NNS attack/NN migraine/JJ
nitroglycerin/NN observed/VBN patients/NNS attack/NN migraine/JJ
CGRP/VBP timing/NN headache/NN
CGRP/NNP relationship/NN suggests/VBZ fact/NN CGRP/VBP timing/NN headache/NN
CGRP/VBP timing/NN headache/NN migraine/JJ
CGRP/VBP fact/NN suggests/VBZ relationship/NN CGRP/NNP migraine/NNP
CGRP/NNP relationship/NN suggests/VBZ fact/NN CGRP/VBP timing/NN headache/NN migraine/JJ
CGRP/NNP migraine/NNP
serotonin/NN release/NN provoke/VB migraine/NN
serotonin/NN release/NN provoke/VB counteract/VB headache/NN
CGRP/NNP release/NN headache/NN
CGRP/NNP release/NN headache/NN counteract/VB provoke/VB migraine/NN
Clonidine/RB attention/NN
Clonidine/RB deficit/NN
Clonidine/RB deficit/NN analysis/NN changes/NNS II/NNP disorder/NN hyperactivity/RB
Clonidine/RB deficit/NN analysis/NN changes/NNS II/NNP disorder/NN
methylphenidate/JJ children/NNS attention/NN
methylphenidate/JJ children/NNS attention/NN deficit/NN
methylphenidate/JJ disorder/NN hyperactivity/JJ
methylphenidate/JJ disorder/NN
methylphenidate/JJ disorder/NN ADHD/NNP
clonidine/NN used/VBN or/CC disorder/NN methylphenidate/JJ children/NNS attention/NN
clonidine/NN used/VBN or/CC disorder/NN methylphenidate/JJ children/NNS attention/NN deficit/NN
clonidine/NN used/VBN or/CC disorder/NN hyperactivity/JJ
clonidine/NN used/VBN or/CC disorder/NN
clonidine/NN used/VBN or/CC disorder/NN ADHD/NNP
methylphenidate/JJ assigned/JJ children/NNS ADHD/NNP
methylphenidate/JJ clonidine/JJ assigned/JJ children/NNS ADHD/NNP
clonidine/NN assigned/JJ children/NNS ADHD/NNP
clonidine/JJ assigned/JJ children/NNS ADHD/NNP
clonidine/NN common/JJ Drowsiness/NNS
methylphenidate/NN or/CC used/VBN Clonidine/NNP appears/VBZ safe/JJ tolerated/VBN ADHD/NN
Clonidine/NNP appears/VBZ safe/JJ tolerated/VBN ADHD/NN
clonidine/NN monitor/VB advise/VB likelihood/NN drowsiness/NNS
acetaminophen/NN produce/VB toxicities/NNS cardiovascular/JJ
acetaminophen/NN produce/VB toxicities/NNS
acetaminophen/NN demonstrated/VBN produce/VB symptoms/NNS anaphylaxis/NNS
acetaminophen/NN administration/NN developed/VBN patients/NNS ill/JJ critically/RB
acetaminophen/NN administration/NN developed/VBN patients/NNS ill/JJ
levonorgestrel/VB dose/NN presence/NN identified/VBD years/NNS had/VBN infarction/NN myocardial/JJ
levonorgestrel/VB dose/NN presence/NN identified/VBD years/NNS had/VBN infarction/NN
levonorgestrel/VB 925/VB women/NNS had/VBN infarction/NN myocardial/JJ
levonorgestrel/VB 925/VB women/NNS had/VBN infarction/NN
estrogen/NN dose/NN presence/NN identified/VBD years/NNS had/VBN infarction/NN myocardial/JJ
estrogen/NN dose/NN presence/NN identified/VBD years/NNS had/VBN infarction/NN
estrogen/NN dose/NN levonorgestrel/VB 925/VB women/NNS had/VBN infarction/NN myocardial/JJ
estrogen/NN dose/NN levonorgestrel/VB 925/VB women/NNS had/VBN infarction/NN
8/CD administration/NN monkeys/NNS rhesus/VBZ Toxicity/RB
aminoquinoline/NN 8/CD administration/NN monkeys/NNS rhesus/VBZ Toxicity/RB
8/CD aminoquinoline/NN 8/CD administration/NN monkeys/NNS rhesus/VBZ Toxicity/RB
-LSB-/NNP 8/CD administration/NN monkeys/NNS rhesus/VBZ Toxicity/RB
4/CD -RSB-/NN -LSB-/NNP 8/CD administration/NN monkeys/NNS rhesus/VBZ Toxicity/RB
amino/CD l/CD 4/CD -RSB-/NN -LSB-/NNP 8/CD administration/NN monkeys/NNS rhesus/VBZ Toxicity/RB
l/CD 4/CD -RSB-/NN -LSB-/NNP 8/CD administration/NN monkeys/NNS rhesus/VBZ Toxicity/RB
methylbutyl/NN l/CD 4/CD -RSB-/NN -LSB-/NNP 8/CD administration/NN monkeys/NNS rhesus/VBZ Toxicity/RB
amino/JJ -RSB-/NN -LSB-/NNP 8/CD administration/NN monkeys/NNS rhesus/VBZ Toxicity/RB
-RSB-/NN -LSB-/NNP 8/CD administration/NN monkeys/NNS rhesus/VBZ Toxicity/RB
5/CD -RSB-/NN -LSB-/NNP 8/CD administration/NN monkeys/NNS rhesus/VBZ Toxicity/RB
l/NNP -RSB-/NN -LSB-/NNP 8/CD administration/NN monkeys/NNS rhesus/VBZ Toxicity/RB
hexyloxy/NN l/NNP -RSB-/NN -LSB-/NNP 8/CD administration/NN monkeys/NNS rhesus/VBZ Toxicity/RB
6/CD 8/CD administration/NN monkeys/NNS rhesus/VBZ Toxicity/RB
methoxy/NN 8/CD administration/NN monkeys/NNS rhesus/VBZ Toxicity/RB
4/CD 8/CD administration/NN monkeys/NNS rhesus/VBZ Toxicity/RB
methylquinoline/NN 8/CD administration/NN monkeys/NNS rhesus/VBZ Toxicity/RB
WR/NNP methylquinoline/NN 8/CD administration/NN monkeys/NNS rhesus/VBZ Toxicity/RB
242511/CD WR/NNP methylquinoline/NN 8/CD administration/NN monkeys/NNS rhesus/VBZ Toxicity/RB
WR/NNP doses/NNS RESULTS/NNS produced/VBD methemoglobinemia/NN
242511/CD WR/NNP doses/NNS RESULTS/NNS produced/VBD methemoglobinemia/NN
WR/NNP 242511/NNP pursued/JJ pretreatment/NN poisoning/NN
242511/NNP pursued/JJ pretreatment/NN poisoning/NN
WR/NNP 242511/NNP pursued/JJ concluded/VBN dissociated/VBN toxicity/NN
242511/NNP pursued/JJ concluded/VBN dissociated/VBN toxicity/NN
benzylisoquinolinium/NN NMBA/NN short/JJ besylate/NN associated/VBN paralysis/NN
thallium/NN dipyridamole/NN hyperemia/NN
Pentoxifylline/NNP inhibit/VB dipyridamole/NN hyperemia/NN
Trental/NNP Pentoxifylline/NNP inhibit/VB dipyridamole/NN hyperemia/NN
Dipyridamole/NNP performed/VBN patients/NNS unable/JJ exercise/VB disease/NN peripheral/JJ
Dipyridamole/NNP performed/VBN patients/NNS unable/JJ exercise/VB disease/NN vascular/NN
Dipyridamole/NNP performed/VBN patients/NNS unable/JJ exercise/VB disease/NN
thallium/NN Dipyridamole/NNP performed/VBN patients/NNS unable/JJ exercise/VB disease/NN peripheral/JJ
thallium/NN Dipyridamole/NNP performed/VBN patients/NNS unable/JJ exercise/VB disease/NN vascular/NN
thallium/NN Dipyridamole/NNP performed/VBN patients/NNS unable/JJ exercise/VB disease/NN
methylxanthine/JJ derivative/NN improve/VB claudication/NN intermittent/JJ
methylxanthine/JJ derivative/NN improve/VB claudication/NN
thallium/VBP induced/VBN hyperemia/NN
theophylline/NN methylxanthines/NNS induced/VBN hyperemia/NN
methylxanthines/NNS induced/VBN hyperemia/NN
pentoxifylline/NN inhibits/VBZ thallium/VBP induced/VBN hyperemia/NN
theophylline/NN lower/JJR decreased/VBD hyperemia/NN
pentoxifylline/NN dose/NN decreased/VBD hyperemia/NN
pentoxyifylline/NN inhibit/VB dipyridamole/NN induced/VBN hyperemia/NN
U/NNP injection/NN causes/VBZ hypertension/NN
II/NNP causes/VBZ hypertension/NN
U/NNP injection/NN causes/VBZ hypertension/NN bradycardia/NN
II/NNP causes/VBZ hypertension/NN bradycardia/NN
corticosterone/JJ level/NN had/VBN induced/VBN erection/JJ penile/JJ
corticosterone/JJ level/NN had/VBN induced/VBN erection/JJ
U/NNP administration/NN II/NNP had/VBN induced/VBN erection/JJ penile/JJ
U/NNP administration/NN II/NNP had/VBN induced/VBN erection/JJ
II/NNP had/VBN induced/VBN erection/JJ penile/JJ
II/NNP had/VBN induced/VBN erection/JJ
U/NNP II/NNP involved/VBN aspects/NNS disorders/NNS psychiatric/JJ
U/NNP II/NNP involved/VBN aspects/NNS disorders/NNS
-/NNP II/NNP involved/VBN aspects/NNS disorders/NNS psychiatric/JJ
-/NNP II/NNP involved/VBN aspects/NNS disorders/NNS
II/NNP involved/VBN aspects/NNS disorders/NNS psychiatric/JJ
II/NNP involved/VBN aspects/NNS disorders/NNS
Acetazolamide/NNP induced/VBN nephrolithiasis/NNS
Acetazolamide/NNP induced/VBN nephrolithiasis/NNS implications/NNS treatment/NN disorders/NNS neuromuscular/NN
Acetazolamide/NNP induced/VBN nephrolithiasis/NNS implications/NNS treatment/NN disorders/NNS
acetazolamide/NN complication/NN Nephrolithiasis/NNS
propafenone/JJ overdose/NN induced/VBN Ebstein/NNP
propafenone/JJ overdose/NN induced/VBN Ebstein/NNP '/POS
propafenone/JJ overdose/NN induced/VBN syndrome/NN platypnea/NN anomaly/JJ s/VBZ
propafenone/JJ overdose/NN induced/VBN syndrome/NN platypnea/NN anomaly/JJ
propafenone/JJ overdose/NN
propafenone/JJ overdose/NN induced/VBN syndrome/NN platypnea/NN
propafenone/JJ overdose/NN induced/VBN syndrome/NN platypnea/NN orthodeoxia/NNP
propafenone/JJ overdose/NN induced/VBN syndrome/NN like/IN
propafenone/JJ overdose/NN induced/VBN syndrome/NN
propafenone/JJ overdose/NN precipitated/VBN occurred/VBD shunt/NN blood/NN ovale/NN patent/NN
propafenone/JJ overdose/NN precipitated/VBN occurred/VBD shunt/NN blood/NN ovale/NN foramen/NN
propafenone/JJ overdose/NN precipitated/VBN occurred/VBD shunt/NN blood/NN ovale/NN
propafenone/JJ overdose/NN
corticosteroids/NNS exchange/NN treatment/NN discontinuation/NN led/VBD resolution/NN MAHA/NNP
aspirin/NN exchange/NN treatment/NN discontinuation/NN led/VBD resolution/NN MAHA/NNP
dipyridamole/NN exchange/NN treatment/NN discontinuation/NN led/VBD resolution/NN MAHA/NNP
cyclosporin/NN react/VBP A/NNP immuno/NN drug/NN known/VBN induce/VB MAHA/NNP
A/NNP immuno/NN drug/NN known/VBN induce/VB MAHA/NNP
CyA/NNP A/NNP immuno/NN drug/NN known/VBN induce/VB MAHA/NNP
oxcarbazepine/VBP switched/VBN treat/VB haloperidol/JJ patients/NNS schizophrenic/JJ
oxcarbazepine/VBP switched/VBN treat/VB haloperidol/JJ patients/NNS schizophrenic/JJ organic/JJ
oxcarbazepine/VBP switched/VBN treat/VB haloperidol/JJ patients/NNS psychotic/NN
Carbamazepine/NNP switched/VBN treat/VB haloperidol/JJ patients/NNS schizophrenic/JJ organic/JJ
Carbamazepine/NNP switched/VBN treat/VB haloperidol/JJ patients/NNS psychotic/NN
chlorpromazine/JJ haloperidol/JJ patients/NNS schizophrenic/JJ
haloperidol/JJ patients/NNS schizophrenic/JJ
haloperidol/JJ patients/NNS schizophrenic/JJ organic/JJ
haloperidol/JJ patients/NNS psychotic/NN
clozapine/JJ haloperidol/JJ patients/NNS schizophrenic/JJ
clozapine/JJ haloperidol/JJ patients/NNS schizophrenic/JJ organic/JJ
clozapine/JJ haloperidol/JJ patients/NNS psychotic/NN
Carbamazepine/NNP switched/VBN treat/VB haloperidol/JJ patients/NNS schizophrenic/JJ
chlorpromazine/JJ haloperidol/JJ patients/NNS schizophrenic/JJ organic/JJ
chlorpromazine/JJ haloperidol/JJ patients/NNS psychotic/NN
calcium/NN Effects/NNPS blockers/NNS induced/VBN toxicity/NN
bupivacaine/NN blockers/NNS induced/VBN toxicity/NN
calcium/NN blockers/NNS influence/NN investigate/VB bupivacaine/NN induced/VBN toxicity/NN
bupivacaine/NN induced/VBN toxicity/NN
bepridil/NN pronounced/JJ modified/VBN decreased/VBD time/NN convulsions/NNS
calcium/NN blockers/NNS decreased/VBD time/NN convulsions/NNS
lactate/NN elevates/VBZ mice/NNS AIDS/NNP
lactate/NN elevates/VBZ causes/VBZ cardiomyopathy/RB
lactate/NN AIDS/NNP
LA/NNP lactate/NN AIDS/NNP
lactate/NN implicated/VBN' implicated/VBN mechanisms/NNS dysfunction/NN mitochondrial/JJ
lactate/NN implicated/VBN' implicated/VBN mechanisms/NNS dysfunction/NN
LA/NNP lactate/NN implicated/VBN' implicated/VBN mechanisms/NNS dysfunction/NN mitochondrial/JJ
LA/NNP lactate/NN implicated/VBN' implicated/VBN mechanisms/NNS dysfunction/NN
lactate/NN implicated/VBN' implicated/VBN cardiomyopathy/NN
lactate/NN implicated/VBN' implicated/VBN cardiomyopathy/NN CM/NNP
LA/NNP lactate/NN implicated/VBN' implicated/VBN cardiomyopathy/NN
LA/NNP lactate/NN implicated/VBN' implicated/VBN cardiomyopathy/NN CM/NNP
zidovudine/NN combination/NN treated/VBN n/VBN week/NN hemizygous/NNS mice/NNS AIDS/NNP
lamivudine/NN zidovudine/NN combination/NN treated/VBN n/VBN week/NN hemizygous/NNS mice/NNS AIDS/NNP
indinavir/NN zidovudine/NN combination/NN treated/VBN n/VBN week/NN hemizygous/NNS mice/NNS AIDS/NNP
calcium/NN SERCA/NNP mRNA/NN echocardiography/NN quantitation/NN abundance/NN markers/NNS CM/NNP
LA/NNP determination/NN echocardiography/NN quantitation/NN abundance/NN markers/NNS CM/NNP
LA/NNP caused/VBD mice/NNS AIDS/NNP
LA/NNP caused/VBD CM/NN
epinephrine/JJ administer/VB scene/NN paramedics/NNS led/VBD onset/NN distress/NN respiratory/JJ
epinephrine/JJ administer/VB scene/NN paramedics/NNS led/VBD onset/NN distress/NN
epinephrine/JJ administer/VB scene/NN paramedics/NNS led/VBD onset/NN distress/NN rash/NN
Epinephrine/NNP has/VBZ viewed/VBN use/NN paramedics/NNS patients/NNS reaction/NN hypertension/NN
Epinephrine/NNP has/VBZ viewed/VBN use/NN paramedics/NNS patients/NNS reaction/NN allergic/JJ
Epinephrine/NNP has/VBZ viewed/VBN use/NN paramedics/NNS patients/NNS reaction/NN
heparin/NN treated/VBN stopped/VBN months/NNS onset/NN anuria/NN
dipyridamole/NN heparin/NN treated/VBN stopped/VBN months/NNS onset/NN anuria/NN
ephedrine/NN doses/NNS adding/VBG propofol/VB obtund/VB response/NN hypotensive/JJ
ephedrine/NN addition/NN appears/VBZ method/NN obtunding/VBG response/NN hypotensive/JJ
ephedrine/NN any/DT patients/NNS use/NN recommend/VB risk/NN tachycardia/NN inducing/VBG ischemia/NN myocardial/JJ
ephedrine/NN any/DT patients/NNS use/NN recommend/VB risk/NN tachycardia/NN inducing/VBG ischemia/NN
propofol/JJ use/NN recommend/VB risk/NN tachycardia/NN inducing/VBG ischemia/NN myocardial/JJ
propofol/JJ use/NN recommend/VB risk/NN tachycardia/NN inducing/VBG ischemia/NN
amphotericin/NNP B/NNP administration/NN developed/VBD patient/NN cirrhosis/NNS
B/NNP administration/NN developed/VBD patient/NN cirrhosis/NNS
amphotericin/NNP B/NNP administration/NN developed/VBD patient/NN cirrhosis/NNS sporotrichosis/NNS
B/NNP administration/NN developed/VBD patient/NN cirrhosis/NNS sporotrichosis/NNS
fangchinoline/NN tetrandrine/NN Effects/NNPS thrombosis/NNS
tetrandrine/NN Effects/NNPS mice/NNS aggregation/NN platelet/NN
tetrandrine/NN Effects/NNPS mice/NNS aggregation/NN
tetrandrine/NN Effects/NNPS thrombosis/NNS
fangchinoline/NN tetrandrine/NN Effects/NNPS mice/NNS aggregation/NN platelet/NN
fangchinoline/NN tetrandrine/NN Effects/NNPS mice/NNS aggregation/NN
TET/NNP effects/NNS investigate/VB thrombosis/NNS induced/VBN epinephrine/NN aggregation/NN coagulation/NN blood/NN
TET/NNP effects/NNS investigate/VB thrombosis/NNS induced/VBN epinephrine/NN aggregation/NN coagulation/NN
FAN/NNP TET/NNP effects/NNS investigate/VB thrombosis/NNS
TET/NNP effects/NNS investigate/VB thrombosis/NNS induced/VBN epinephrine/NN aggregation/NN platelet/JJ
TET/NNP effects/NNS investigate/VB thrombosis/NNS induced/VBN epinephrine/NN aggregation/NN
epinephrine/NN aggregation/NN platelet/JJ
epinephrine/NN aggregation/NN
EP/NNP epinephrine/NN aggregation/NN platelet/JJ
EP/NNP epinephrine/NN aggregation/NN
FAN/NNP TET/NNP effects/NNS investigate/VB thrombosis/NNS induced/VBN epinephrine/NN aggregation/NN coagulation/NN blood/NN
FAN/NNP TET/NNP effects/NNS investigate/VB thrombosis/NNS induced/VBN epinephrine/NN aggregation/NN coagulation/NN
epinephrine/NN aggregation/NN coagulation/NN blood/NN
epinephrine/NN aggregation/NN coagulation/NN
EP/NNP epinephrine/NN aggregation/NN coagulation/NN blood/NN
EP/NNP epinephrine/NN aggregation/NN coagulation/NN
TET/NNP effects/NNS investigate/VB thrombosis/NNS
FAN/NNP TET/NNP effects/NNS investigate/VB thrombosis/NNS induced/VBN epinephrine/NN aggregation/NN platelet/JJ
FAN/NNP TET/NNP effects/NNS investigate/VB thrombosis/NNS induced/VBN epinephrine/NN aggregation/NN
acetylsalicylic/JJ acid/NN showed/VBD showed/VBD inhibition/NN thrombosis/NNS
acid/NN showed/VBD showed/VBD inhibition/NN thrombosis/NNS
ASA/UH mg/NN acid/NN showed/VBD showed/VBD inhibition/NN thrombosis/NNS
FAN/NNP TET/NNP administration/NN showed/VBD inhibition/NN thrombosis/NNS
TET/NNP administration/NN showed/VBD inhibition/NN thrombosis/NNS
TET/NNP showed/VBD aggregations/NNS platelet/NN
TET/NNP showed/VBD aggregations/NNS
FAN/NNP TET/NNP showed/VBD aggregations/NNS platelet/NN
FAN/NNP TET/NNP showed/VBD aggregations/NNS
lindane/NN treatment/NN consider/VBP initiated/VBN Treatment/NNP scabies/NNS
gamma/CD hexachloride/NN lindane/NN treatment/NN consider/VBP initiated/VBN Treatment/NNP scabies/NNS
benzene/NN hexachloride/NN lindane/NN treatment/NN consider/VBP initiated/VBN Treatment/NNP scabies/NNS
hexachloride/NN lindane/NN treatment/NN consider/VBP initiated/VBN Treatment/NNP scabies/NNS
pilocarpine/VB reported/VBN seizures/NNS
pilocarpine/VB reported/VBN used/VBN localize/VB genes/NNS seizure/NN
pilocarpine/VB seizures/NNS
pilocarpine/VB tested/VBN A/NN induced/VBN seizures/NNS
divalproex/VB reduced/VBN deficits/NNS cognitive/JJ
divalproex/VB reduced/VBN deficits/NNS cognitive/JJ and/CC
divalproex/VB reduced/VBN deficits/NNS cognitive/JJ functional/JJ
divalproex/VB reduced/VBN deficits/NNS
sodium/NN divalproex/VB reduced/VBN deficits/NNS cognitive/JJ
sodium/NN divalproex/VB reduced/VBN deficits/NNS cognitive/JJ and/CC
sodium/NN divalproex/VB reduced/VBN deficits/NNS cognitive/JJ functional/JJ
sodium/NN divalproex/VB reduced/VBN deficits/NNS
Lithium/NNP remains/VBZ treatment/NN disorder/NNP bipolar/NNP
Lithium/NNP remains/VBZ treatment/NN disorder/NNP
lithium/NN effects/NNS management/NN polyuria/NN
lithium/NN effects/NNS remain/VBP written/VBN management/NN polyuria/NN
lithium/NN effects/NNS management/NN polyuria/NN tremor/NN
lithium/NN effects/NNS remain/VBP written/VBN management/NN polyuria/NN tremor/NN
divalproex/VB alleviate/VB impairments/NNS cognitive/JJ
divalproex/VB alleviate/VB impairments/NNS cognitive/JJ and/CC
divalproex/VB alleviate/VB impairments/NNS cognitive/JJ functional/JJ
divalproex/VB alleviate/VB impairments/NNS
sodium/NN divalproex/VB alleviate/VB impairments/NNS cognitive/JJ
sodium/NN divalproex/VB alleviate/VB impairments/NNS cognitive/JJ and/CC
sodium/NN divalproex/VB alleviate/VB impairments/NNS cognitive/JJ functional/JJ
sodium/NN divalproex/VB alleviate/VB impairments/NNS
lithium/NN switching/VBG patients/NNS bipolar/JJ
divalproex/VB switching/VBG patients/NNS bipolar/JJ
sodium/NN divalproex/VB switching/VBG patients/NNS bipolar/JJ
divalproex/NN sodium/NN lithium/NN substitution/NN helpful/JJ reducing/VBG cognitive/NN
divalproex/NN sodium/NN lithium/NN substitution/NN helpful/JJ reducing/VBG cognitive/NN motivational/JJ
divalproex/NN sodium/NN lithium/NN substitution/NN helpful/JJ reducing/VBG cognitive/NN or/CC
divalproex/NN sodium/NN lithium/NN substitution/NN helpful/JJ reducing/VBG cognitive/NN deficits/NNS creative/JJ
divalproex/NN sodium/NN lithium/NN substitution/NN helpful/JJ reducing/VBG cognitive/NN deficits/NNS
sodium/NN lithium/NN substitution/NN helpful/JJ reducing/VBG cognitive/NN
sodium/NN lithium/NN substitution/NN helpful/JJ reducing/VBG cognitive/NN motivational/JJ
sodium/NN lithium/NN substitution/NN helpful/JJ reducing/VBG cognitive/NN or/CC
sodium/NN lithium/NN substitution/NN helpful/JJ reducing/VBG cognitive/NN deficits/NNS creative/JJ
sodium/NN lithium/NN substitution/NN helpful/JJ reducing/VBG cognitive/NN deficits/NNS
lithium/NN substitution/NN helpful/JJ reducing/VBG cognitive/NN deficits/NNS attributed/VBN lithium/NN patients/NNS bipolar/NNP
lithium/NN patients/NNS bipolar/NNP
divalproex/NN sodium/NN lithium/NN substitution/NN helpful/JJ reducing/VBG cognitive/NN deficits/NNS attributed/VBN lithium/NN patients/NNS bipolar/NNP
sodium/NN lithium/NN substitution/NN helpful/JJ reducing/VBG cognitive/NN deficits/NNS attributed/VBN lithium/NN patients/NNS bipolar/NNP
divalproex/NN sodium/NN alternative/NN lithium/NN patients/NNS experiencing/VBG deficits/NNS cognitive/JJ
divalproex/NN sodium/NN alternative/NN lithium/NN patients/NNS experiencing/VBG deficits/NNS
sodium/NN alternative/NN lithium/NN patients/NNS experiencing/VBG deficits/NNS cognitive/JJ
sodium/NN alternative/NN lithium/NN patients/NNS experiencing/VBG deficits/NNS
divalproex/NN sodium/NN alternative/NN lithium/NN patients/NNS experiencing/VBG deficits/NNS loss/NN
divalproex/NN sodium/NN alternative/NN lithium/NN patients/NNS experiencing/VBG deficits/NNS loss/NN creativity/NN of/IN
divalproex/NN sodium/NN alternative/NN lithium/NN patients/NNS experiencing/VBG deficits/NNS loss/NN creativity/NN
sodium/NN alternative/NN lithium/NN patients/NNS experiencing/VBG deficits/NNS loss/NN
sodium/NN alternative/NN lithium/NN patients/NNS experiencing/VBG deficits/NNS loss/NN creativity/NN of/IN
sodium/NN alternative/NN lithium/NN patients/NNS experiencing/VBG deficits/NNS loss/NN creativity/NN
divalproex/NN sodium/NN alternative/NN lithium/NN patients/NNS experiencing/VBG deficits/NNS impairments/NNS functional/JJ
divalproex/NN sodium/NN alternative/NN lithium/NN patients/NNS experiencing/VBG deficits/NNS impairments/NNS
sodium/NN alternative/NN lithium/NN patients/NNS experiencing/VBG deficits/NNS impairments/NNS functional/JJ
sodium/NN alternative/NN lithium/NN patients/NNS experiencing/VBG deficits/NNS impairments/NNS
lithium/NN patients/NNS bipolar/JJ
divalproex/NN sodium/NN alternative/NN lithium/NN patients/NNS bipolar/JJ
sodium/NN alternative/NN lithium/NN patients/NNS bipolar/JJ
doxorubicin/NN function/NN indicator/NN echocardiography/NN survivors/NNS cancer/NN
Dobutamine/JJ echocardiography/NN survivors/NNS cancer/NN
dobutamine/JJ infusion/NN using/VBG performed/VBN develop/VB due/JJ test/NN damage/NN cardiac/JJ
dobutamine/JJ infusion/NN using/VBG performed/VBN develop/VB due/JJ test/NN damage/NN
doxorubicin/NN due/JJ develop/VB performed/VBN using/VBG differentiate/VB long/JJ survivors/NNS cancer/NN
doxorubicin/NN treated/VBN cancer/NN
dobutamine/JJ infusion/NN using/VBG differentiate/VB long/JJ survivors/NNS cancer/NN
doxorubicin/NN due/JJ test/NN damage/NN cardiac/JJ
doxorubicin/NN due/JJ test/NN damage/NN
doxorubicin/NN treated/VBN cancer/NN survivors/NNS long/JJ differentiate/VB using/VBG performed/VBN develop/VB due/JJ test/NN damage/NN cardiac/JJ
doxorubicin/NN treated/VBN cancer/NN survivors/NNS long/JJ differentiate/VB using/VBG performed/VBN develop/VB due/JJ test/NN damage/NN
lithium/NN exposed/VBN screening/NN Cross/NNP induced/VBN malformations/NNS cardiac/JJ
lithium/NN exposed/VBN screening/NN Cross/NNP induced/VBN malformations/NNS
lithium/NN presence/NN assessment/NN provide/VB gestation/NN exposed/VBN screening/NN Cross/NNP induced/VBN malformations/NNS cardiac/JJ
lithium/NN presence/NN assessment/NN provide/VB gestation/NN exposed/VBN screening/NN Cross/NNP induced/VBN malformations/NNS
cocaine/NN nephritis/NNS Henoch/NNP cases/NNS hypertension/NN microangiopathy/NN nephritis/NNS lupus/JJ
cocaine/NN nephritis/NNS Henoch/NNP cases/NNS hypertension/NN microangiopathy/NN nephritis/NNS
cocaine/NN nephritis/NNS Henoch/NNP cases/NNS hypertension/NN microangiopathy/NN thrombotic/JJ
cocaine/NN nephritis/NNS Henoch/NNP cases/NNS hypertension/NN microangiopathy/NN
cocaine/NN nephritis/NNS glomerulonephritis/NNS
cocaine/NN nephritis/NNS Henoch/NNP
cocaine/NN nephritis/NNS Schonlein/JJ
cocaine/NN nephritis/NNS
cocaine/NN nephritis/NNS Henoch/NNP cases/NNS hypertension/NN malignant/JJ
cocaine/NN nephritis/NNS Henoch/NNP cases/NNS hypertension/NN
Norepinephrine/NNP signaling/VBG critical/JJ induced/VBN anxiety/NN
dopamine/JJ beta/NN performance/NN induced/VBN anxiety/NN
norepinephrine/NN lack/VBP mice/NNS performance/NN induced/VBN anxiety/NN
NE/NNP norepinephrine/NN lack/VBP mice/NNS performance/NN induced/VBN anxiety/NN
disulfiram/NN administration/NN mice/NNS Cocaine/NNP induced/VBN attenuated/VBN anxiety/NN
dopamine/JJ beta/NN disulfiram/NN administration/NN mice/NNS Cocaine/NNP induced/VBN attenuated/VBN anxiety/NN
prazosin/NN had/VBD C/VBD type/NN pretreatment/JJ antagonist/NN anxiety/NN
yohimbine/NN prazosin/NN had/VBD C/VBD type/NN pretreatment/JJ antagonist/NN anxiety/NN
propranolol/JJ cocaine/NN antagonist/NN anxiety/NN
prazosin/NN enalapril/NN safety/NN phase/NN patients/NNS failure/NN congestive/JJ
prazosin/NN enalapril/NN safety/NN phase/NN patients/NNS failure/NN heart/NN
prazosin/NN enalapril/NN safety/NN phase/NN patients/NNS failure/NN
enalapril/NN safety/NN phase/NN patients/NNS failure/NN congestive/JJ
enalapril/NN safety/NN phase/NN patients/NNS failure/NN heart/NN
enalapril/NN safety/NN phase/NN patients/NNS failure/NN
angiotensin/NN introduction/NN converting/VBG treatment/NN patients/NNS failure/NN congestive/JJ
angiotensin/NN introduction/NN converting/VBG treatment/NN patients/NNS failure/NN heart/NN
angiotensin/NN introduction/NN converting/VBG treatment/NN patients/NNS failure/NN
converting/VBG treatment/NN patients/NNS failure/NN congestive/JJ
converting/VBG treatment/NN patients/NNS failure/NN heart/NN
converting/VBG treatment/NN patients/NNS failure/NN
enzyme/JJ inhibitors/NNS converting/VBG treatment/NN patients/NNS failure/NN congestive/JJ
enzyme/JJ inhibitors/NNS converting/VBG treatment/NN patients/NNS failure/NN heart/NN
enzyme/JJ inhibitors/NNS converting/VBG treatment/NN patients/NNS failure/NN
ACE/NNP inhibitors/NNS converting/VBG treatment/NN patients/NNS failure/NN congestive/JJ
ACE/NNP inhibitors/NNS converting/VBG treatment/NN patients/NNS failure/NN heart/NN
ACE/NNP inhibitors/NNS converting/VBG treatment/NN patients/NNS failure/NN
inhibitors/NNS converting/VBG treatment/NN patients/NNS failure/NN congestive/JJ
inhibitors/NNS converting/VBG treatment/NN patients/NNS failure/NN heart/NN
inhibitors/NNS converting/VBG treatment/NN patients/NNS failure/NN
enalapril/NN safety/NN assess/VB designed/VBN compared/VBD incidence/NN hypotension/NN
enalapril/VBP hypotension/NN
danazol/NN treatment/NN hamartoma/NN Bile/JJ
danazol/NN treatment/NN hamartoma/NN duct/NN
danazol/NN treatment/NN hamartoma/NN
danazol/JJ treatment/NN patient/NN developed/VBN hamartoma/NN bile/NN
danazol/JJ treatment/NN patient/NN developed/VBN hamartoma/NN duct/NN
danazol/JJ treatment/NN patient/NN developed/VBN hamartoma/NN
lidocaine/NN hyperalgesia/NN
ketamine/NN lidocaine/NN hyperalgesia/NN
lidocaine/JJ ketamine/JJ hyperalgesia/NN
lidocaine/JJ brush/NN pain/NN
ketamine/JJ hyperalgesia/NN
ketamine/JJ lidocaine/JJ brush/NN pain/NN
Ketamine/NNP reduced/VBD evoked/VBD hyperalgesia/NN
Ketamine/NNP reduced/VBD evoked/VBD tended/VBD reduce/VB brush/NN pain/NN
Lidocaine/NNP reduced/VBD area/NN hyperalgesia/NN
lidocaine/NN ketamine/NN hyperalgesia/NN
lidocaine/NN ketamine/NN effects/NNS suggest/VBP mediated/VBN types/NNS hyperalgesia/NN
ketamine/NN hyperalgesia/NN
ketamine/NN effects/NNS suggest/VBP mediated/VBN types/NNS hyperalgesia/NN
MPEP/NNP action/NN associated/VBN neurotoxicity/RB
dopamine/JJ outflow/NN decrease/NN associated/VBN neurotoxicity/RB
dopamine/JJ outflow/NN decrease/NN hyperthermia/NN
methamphetamine/NN antagonist/NN action/NN associated/VBN neurotoxicity/RB
MPEP/NNP action/NN associated/VBN decrease/NN hyperthermia/NN
methamphetamine/NN neurones/NNS toxicity/NN
MPEP/NNP mGluR/NN blockade/NN protect/VB neurones/NNS toxicity/NN
dopamine/JJ efflux/NN induced/VBN induced/VBN' decrease/NN hyperthermia/NN
MPEP/NNP rendered/VBN Neuroprotection/NNP associated/VBN induced/VBN induced/VBN' decrease/NN hyperthermia/NN
diethylstilbestrol/NN exposed/VBN adenocarcinoma/NN clear/JJ
diethylstilbestrol/NN exposed/VBN adenocarcinoma/NN cell/NN
diethylstilbestrol/NN exposed/VBN adenocarcinoma/NN
diethylstilbestrol/NN exposed/VBN adenocarcinoma/NN vagina/NN of/IN
diethylstilbestrol/NN exposed/VBN adenocarcinoma/NN vagina/NN the/DT
diethylstilbestrol/NN exposed/VBN adenocarcinoma/NN vagina/NN
azathioprine/NN Treatment/NNP psoriasis/NNS
Azathioprine/JJ treatment/NN benefited/VBD 19/CD patients/NNS suffering/VBG psoriasis/NNS
azathioprine/JJ therapy/NN continued/VBN detected/VBN damage/NN liver/NN
azathioprine/JJ therapy/NN continued/VBN detected/VBN damage/NN
ephedrine/RB reduces/VBZ induced/VBZ hypotension/NN
ephedrine/RB reduces/VBZ
ephedrine/RB reduces/VBZ oxygenation/NN frontal/JJ
ephedrine/RB reduces/VBZ oxygenation/NN lobe/NN
ephedrine/RB reduces/VBZ oxygenation/NN
Phenylephrine/NNP reduces/VBZ induced/VBZ hypotension/NN
ephedrine/NN phenylephrine/NN effect/NN describe/VBP induced/VBN hypotension/NN
phenylephrine/NN effect/NN describe/VBP induced/VBN hypotension/NN
ephedrine/NN maintains/VBZ has/VBZ CONCLUSIONS/NNS utilization/NN hypotension/NN
phenylephrine/JJ correct/JJ hypotension/NN
IH/NN induced/VBN cardiotoxicity/RB
636/CD proanthocyanidin/NN extract/VB protection/NN damage/NN associated/VBN amiodarone/NN induced/VBN cardiotoxicity/RB
grape/JJ proanthocyanidin/NN extract/VB protection/NN damage/NN associated/VBN amiodarone/NN induced/VBN cardiotoxicity/RB
seed/NN proanthocyanidin/NN extract/VB protection/NN damage/NN associated/VBN amiodarone/NN induced/VBN cardiotoxicity/RB
proanthocyanidin/NN extract/VB protection/NN damage/NN associated/VBN amiodarone/NN induced/VBN cardiotoxicity/RB
extract/VB protection/NN damage/NN associated/VBN amiodarone/NN induced/VBN cardiotoxicity/RB
acetaminophen/NN associated/VBN amiodarone/NN toxicity/NN lung/NN
acetaminophen/NN associated/VBN amiodarone/NN toxicity/NN
doxorubicin/NN toxicity/NN amiodarone/NN associated/VBN induced/VBN nephrotoxicity/RB
IH/NN induced/VBN amiodarone/NN associated/VBN deaths/NNS apoptotic/JJ necrotic/JJ
636/CD proanthocyanidin/NN extract/VB protection/NN damage/NN associated/VBN deaths/NNS apoptotic/JJ necrotic/JJ
grape/JJ proanthocyanidin/NN extract/VB protection/NN damage/NN associated/VBN deaths/NNS apoptotic/JJ necrotic/JJ
seed/NN proanthocyanidin/NN extract/VB protection/NN damage/NN associated/VBN deaths/NNS apoptotic/JJ necrotic/JJ
proanthocyanidin/NN extract/VB protection/NN damage/NN associated/VBN deaths/NNS apoptotic/JJ necrotic/JJ
extract/VB protection/NN damage/NN associated/VBN deaths/NNS apoptotic/JJ necrotic/JJ
doxorubicin/NN toxicity/NN lung/NN
doxorubicin/NN toxicity/NN
IH/NN induced/VBN amiodarone/NN associated/VBN induced/VBN nephrotoxicity/RB
636/CD proanthocyanidin/NN extract/VB protection/NN damage/NN associated/VBN induced/VBN nephrotoxicity/RB
grape/JJ proanthocyanidin/NN extract/VB protection/NN damage/NN associated/VBN induced/VBN nephrotoxicity/RB
seed/NN proanthocyanidin/NN extract/VB protection/NN damage/NN associated/VBN induced/VBN nephrotoxicity/RB
proanthocyanidin/NN extract/VB protection/NN damage/NN associated/VBN induced/VBN nephrotoxicity/RB
extract/VB protection/NN damage/NN associated/VBN induced/VBN nephrotoxicity/RB
IH/NN induced/VBN amiodarone/NN toxicity/NN lung/NN
IH/NN induced/VBN amiodarone/NN toxicity/NN
636/CD proanthocyanidin/NN extract/VB protection/NN damage/NN associated/VBN amiodarone/NN toxicity/NN lung/NN
636/CD proanthocyanidin/NN extract/VB protection/NN damage/NN associated/VBN amiodarone/NN toxicity/NN
grape/JJ proanthocyanidin/NN extract/VB protection/NN damage/NN associated/VBN amiodarone/NN toxicity/NN lung/NN
grape/JJ proanthocyanidin/NN extract/VB protection/NN damage/NN associated/VBN amiodarone/NN toxicity/NN
seed/NN proanthocyanidin/NN extract/VB protection/NN damage/NN associated/VBN amiodarone/NN toxicity/NN lung/NN
seed/NN proanthocyanidin/NN extract/VB protection/NN damage/NN associated/VBN amiodarone/NN toxicity/NN
proanthocyanidin/NN extract/VB protection/NN damage/NN associated/VBN amiodarone/NN toxicity/NN lung/NN
proanthocyanidin/NN extract/VB protection/NN damage/NN associated/VBN amiodarone/NN toxicity/NN
extract/VB protection/NN damage/NN associated/VBN amiodarone/NN toxicity/NN lung/NN
extract/VB protection/NN damage/NN associated/VBN amiodarone/NN toxicity/NN
acetaminophen/NN associated/VBN amiodarone/NN induced/VBN cardiotoxicity/RB
amiodarone/NN associated/VBN induced/VBN nephrotoxicity/RB
amiodarone/NN induced/VBN cardiotoxicity/RB
IH/NNP ability/NN assessed/VBD seed/NN proanthocyanidin/VBN induced/VBN cardiotoxicity/RB
636/CD IH/NNP ability/NN assessed/VBD seed/NN proanthocyanidin/VBN induced/VBN cardiotoxicity/RB
grape/JJ seed/NN proanthocyanidin/VBN induced/VBN cardiotoxicity/RB
seed/NN proanthocyanidin/VBN induced/VBN cardiotoxicity/RB
proanthocyanidin/VBN induced/VBN cardiotoxicity/RB
extract/VB proanthocyanidin/VBN induced/VBN cardiotoxicity/RB
GSPE/NNP extract/VB proanthocyanidin/VBN induced/VBN cardiotoxicity/RB
acetaminophen/NN prevent/VB extract/VB proanthocyanidin/VBN induced/VBN toxicity/NN lung/NN
acetaminophen/NN prevent/VB extract/VB proanthocyanidin/VBN induced/VBN toxicity/NN
AAP/NNP acetaminophen/NN prevent/VB extract/VB proanthocyanidin/VBN induced/VBN toxicity/NN lung/NN
AAP/NNP acetaminophen/NN prevent/VB extract/VB proanthocyanidin/VBN induced/VBN toxicity/NN
doxorubicin/NN toxicity/NN induced/VBN proanthocyanidin/VBN induced/VBN nephrotoxicity/NN
DOX/NNP doxorubicin/NN toxicity/NN induced/VBN proanthocyanidin/VBN induced/VBN nephrotoxicity/NN
doxorubicin/NN toxicity/NN lung/NN
doxorubicin/NN toxicity/NN
DOX/NNP doxorubicin/NN toxicity/NN lung/NN
DOX/NNP doxorubicin/NN toxicity/NN
IH/NNP ability/NN assessed/VBD seed/NN proanthocyanidin/VBN induced/VBN nephrotoxicity/NN
636/CD IH/NNP ability/NN assessed/VBD seed/NN proanthocyanidin/VBN induced/VBN nephrotoxicity/NN
grape/JJ seed/NN proanthocyanidin/VBN induced/VBN nephrotoxicity/NN
seed/NN proanthocyanidin/VBN induced/VBN nephrotoxicity/NN
proanthocyanidin/VBN induced/VBN nephrotoxicity/NN
extract/VB proanthocyanidin/VBN induced/VBN nephrotoxicity/NN
GSPE/NNP extract/VB proanthocyanidin/VBN induced/VBN nephrotoxicity/NN
IH/NNP ability/NN assessed/VBD seed/NN proanthocyanidin/VBN induced/VBN toxicity/NN lung/NN
IH/NNP ability/NN assessed/VBD seed/NN proanthocyanidin/VBN induced/VBN toxicity/NN
636/CD IH/NNP ability/NN assessed/VBD seed/NN proanthocyanidin/VBN induced/VBN toxicity/NN lung/NN
636/CD IH/NNP ability/NN assessed/VBD seed/NN proanthocyanidin/VBN induced/VBN toxicity/NN
grape/JJ seed/NN proanthocyanidin/VBN induced/VBN toxicity/NN lung/NN
grape/JJ seed/NN proanthocyanidin/VBN induced/VBN toxicity/NN
seed/NN proanthocyanidin/VBN induced/VBN toxicity/NN lung/NN
seed/NN proanthocyanidin/VBN induced/VBN toxicity/NN
proanthocyanidin/VBN induced/VBN toxicity/NN lung/NN
proanthocyanidin/VBN induced/VBN toxicity/NN
extract/VB proanthocyanidin/VBN induced/VBN toxicity/NN lung/NN
extract/VB proanthocyanidin/VBN induced/VBN toxicity/NN
GSPE/NNP extract/VB proanthocyanidin/VBN induced/VBN toxicity/NN lung/NN
GSPE/NNP extract/VB proanthocyanidin/VBN induced/VBN toxicity/NN
acetaminophen/NN prevent/VB extract/VB proanthocyanidin/VBN induced/VBN cardiotoxicity/RB
AAP/NNP acetaminophen/NN prevent/VB extract/VB proanthocyanidin/VBN induced/VBN cardiotoxicity/RB
amiodarone/NN nephrotoxicity/NN
AMI/NNP nephrotoxicity/NN
amiodarone/NN nephrotoxicity/NN induced/VBN proanthocyanidin/VBN induced/VBN cardiotoxicity/RB
AMI/NNP nephrotoxicity/NN induced/VBN proanthocyanidin/VBN induced/VBN cardiotoxicity/RB
GSPE/JJ preexposure/NN absence/NN revealed/VBD moderate/JJ damage/NN tissue/NN
GSPE/JJ preexposure/NN absence/NN revealed/VBD moderate/JJ damage/NN
GSPE/NNP blocked/VBN organs/NNS necrosis/VBZ
ipratropium/NN effects/NNS bromide/VBP disease/NN chronic/JJ
ipratropium/NN effects/NNS bromide/VBP disease/NN obstructive/JJ
ipratropium/NN effects/NNS bromide/VBP disease/NN pulmonary/JJ
ipratropium/NN effects/NNS bromide/VBP disease/NN
bromide/VBP disease/NN chronic/JJ
bromide/VBP disease/NN obstructive/JJ
bromide/VBP disease/NN pulmonary/JJ
bromide/VBP disease/NN
theophylline/VBP bromide/VBP disease/NN chronic/JJ
theophylline/VBP bromide/VBP disease/NN obstructive/JJ
theophylline/VBP bromide/VBP disease/NN pulmonary/JJ
theophylline/VBP bromide/VBP disease/NN
ipratropium/NN aerosol/NN dose/NN effects/NNS tablets/NNS compared/VBN double/JJ controlled/VBN disease/NN chronic/JJ
ipratropium/NN aerosol/NN dose/NN effects/NNS tablets/NNS compared/VBN double/JJ controlled/VBN disease/NN obstructive/JJ
ipratropium/NN aerosol/NN dose/NN effects/NNS tablets/NNS compared/VBN double/JJ controlled/VBN disease/NN pulmonary/JJ
ipratropium/NN aerosol/NN dose/NN effects/NNS tablets/NNS compared/VBN double/JJ controlled/VBN disease/NN
bromide/NN aerosol/NN dose/NN effects/NNS tablets/NNS compared/VBN double/JJ controlled/VBN disease/NN chronic/JJ
bromide/NN aerosol/NN dose/NN effects/NNS tablets/NNS compared/VBN double/JJ controlled/VBN disease/NN obstructive/JJ
bromide/NN aerosol/NN dose/NN effects/NNS tablets/NNS compared/VBN double/JJ controlled/VBN disease/NN pulmonary/JJ
bromide/NN aerosol/NN dose/NN effects/NNS tablets/NNS compared/VBN double/JJ controlled/VBN disease/NN
theophylline/NN tablets/NNS compared/VBN double/JJ controlled/VBN disease/NN chronic/JJ
theophylline/NN tablets/NNS compared/VBN double/JJ controlled/VBN disease/NN obstructive/JJ
theophylline/NN tablets/NNS compared/VBN double/JJ controlled/VBN disease/NN pulmonary/JJ
theophylline/NN tablets/NNS compared/VBN double/JJ controlled/VBN disease/NN
theophylline/JJ use/NN involve/VB systems/NNS cardiovascular/JJ
theophylline/JJ use/NN involve/VB systems/NNS cardiovascular/JJ and/CC
theophylline/JJ use/NN involve/VB systems/NNS cardiovascular/JJ gastrointestinal/JJ
theophylline/JJ use/NN involve/VB systems/NNS
ipratropium/NN bronchodilator/NN theophylline/NN patients/NNS obstruction/NN chronic/JJ
ipratropium/NN bronchodilator/NN theophylline/NN patients/NNS obstruction/NN airflow/NN
ipratropium/NN bronchodilator/NN theophylline/NN patients/NNS obstruction/NN
theophylline/NN patients/NNS obstruction/NN chronic/JJ
theophylline/NN patients/NNS obstruction/NN airflow/NN
theophylline/NN patients/NNS obstruction/NN
nitrendipine/VBP nephrosclerosis/NNS rats/NNS hypertension/NN renovascular/NN
nitrendipine/VBP nephrosclerosis/NNS rats/NNS hypertension/NN
calcium/NN blocker/NN effect/NN nitrendipine/VBP nephrosclerosis/NNS
calcium/NN blocker/NN effect/NN nitrendipine/VBP nephrosclerosis/NNS rats/NNS hypertension/NN renovascular/NN
calcium/NN blocker/NN effect/NN nitrendipine/VBP nephrosclerosis/NNS rats/NNS hypertension/NN
nitrendipine/NN treatment/NN effect/NN studied/VBN rats/NNS kidney/NN hypertension/NN renovascular/NN
nitrendipine/NN treatment/NN effect/NN studied/VBN rats/NNS kidney/NN hypertension/NN
angiotensin/NN converting/VBG pressure/NN albuminuria/NN
enalapril/NN converting/VBG angiotensin/NN effect/NN studied/VBN rats/NNS kidney/NN hypertension/NN renovascular/NN
enalapril/NN converting/VBG angiotensin/NN effect/NN studied/VBN rats/NNS kidney/NN hypertension/NN
enalapril/NN converting/VBG pressure/NN albuminuria/NN
angiotensin/NN effect/NN studied/VBN rats/NNS kidney/NN hypertension/NN renovascular/NN
angiotensin/NN effect/NN studied/VBN rats/NNS kidney/NN hypertension/NN
calcium/NN nitrendipine/NN treatment/NN effect/NN angiotensin/NN converting/VBG pressure/NN albuminuria/NN
calcium/NN nitrendipine/NN treatment/NN effect/NN studied/VBN rats/NNS kidney/NN hypertension/NN renovascular/NN
calcium/NN nitrendipine/NN treatment/NN effect/NN studied/VBN rats/NNS kidney/NN hypertension/NN
nitrendipine/VBN assigned/VBN rats/NNS hypertensive/JJ
nitrendipine/VBN assigned/VBN groups/NNS controls/NNS hypertensive/JJ
enalapril/NN controls/NNS groups/NNS assigned/VBN rats/NNS hypertensive/JJ
enalapril/NN controls/NNS hypertensive/JJ
enalapril/JJ treatment/NN change/VB excretion/NNS glomerulosclerosis/NNS
nitrendipine/NN contrast/NN controls/VBZ hr/NN hypertensive/NN
nitrendipine/NN treated/VBN controls/NNS hypertensive/JJ
nitrendipine/NN increased/VBN index/NN glomerulosclerosis/JJ
nitrendipine/JJ group/NN higher/JJR in/IN treated/VBN controls/NNS hypertensive/JJ
enalapril/NN treated/VBN controls/NNS hypertensive/JJ
perhexiline/JJ maleate/NN noted/VBN used/VBD treatment/NN pectoris/NNS angina/NN
perhexiline/JJ maleate/NN noted/VBN used/VBD treatment/NN pectoris/NNS
maleate/NN noted/VBN used/VBD treatment/NN pectoris/NNS angina/NN
maleate/NN noted/VBN used/VBD treatment/NN pectoris/NNS
MFL/NNP leucovorin/NN FU/NNP mitoxantrone/NN toxicity/NN
mitoxantrone/NN toxicity/NN
leucovorin/NN FU/NNP mitoxantrone/NN treated/VBD cancer/NN breast/NN
leucovorin/NN FU/NNP mitoxantrone/NN treated/VBD cancer/NN
leucovorin/NN FU/NNP mitoxantrone/NN toxicity/NN
5/CD dose/NN mitoxantrone/NN treated/VBD cancer/NN breast/NN
5/CD dose/NN mitoxantrone/NN treated/VBD cancer/NN
FU/NNP mitoxantrone/NN treated/VBD cancer/NN breast/NN
FU/NNP mitoxantrone/NN treated/VBD cancer/NN
MFL/NNP leucovorin/NN FU/NNP mitoxantrone/NN treated/VBD cancer/NN breast/NN
MFL/NNP leucovorin/NN FU/NNP mitoxantrone/NN treated/VBD cancer/NN
mitoxantrone/NN treated/VBD cancer/NN breast/NN
mitoxantrone/NN treated/VBD cancer/NN
5/CD dose/NN mitoxantrone/NN toxicity/NN
FU/NNP mitoxantrone/NN toxicity/NN
leucovorin/NN treated/VBN cancer/NN breast/NN
leucovorin/NN treated/VBN cancer/NN
5/CD infusion/NN day/NN m/NN mitoxantrone/NN treated/VBN cancer/NN breast/NN
5/CD infusion/NN day/NN m/NN mitoxantrone/NN treated/VBN cancer/NN
FU/NNP infusion/NN day/NN m/NN mitoxantrone/NN treated/VBN cancer/NN breast/NN
FU/NNP infusion/NN day/NN m/NN mitoxantrone/NN treated/VBN cancer/NN
mitoxantrone/NN treated/VBN cancer/NN breast/NN
mitoxantrone/NN treated/VBN cancer/NN
MFL/NNP regimen/NN achieves/VBZ induces/VBZ toxicity/NN
regimen/NN achieves/VBZ induces/VBZ toxicity/NN
propranolol/NN disease/NN Parkinson/NNP
propranolol/NN disease/NN Parkinson/NNP '/POS
propranolol/NN disease/NN s/JJ
propranolol/NN disease/NN
propranolol/NN dyskinesia/NN
levodopa/NN Improvement/NNP dyskinesia/NN propranolol/NN disease/NN Parkinson/NNP
levodopa/NN Improvement/NNP dyskinesia/NN propranolol/NN disease/NN Parkinson/NNP '/POS
levodopa/NN Improvement/NNP dyskinesia/NN propranolol/NN disease/NN s/JJ
levodopa/NN Improvement/NNP dyskinesia/NN propranolol/NN disease/NN
propranolol/JJ low/JJ received/VBD patients/NNS suffering/VBG disease/NN Parkinson/NNP
propranolol/JJ low/JJ received/VBD patients/NNS suffering/VBG disease/NN Parkinson/NNP '/POS
propranolol/JJ low/JJ received/VBD patients/NNS suffering/VBG disease/NN s/JJ
propranolol/JJ low/JJ received/VBD patients/NNS suffering/VBG disease/NN
propranolol/JJ low/JJ received/VBD patients/NNS suffering/VBG disease/NN PD/NNP
propranolol/JJ low/JJ received/VBD patients/NNS suffering/VBG dyskinesia/NN
levodopa/NN improve/VB induced/VBN dyskinesia/NN PD/NNP
Thalidomide/NNP limited/VBN single/JJ activity/NN non/NN
Thalidomide/NNP limited/VBN single/JJ lymphomas/NNS Hodgkin/NNP
Thalidomide/NNP limited/VBN single/JJ lymphomas/NNS
Thalidomide/NNP limited/VBN single/JJ B/NNP Leukemia/NNP
Thalidomide/NNP limited/VBN single/JJ trial/NN Cancer/NNP
Thalidomide/NNP agent/NN activity/NN myeloma/NN lymphoma/NN lymphoplasmacytic/JJ
Thalidomide/NNP agent/NN activity/NN myeloma/NN lymphoma/NN
Thalidomide/NNP agent/NN activity/NN myeloma/NN lymphoma/NN mantle/JJ
Thalidomide/NNP agent/NN activity/NN myeloma/NN lymphoma/NN cell/NN
Thalidomide/NNP agent/NN activity/NN myeloma/NN lymphoma/NN
Thalidomide/NNP agent/NN activity/NN myeloma/NN multiple/JJ
Thalidomide/NNP agent/NN activity/NN myeloma/NN
thalidomide/JJ mg/NN received/VBN lymphomas/NNS
thalidomide/NN lymphomas/NNS
lenalidomide/NN agent/NN reported/VBN level/NN demonstrate/VB thalidomide/NN lymphomas/NNS
maltolyl/JJ p/NN compound/NN attenuates/VBZ deficits/NNS cognitive/JJ
maltolyl/JJ p/NN compound/NN attenuates/VBZ deficits/NNS
p/NN compound/NN attenuates/VBZ deficits/NNS cognitive/JJ
p/NN compound/NN attenuates/VBZ deficits/NNS
coumarate/NN p/NN compound/NN attenuates/VBZ deficits/NNS cognitive/JJ
coumarate/NN p/NN compound/NN attenuates/VBZ deficits/NNS
maltolyl/JJ p/NN compound/NN attenuates/VBZ shows/VBZ models/NNS vitro/NN dementia/NN
p/NN compound/NN attenuates/VBZ shows/VBZ models/NNS vitro/NN dementia/NN
coumarate/NN p/NN compound/NN attenuates/VBZ shows/VBZ models/NNS vitro/NN dementia/NN
maltolyl/JJ p/NN improve/VB decline/NN cognitive/JJ
maltolyl/JJ p/NN improve/VB decline/NN
p/NN improve/VB decline/NN cognitive/JJ
p/NN improve/VB decline/NN
coumarate/NN improve/VB decline/NN cognitive/JJ
coumarate/NN improve/VB decline/NN
amyloid/JJ peptide/NN injected/VBD p/NN improve/VB decline/NN cognitive/JJ
amyloid/JJ peptide/NN injected/VBD p/NN improve/VB decline/NN
beta/JJ peptide/NN injected/VBD p/NN improve/VB decline/NN cognitive/JJ
beta/JJ peptide/NN injected/VBD p/NN improve/VB decline/NN
peptide/NN injected/VBD p/NN improve/VB decline/NN cognitive/JJ
peptide/NN injected/VBD p/NN improve/VB decline/NN
1/CD peptide/NN injected/VBD p/NN improve/VB decline/NN cognitive/JJ
1/CD peptide/NN injected/VBD p/NN improve/VB decline/NN
42/CD 1/CD peptide/NN injected/VBD p/NN improve/VB decline/NN cognitive/JJ
42/CD 1/CD peptide/NN injected/VBD p/NN improve/VB decline/NN
Maltolyl/JJ p/NN found/VBN attenuate/VB deficits/NNS cognitive/JJ
Maltolyl/JJ p/NN found/VBN attenuate/VB deficits/NNS
p/NN found/VBN attenuate/VB deficits/NNS cognitive/JJ
p/NN found/VBN attenuate/VB deficits/NNS
coumarate/NN found/VBN attenuate/VB deficits/NNS cognitive/JJ
coumarate/NN found/VBN attenuate/VB deficits/NNS
amyloid/JJ peptide/NN hippocampus/NNS observed/VBN death/NN reduce/VB attenuate/VB deficits/NNS cognitive/JJ
amyloid/JJ peptide/NN hippocampus/NNS observed/VBN death/NN reduce/VB attenuate/VB deficits/NNS
beta/JJ peptide/NN hippocampus/NNS observed/VBN death/NN reduce/VB attenuate/VB deficits/NNS cognitive/JJ
beta/JJ peptide/NN hippocampus/NNS observed/VBN death/NN reduce/VB attenuate/VB deficits/NNS
peptide/NN hippocampus/NNS observed/VBN death/NN reduce/VB attenuate/VB deficits/NNS cognitive/JJ
peptide/NN hippocampus/NNS observed/VBN death/NN reduce/VB attenuate/VB deficits/NNS
1/CD peptide/NN hippocampus/NNS observed/VBN death/NN reduce/VB attenuate/VB deficits/NNS cognitive/JJ
1/CD peptide/NN hippocampus/NNS observed/VBN death/NN reduce/VB attenuate/VB deficits/NNS
42/CD 1/CD peptide/NN hippocampus/NNS observed/VBN death/NN reduce/VB attenuate/VB deficits/NNS cognitive/JJ
42/CD 1/CD peptide/NN hippocampus/NNS observed/VBN death/NN reduce/VB attenuate/VB deficits/NNS
maltolyl/JJ p/NN suggests/VBZ candidate/NN characterized/VBN death/NN decline/NN
maltolyl/JJ p/NN suggests/VBZ candidate/NN characterized/VBN death/NN function/NN of/IN
maltolyl/JJ p/NN suggests/VBZ candidate/NN characterized/VBN death/NN function/NN cognitive/JJ
maltolyl/JJ p/NN suggests/VBZ candidate/NN characterized/VBN death/NN function/NN
p/NN suggests/VBZ candidate/NN characterized/VBN death/NN decline/NN
p/NN suggests/VBZ candidate/NN characterized/VBN death/NN function/NN of/IN
p/NN suggests/VBZ candidate/NN characterized/VBN death/NN function/NN cognitive/JJ
p/NN suggests/VBZ candidate/NN characterized/VBN death/NN function/NN
coumarate/NN candidate/NN characterized/VBN death/NN decline/NN
coumarate/NN candidate/NN characterized/VBN death/NN function/NN of/IN
coumarate/NN candidate/NN characterized/VBN death/NN function/NN cognitive/JJ
coumarate/NN candidate/NN characterized/VBN death/NN function/NN
maltolyl/JJ p/NN suggests/VBZ candidate/NN disease/NN Alzheimer/NNP
maltolyl/JJ p/NN suggests/VBZ candidate/NN disease/NN Alzheimer/NNP '/POS
maltolyl/JJ p/NN suggests/VBZ candidate/NN disease/NN s/JJ
maltolyl/JJ p/NN suggests/VBZ candidate/NN disease/NN
p/NN suggests/VBZ candidate/NN disease/NN Alzheimer/NNP
p/NN suggests/VBZ candidate/NN disease/NN Alzheimer/NNP '/POS
p/NN suggests/VBZ candidate/NN disease/NN s/JJ
p/NN suggests/VBZ candidate/NN disease/NN
coumarate/NN candidate/NN disease/NN Alzheimer/NNP
coumarate/NN candidate/NN disease/NN Alzheimer/NNP '/POS
coumarate/NN candidate/NN disease/NN s/JJ
coumarate/NN candidate/NN disease/NN
maltolyl/JJ p/NN suggests/VBZ candidate/NN characterized/VBN death/NN neuronal/NN
maltolyl/JJ p/NN suggests/VBZ candidate/NN characterized/VBN death/NN
p/NN suggests/VBZ candidate/NN characterized/VBN death/NN neuronal/NN
p/NN suggests/VBZ candidate/NN characterized/VBN death/NN
coumarate/NN candidate/NN characterized/VBN death/NN neuronal/NN
coumarate/NN candidate/NN characterized/VBN death/NN
VPA/NNP signs/NNS consciousness/NN marked/VBD hyperammonemia/NN
VPA/NNP signs/NNS consciousness/NN marked/VBD slowing/NN frequency/NN seizure/NN
Galanthamine/JJ hydrobromide/NN used/VBN patient/NN demonstrating/VBG effects/NNS overdosage/NN
hydrobromide/NN used/VBN patient/NN demonstrating/VBG effects/NNS overdosage/NN
nitrazepam/NN overdose/NN took/VBD received/VBD symptoms/NNS withdrawal/NN
nitrazepam/NN overdose/NN took/VBD received/VBD symptoms/NNS
chlormethiazole/NN doses/NNS received/VBD symptoms/NNS withdrawal/NN
chlormethiazole/NN doses/NNS received/VBD symptoms/NNS
alcohol/NN symptoms/NNS withdrawal/NN
alcohol/NN symptoms/NNS
chlormethiazole/NN doses/NNS received/VBD took/VBD overdose/NN
alcohol/NN symptoms/NNS received/VBD took/VBD overdose/NN
chlormethiazole/JJ intoxication/NN those/DT two/CD patient/NN overdose/NN
physostigmine/NN attenuated/VBN potentiated/VBN hyperactivity/RB
methscopolamine/NN had/VBD effect/NN hyperactivity/NN
neostigmine/NN methscopolamine/NN had/VBD effect/NN hyperactivity/NN
serotonin/NN depletor/NN chlorophenylalamine/NN pretreatment/NN caused/VBD hyperactivity/NN
p/NN pretreatment/NN caused/VBD hyperactivity/NN
chlorophenylalamine/NN pretreatment/NN caused/VBD hyperactivity/NN
Zonisamide/NNP broad/JJ drug/NN used/VBN treat/VB types/NNS seizures/NNS
midazolam/NN arrest/NN death/NN
midazolam/NN administration/NN associated/VBN arrest/NN death/NN
carbon/NN tetrachloride/NN relationship/NN Phenobarbitone/NNP enlargement/NN
carbon/NN tetrachloride/NN relationship/NN Phenobarbitone/NNP enlargement/NN liver/NN of/IN
carbon/NN tetrachloride/NN relationship/NN Phenobarbitone/NNP enlargement/NN liver/NN the/DT
carbon/NN tetrachloride/NN relationship/NN Phenobarbitone/NNP enlargement/NN liver/NN
tetrachloride/NN relationship/NN Phenobarbitone/NNP enlargement/NN
tetrachloride/NN relationship/NN Phenobarbitone/NNP enlargement/NN liver/NN of/IN
tetrachloride/NN relationship/NN Phenobarbitone/NNP enlargement/NN liver/NN the/DT
tetrachloride/NN relationship/NN Phenobarbitone/NNP enlargement/NN liver/NN
Phenobarbitone/NNP induced/NNP cirrhosis/NNS
carbon/NN tetrachloride/NN relationship/NN Phenobarbitone/NNP induced/NNP cirrhosis/NNS
tetrachloride/NN relationship/NN Phenobarbitone/NNP induced/NNP cirrhosis/NNS
carbon/NN tetrachloride/NN yield/NN given/VBN induced/VBN enlargement/NN
carbon/NN tetrachloride/NN yield/NN given/VBN induced/VBN enlargement/NN liver/NN of/IN
carbon/NN tetrachloride/NN yield/NN given/VBN induced/VBN enlargement/NN liver/NN the/DT
carbon/NN tetrachloride/NN yield/NN given/VBN induced/VBN enlargement/NN liver/NN
tetrachloride/NN yield/NN given/VBN induced/VBN enlargement/NN
tetrachloride/NN yield/NN given/VBN induced/VBN enlargement/NN liver/NN of/IN
tetrachloride/NN yield/NN given/VBN induced/VBN enlargement/NN liver/NN the/DT
tetrachloride/NN yield/NN given/VBN induced/VBN enlargement/NN liver/NN
carbon/NN tetrachloride/NN dose/NN giving/VBG increased/VBN primed/VBN given/VBN induced/VBN enlargement/NN
carbon/NN tetrachloride/NN dose/NN giving/VBG increased/VBN primed/VBN given/VBN induced/VBN enlargement/NN liver/NN of/IN
carbon/NN tetrachloride/NN dose/NN giving/VBG increased/VBN primed/VBN given/VBN induced/VBN enlargement/NN liver/NN the/DT
carbon/NN tetrachloride/NN dose/NN giving/VBG increased/VBN primed/VBN given/VBN induced/VBN enlargement/NN liver/NN
tetrachloride/NN dose/NN giving/VBG increased/VBN primed/VBN given/VBN induced/VBN enlargement/NN
tetrachloride/NN dose/NN giving/VBG increased/VBN primed/VBN given/VBN induced/VBN enlargement/NN liver/NN of/IN
tetrachloride/NN dose/NN giving/VBG increased/VBN primed/VBN given/VBN induced/VBN enlargement/NN liver/NN the/DT
tetrachloride/NN dose/NN giving/VBG increased/VBN primed/VBN given/VBN induced/VBN enlargement/NN liver/NN
carbon/NN tetrachloride/NN yield/NN cirrhosis/NNS defined/VBN nodular/VB normal/JJ g/NN dl/NN splenomegaly/NN
tetrachloride/NN yield/NN cirrhosis/NNS defined/VBN nodular/VB normal/JJ g/NN dl/NN splenomegaly/NN
carbon/NN tetrachloride/NN dose/NN giving/VBG increased/VBN primed/VBN given/VBN yield/NN cirrhosis/NNS defined/VBN nodular/VB normal/JJ g/NN dl/NN splenomegaly/NN
tetrachloride/NN dose/NN giving/VBG increased/VBN primed/VBN given/VBN yield/NN cirrhosis/NNS defined/VBN nodular/VB normal/JJ g/NN dl/NN splenomegaly/NN
phenobarbitone/NN given/VBN yield/NN cirrhosis/NNS defined/VBN nodular/VB testicular/VB atrophy/RB
phenobarbitone/NN peak/NN giving/VBG increased/VBN primed/VBN given/VBN yield/NN cirrhosis/NNS defined/VBN nodular/VB testicular/VB atrophy/RB
carbon/NN tetrachloride/NN yield/NN cirrhosis/NNS defined/VBN nodular/VB testicular/VB atrophy/RB
tetrachloride/NN yield/NN cirrhosis/NNS defined/VBN nodular/VB testicular/VB atrophy/RB
carbon/NN tetrachloride/NN dose/NN giving/VBG increased/VBN primed/VBN given/VBN yield/NN cirrhosis/NNS defined/VBN nodular/VB testicular/VB atrophy/RB
tetrachloride/NN dose/NN giving/VBG increased/VBN primed/VBN given/VBN yield/NN cirrhosis/NNS defined/VBN nodular/VB testicular/VB atrophy/RB
phenobarbitone/NN given/VBN yield/NN cirrhosis/NNS defined/VBN nodular/VB normal/JJ g/NN dl/NN splenomegaly/NN
phenobarbitone/NN peak/NN giving/VBG increased/VBN primed/VBN given/VBN yield/NN cirrhosis/NNS defined/VBN nodular/VB normal/JJ g/NN dl/NN splenomegaly/NN
phenobarbitone/NN given/VBN yield/NN cirrhosis/NNS defined/VBN nodular/VB ascites/VBZ
phenobarbitone/NN peak/NN giving/VBG increased/VBN primed/VBN given/VBN yield/NN cirrhosis/NNS defined/VBN nodular/VB ascites/VBZ
carbon/NN tetrachloride/NN yield/NN cirrhosis/NNS defined/VBN nodular/VB ascites/VBZ
tetrachloride/NN yield/NN cirrhosis/NNS defined/VBN nodular/VB ascites/VBZ
carbon/NN tetrachloride/NN dose/NN giving/VBG increased/VBN primed/VBN given/VBN yield/NN cirrhosis/NNS defined/VBN nodular/VB ascites/VBZ
tetrachloride/NN dose/NN giving/VBG increased/VBN primed/VBN given/VBN yield/NN cirrhosis/NNS defined/VBN nodular/VB ascites/VBZ
ceftriaxone/NN induced/VBN hepatitis/NNP erythroblastocytopenia/NN
beta/JJ antibiotic/NN withholding/VBG returned/VBD was/VBD increase/NN decrease/NN concentration/NN caused/VBN anemia/NN erythroblastocytopenia/NN
lactam/NN antibiotic/NN withholding/VBG returned/VBD was/VBD increase/NN decrease/NN concentration/NN caused/VBN anemia/NN erythroblastocytopenia/NN
beta/JJ antibiotic/NN withholding/VBG returned/VBD was/VBD increase/NN decrease/NN concentration/NN caused/VBN anemia/NN autoimmune/JJ
beta/JJ antibiotic/NN withholding/VBG returned/VBD was/VBD increase/NN decrease/NN concentration/NN caused/VBN anemia/NN hemolytic/JJ
beta/JJ antibiotic/NN withholding/VBG returned/VBD was/VBD increase/NN decrease/NN concentration/NN caused/VBN anemia/NN
lactam/NN antibiotic/NN withholding/VBG returned/VBD was/VBD increase/NN decrease/NN concentration/NN caused/VBN anemia/NN autoimmune/JJ
lactam/NN antibiotic/NN withholding/VBG returned/VBD was/VBD increase/NN decrease/NN concentration/NN caused/VBN anemia/NN hemolytic/JJ
lactam/NN antibiotic/NN withholding/VBG returned/VBD was/VBD increase/NN decrease/NN concentration/NN caused/VBN anemia/NN
bilirubin/NN increase/NN decrease/NN concentration/NN caused/VBN anemia/NN autoimmune/JJ
bilirubin/NN increase/NN decrease/NN concentration/NN caused/VBN anemia/NN hemolytic/JJ
bilirubin/NN increase/NN decrease/NN concentration/NN caused/VBN anemia/NN
bilirubin/NN increase/NN decrease/NN concentration/NN caused/VBN anemia/NN erythroblastocytopenia/NN
nimodipine/NN Effect/NN stroke/NN acute/JJ
nimodipine/NN Effect/NN stroke/NN
Nimodipine/NNP Trial/NNP Stroke/NNP
Nimodipine/NNP Trial/NNP BACKGROUND/NNP reduction/NN pressure/NN outcome/NN stroke/NN acute/JJ
Nimodipine/NNP Trial/NNP BACKGROUND/NNP reduction/NN pressure/NN outcome/NN stroke/NN
nimodipine/NN correlation/NN found/VBN Trial/NNP Stroke/NNP
nimodipine/NN correlation/NN found/VBN Trial/NNP BACKGROUND/NNP reduction/NN pressure/NN outcome/NN stroke/NN acute/JJ
nimodipine/NN correlation/NN found/VBN Trial/NNP BACKGROUND/NNP reduction/NN pressure/NN outcome/NN stroke/NN
nimodipine/VBP mg/NN METHODS/NNP allocated/VBN Patients/NNS diagnosis/NN stroke/NN ischemic/JJ
nimodipine/VBP mg/NN METHODS/NNP allocated/VBN Patients/NNS diagnosis/NN stroke/NN
nimodipine/VBP mg/NN mg/NN METHODS/NNP allocated/VBN Patients/NNS diagnosis/NN stroke/NN ischemic/JJ
nimodipine/VBP mg/NN mg/NN METHODS/NNP allocated/VBN Patients/NNS diagnosis/NN stroke/NN
nimodipine/NN stroke/NN acute/JJ
nimodipine/NN stroke/NN
combination/NN due/JJ hepatitis/VBZ Granulomatous/NNS
combination/NN due/JJ hepatitis/VBZ
of/IN amoxicillin/NNP combination/NN due/JJ hepatitis/VBZ Granulomatous/NNS
of/IN amoxicillin/NNP combination/NN due/JJ hepatitis/VBZ
amoxicillin/NNP combination/NN due/JJ hepatitis/VBZ Granulomatous/NNS
amoxicillin/NNP combination/NN due/JJ hepatitis/VBZ
and/CC amoxicillin/NNP combination/NN due/JJ hepatitis/VBZ Granulomatous/NNS
and/CC amoxicillin/NNP combination/NN due/JJ hepatitis/VBZ
clavulanic/JJ acid/NN amoxicillin/NNP combination/NN due/JJ hepatitis/VBZ Granulomatous/NNS
clavulanic/JJ acid/NN amoxicillin/NNP combination/NN due/JJ hepatitis/VBZ
acid/NN amoxicillin/NNP combination/NN due/JJ hepatitis/VBZ Granulomatous/NNS
acid/NN amoxicillin/NNP combination/NN due/JJ hepatitis/VBZ
amiodarone/JJ therapy/NN Pneumonitis/NNS effusion/NN neuropathy/NN
amiodarone/JJ therapy/NN Pneumonitis/NNS effusion/NN pleural/JJ
amiodarone/JJ therapy/NN Pneumonitis/NNS effusion/NN pleural/JJ and/CC
amiodarone/JJ therapy/NN Pneumonitis/NNS effusion/NN pleural/JJ pericardial/JJ
amiodarone/JJ therapy/NN Pneumonitis/NNS effusion/NN
amiodarone/NN treated/VBN patient/NN disease/NN sinuatrial/JJ
amiodarone/NN treated/VBN patient/NN disease/NN
amiodarone/NN treated/VBN control/NN tachyarrhythmias/NNS supraventricular/JJ
amiodarone/NN treated/VBN control/NN tachyarrhythmias/NNS
steroid/JJ therapy/NN need/NN diagnosis/NN pneumonitis/NNS
fusidic/JJ acid/NN disease/NN Crohn/NNP
fusidic/JJ acid/NN disease/NN Crohn/NNP '/POS
fusidic/JJ acid/NN disease/NN s/JJ
fusidic/JJ acid/NN disease/NN
acid/NN disease/NN Crohn/NNP
acid/NN disease/NN Crohn/NNP '/POS
acid/NN disease/NN s/JJ
acid/NN disease/NN
cyclosporin/NN similar/JJ properties/NNS antibiotic/JJ Treatment/NNP disease/NN Crohn/NNP
cyclosporin/NN similar/JJ properties/NNS antibiotic/JJ Treatment/NNP disease/NN Crohn/NNP '/POS
cyclosporin/NN similar/JJ properties/NNS antibiotic/JJ Treatment/NNP disease/NN s/JJ
cyclosporin/NN similar/JJ properties/NNS antibiotic/JJ Treatment/NNP disease/NN
fusidic/JJ treatment/NN pharmacodynamics/NN active/JJ estimate/VB undertaken/VBN need/NN development/NN treatments/NNS disease/NN Crohn/NNP
fusidic/JJ treatment/NN pharmacodynamics/NN active/JJ estimate/VB undertaken/VBN need/NN development/NN treatments/NNS disease/NN Crohn/NNP '/POS
fusidic/JJ treatment/NN pharmacodynamics/NN active/JJ estimate/VB undertaken/VBN need/NN development/NN treatments/NNS disease/NN s/JJ
fusidic/JJ treatment/NN pharmacodynamics/NN active/JJ estimate/VB undertaken/VBN need/NN development/NN treatments/NNS disease/NN
acid/JJ treatment/NN pharmacodynamics/NN active/JJ estimate/VB undertaken/VBN need/NN development/NN treatments/NNS disease/NN Crohn/NNP
acid/JJ treatment/NN pharmacodynamics/NN active/JJ estimate/VB undertaken/VBN need/NN development/NN treatments/NNS disease/NN Crohn/NNP '/POS
acid/JJ treatment/NN pharmacodynamics/NN active/JJ estimate/VB undertaken/VBN need/NN development/NN treatments/NNS disease/NN s/JJ
acid/JJ treatment/NN pharmacodynamics/NN active/JJ estimate/VB undertaken/VBN need/NN development/NN treatments/NNS disease/NN
fusidic/JJ acid/NN benefit/NN patients/NNS Crohn/NNP
fusidic/JJ acid/NN benefit/NN patients/NNS '/POS
fusidic/JJ acid/NN benefit/NN patients/NNS s/NN
fusidic/JJ acid/NN benefit/NN patients/NNS disease/NN
acid/NN benefit/NN patients/NNS Crohn/NNP
acid/NN benefit/NN patients/NNS '/POS
acid/NN benefit/NN patients/NNS s/NN
acid/NN benefit/NN patients/NNS disease/NN
fusidic/JJ acid/NN use/NN rationale/NN exist/VB level/NN disease/NN inflammatory/JJ
fusidic/JJ acid/NN use/NN rationale/NN exist/VB level/NN disease/NN bowel/NN
fusidic/JJ acid/NN use/NN rationale/NN exist/VB level/NN disease/NN
acid/NN use/NN rationale/NN exist/VB level/NN disease/NN inflammatory/JJ
acid/NN use/NN rationale/NN exist/VB level/NN disease/NN bowel/NN
acid/NN use/NN rationale/NN exist/VB level/NN disease/NN
cimetidine/JJ trough/NN 0/CD less/JJR ml/NNS renal/JJ
cimetidine/JJ trough/NN 0/CD less/JJR ml/NNS renal/JJ and/CC
cimetidine/JJ trough/NN 0/CD less/JJR ml/NNS liver/NN
cimetidine/JJ trough/NN 0/CD less/JJR ml/NNS dysfunction/NN
risperidone/NN profile/NN produce/VB efficacy/NN symptoms/NNS psychotic/JJ
risperidone/NN profile/NN produce/VB efficacy/NN symptoms/NNS
creatinine/JJ >/NNS Controls/NNP CRF/NNP
creatinine/JJ >/NNS Controls/NNP ESRD/NNP
creatinine/JJ >/NNS n/JJ 748/CD CRF/NNP
creatinine/JJ >/NNS Controls/NNP ESRD/NNP
creatinine/NN levels/NNS percentage/NN patients/NNS syndrome/NN hepatorenal/JJ
creatinine/NN levels/NNS percentage/NN patients/NNS syndrome/NN
creatinine/NN higher/JJR levels/NNS percentage/NN patients/NNS syndrome/NN hepatorenal/JJ
creatinine/NN higher/JJR levels/NNS percentage/NN patients/NNS syndrome/NN
creatinine/NN levels/NNS had/VBD patients/NNS CRF/NNP
creatinine/NN levels/NNS had/VBD patients/NNS CRF/NNP ESRD/NNP
creatinine/NN higher/JJR levels/NNS had/VBD patients/NNS CRF/NNP
creatinine/NN higher/JJR levels/NNS had/VBD patients/NNS CRF/NNP ESRD/NNP
creatinine/NN increase/NN factors/NNS development/NN CRF/NNP
creatinine/NN increase/NN factors/NNS ESRD/VBD
creatinine/NN preoperative/NN have/VBP likely/JJ have/VB syndrome/NN hepatorenal/JJ
creatinine/NN preoperative/NN have/VBP likely/JJ have/VB syndrome/NN
creatinine/NN preoperative/NN have/VBP Patients/NNS develop/VBP ESRD/NNP
creatinine/NN increase/NN predictive/NNS development/NN CRF/NNP
creatinine/NN increase/NN predictive/NNS development/NN CRF/NNP ESRD/NNP
pilocarpine/NN induced/VBN Investigation/NNP involvement/NN model/NN epilepsy/NN
pilocarpine/JJ model/NN phase/NN oxidase/NN expression/NN provoke/VB' provoke/VB sufficient/JJ generation/NN FR/NNP epilepticus/NNS status/NN
pilocarpine/JJ model/NN phase/NN oxidase/NN expression/NN provoke/VB' provoke/VB sufficient/JJ generation/NN FR/NNP epilepticus/NNS
anthracycline/NN induced/VBN cardiotoxicity/RB
Anthracyclines/NNS drugs/NNS cause/VB dose/NN related/VBN cardiotoxicity/RB
anthracycline/NN therapy/NN cardiotoxicity/NN highlights/VBZ need/NN search/VB methods/NNS sensitive/JJ predicting/VBG dysfunction/NN cardiac/JJ
anthracycline/NN therapy/NN cardiotoxicity/NN highlights/VBZ need/NN search/VB methods/NNS sensitive/JJ predicting/VBG dysfunction/NN
anthracycline/NN therapy/NN cardiotoxicity/NN
daunorubicin/NN treated/VBN leukemia/NN acute/JJ
daunorubicin/NN treated/VBN leukemia/NN
DNR/NNP daunorubicin/NN treated/VBN leukemia/NN acute/JJ
DNR/NNP daunorubicin/NN treated/VBN leukemia/NN
daunorubicin/NN treated/VBN leukemia/NN induced/VBN cardiotoxicity/RB
DNR/NNP daunorubicin/NN treated/VBN leukemia/NN induced/VBN cardiotoxicity/RB
anthracycline/NN induced/VBN leukemia/NN acute/JJ
anthracycline/NN induced/VBN leukemia/NN
anthracycline/NN induced/VBN cardiotoxicity/RB
DNR/NNP treated/VBN patients/NNS leukemia/NN acute/JJ
DNR/NNP treated/VBN patients/NNS leukemia/NN
anthracycline/NN indicator/NN useful/JJ cardiotoxicity/JJ
etoposide/NN cisplatinum/NN acid/NN adenocarcinoma/NN gastric/JJ
etoposide/NN cisplatinum/NN acid/NN adenocarcinoma/NN
folinic/JJ acid/NN adenocarcinoma/NN gastric/JJ
folinic/JJ acid/NN adenocarcinoma/NN
acid/NN adenocarcinoma/NN gastric/JJ
acid/NN adenocarcinoma/NN
5/CD dose/NN fluorouracil/NN cisplatinum/NN acid/NN adenocarcinoma/NN gastric/JJ
5/CD dose/NN fluorouracil/NN cisplatinum/NN acid/NN adenocarcinoma/NN
fluorouracil/NN cisplatinum/NN acid/NN adenocarcinoma/NN gastric/JJ
fluorouracil/NN cisplatinum/NN acid/NN adenocarcinoma/NN
cisplatinum/NN acid/NN adenocarcinoma/NN gastric/JJ
cisplatinum/NN acid/NN adenocarcinoma/NN
folinic/JJ fluorouracil/JJ infusion/NN lasting/VBG coma/NN lapsed/VBN developed/VBD symptoms/NNS confusion/NN irritability/NN
acid/JJ infusion/NN lasting/VBG coma/NN lapsed/VBN developed/VBD symptoms/NNS confusion/NN irritability/NN
5/CD lasting/VBG coma/NN lapsed/VBN developed/VBD symptoms/NNS confusion/NN irritability/NN
fluorouracil/JJ infusion/NN lasting/VBG coma/NN lapsed/VBN developed/VBD symptoms/NNS confusion/NN irritability/NN
5/CD dose/NN due/JJ neurotoxicity/RB
fluorouracil/NN due/JJ neurotoxicity/RB
folinic/JJ acid/NN unlikely/JJ suspected/JJ fluorouracil/NN due/JJ neurotoxicity/RB
acid/NN unlikely/JJ suspected/JJ fluorouracil/NN due/JJ neurotoxicity/RB
fluorocitrate/NN fluoroacetate/NN due/JJ neurotoxicity/NN
thiamine/JJ deficiency/NN fluoroacetate/NN due/JJ neurotoxicity/NN
fluoroacetate/NN due/JJ neurotoxicity/NN
dihydrouracil/JJ deficiency/NN fluoroacetate/NN due/JJ neurotoxicity/NN
5/CD pathogenesis/NNS due/JJ neurotoxicity/NN
fluorouracil/JJ neurotoxicity/NN
folinic/JJ therapy/NN become/VBN regimen/NN cancers/NNS
acid/NN therapy/NN become/VBN regimen/NN cancers/NNS
5/CD dose/NN High/NNP become/VBN regimen/NN cancers/NNS
fluorouracil/NN High/NNP become/VBN regimen/NN cancers/NNS
acetaminophen/NN factor/NN failure/NN chronic/JJ
acetaminophen/NN factor/NN failure/NN renal/JJ
acetaminophen/NN factor/NN failure/NN
acetaminophen/NN use/NN associated/VBN failure/NN chronic/JJ
acetaminophen/NN use/NN associated/VBN failure/NN renal/JJ
acetaminophen/NN use/NN associated/VBN failure/NN
acetaminophen/NN use/NN associated/VBN failure/NN ESRD/NNP
acetaminophen/NN phenacetin/NN contribute/VB burden/NN ESRD/NNP
acetaminophen/NN use/NN increases/VBZ risk/NN ESRD/NNP
terbutaline/NN treatment/NN abnormalities/NNS Neuroinflammation/NN
terbutaline/NN treatment/NN abnormalities/NNS Neuroinflammation/NN behavioral/JJ
terbutaline/NN treatment/NN abnormalities/NNS
Terbutaline/RB associated/VBN 2/CD agonist/NN used/VBN arrest/VB labor/NN preterm/NN
Terbutaline/RB associated/VBN 2/CD agonist/NN used/VBN arrest/VB labor/NN
ketoconazole/NN treated/VBN syndrome/NN Cushing/NNP
ketoconazole/NN treated/VBN syndrome/NN Cushing/NNP '/POS
ketoconazole/NN treated/VBN syndrome/NN s/JJ
ketoconazole/NN treated/VBN syndrome/NN
cortisol/NN levels/NNS plasma/NN achieved/VBN demonstrated/VBD hypertension/NN
pegylated/JJ interferon/NN C/NNP chronic/JJ
pegylated/JJ interferon/NN C/NNP hepatitis/NNP
pegylated/JJ interferon/NN C/NNP
interferon/NN C/NNP chronic/JJ
interferon/NN C/NNP hepatitis/NNP
interferon/NN C/NNP
ribavirin/NN treatment/NN interferon/NN C/NNP chronic/JJ
ribavirin/NN treatment/NN interferon/NN C/NNP hepatitis/NNP
ribavirin/NN treatment/NN interferon/NN C/NNP
pegylated/JJ interferon/NN administration/NN alpha/NN 2/CD ribavirin/NNP hepatitis/NN chronic/JJ
pegylated/JJ interferon/NN administration/NN alpha/NN 2/CD ribavirin/NNP hepatitis/NN
pegylated/JJ interferon/NN administration/NN weeks/NNS experienced/VBD C/NNP
interferon/NN administration/NN alpha/NN 2/CD ribavirin/NNP hepatitis/NN chronic/JJ
interferon/NN administration/NN alpha/NN 2/CD ribavirin/NNP hepatitis/NN
interferon/NN administration/NN weeks/NNS experienced/VBD C/NNP
IFN/NNP interferon/NN administration/NN alpha/NN 2/CD ribavirin/NNP hepatitis/NN chronic/JJ
IFN/NNP interferon/NN administration/NN alpha/NN 2/CD ribavirin/NNP hepatitis/NN
IFN/NNP interferon/NN administration/NN weeks/NNS experienced/VBD C/NNP
alpha/NN 2/CD ribavirin/NNP hepatitis/NN chronic/JJ
alpha/NN 2/CD ribavirin/NNP hepatitis/NN
alpha/NN administration/NN weeks/NNS experienced/VBD C/NNP
2/CD ribavirin/NNP hepatitis/NN chronic/JJ
2/CD ribavirin/NNP hepatitis/NN
2/CD alpha/NN administration/NN weeks/NNS experienced/VBD C/NNP
b/SYM 2/CD ribavirin/NNP hepatitis/NN chronic/JJ
b/SYM 2/CD ribavirin/NNP hepatitis/NN
b/SYM 2/CD alpha/NN administration/NN weeks/NNS experienced/VBD C/NNP
pegylated/JJ interferon/NN administration/NN weeks/NNS experienced/VBD C/NNP CHC/NNP
interferon/NN administration/NN weeks/NNS experienced/VBD C/NNP CHC/NNP
IFN/NNP interferon/NN administration/NN weeks/NNS experienced/VBD C/NNP CHC/NNP
alpha/NN administration/NN weeks/NNS experienced/VBD C/NNP CHC/NNP
2/CD alpha/NN administration/NN weeks/NNS experienced/VBD C/NNP CHC/NNP
b/SYM 2/CD alpha/NN administration/NN weeks/NNS experienced/VBD C/NNP CHC/NNP
ribavirin/NNP hepatitis/NN chronic/JJ
ribavirin/NNP hepatitis/NN
ribavirin/NNP 2/CD alpha/NN administration/NN weeks/NNS experienced/VBD C/NNP
ribavirin/NNP 2/CD alpha/NN administration/NN weeks/NNS experienced/VBD C/NNP CHC/NNP
pegylated/JJ interferon/NN administration/NN weeks/NNS experienced/VBD diplopia/NN
interferon/NN administration/NN weeks/NNS experienced/VBD diplopia/NN
IFN/NNP interferon/NN administration/NN weeks/NNS experienced/VBD diplopia/NN
alpha/NN administration/NN weeks/NNS experienced/VBD diplopia/NN
2/CD alpha/NN administration/NN weeks/NNS experienced/VBD diplopia/NN
b/SYM 2/CD alpha/NN administration/NN weeks/NNS experienced/VBD diplopia/NN
ribavirin/NNP 2/CD alpha/NN administration/NN weeks/NNS experienced/VBD diplopia/NN
pegylated/JJ alpha/NNP ribavirin/NNP CHC/NNP
IFN/NNP alpha/NNP ribavirin/NNP CHC/NNP
alpha/NNP ribavirin/NNP CHC/NNP
2/CD alpha/NNP ribavirin/NNP CHC/NNP
b/SYM alpha/NNP ribavirin/NNP CHC/NNP
IFN/NNP therapy/NN complications/NNS review/NN present/VBP reported/VBN myasthenia/NN associated/VBN therapy/NN alpha/NNP ribavirin/NNP CHC/NNP
ribavirin/NNP CHC/NNP
asenapine/JJ trial/NN Efficacy/NN schizophrenia/NN
haloperidol/JJ asenapine/JJ trial/NN Efficacy/NN schizophrenia/NN
Asenapine/NNP approved/VBN adults/NNS treatment/NN schizophrenia/NN
Asenapine/NNP approved/VBN approved/VBN' episodes/NNS manic/JJ
Asenapine/NNP approved/VBN approved/VBN' episodes/NNS associated/VBN disorder/NNP bipolar/NNP
Asenapine/NNP approved/VBN approved/VBN' episodes/NNS associated/VBN disorder/NNP I/NNP
Asenapine/NNP approved/VBN approved/VBN' episodes/NNS associated/VBN disorder/NNP
Asenapine/NNP approved/VBN approved/VBN' episodes/NNS associated/VBN features/NNS psychotic/JJ
asenapine/NN treatment/NN patients/NNS schizophrenia/NN
asenapine/NN mg/VBP trial/NN patients/NNS schizophrenia/NN
haloperidol/NN BID/NNP mg/VBP trial/NN patients/NNS schizophrenia/NN
captopril/JJ Reversibility/RB induced/VBN insufficiency/NN renal/JJ
captopril/JJ Reversibility/RB induced/VBN insufficiency/NN
captopril/JJ Reversibility/RB induced/VBN case/NN hypertension/NN renovascular/NN
captopril/JJ Reversibility/RB induced/VBN case/NN hypertension/NN
captopril/NN treatment/NN function/NN deterioration/NN developed/VBD kidney/NN artery/NN report/VBP case/NN hypertension/NN
captopril/NN induced/VBN failure/NN renal/JJ
captopril/NN induced/VBN failure/NN
lamivudine/NN ve/VB virus/NN infected/VBN co/NN HIV/NN
lamivudine/NN ve/VB virus/NN infected/VBN co/NN
lamivudine/NN associated/VBN infection/NN
na/TO ve/VB lamivudine/NN associated/VBN infection/NN implications/NNS co/NNPS HBV/NNP
na/TO ve/VB lamivudine/NN associated/VBN infection/NN implications/NNS co/NNPS HBV/NNP and/CC
na/TO ve/VB lamivudine/NN associated/VBN infection/NN implications/NNS co/NNPS HBV/NNP HIV/NNP
na/TO ve/VB lamivudine/NN associated/VBN infection/NN implications/NNS co/NNPS
na/TO ve/VB lamivudine/NN associated/VBN infection/NN infected/VBN
na/TO ve/VB virus/NN hepatitis/NNP
na/TO ve/VB virus/NN B/NNP
na/TO ve/VB virus/NN
na/TO ve/VB virus/NN HBV/NNP
na/TO ve/VB virus/NN infected/VBN
lamivudine/NN associated/VBN infection/NN implications/NNS co/NNPS HBV/NNP
lamivudine/NN associated/VBN infection/NN implications/NNS co/NNPS HBV/NNP and/CC
lamivudine/NN associated/VBN infection/NN implications/NNS co/NNPS HBV/NNP HIV/NNP
lamivudine/NN associated/VBN infection/NN implications/NNS co/NNPS
lamivudine/NN associated/VBN infection/NN infected/VBN
lamivudine/NN ve/VB virus/NN hepatitis/NNP
lamivudine/NN ve/VB virus/NN B/NNP
lamivudine/NN ve/VB virus/NN
lamivudine/NN ve/VB virus/NN HBV/NNP
lamivudine/NN ve/VB virus/NN infected/VBN
na/TO ve/VB virus/NN infected/VBN co/NN HIV/NN
na/TO ve/VB virus/NN infected/VBN co/NN
na/TO ve/VB lamivudine/NN associated/VBN infection/NN
lamivudine/JJ investigate/VB study/NN infection/NN ve/VB co/NN immunodeficiency/JJ human/JJ
lamivudine/JJ investigate/VB study/NN infection/NN ve/VB co/NN immunodeficiency/JJ
lamivudine/JJ investigate/VB study/NN infection/NN ve/VB co/NN virus/NN
lamivudine/JJ investigate/VB study/NN infection/NN ve/VB co/NN HIV/NNP
lamivudine/JJ investigate/VB study/NN infection/NN ve/VB co/NN
lamivudine/JJ investigate/VB study/NN infection/NN
lamivudine/NN strains/NNS lamivudine/JJ investigate/VB study/NN infection/NN ve/VB co/NN immunodeficiency/JJ human/JJ
lamivudine/NN strains/NNS lamivudine/JJ investigate/VB study/NN infection/NN ve/VB co/NN immunodeficiency/JJ
lamivudine/NN strains/NNS lamivudine/JJ investigate/VB study/NN infection/NN ve/VB co/NN virus/NN
lamivudine/NN strains/NNS lamivudine/JJ investigate/VB study/NN infection/NN ve/VB co/NN HIV/NNP
lamivudine/NN strains/NNS lamivudine/JJ investigate/VB study/NN infection/NN ve/VB co/NN
lamivudine/NN strains/NNS lamivudine/JJ investigate/VB study/NN infection/NN
na/TO ve/VB infection/NN study/NN investigate/VB lamivudine/JJ strains/NNS hepatitis/NNP
na/TO ve/VB infection/NN study/NN investigate/VB lamivudine/JJ strains/NNS B/NNP
lamivudine/JJ strains/NNS hepatitis/NNP
lamivudine/JJ strains/NNS B/NNP
lamivudine/NN strains/NNS hepatitis/NNP
lamivudine/NN strains/NNS B/NNP
na/TO ve/VB co/NN immunodeficiency/JJ human/JJ
na/TO ve/VB co/NN immunodeficiency/JJ
na/TO ve/VB co/NN virus/NN
na/TO ve/VB co/NN HIV/NNP
na/TO ve/VB co/NN
na/TO ve/VB infection/NN
lamivudine/NN ve/VB co/NN HIV/NN
lamivudine/NN ve/VB co/NN
lamivudine/NN ve/VB studied/VBN infection/NN
na/TO ve/VB lamivudine/NN Thirty/NNP patients/NNS HBV/NN
na/TO ve/VB lamivudine/NN Thirty/NNP co/NN HIV/NN
na/TO ve/VB lamivudine/NN Thirty/NNP co/NN
na/TO ve/VB lamivudine/NN Thirty/NNP co/NN patients/NNS infected/JJ
na/TO ve/VB patients/NNS HBV/NNP
na/TO ve/VB patients/NNS infected/JJ
na/TO ve/VB mono/NN HBV/NNP
na/TO ve/VB mono/NN
na/TO ve/VB lamivudine/NN Thirty/NNP patients/NNS infected/JJ
lamivudine/NN Thirty/NNP patients/NNS HBV/NN
lamivudine/NN Thirty/NNP co/NN HIV/NN
lamivudine/NN Thirty/NNP co/NN
lamivudine/NN Thirty/NNP co/NN patients/NNS infected/JJ
lamivudine/NN ve/VB patients/NNS HBV/NNP
lamivudine/NN ve/VB patients/NNS infected/JJ
lamivudine/NN ve/VB mono/NN HBV/NNP
lamivudine/NN ve/VB mono/NN
lamivudine/NN Thirty/NNP patients/NNS infected/JJ
na/TO ve/VB co/NN HIV/NN
na/TO ve/VB co/NN
na/TO ve/VB studied/VBN infection/NN
lamivudine/VBP detected/VBN 3/CD mono/NN patients/NNS 10/CD HBV/NN
lamivudine/VBP detected/VBN 3/CD mono/NN co/NN HIV/NN
lamivudine/VBP detected/VBN 3/CD mono/NN co/NN
lamivudine/VBP detected/VBN 3/CD mono/NN patients/NNS infected/JJ
lamivudine/VBP detected/VBN 3/CD mono/NN patients/NNS hepatitis/NNP
lamivudine/VBP detected/VBN 3/CD mono/NN patients/NNS B/NNP
na/NNP HBV/NNP
na/NNP HBV/NNP lamivudine/NNP co/NN HIV/NN
na/NNP HBV/NNP lamivudine/NNP co/NN
na/NNP HBV/NNP lamivudine/NNP patients/NNS infected/JJ
lamivudine/NNP HBV/NNP
lamivudine/NNP co/NN HIV/NN
lamivudine/NNP co/NN
lamivudine/NNP patients/NNS infected/JJ
lamivudine/JJ result/VB remains/VBZ applied/VBN Africa/NNP likely/JJ have/VB implications/NNS management/NN HBV/NNP
lamivudine/JJ result/VB remains/VBZ co/VBP HIV/NNP
lamivudine/JJ result/VB remains/VBZ co/VBP
lamivudine/JJ result/VB remains/VBZ co/VBP patients/NNS infected/JJ
bupivacaine/NN injection/NN deficit/NN neurological/JJ
bupivacaine/NN injection/NN deficit/NN
bupivacaine/NN mg/NN occurred/VBD case/NN deficit/NN neurological/JJ
bupivacaine/NN mg/NN occurred/VBD case/NN deficit/NN
Levodopa/NNP induced/VBN disease/NN Parkinson/NNP
Levodopa/NNP induced/VBN disease/NN Parkinson/NNP '/POS
Levodopa/NNP induced/VBN disease/NN s/JJ
Levodopa/NNP induced/VBN disease/NN
Levodopa/NNP drug/NN treatment/NN disease/NN Parkinson/NNP
Levodopa/NNP drug/NN treatment/NN disease/NN Parkinson/NNP '/POS
Levodopa/NNP drug/NN treatment/NN disease/NN s/JJ
Levodopa/NNP drug/NN treatment/NN disease/NN
dopamine/NN use/NN long/JJ precursor/NN complicated/VBN fluctuations/NNS dyskinesias/NNS
dopamine/JJ subtypes/NNS mechanisms/NNS presynaptic/NN role/NN focus/NN lines/NNS preclinical/JJ induced/NNP dyskinesias/NNS
glutamate/NN receptors/NNS mechanisms/NNS presynaptic/NN role/NN focus/NN lines/NNS preclinical/JJ induced/NNP dyskinesias/NNS
heparan/NN sulphate/NN Reduction/NN induced/VBN nephropathy/NN diabetic/JJ
heparan/NN sulphate/NN Reduction/NN induced/VBN nephropathy/NN
sulphate/NN Reduction/NN induced/VBN nephropathy/NN diabetic/JJ
sulphate/NN Reduction/NN induced/VBN nephropathy/NN
streptozotocin/NN studied/VBN induction/NN diabetes/NN
Heparan/NN sulphate/NN associated/VBN glomerular/NN studied/VBN induction/NN diabetes/NN
sulphate/NN associated/VBN glomerular/NN studied/VBN induction/NN diabetes/NN
cuprolinic/JJ blue/NN employing/VBG associated/VBN glomerular/NN studied/VBN induction/NN diabetes/NN
blue/NN employing/VBG associated/VBN glomerular/NN studied/VBN induction/NN diabetes/NN
streptozotocin/NN rats/NNS diabetic/JJ
heparan/NN barrier/NN excretion/NN rats/NNS diabetic/JJ
sulphate/NN barrier/NN excretion/NN rats/NNS diabetic/JJ
Verapamil/JJ withdrawal/NN woman/NN hypertensive/JJ
captopril/NN introduction/NN coincided/VBD woman/NN hypertension/NN
verapamil/NN withdrawal/NN introduction/NN coincided/VBD woman/NN hypertension/NN
captopril/NN introduction/NN coincided/VBD infarction/NN myocardial/JJ
captopril/NN introduction/NN coincided/VBD infarction/NN
corticosterone/NN level/NN occurs/VBZ observed/JJ hypotension/NN
cyclophosphamide/VB granulomatosis/NNS cancer/NN Wegener/NNP
cyclophosphamide/VB granulomatosis/NNS cancer/NN Wegener/NNP '/POS
cyclophosphamide/VB granulomatosis/NNS s/VBZ
cyclophosphamide/VB granulomatosis/NNS
cyclophosphamide/NN relation/NN cancer/NN risk/NN assess/VB patients/NNS granulomatosis/NNS Wegener/NNP
cyclophosphamide/NN relation/NN cancer/NN risk/NN assess/VB patients/NNS granulomatosis/NNS Wegener/NNP '/POS
cyclophosphamide/NN relation/NN cancer/NN risk/NN assess/VB patients/NNS granulomatosis/NNS s/JJ
cyclophosphamide/NN relation/NN cancer/NN risk/NN assess/VB patients/NNS granulomatosis/NNS
cyclophosphamide/NN relationship/NN dose/NN indicate/VBP operating/VBG granulomatosis/JJ Wegener/NNP
cyclophosphamide/NN relationship/NN dose/NN indicate/VBP operating/VBG granulomatosis/JJ Wegener/NNP '/POS
cyclophosphamide/NN relationship/NN dose/NN indicate/VBP operating/VBG granulomatosis/JJ s/VBZ
cyclophosphamide/NN relationship/NN dose/NN indicate/VBP operating/VBG granulomatosis/JJ
bisphosphonate/NN proteinuria/NN failure/NN acute/JJ
bisphosphonate/NN proteinuria/NN failure/NN renal/JJ
bisphosphonate/NN proteinuria/NN failure/NN
bisphosphonate/NN proteinuria/NN alendronate/VBD administration/NN patient/NN glomerulosclerosis/NNS focal/JJ
bisphosphonate/NN proteinuria/NN alendronate/VBD administration/NN patient/NN glomerulosclerosis/NNS segmental/JJ
bisphosphonate/NN proteinuria/NN alendronate/VBD administration/NN patient/NN glomerulosclerosis/NNS
bisphosphonate/NN proteinuria/NN
alendronate/VBD administration/NN patient/NN glomerulosclerosis/NNS focal/JJ
alendronate/VBD administration/NN patient/NN glomerulosclerosis/NNS segmental/JJ
alendronate/VBD administration/NN patient/NN glomerulosclerosis/NNS
steroid/JJ therapy/NN responding/VBG man/NN syndrome/NN nephrotic/JJ
steroid/JJ therapy/NN responding/VBG man/NN syndrome/NN
steroid/JJ therapy/NN responding/VBG man/NN syndrome/NN due/JJ glomerulosclerosis/NNS focal/JJ
steroid/JJ therapy/NN responding/VBG man/NN syndrome/NN due/JJ glomerulosclerosis/NNS segmental/JJ
steroid/JJ therapy/NN responding/VBG man/NN syndrome/NN due/JJ glomerulosclerosis/NNS
bisphosphonate/JJ administration/NN days/NNS increased/VBD g/NN failure/NN acute/JJ
bisphosphonate/JJ administration/NN days/NNS increased/VBD g/NN failure/NN renal/JJ
bisphosphonate/JJ administration/NN days/NNS increased/VBD g/NN failure/NN
bisphosphonates/NNS intravenous/JJ aggravate/VB failure/NN proteinuria/JJ acute/JJ
bisphosphonates/NNS intravenous/JJ aggravate/VB failure/NN renal/JJ
bisphosphonates/NNS intravenous/JJ aggravate/VB failure/NN
bisphosphonates/NNS intravenous/JJ aggravate/VB failure/NN proteinuria/JJ
dobutamine/NN detecting/VBG ECG/NNP lead/VB assess/VB using/VBG m/NN Sestamibi/NNP single/JJ emission/NN computed/VBN assess/VB presence/NN ischemia/NN
Tc/NNP m/NN Sestamibi/NNP single/JJ emission/NN computed/VBN assess/VB presence/NN ischemia/NN
99/CD m/NN Sestamibi/NNP single/JJ emission/NN computed/VBN assess/VB presence/NN ischemia/NN
m/NN Sestamibi/NNP single/JJ emission/NN computed/VBN assess/VB presence/NN ischemia/NN
Sestamibi/NNP single/JJ emission/NN computed/VBN assess/VB presence/NN ischemia/NN
Tc/NNP m/NN using/VBG assess/VB induced/VBN ischemia/NN myocardial/JJ
Tc/NNP m/NN using/VBG assess/VB induced/VBN ischemia/NN
99/CD m/NN using/VBG assess/VB induced/VBN ischemia/NN myocardial/JJ
99/CD m/NN using/VBG assess/VB induced/VBN ischemia/NN
m/NN using/VBG assess/VB induced/VBN ischemia/NN myocardial/JJ
m/NN using/VBG assess/VB induced/VBN ischemia/NN
Sestamibi/NNP m/NN using/VBG assess/VB induced/VBN ischemia/NN myocardial/JJ
Sestamibi/NNP m/NN using/VBG assess/VB induced/VBN ischemia/NN
corticosteroids/NNS reactions/NNS allergic/JJ
corticosteroids/NNS reactions/NNS
paramethasone/NN different/JJ Corticosteroids/NNS produced/VBD reactions/NNS hypersensitivity/JJ
paramethasone/NN caused/VBN allergy/NN
Organophosphate/NNP induced/VBN convulsions/NNS damages/NNS neuropathological/JJ
Organophosphate/NNP induced/VBN convulsions/NNS damages/NNS
Organophosphate/NNP induced/VBN convulsions/NNS
acetylcholine/JJ levels/NNS elevates/VBZ system/NN irreversible/NN result/NN toxicity/NN
ACh/NNP levels/NNS elevates/VBZ system/NN irreversible/NN result/NN toxicity/NN
OPs/NNP toxicity/NN
DFP/NNP treated/VBN showed/VBD OP/NN induced/VBN signs/NNS toxicity/NN
OP/NN induced/VBN signs/NNS toxicity/NN
atropine/NN showed/VBD OP/NN induced/VBN signs/NNS toxicity/NN
DFP/NNP given/VBN prevented/VBD shortened/VBN occurrence/NN signs/NNS poisoning/NN
2/CD PAM/NN CPA/NNP given/VBN prevented/VBD shortened/VBN occurrence/NN signs/NNS poisoning/NN
PAM/NN CPA/NNP given/VBN prevented/VBD shortened/VBN occurrence/NN signs/NNS poisoning/NN
atropine/NN DFP/NNP given/VBN prevented/VBD shortened/VBN occurrence/NN signs/NNS poisoning/NN
diazepam/NN CPA/NNP given/VBN prevented/VBD shortened/VBN occurrence/NN signs/NNS poisoning/NN
CPA/NNP given/VBN prevented/VBD shortened/VBN occurrence/NN signs/NNS poisoning/NN
MK/NNP 801/NNP offer/VB protection/NN toxicity/NNP
801/NNP offer/VB protection/NN toxicity/NNP
DFP/NNP toxicity/NNP
Atropine/NNP offer/VB protection/NN toxicity/NNP
CPA/NNP prevented/VBD reduced/VBD toxicity/NN
diazepam/NN CPA/NNP prevented/VBD reduced/VBD toxicity/NN
2/CD PAM/NN CPA/NNP prevented/VBD reduced/VBD toxicity/NN
PAM/NN CPA/NNP prevented/VBD reduced/VBD toxicity/NN
DFP/NNP toxicity/NN reduced/VBD prevented/VBD occurrence/NN signs/NNS poisoning/NN
2/CD PAM/NN CPA/NNP prevented/VBD occurrence/NN signs/NNS poisoning/NN
PAM/NN CPA/NNP prevented/VBD occurrence/NN signs/NNS poisoning/NN
DFP/NNP toxicity/NN
atropine/NN combination/NN PAM/NN CPA/NNP prevented/VBD occurrence/NN signs/NNS poisoning/NN
atropine/NN combination/NN PAM/NN CPA/NNP prevented/VBD reduced/VBD toxicity/NN
diazepam/NN CPA/NNP prevented/VBD occurrence/NN signs/NNS poisoning/NN
CPA/NNP prevented/VBD occurrence/NN signs/NNS poisoning/NN
aspirin/NN reduces/VBZ reduces/VBZ risk/NN stroke/NN
warfarin/NN reduces/VBZ risk/NN stroke/NN
aspirin/VB preventing/VBG strokes/NNS
warfarin/NN superior/JJ aspirin/VB preventing/VBG strokes/NNS
Ximelagatran/NNP found/VBN efficient/JJ antagonist/VBP prevention/NN events/NNS embolic/JJ
Ximelagatran/NNP found/VBN efficient/JJ antagonist/VBP prevention/NN events/NNS
vitamin/NNP K/NNP antagonist/VBP prevention/NN events/NNS embolic/JJ
vitamin/NNP K/NNP antagonist/VBP prevention/NN events/NNS
K/NNP antagonist/VBP prevention/NN events/NNS embolic/JJ
K/NNP antagonist/VBP prevention/NN events/NNS
vitamin/NNP K/NNP antagonist/VBP withdrawn/VBN tests/NNS abnormal/JJ
vitamin/NNP K/NNP antagonist/VBP withdrawn/VBN tests/NNS liver/NN
vitamin/NNP K/NNP antagonist/VBP withdrawn/VBN tests/NNS function/NN
K/NNP antagonist/VBP withdrawn/VBN tests/NNS abnormal/JJ
K/NNP antagonist/VBP withdrawn/VBN tests/NNS liver/NN
K/NNP antagonist/VBP withdrawn/VBN tests/NNS function/NN
warfarin/NN superior/JJ platelet/VB therapy/NN events/NNS embolic/JJ
warfarin/NN superior/JJ platelet/VB therapy/NN events/NNS
Clopidogrel/NNP Trial/NNP W/NNP demonstrated/VBN superior/JJ platelet/VB therapy/NN events/NNS embolic/JJ
Clopidogrel/NNP Trial/NNP W/NNP demonstrated/VBN superior/JJ platelet/VB therapy/NN events/NNS
clopidogrel/NNS aspirin/NN therapy/NN events/NNS embolic/JJ
clopidogrel/NNS aspirin/NN therapy/NN events/NNS
Irbesartan/NNP Trial/NNP W/NNP demonstrated/VBN superior/JJ platelet/VB therapy/NN events/NNS embolic/JJ
Irbesartan/NNP Trial/NNP W/NNP demonstrated/VBN superior/JJ platelet/VB therapy/NN events/NNS
Clopidogrel/NNP Trial/NNP Atrial/NNP
Clopidogrel/NNP Trial/NNP Fibrillation/NNP
clopidogrel/NNS aspirin/NN therapy/NN platelet/VB superior/JJ demonstrated/VBN W/NNP Trial/NNP Atrial/NNP
clopidogrel/NNS aspirin/NN therapy/NN platelet/VB superior/JJ demonstrated/VBN W/NNP Trial/NNP Fibrillation/NNP
aspirin/NN therapy/NN events/NNS embolic/JJ
aspirin/NN therapy/NN events/NNS
warfarin/NN superior/JJ demonstrated/VBN W/NNP Trial/NNP Atrial/NNP
warfarin/NN superior/JJ demonstrated/VBN W/NNP Trial/NNP Fibrillation/NNP
Irbesartan/NNP Trial/NNP Atrial/NNP
Irbesartan/NNP Trial/NNP Fibrillation/NNP
aspirin/NN therapy/NN platelet/VB superior/JJ demonstrated/VBN W/NNP Trial/NNP Atrial/NNP
aspirin/NN therapy/NN platelet/VB superior/JJ demonstrated/VBN W/NNP Trial/NNP Fibrillation/NNP
Idraparinux/NNP evaluated/VBN patients/NNS fibrillation/NN atrial/JJ
Idraparinux/NNP evaluated/VBN patients/NNS fibrillation/NN
angiotensin/NNP receptor/NNP inhibitors/NNS converting/VBG blocking/VBG hold/VB remodelling/NN cardiac/JJ
angiotensin/NNP receptor/NNP inhibitors/NNS converting/VBG blocking/VBG hold/VB remodelling/NN
II/NNP receptor/NNP inhibitors/NNS converting/VBG blocking/VBG hold/VB remodelling/NN cardiac/JJ
II/NNP receptor/NNP inhibitors/NNS converting/VBG blocking/VBG hold/VB remodelling/NN
angiotensin/NNP receptor/NNP inhibitors/NNS converting/VBG blocking/VBG hold/VB promise/NN fibrillation/NN atrial/JJ
angiotensin/NNP receptor/NNP inhibitors/NNS converting/VBG blocking/VBG hold/VB promise/NN fibrillation/NN
II/NNP receptor/NNP inhibitors/NNS converting/VBG blocking/VBG hold/VB promise/NN fibrillation/NN atrial/JJ
II/NNP receptor/NNP inhibitors/NNS converting/VBG blocking/VBG hold/VB promise/NN fibrillation/NN
Angiotensin/NNP converting/VBG blocking/VBG hold/VB remodelling/NN cardiac/JJ
Angiotensin/NNP converting/VBG blocking/VBG hold/VB remodelling/NN
Angiotensin/NNP converting/VBG blocking/VBG hold/VB promise/NN fibrillation/NN atrial/JJ
Angiotensin/NNP converting/VBG blocking/VBG hold/VB promise/NN fibrillation/NN
5/CD induced/VBN exencephaly/NN
azacytidine/RB 13/CD let/VBP induced/VBN exencephaly/NN
angiotensin/NN converting/VBG hypertension/NN
tizanidine/NN initiation/NN Hypotension/NNP treated/VBN angiotensin/NN converting/VBG hypertension/NN
angiotensin/NN treated/VBN Hypotension/NNP
angiotensin/NN treated/VBN Adults/NNS have/VB ability/NN respond/VB hypotension/VB
angiotensin/NN converting/VBG control/VB hypertension/NN
angiotensin/NN chronically/NNS treatment/NN spasticity/NN
lisinopril/NN treated/VBN chronically/NNS treatment/NN spasticity/NN
tizanidine/NN addition/NN hypotension/NN developed/VBD hypertension/NN
tizanidine/NN addition/NN hypotension/NN developed/VBD hypertension/NN control/VB converting/VBG angiotensin/NN chronically/NNS treatment/NN spasticity/NN
angiotensin/NN converting/VBG control/VB hypertension/NN developed/VBD hypotension/NN
lisinopril/NN treated/VBN chronically/NNS angiotensin/NN converting/VBG control/VB hypertension/NN
tizanidine/NN agents/NNS interaction/NN kept/VBN treat/VB hypertension/NN
tizanidine/NN agents/NNS interaction/NN kept/VBN treat/VB hypertension/NN spasticity/NN
FK/NNP utility/NN complicated/VBN hypertension/NN nephrotoxicity/NN
506/CD FK/NNP utility/NN complicated/VBN hypertension/NN nephrotoxicity/NN
nitric/JJ activity/NN 1/CD expression/NN 1/CD hypertension/NN
oxide/NN activity/NN 1/CD expression/NN 1/CD hypertension/NN
FR/NNP antagonist/VBP studied/VBN hypertension/NN
139317/CD FR/NNP antagonist/VBP studied/VBN hypertension/NN
FR/NNP administration/NN prevented/VBD FK/NNP induced/VBN hypertension/NN
139317/CD FR/NNP administration/NN prevented/VBD FK/NNP induced/VBN hypertension/NN
TRI/NNP antagonize/VB hypothermia/NN
5/CD potentiate/VB antagonize/VB hypothermia/NN
hydroxytryptophan/JJ twitches/NNS 5/CD potentiate/VB antagonize/VB hypothermia/NN
dopamine/NNP D/NNP hydroxy/NN d/SYM induced/VBN hyperactivity/RB
phenylephrine/NN evoked/VBN stimulation/NN aggressiveness/NN
clonidine/NN evoked/VBN aggressiveness/NN
heparin/NN collagenase/NN 014/CD induction/NN ICH/NNP fold/VBP 4/CD 6/CD over/RB seen/VBN animals/NNS bleeding/NN
heparin/NN collagenase/NN 014/CD induction/NN ICH/NNP
heparin/NN collagenase/NN 014/CD induction/NN ICH/NNP fold/VBP 4/CD 6/CD over/RB seen/VBN animals/NNS ICH/NN
NMDA/NNP enhancement/NN antihyperalgesia/NN model/NN pain/NN
NMDA/NNP enhancement/NN differences/NNS comparisons/NNS models/NNS pain/NN acute/JJ
NMDA/NNP enhancement/NN differences/NNS comparisons/NNS models/NNS pain/NN
morphine/JJ antihyperalgesia/NN model/NN pain/NN
capsaicin/NN model/NN pain/NN
morphine/JJ antihyperalgesia/NN enhancement/NN differences/NNS comparisons/NNS models/NNS pain/NN acute/JJ
morphine/JJ antihyperalgesia/NN enhancement/NN differences/NNS comparisons/NNS models/NNS pain/NN
capsaicin/NN model/NN antihyperalgesia/NN enhancement/NN differences/NNS comparisons/NNS models/NNS pain/NN acute/JJ
capsaicin/NN model/NN antihyperalgesia/NN enhancement/NN differences/NNS comparisons/NNS models/NNS pain/NN
N/NNP aspartate/VBP models/NNS acute/JJ
N/NNP aspartate/VBP models/NNS pain/NN
methyl/NN N/NNP aspartate/VBP models/NNS acute/JJ
methyl/NN N/NNP aspartate/VBP models/NNS pain/NN
D/NNP methyl/NN N/NNP aspartate/VBP models/NNS acute/JJ
D/NNP methyl/NN N/NNP aspartate/VBP models/NNS pain/NN
aspartate/VBP models/NNS acute/JJ
aspartate/VBP models/NNS pain/NN
NMDA/NNP antagonists/NNS aspartate/VBP models/NNS acute/JJ
NMDA/NNP antagonists/NNS aspartate/VBP models/NNS pain/NN
morphine/NN effects/NNS enhance/VB aspartate/VBP models/NNS acute/JJ
morphine/NN effects/NNS enhance/VB aspartate/VBP models/NNS pain/NN
dextromethorphan/NN antinociception/NN Enhancement/NNP seen/VBN males/NNS models/NNS acute/JJ
dextromethorphan/NN antinociception/NN Enhancement/NNP seen/VBN males/NNS models/NNS pain/NN
morphine/JJ antinociception/NN Enhancement/NNP seen/VBN males/NNS models/NNS acute/JJ
morphine/JJ antinociception/NN Enhancement/NNP seen/VBN males/NNS models/NNS pain/NN
NMDA/NNP antagonists/NNS interaction/NN sexually/NN demonstrate/VBP model/NN pain/NN
NMDA/NNP antagonists/NNS interaction/NN sexually/NN demonstrate/VBP model/NN distinguished/JJ those/DT observed/VBN models/NNS acute/JJ
NMDA/NNP antagonists/NNS interaction/NN sexually/NN demonstrate/VBP model/NN distinguished/JJ those/DT observed/VBN models/NNS pain/NN
morphine/NN antagonists/NNS interaction/NN sexually/NN demonstrate/VBP model/NN pain/NN
morphine/NN antagonists/NNS interaction/NN sexually/NN demonstrate/VBP model/NN distinguished/JJ those/DT observed/VBN models/NNS acute/JJ
morphine/NN antagonists/NNS interaction/NN sexually/NN demonstrate/VBP model/NN distinguished/JJ those/DT observed/VBN models/NNS pain/NN
FK/NNP nephropathy/JJ
506/CD FK/NNP nephropathy/JJ
FK/NNP nephropathy/JJ nephropathy/NN
506/CD FK/NNP nephropathy/JJ nephropathy/NN
FK/NN nephropathy/NN nephropathy/JJ
506/CD nephropathy/NN nephropathy/JJ
FK/NN nephropathy/NN
506/CD nephropathy/NN
FK/NNP nephropathy/JJ nephropathy/NN type/NN rejection/NN nephropathy/NN IgA/NN
FK/NNP nephropathy/JJ nephropathy/NN type/NN rejection/NN nephropathy/NN
506/CD FK/NNP nephropathy/JJ nephropathy/NN type/NN rejection/NN nephropathy/NN IgA/NN
506/CD FK/NNP nephropathy/JJ nephropathy/NN type/NN rejection/NN nephropathy/NN
FK/NN nephropathy/NN type/NN rejection/NN nephropathy/NN IgA/NN
FK/NN nephropathy/NN type/NN rejection/NN nephropathy/NN
506/CD nephropathy/NN type/NN rejection/NN nephropathy/NN IgA/NN
506/CD nephropathy/NN type/NN rejection/NN nephropathy/NN
FK/VBP nephropathy/NN
506/CD nephropathy/NN
FK/NNP 506/NNP consisted/VBD nephropathy/RB
506/NNP consisted/VBD nephropathy/RB
FK/NNP 506/NNP consisted/VBD vacuolization/NN form/NN fibrosis/NN interstitial/JJ
FK/NNP 506/NNP consisted/VBD vacuolization/NN form/NN fibrosis/NN
506/NNP consisted/VBD vacuolization/NN form/NN fibrosis/NN interstitial/JJ
506/NNP consisted/VBD vacuolization/NN form/NN fibrosis/NN
FK/VBP higher/JJR group/NN nephropathy/JJ
506/CD group/NN nephropathy/JJ
FK/VBP higher/JJR those/DT group/NN nephropathy/NN
506/CD group/NN higher/JJR those/DT group/NN nephropathy/NN
FK/NNP chronic/NN group/NN those/DT higher/JJR group/NN nephropathy/JJ
506/CD FK/NNP chronic/NN group/NN those/DT higher/JJR group/NN nephropathy/JJ
FK/NNP chronic/NN group/NN nephropathy/NN
506/CD FK/NNP chronic/NN group/NN nephropathy/NN
creatinine/JJ levels/NNS FK/VBP higher/JJR group/NN nephropathy/JJ
creatinine/JJ levels/NNS FK/VBP higher/JJR those/DT group/NN nephropathy/NN
FK/NNP 506/NNP consists/VBZ nephropathy/RB
506/NNP consists/VBZ nephropathy/RB
FK/NNP 506/NNP consists/VBZ demonstrates/VBZ condition/NN nephropathy/RB
506/NNP consists/VBZ demonstrates/VBZ condition/NN nephropathy/RB
FK/NNP 506/NNP condition/NN demonstrates/VBZ consists/VBZ nephropathy/RB
506/NNP condition/NN demonstrates/VBZ consists/VBZ nephropathy/RB
FK/NNP 506/NNP condition/NN nephropathy/RB
506/NNP condition/NN nephropathy/RB
Flurbiprofen/NNP arthritis/NN juvenile/JJ
Flurbiprofen/NNP arthritis/NN rheumatoid/JJ
Flurbiprofen/NNP arthritis/NN
flurbiprofen/NN treated/VBN patients/NNS had/VBD baseline/NN indices/NNS arthritis/NN
flurbiprofen/NN treated/VBN patients/NNS arthritis/NN juvenile/JJ
flurbiprofen/NN treated/VBN patients/NNS arthritis/NN rheumatoid/JJ
flurbiprofen/NN treated/VBN patients/NNS arthritis/NN
potassium/NN known/VBN medications/NNS given/VBN suggestive/NN relationship/NN sulindac/NN hyperkalemia/NN
adriamycin/NN carcinoma/NN bladder/NN
adriamycin/NN carcinoma/NN
Adriamycin/NNP administered/VBN resection/NN T/NNP tumors/NNS bladder/NN
Adriamycin/NNP administered/VBN resection/NN T/NNP tumors/NNS
sulfasalazine/NN therapy/NN colitis/NNS ulcerative/NN
sulfasalazine/NN therapy/NN colitis/NNS
sulfasalazine/NN lupus/NNS manifested/VBD serositis/NNS
sulfasalazine/JJ treat/VB disease/NN inflammatory/JJ
sulfasalazine/JJ treat/VB disease/NN bowel/NN
sulfasalazine/JJ treat/VB disease/NN
sulfasalazine/NN signs/NNS aware/JJ Physicians/NNP use/VBP sulfasalazine/JJ treat/VB disease/NN inflammatory/JJ
sulfasalazine/NN signs/NNS aware/JJ Physicians/NNP use/VBP sulfasalazine/JJ treat/VB disease/NN bowel/NN
sulfasalazine/NN signs/NNS aware/JJ Physicians/NNP use/VBP sulfasalazine/JJ treat/VB disease/NN
CC/NNP complications/NNS thromboembolic/JJ
CC/NNP intake/NN disturbance/NN uncommon/JJ include/VB search/NN literature/NN complications/NNS thromboembolic/JJ
CC/NNP treating/VBG patients/NNS infertility/NN
dapsone/NN dose/NN taking/VBG associated/VBN hemolysis/NNS
dapsone/NN dose/NN taking/VBG developed/VBD woman/NN trait/NN leprosy/NNP
sodium/NN channel/NN induced/VBN leads/NNS nephropathy/JJ
Doxorubicin/NNP induced/VBN leads/NNS nephropathy/JJ
sodium/NN channel/NN retention/NN volume/NN
sodium/NN channel/NN retention/NN
sodium/NN channel/NN retention/NN fibrosis/NN
Doxorubicin/NNP induced/VBN channel/NN retention/NN volume/NN
Doxorubicin/NNP induced/VBN channel/NN retention/NN
Doxorubicin/NNP induced/VBN channel/NN retention/NN fibrosis/NN
aldosterone/NN kinase/NN shown/VBN participate/VB mediate/VB fibrosis/NN
aldosterone/NN levels/NNS increased/VBD mice/NNS nephrotic/JJ
sodium/NN excretion/NN reached/VBD associated/VBN gain/NN weight/NN
sodium/NN excretion/NN reached/VBD associated/VBN gain/NN
urea/NN concentrations/NNS increased/VBD course/NN syndrome/NN nephrotic/JJ
urea/NN concentrations/NNS increased/VBD course/NN syndrome/NN
urea/NN concentrations/NNS increased/VBD mice/NNS uremia/NN
Simvastatin/NNP medications/NNS human/JJ
Simvastatin/NNP medications/NNS immunodeficiency/JJ
Simvastatin/NNP medications/NNS virus/NN
amiodarone/NN Simvastatin/NNP medications/NNS human/JJ
amiodarone/NN Simvastatin/NNP medications/NNS immunodeficiency/JJ
amiodarone/NN Simvastatin/NNP medications/NNS virus/NN
sulphasalazine/NN received/VBD disease/NN inflammatory/JJ
sulphasalazine/NN received/VBD disease/NN bowel/NN
sulphasalazine/NN received/VBD disease/NN
sulphasalazine/NN received/VBD disease/NN born/VBN infants/NNS found/VBN have/VB anomalies/NNS congenital/JJ
sulphasalazine/NN received/VBD disease/NN born/VBN infants/NNS found/VBN have/VB anomalies/NNS
haloperidol/NN study/NN found/VBN effective/JJ treatment/NN syndromes/NNS psychotic/JJ
haloperidol/NN study/NN found/VBN effective/JJ treatment/NN syndromes/NNS
haloperidol/NN study/NN found/VBN effective/JJ treatment/NN syndromes/NNS belonging/VBG
haloperidol/NN study/NN found/VBN effective/JJ treatment/NN syndromes/NNS belonging/VBG predominantly/RB
haloperidol/NN study/NN found/VBN effective/JJ treatment/NN syndromes/NNS belonging/VBG group/NN to/TO
haloperidol/NN study/NN found/VBN effective/JJ treatment/NN syndromes/NNS belonging/VBG group/NN the/DT
haloperidol/NN study/NN found/VBN effective/JJ treatment/NN syndromes/NNS belonging/VBG group/NN schizophrenia/NN
haloperidol/NN study/NN found/VBN effective/JJ treatment/NN syndromes/NNS belonging/VBG group/NN
sirolimus/NNS associated/VBN dysfunction/NN proteinuria/JJ acute/JJ
sirolimus/NNS associated/VBN dysfunction/NN renal/JJ
sirolimus/NNS associated/VBN dysfunction/NN
sirolimus/NNS associated/VBN dysfunction/NN acute/JJ
sirolimus/NNS associated/VBN dysfunction/NN renal/JJ
sirolimus/NNS associated/VBN dysfunction/NN
angiotensin/NN use/VB minimised/VBN close/VB monitoring/NN function/NN proteinuria/NN
angiotensin/NN use/VB occurs/VBZ proteinuria/NN
angiotensin/JJ blockers/NNS inhibitors/NNS converting/VBG use/VB minimised/VBN close/VB monitoring/NN function/NN proteinuria/NN
II/NNP blockers/NNS inhibitors/NNS converting/VBG use/VB minimised/VBN close/VB monitoring/NN function/NN proteinuria/NN
angiotensin/JJ blockers/NNS inhibitors/NNS converting/VBG use/VB occurs/VBZ proteinuria/NN
II/NNP blockers/NNS inhibitors/NNS converting/VBG use/VB occurs/VBZ proteinuria/NN
coniine/NN sulfate/NN caused/VBN deformations/NNS
coniine/NN sulfate/NN caused/VBN deformations/NNS flexion/NN excessive/JJ
coniine/NN sulfate/NN caused/VBN deformations/NNS flexion/NN
coniine/NN sulfate/NN caused/VBN deformations/NNS flexion/NN or/CC
coniine/NN sulfate/NN caused/VBN deformations/NNS flexion/NN extension/NN
coniine/NN sulfate/NN caused/VBN deformations/NNS flexion/NN toes/NNS of/IN
coniine/NN sulfate/NN caused/VBN deformations/NNS flexion/NN toes/NNS one/CD
coniine/NN sulfate/NN caused/VBN deformations/NNS flexion/NN toes/NNS one/CD or/CC
coniine/NN sulfate/NN caused/VBN deformations/NNS flexion/NN toes/NNS one/CD more/JJR
coniine/NN sulfate/NN caused/VBN deformations/NNS flexion/NN toes/NNS
nicotine/NN coniine/NN sulfate/NN caused/VBN deformations/NNS
nicotine/NN coniine/NN sulfate/NN caused/VBN deformations/NNS flexion/NN excessive/JJ
nicotine/NN coniine/NN sulfate/NN caused/VBN deformations/NNS flexion/NN
nicotine/NN coniine/NN sulfate/NN caused/VBN deformations/NNS flexion/NN or/CC
nicotine/NN coniine/NN sulfate/NN caused/VBN deformations/NNS flexion/NN extension/NN
nicotine/NN coniine/NN sulfate/NN caused/VBN deformations/NNS flexion/NN toes/NNS of/IN
nicotine/NN coniine/NN sulfate/NN caused/VBN deformations/NNS flexion/NN toes/NNS one/CD
nicotine/NN coniine/NN sulfate/NN caused/VBN deformations/NNS flexion/NN toes/NNS one/CD or/CC
nicotine/NN coniine/NN sulfate/NN caused/VBN deformations/NNS flexion/NN toes/NNS one/CD more/JJR
nicotine/NN coniine/NN sulfate/NN caused/VBN deformations/NNS flexion/NN toes/NNS
Clomipramine/JJ exposure/NN include/VBP anxiety/NN inflexibility/NN behavioral/JJ
Clomipramine/JJ exposure/NN include/VBP anxiety/NN inflexibility/NN
Clomipramine/JJ exposure/NN dysfunction/NN corticostriatal/JJ
Clomipramine/JJ exposure/NN dysfunction/NN
norepinephrine/JJ rate/NN augmentation/NN tachycardia/NN
nitroglycerin/NN hydralazine/NN induced/VBN hypotension/NN contrast/NN observed/JJ tachycardia/NN
hydralazine/NN induced/VBN hypotension/NN contrast/NN observed/JJ tachycardia/NN
norepinephrine/JJ rate/NN augmentation/NN tachycardia/NN observed/JJ contrast/NN hypotension/NN
sulfonylureas/NNS reported/VBN induced/VBN hepatotoxicity/RB
sulfonylurea/NN reports/NNS hepatotoxicity/NN
glyburide/JJ therapy/NN initiation/NN developed/VBD patients/NNS mellitus/NNS type/NN
glyburide/JJ therapy/NN initiation/NN developed/VBD patients/NNS mellitus/NNS II/CD
glyburide/JJ therapy/NN initiation/NN developed/VBD patients/NNS mellitus/NNS diabetes/NN
glyburide/JJ therapy/NN initiation/NN developed/VBD patients/NNS mellitus/NNS
aspirin/NN administration/NN co/NN carcinomas/NNS bladder/NN
aspirin/NN administration/NN co/NN carcinomas/NNS
aspirin/NN administration/NN co/NN carcinomas/NNS induction/NN tumors/NNS forestomach/JJ
aspirin/NN administration/NN co/NN carcinomas/NNS induction/NN tumors/NNS
aspirin/NN effect/NN due/JJ consistent/JJ experiment/NN suggesting/VBG involved/VBN carcinogenesis/NNS
FANFT/JJ carcinogenesis/NNS
FANFT/NNP effect/NN due/JJ consistent/JJ experiment/NN suggesting/VBG involved/VBN carcinogenesis/NNS
Sodium/JJ status/NN influences/VBZ nephrotoxicity/NN
oxycodone/NN effects/NNS adults/NNS suffering/VBG chronic/NN pain/NN
oxycodone/NN similar/JJ aged/VBN suggests/VBZ that/DT suffering/VBG changes/NNS chronic/JJ
oxycodone/NN similar/JJ aged/VBN suggests/VBZ that/DT suffering/VBG changes/NNS neurocognitive/NN pain/NN
nicotine/CD mg/NN caused/VBN locomotor/NN
nicotine/CD mg/NN caused/VBN hypoactivity/RB
nicotine/NN enhanced/VBD operated/VBD lesions/VBZ significantly/RB locomotor/NN
nicotine/NN enhanced/VBD operated/VBD lesions/VBZ significantly/RB locomotor/NN caused/VBN hypoactivity/RB
Metamizol/JJ potentiates/NNS morphine/VBP antinociception/NN constipation/NN
metamizol/NN effects/NNS constipating/VBG
charcoal/NN test/NN used/VBN assessed/VBN using/VBG model/NN nociception/NN pain/NN
metamizol/NN potentiate/VB suggesting/VBG produced/VBD constipation/NN
morphine/NN interaction/NN show/VBP suggesting/VBG useful/JJ treatment/NN pain/NN chronic/JJ
morphine/NN interaction/NN show/VBP suggesting/VBG useful/JJ treatment/NN pain/NN
metamizol/NN morphine/NN interaction/NN show/VBP suggesting/VBG useful/JJ treatment/NN pain/NN chronic/JJ
metamizol/NN morphine/NN interaction/NN show/VBP suggesting/VBG useful/JJ treatment/NN pain/NN
adriamycin/NN induced/VBN damage/NN renal/JJ
adriamycin/NN induced/VBN damage/NN
adriamycin/NN injection/NN induced/VBN damage/NN renal/JJ
adriamycin/NN injection/NN induced/VBN damage/NN
adriamycin/NN elicited/VBD proteinuria/NN glomerulosclerosis/NNS focal/JJ
adriamycin/NN elicited/VBD proteinuria/NN glomerulosclerosis/NNS
adriamycin/NN elicited/VBD proteinuria/NN nephrotic/JJ
adriamycin/NN elicited/VBD proteinuria/NN damage/NN renal/JJ
adriamycin/NN elicited/VBD proteinuria/NN damage/NN interstitial/JJ
adriamycin/NN elicited/VBD proteinuria/NN damage/NN
adriamycin/NN severity/NN damage/NN renal/JJ
adriamycin/NN severity/NN damage/NN
benzylthiouracil/NN carbimazole/NN reactivity/NN hepatitis/NN Toxic/JJ
benzylthiouracil/NN carbimazole/NN reactivity/NN hepatitis/NN
carbimazole/NN induced/VBN hepatitis/NN cholestatic/JJ
carbimazole/NN induced/VBN hepatitis/NN
N/NNP omercazole/NN carbimazole/NN induced/VBN hepatitis/NN cholestatic/JJ
N/NNP omercazole/NN carbimazole/NN induced/VBN hepatitis/NN
omercazole/NN carbimazole/NN induced/VBN hepatitis/NN cholestatic/JJ
omercazole/NN carbimazole/NN induced/VBN hepatitis/NN
Benzylthiouracil/NNP replaced/VBN appeared/VBD hepatitis/NN
Basd/NNP ne/NNP Benzylthiouracil/NNP replaced/VBN appeared/VBD hepatitis/NN
ne/NNP Benzylthiouracil/NNP replaced/VBN appeared/VBD hepatitis/NN
alprazolam/NN disorder/NN panic/NN
alprazolam/NN disorder/NN
alprazolam/NN disorder/NN agoraphobia/NN
alprazolam/NN randomised/VBN criteria/NNS disorder/NN panic/NN
alprazolam/NN randomised/VBN criteria/NNS disorder/NN
alprazolam/NN randomised/VBN criteria/NNS disorder/NN agoraphobia/NN
alprazolam/NN patients/NNS developed/VBD reactions/NNS depression/NN aggression/NN
alprazolam/NN patients/NNS developed/VBD reactions/NNS effects/NNS irritability/NN
adrenaline/NN containing/VBG mg/VBP observed/VBN increase/NN accompanied/VBN fibrillation/NN loss/NN
adrenaline/NN containing/VBG mg/VBP observed/VBN increase/NN accompanied/VBN fibrillation/NN loss/NN consciousness/NN of/IN
adrenaline/NN containing/VBG mg/VBP observed/VBN increase/NN accompanied/VBN fibrillation/NN loss/NN consciousness/NN
mepivacaine/JJ 850/CD block/NN performance/NN mg/VBP observed/VBN increase/NN accompanied/VBN fibrillation/NN agitation/NN
adrenaline/NN containing/VBG mg/VBP observed/VBN increase/NN accompanied/VBN fibrillation/NN agitation/NN
mepivacaine/JJ 850/CD block/NN performance/NN mg/VBP observed/VBN increase/NN accompanied/VBN fibrillation/NN shouts/NNS incomprehensible/NN
mepivacaine/JJ 850/CD block/NN performance/NN mg/VBP observed/VBN increase/NN accompanied/VBN fibrillation/NN shouts/NNS
mepivacaine/JJ 850/CD block/NN performance/NN mg/VBP containing/VBG adrenaline/NN contracture/NN Dupuytren/NNP
mepivacaine/JJ 850/CD block/NN performance/NN mg/VBP containing/VBG adrenaline/NN contracture/NN Dupuytren/NNP '/POS
mepivacaine/JJ 850/CD block/NN performance/NN mg/VBP containing/VBG adrenaline/NN contracture/NN s/JJ
mepivacaine/JJ 850/CD block/NN performance/NN mg/VBP containing/VBG adrenaline/NN contracture/NN
adrenaline/NN contracture/NN Dupuytren/NNP
adrenaline/NN contracture/NN Dupuytren/NNP '/POS
adrenaline/NN contracture/NN s/JJ
adrenaline/NN contracture/NN
adrenaline/NN containing/VBG mg/VBP observed/VBN increase/NN accompanied/VBN fibrillation/NN shouts/NNS incomprehensible/NN
adrenaline/NN containing/VBG mg/VBP observed/VBN increase/NN accompanied/VBN fibrillation/NN shouts/NNS
mepivacaine/JJ 850/CD block/NN performance/NN mg/VBP observed/VBN increase/NN accompanied/VBN fibrillation/NN loss/NN
mepivacaine/JJ 850/CD block/NN performance/NN mg/VBP observed/VBN increase/NN accompanied/VBN fibrillation/NN loss/NN consciousness/NN of/IN
mepivacaine/JJ 850/CD block/NN performance/NN mg/VBP observed/VBN increase/NN accompanied/VBN fibrillation/NN loss/NN consciousness/NN
dipyridamole/JJ Effects/NNPS induced/VBN injury/NN myocardial/JJ
dipyridamole/JJ Effects/NNPS induced/VBN injury/NN
hydrocortisone/JJ dipyridamole/JJ Effects/NNPS induced/VBN injury/NN myocardial/JJ
hydrocortisone/JJ dipyridamole/JJ Effects/NNPS induced/VBN injury/NN
acetylsalicylic/JJ acid/NN Effects/NNPS induced/VBN injury/NN myocardial/JJ
acetylsalicylic/JJ acid/NN Effects/NNPS induced/VBN injury/NN
acid/NN Effects/NNPS induced/VBN injury/NN myocardial/JJ
acid/NN Effects/NNPS induced/VBN injury/NN
epinephrine/JJ infusion/NN injury/NN producing/VBG model/NN developed/VBN study/VB effects/NNS alter/VB evolution/NN infarction/NN myocardial/JJ
epinephrine/JJ infusion/NN injury/NN producing/VBG model/NN developed/VBN study/VB effects/NNS alter/VB evolution/NN infarction/NN
chlorofluorocarbons/NNS substitutes/NNS Epidemic/NNP disease/NN liver/NN
chlorofluorocarbons/NNS substitutes/NNS Epidemic/NNP disease/NN
ozone/NN used/VBN hydrochlorofluorocarbons/NNS caused/VBN disease/NN liver/NN
ozone/NN used/VBN hydrochlorofluorocarbons/NNS caused/VBN disease/NN
hydrochlorofluorocarbons/NNS caused/VBN disease/NN liver/NN
hydrochlorofluorocarbons/NNS caused/VBN disease/NN
trifluoroacetyl/JJ intermediates/NNS implicated/VBN hepatotoxicity/NN
1/CD way/NN metabolised/VBN bromo/NN trifluoroethane/VBN form/VB intermediates/NNS implicated/VBN hepatotoxicity/NN
bromo/NN trifluoroethane/VBN form/VB intermediates/NNS implicated/VBN hepatotoxicity/NN
1/CD bromo/NN trifluoroethane/VBN form/VB intermediates/NNS implicated/VBN hepatotoxicity/NN
chloro/NNP -/NNP 1/CD bromo/NN trifluoroethane/VBN form/VB intermediates/NNS implicated/VBN hepatotoxicity/NN
-/NNP 1/CD bromo/NN trifluoroethane/VBN form/VB intermediates/NNS implicated/VBN hepatotoxicity/NN
2/CD -/NNP 1/CD bromo/NN trifluoroethane/VBN form/VB intermediates/NNS implicated/VBN hepatotoxicity/NN
2/CD -/NNP 1/CD bromo/NN trifluoroethane/VBN form/VB intermediates/NNS implicated/VBN hepatotoxicity/NN
2/CD -/NNP 1/CD bromo/NN trifluoroethane/VBN form/VB intermediates/NNS implicated/VBN hepatotoxicity/NN
trifluoroethane/VBN form/VB intermediates/NNS implicated/VBN hepatotoxicity/NN
halothane/VB trifluoroethane/VBN form/VB intermediates/NNS implicated/VBN hepatotoxicity/NN
halothane/NN hepatotoxicity/NN
HCFCs/NNS 123/NNP result/VB disease/NN liver/NN
HCFCs/NNS 123/NNP result/VB disease/NN
123/NNP result/VB disease/NN liver/NN
123/NNP result/VB disease/NN
and/CC 123/NNP result/VB disease/NN liver/NN
and/CC 123/NNP result/VB disease/NN
124/NNP 123/NNP result/VB disease/NN liver/NN
124/NNP 123/NNP result/VB disease/NN
HCFCs/NNS beings/NNS exposure/NN result/VB injury/NN liver/NN
HCFCs/NNS beings/NNS exposure/NN result/VB injury/NN
123/CD HCFCs/NNS beings/NNS exposure/NN result/VB injury/NN liver/NN
123/CD HCFCs/NNS beings/NNS exposure/NN result/VB injury/NN
and/CC HCFCs/NNS beings/NNS exposure/NN result/VB injury/NN liver/NN
and/CC HCFCs/NNS beings/NNS exposure/NN result/VB injury/NN
124/CD HCFCs/NNS beings/NNS exposure/NN result/VB injury/NN liver/NN
124/CD HCFCs/NNS beings/NNS exposure/NN result/VB injury/NN
trifluoroacetyl/NN suggest/VBP known/VBN mechanism/NN hepatotoxicity/NN
carbidopa/JJ preparation/NN receiving/VBG presented/VBN had/VBD onset/NN hallucinosis/NNS
//JJ preparation/NN receiving/VBG presented/VBN had/VBD onset/NN hallucinosis/NNS
levodopa/NN preparation/NN receiving/VBG presented/VBN had/VBD onset/NN hallucinosis/NNS
carbidopa/JJ preparation/NN receiving/VBG presented/VBN had/VBD failure/NN chronic/JJ
carbidopa/JJ preparation/NN receiving/VBG presented/VBN had/VBD failure/NN renal/JJ
carbidopa/JJ preparation/NN receiving/VBG presented/VBN had/VBD failure/NN
//JJ preparation/NN receiving/VBG presented/VBN had/VBD failure/NN chronic/JJ
//JJ preparation/NN receiving/VBG presented/VBN had/VBD failure/NN renal/JJ
//JJ preparation/NN receiving/VBG presented/VBN had/VBD failure/NN
levodopa/NN preparation/NN receiving/VBG presented/VBN had/VBD failure/NN chronic/JJ
levodopa/NN preparation/NN receiving/VBG presented/VBN had/VBD failure/NN renal/JJ
levodopa/NN preparation/NN receiving/VBG presented/VBN had/VBD failure/NN
carbidopa/JJ preparation/NN receiving/VBG presented/VBN had/VBD onset/NN hallucinosis/NNS seizures/NNS
//JJ preparation/NN receiving/VBG presented/VBN had/VBD onset/NN hallucinosis/NNS seizures/NNS
levodopa/NN preparation/NN receiving/VBG presented/VBN had/VBD onset/NN hallucinosis/NNS seizures/NNS
losartan/NN administration/NN developed/VBD case/NN 70/CD man/NN hypertensive/NN
losartan/NN administration/NN developed/VBD case/NN 70/CD man/NN kidney/NN insufficiency/NN chronic/JJ
losartan/NN administration/NN developed/VBD case/NN 70/CD man/NN kidney/NN insufficiency/NN renal/JJ
losartan/NN administration/NN developed/VBD case/NN 70/CD man/NN kidney/NN insufficiency/NN
losartan/NN prescribed/VBN dysfunction/NN systolic/JJ
losartan/NN prescribed/VBN dysfunction/NN
furosemide/NN high/JJ lasted/VBD anuria/NN
amine/JJ infusion/NN furosemide/NN high/JJ lasted/VBD anuria/NN
angiotensin/NN system/NN renin/NN activation/NN resulted/VBD stenosis/NNS failure/NN heart/NN
angiotensin/NN system/NN renin/NN activation/NN resulted/VBD stenosis/NNS failure/NN
angiotensin/NN system/NN renin/NN activation/NN resulted/VBD stenosis/NNS renal/JJ
angiotensin/NN system/NN renin/NN activation/NN resulted/VBD stenosis/NNS artery/NN
angiotensin/NN system/NN renin/NN activation/NN resulted/VBD stenosis/NNS
losartan/NN cause/VB patients/NNS disease/NN renovascular/NN
losartan/NN cause/VB patients/NNS disease/NN
angiotensin/NNP losartan/NN cause/VB patients/NNS disease/NN renovascular/NN
angiotensin/NNP losartan/NN cause/VB patients/NNS disease/NN
II/NNP losartan/NN cause/VB patients/NNS disease/NN renovascular/NN
II/NNP losartan/NN cause/VB patients/NNS disease/NN
citrate/NN toxicity/NN
citrate/NN toxicity/NN
calcium/NN gluconate/NN treatment/NN initiated/VBN subsided/VBD contractions/NNS muscle/NN
calcium/NN gluconate/NN treatment/NN initiated/VBN subsided/VBD contractions/NNS
gluconate/NN treatment/NN initiated/VBN subsided/VBD contractions/NNS muscle/NN
gluconate/NN treatment/NN initiated/VBN subsided/VBD contractions/NNS
calcium/NN chelation/NN reaction/NN consistent/JJ anticoagulant/NN resulting/VBG hypocalcemia/NN
bumetanide/NN diuretic/NN cause/VB hypocalcemia/NN
loop/NN diuretic/NN cause/VB hypocalcemia/NN
diuretic/NN cause/VB hypocalcemia/NN
citrate/VB toxicity/NN
GABA/NNP receptor/NNP effects/NNS sensitive/JJ seizures/NNS
benzodiazepine/NN site/NN carboxylate/NN injection/NN resistance/NN seizures/NNS
GABA/NNP agonist/NN site/NN carboxylate/NN injection/NN resistance/NN seizures/NNS
diazepam/NN induced/VBN seizures/NNS
diazepam/NN test/NN plus/NN induced/VBN diazepam/NN induced/VBN seizures/NNS
lopinavir/VB related/VBD neonates/NNS toxicity/NN cardiac/JJ
lopinavir/VB related/VBD neonates/NNS toxicity/NN
//JJ therapy/NN lopinavir/VB related/VBD neonates/NNS toxicity/NN cardiac/JJ
//JJ therapy/NN lopinavir/VB related/VBD neonates/NNS toxicity/NN
ritonavir/NN therapy/NN lopinavir/VB related/VBD neonates/NNS toxicity/NN cardiac/JJ
ritonavir/NN therapy/NN lopinavir/VB related/VBD neonates/NNS toxicity/NN
bupivacaine/NN received/VBD None/NN limb/NN paralysis/NN
argatroban/NN elevation/NN thrombocytopenia/NN thrombosis/NNS
argatroban/NN elevation/NN thrombocytopenia/NN
heparin/NN history/NN patient/NN argatroban/NN elevation/NN thrombocytopenia/NN thrombosis/NNS
heparin/NN history/NN patient/NN argatroban/NN elevation/NN thrombocytopenia/NN
heparin/NN history/NN patients/NNS HIT/NNP thrombosis/NNS HITT/NNP
heparin/NN history/NN patients/NNS HIT/NNP thrombosis/NNS
heparin/NN history/NN patients/NNS thrombocytopenia/NN
heparin/NN history/NN patients/NNS thrombocytopenia/NN HIT/NNP
heparin/NN history/NN patients/NNS HIT/NNP
argatroban/NN administered/VBN year/NN history/NN HITT/NNP
argatroban/NN administered/VBN year/NN old/JJ patient/JJ critically/RB
argatroban/NN administered/VBN year/NN old/JJ patient/JJ ill/RB
argatroban/NN concentrations/NNS measured/VBN RESULTS/NNS observed/JJ published/VBN minutes/NNS -RSB-/NNS hepatic/JJ
argatroban/NN concentrations/NNS measured/VBN RESULTS/NNS observed/JJ published/VBN minutes/NNS -RSB-/NNS impairment/NN
argatroban/NN minutes/NNS measured/VBN RESULTS/NNS observed/JJ published/VBN minutes/NNS -RSB-/NNS hepatic/JJ
argatroban/NN minutes/NNS measured/VBN RESULTS/NNS observed/JJ published/VBN minutes/NNS -RSB-/NNS impairment/NN
argatroban/NN concentration/NN Correlation/NNP suggest/VBP contributed/VBN coagulopathy/NN
argatroban/NN levels/NNS contributed/VBN coagulopathy/NN
argatroban/NN concentration/NN measure/VB report/NN extended/VBD coagulopathy/RB
K/NNP Na/NNP cardiac/JJ affinities/NNS Changes/NNS ATPase/NNP hypertension/NN
sodium/NN affinities/NNS Changes/NNS ATPase/NNP hypertension/NN
Na/NNP cardiac/JJ affinities/NNS Changes/NNS ATPase/NNP hypertension/NN
ATP/NN sodium/NN affinities/NNS Changes/NNS ATPase/NNP hypertension/NN
sodium/NN level/NN elevation/NN documented/VBN models/NNS hypertension/NN
K/NNP Na/NNP cardiac/JJ response/NN induced/NNS hypertension/NN
Na/NNP +/NNP transport/NN disturbances/NNS basis/NN assess/VB studied/VBD response/NN induced/NNS hypertension/NN
Na/NNP cardiac/JJ response/NN induced/NNS hypertension/NN
N/NNS inhibition/NN response/NN induced/NNS hypertension/NN
G/NNP N/NNS inhibition/NN response/NN induced/NNS hypertension/NN
nitro/NN response/NN induced/NNS hypertension/NN
L/NNP nitro/NN response/NN induced/NNS hypertension/NN
arginine/JJ ester/NN response/NN induced/NNS hypertension/NN
methyl/NN ester/NN response/NN induced/NNS hypertension/NN
ester/NN response/NN induced/NNS hypertension/NN
L/NNP ester/NN response/NN induced/NNS hypertension/NN
NAME/NNP L/NNP ester/NN response/NN induced/NNS hypertension/NN
K/NNP Na/NNP ATPase/NN activity/NN increased/VBD recovery/NN hypertension/NN
Na/NNP ATPase/NN activity/NN increased/VBD recovery/NN hypertension/NN
ATP/NNP affinity/NN due/JJ increased/VBD recovery/NN hypertension/NN
ATP/NNP value/NN revealed/VBD site/NN increased/VBD recovery/NN hypertension/NN
NO/RB Inhibition/NNP synthase/NN induced/VBN hypertension/NN accompanied/VBN +/NNP depressed/JJ
K/NNP Na/NNP properties/NNS hypertension/NN
K/NNP Na/NNP properties/NNS hypertension/NN accompanied/VBN +/NNP depressed/JJ
Na/NNP +/NNP accompanied/VBN hypertension/NN
Na/NNP +/NNP consequence/NN cells/NNS extrusion/NN hypertension/NN
Na/NNP properties/NNS hypertension/NN
Na/NNP +/NNP depressed/JJ
Na/NNP +/NNP consequence/NN cells/NNS extrusion/NN hypertension/NN accompanied/VBN +/NNP depressed/JJ
Na/NNP properties/NNS hypertension/NN accompanied/VBN +/NNP depressed/JJ
amiodarone/JJ treatment/NN tachycardia/NN atrial/JJ
amiodarone/JJ treatment/NN tachycardia/NN
amiodarone/JJ treatment/NN occurring/VBG abnormalities/NNS intraventricular/NN
amiodarone/JJ treatment/NN occurring/VBG abnormalities/NNS conduction/NN
amiodarone/JJ treatment/NN occurring/VBG abnormalities/NNS
amiodarone/JJ discontinuation/NN days/NNS showed/VBD flutter/NN atrial/JJ
amiodarone/JJ discontinuation/NN days/NNS showed/VBD flutter/NN
modafinil/NN effect/NN sleepiness/NNS daytime/JJ
modafinil/NN effect/NN sleepiness/NNS
Modafinil/NNP associated/VBN latency/NN decrease/NN sleepiness/NNS daytime/JJ
Modafinil/NNP associated/VBN latency/NN decrease/NN sleepiness/NNS
modafinil/NN promotes/VBZ decreases/VBZ sleepiness/NNS daytime/JJ
modafinil/NN promotes/VBZ decreases/VBZ sleepiness/NNS
cocaine/NN use/NN associated/VBN Stroke/NNP
cocaine/NN use/NN related/VBN stroke/VB
cocaine/NN use/NN followed/VBD Stroke/NNP
cocaine/NN use/NN related/VBN incidence/NN increasing/VBG indicate/VBP exceeds/VBZ stroke/NN frequency/NN hemorrhage/NN intracranial/JJ
cocaine/NN use/NN related/VBN incidence/NN increasing/VBG indicate/VBP exceeds/VBZ stroke/NN frequency/NN hemorrhage/NN
cocaine/NN -/VBD indicate/VBP exceeds/VBZ stroke/NN frequency/NN hemorrhage/NN intracranial/JJ
cocaine/NN -/VBD indicate/VBP exceeds/VBZ stroke/NN frequency/NN hemorrhage/NN
cocaine/NN administration/NN route/NN follow/VB indicate/VBP exceeds/VBZ stroke/NN frequency/NN hemorrhage/NN intracranial/JJ
cocaine/NN administration/NN route/NN follow/VB indicate/VBP exceeds/VBZ stroke/NN frequency/NN hemorrhage/NN
cocaine/NN use/NN associated/VBN indicate/VBP exceeds/VBZ stroke/NN frequency/NN hemorrhage/NN intracranial/JJ
cocaine/NN use/NN associated/VBN indicate/VBP exceeds/VBZ stroke/NN frequency/NN hemorrhage/NN
cocaine/NN 5/CD stroke/NN frequency/NN hemorrhage/NN intracranial/JJ
cocaine/NN 5/CD stroke/NN frequency/NN hemorrhage/NN
cocaine/NN use/NN related/VBN incidence/NN stroke/NN
cocaine/NN use/NN related/VBN incidence/NN increasing/VBG indicate/VBP -/VBD occurs/VBZ stroke/NN
cocaine/NN use/NN related/VBN incidence/NN increasing/VBG indicate/VBP follow/VB stroke/NN
cocaine/NN use/NN related/VBN incidence/NN increasing/VBG indicate/VBP associated/VBN stroke/NN
cocaine/NN use/NN related/VBN incidence/NN increasing/VBG indicate/VBP exceeds/VBZ stroke/NN
cocaine/NN -/VBD indicate/VBP increasing/VBG incidence/NN stroke/NN
cocaine/NN -/VBD occurs/VBZ stroke/NN
cocaine/NN -/VBD indicate/VBP follow/VB stroke/NN
cocaine/NN -/VBD indicate/VBP associated/VBN stroke/NN
cocaine/NN -/VBD indicate/VBP exceeds/VBZ stroke/NN
cocaine/NN administration/NN route/NN follow/VB indicate/VBP increasing/VBG incidence/NN stroke/NN
cocaine/NN administration/NN route/NN follow/VB indicate/VBP -/VBD occurs/VBZ stroke/NN
cocaine/NN administration/NN route/NN follow/VB stroke/NN
cocaine/NN administration/NN route/NN follow/VB indicate/VBP associated/VBN stroke/NN
cocaine/NN administration/NN route/NN follow/VB indicate/VBP exceeds/VBZ stroke/NN
cocaine/NN use/NN associated/VBN indicate/VBP increasing/VBG incidence/NN stroke/NN
cocaine/NN use/NN associated/VBN indicate/VBP -/VBD occurs/VBZ stroke/NN
cocaine/NN use/NN associated/VBN indicate/VBP follow/VB stroke/NN
cocaine/NN use/NN associated/VBN stroke/NN
cocaine/NN use/NN associated/VBN indicate/VBP exceeds/VBZ stroke/NN
cocaine/NN 5/CD stroke/NN exceeds/VBZ indicate/VBP increasing/VBG incidence/NN stroke/NN
cocaine/NN 5/CD stroke/NN exceeds/VBZ indicate/VBP -/VBD occurs/VBZ stroke/NN
cocaine/NN 5/CD stroke/NN exceeds/VBZ indicate/VBP follow/VB stroke/NN
cocaine/NN 5/CD stroke/NN exceeds/VBZ indicate/VBP associated/VBN stroke/NN
cocaine/NN 5/CD stroke/NN
cocaine/NN use/NN related/VBN incidence/NN increasing/VBG indicate/VBP associated/VBN aneurysms/NNS intracranial/JJ
cocaine/NN use/NN related/VBN incidence/NN increasing/VBG indicate/VBP associated/VBN aneurysms/NNS
cocaine/NN -/VBD indicate/VBP associated/VBN aneurysms/NNS intracranial/JJ
cocaine/NN -/VBD indicate/VBP associated/VBN aneurysms/NNS
cocaine/NN administration/NN route/NN follow/VB indicate/VBP associated/VBN aneurysms/NNS intracranial/JJ
cocaine/NN administration/NN route/NN follow/VB indicate/VBP associated/VBN aneurysms/NNS
cocaine/NN use/NN associated/VBN aneurysms/NNS intracranial/JJ
cocaine/NN use/NN associated/VBN aneurysms/NNS
cocaine/NN 5/CD stroke/NN exceeds/VBZ indicate/VBP associated/VBN aneurysms/NNS intracranial/JJ
cocaine/NN 5/CD stroke/NN exceeds/VBZ indicate/VBP associated/VBN aneurysms/NNS
cocaine/NN use/NN related/VBN incidence/NN increasing/VBG indicate/VBP associated/VBN arteriovenous/VBZ
cocaine/NN use/NN related/VBN incidence/NN increasing/VBG indicate/VBP associated/VBN arteriovenous/VBZ malformations/NNS
cocaine/NN -/VBD indicate/VBP associated/VBN arteriovenous/VBZ
cocaine/NN -/VBD indicate/VBP associated/VBN arteriovenous/VBZ malformations/NNS
cocaine/NN administration/NN route/NN follow/VB indicate/VBP associated/VBN arteriovenous/VBZ
cocaine/NN administration/NN route/NN follow/VB indicate/VBP associated/VBN arteriovenous/VBZ malformations/NNS
cocaine/NN use/NN associated/VBN arteriovenous/VBZ
cocaine/NN use/NN associated/VBN arteriovenous/VBZ malformations/NNS
cocaine/NN 5/CD stroke/NN exceeds/VBZ indicate/VBP associated/VBN arteriovenous/VBZ
cocaine/NN 5/CD stroke/NN exceeds/VBZ indicate/VBP associated/VBN arteriovenous/VBZ malformations/NNS
99/CD mTc/NN induced/VBN infarction/NN myocardial/JJ
99/CD mTc/NN induced/VBN infarction/NN
mTc/NN induced/VBN infarction/NN myocardial/JJ
mTc/NN induced/VBN infarction/NN
glucarate/RB detection/NN mTc/NN induced/VBN infarction/NN myocardial/JJ
glucarate/RB detection/NN mTc/NN induced/VBN infarction/NN
isoproterenol/NN obtained/VBN implies/VBZ model/NN used/VBN produce/VB infarction/NN
glucaric/JJ acid/NN based/VBN radiopharmaceutical/NN infarct/NN
acid/NN based/VBN radiopharmaceutical/NN infarct/NN
99/CD mTc/NN induced/VBN infarction/NN myocardial/JJ
99/CD mTc/NN induced/VBN infarction/NN
mTc/NN induced/VBN infarction/NN myocardial/JJ
mTc/NN induced/VBN infarction/NN
glucarate/NN easy/JJ mTc/NN induced/VBN infarction/NN myocardial/JJ
glucarate/NN easy/JJ mTc/NN induced/VBN infarction/NN
isoproterenol/JJ administration/NN developed/VBD h/NN infarct/JJ
bromocriptine/JJ treatment/NN prolactinomas/NNS
bromocriptine/NN effects/NNS clarify/VB cells/NNS prolactinoma/NN
bromocriptine/NN effects/NNS clarify/VB applied/VBN induced/VBN h/NN cells/NNS prolactinoma/NN
bromocriptine/NN injection/NN applied/VBN clarify/VB cells/NNS prolactinoma/NN
bromocriptine/NN injection/NN applied/VBN induced/VBN h/NN cells/NNS prolactinoma/NN
bromocriptine/JJ treatment/NN cells/NNS adenoma/NN
venlafaxine/NN overdose/NN took/VBD woman/NN depression/NN major/JJ
venlafaxine/NN overdose/NN took/VBD woman/NN depression/NN
Ketoconazole/NNP induced/VBN sequelae/NN neurologic/JJ
Ketoconazole/NNP induced/VBN sequelae/NN
gum/NNP Arabic/NNP nephrotoxicity/NN
Arabic/NNP nephrotoxicity/NN
gentamicin/NN nephrotoxicity/NN
gum/NN rats/NNS treatment/NN effect/NN assessed/VBD Arabic/NNP failure/NN induced/VBN gentamicin/NN nephrotoxicity/RB
Arabic/NNP failure/NN induced/VBN gentamicin/NN nephrotoxicity/RB
gentamicin/NN nephrotoxicity/RB
GM/NNP gentamicin/NN nephrotoxicity/RB
glutathione/NN plasma/NN measuring/VBG assessed/VBN Nephrotoxicity/NNP
GSH/NNP glutathione/NN plasma/NN measuring/VBG assessed/VBN Nephrotoxicity/NNP
urea/NN creatinine/NN concentrations/NNS measuring/VBG assessed/VBN Nephrotoxicity/NNP
creatinine/NN concentrations/NNS measuring/VBG assessed/VBN Nephrotoxicity/NNP
GSH/NNP that/DT decreased/VBD %/NN GM/NNP necrosis/NNS tubular/JJ
GSH/NNP that/DT decreased/VBD %/NN GM/NNP necrosis/NNS
urea/NN creatinine/NN increased/VBD gum/NN indicated/VBD decreased/VBD %/NN GM/NNP necrosis/NNS tubular/JJ
urea/NN creatinine/NN increased/VBD gum/NN indicated/VBD decreased/VBD %/NN GM/NNP necrosis/NNS
GM/NNP Arabic/NNP increased/VBD gum/NN indicated/VBD decreased/VBD %/NN GM/NNP necrosis/NNS tubular/JJ
GM/NNP Arabic/NNP increased/VBD gum/NN indicated/VBD decreased/VBD %/NN GM/NNP necrosis/NNS
GM/NNP cellulose/NNP treated/VBN rats/NNS compared/VBN gum/NN indicated/VBD decreased/VBD %/NN GM/NNP necrosis/NNS tubular/JJ
GM/NNP cellulose/NNP treated/VBN rats/NNS compared/VBN gum/NN indicated/VBD decreased/VBD %/NN GM/NNP necrosis/NNS
GM/NNP cellulose/NNP group/NN %/NN %/NN GM/NNP necrosis/NNS tubular/JJ
GM/NNP cellulose/NNP group/NN %/NN %/NN GM/NNP necrosis/NNS
GM/NNP necrosis/NNS tubular/JJ
GM/NNP necrosis/NNS
GM/NNP given/VBN rats/NNS severe/JJ appeared/VBN necrosis/NNS tubular/JJ
GM/NNP given/VBN rats/NNS severe/JJ appeared/VBN necrosis/NNS
GM/NNP than/IN severe/JJ appeared/VBN necrosis/NNS tubular/JJ
GM/NNP than/IN severe/JJ appeared/VBN necrosis/NNS
creatinine/NN increased/VBD gum/NN indicated/VBD decreased/VBD %/NN GM/NNP necrosis/NNS tubular/JJ
creatinine/NN increased/VBD gum/NN indicated/VBD decreased/VBD %/NN GM/NNP necrosis/NNS
gum/NN indicated/VBD decreased/VBD %/NN GM/NNP necrosis/NNS tubular/JJ
gum/NN indicated/VBD decreased/VBD %/NN GM/NNP necrosis/NNS
Arabic/NNP increased/VBD gum/NN indicated/VBD decreased/VBD %/NN GM/NNP necrosis/NNS tubular/JJ
Arabic/NNP increased/VBD gum/NN indicated/VBD decreased/VBD %/NN GM/NNP necrosis/NNS
gum/NNP Arabic/NNP given/VBN rats/NNS severe/JJ appeared/VBN necrosis/NNS tubular/JJ
gum/NNP Arabic/NNP given/VBN rats/NNS severe/JJ appeared/VBN necrosis/NNS
Arabic/NNP given/VBN rats/NNS severe/JJ appeared/VBN necrosis/NNS tubular/JJ
Arabic/NNP given/VBN rats/NNS severe/JJ appeared/VBN necrosis/NNS
gum/NN treatment/NN induced/VBN nephrotoxicity/RB
Arabic/JJ treatment/NN induced/VBN nephrotoxicity/RB
GM/NNP indices/NNS some/DT amelioration/NN induced/VBN nephrotoxicity/RB
everolimus/NNS associated/JJ neuritis/NNS brachial/JJ
everolimus/NNS associated/JJ neuritis/NNS
aminophylline/NN threshold/NN initiating/VBG failure/NN respiratory/JJ
aminophylline/NN threshold/NN initiating/VBG failure/NN
aminophylline/NN threshold/NN threshold/NN' failure/NN respiratory/JJ
aminophylline/NN threshold/NN threshold/NN' failure/NN
PO/NNP oxygen/NN pressures/NNS kept/VBN reduced/VBN threshold/NN ventricular/NN
PO/NNP oxygen/NN pressures/NNS kept/VBN reduced/VBN threshold/NN fibrillation/NN
2/CD PO/NNP oxygen/NN pressures/NNS kept/VBN reduced/VBN threshold/NN ventricular/NN
2/CD PO/NNP oxygen/NN pressures/NNS kept/VBN reduced/VBN threshold/NN fibrillation/NN
carbon/NN dioxide/NN oxygen/NN pressures/NNS kept/VBN reduced/VBN threshold/NN ventricular/NN
carbon/NN dioxide/NN oxygen/NN pressures/NNS kept/VBN reduced/VBN threshold/NN fibrillation/NN
dioxide/NN oxygen/NN pressures/NNS kept/VBN reduced/VBN threshold/NN ventricular/NN
dioxide/NN oxygen/NN pressures/NNS kept/VBN reduced/VBN threshold/NN fibrillation/NN
CO/CD 2/CD oxygen/NN pressures/NNS kept/VBN reduced/VBN threshold/NN ventricular/NN
CO/CD 2/CD oxygen/NN pressures/NNS kept/VBN reduced/VBN threshold/NN fibrillation/NN
2/CD oxygen/NN pressures/NNS kept/VBN reduced/VBN threshold/NN ventricular/NN
2/CD oxygen/NN pressures/NNS kept/VBN reduced/VBN threshold/NN fibrillation/NN
oxygen/NN pressures/NNS kept/VBN reduced/VBN threshold/NN ventricular/NN
oxygen/NN pressures/NNS kept/VBN reduced/VBN threshold/NN fibrillation/NN
aminophylline/NN infusion/NN resulted/VBD produced/VBN failure/NN respiratory/JJ
aminophylline/NN infusion/NN resulted/VBD produced/VBN failure/NN
aminophylline/NN infusion/NN resulted/VBD produced/VBN hypoventilation/NN
aminophylline/JJ agents/NNS play/VB contribute/VB incidence/NN arrhythmias/NNS failure/NN respiratory/JJ
aminophylline/JJ agents/NNS play/VB contribute/VB incidence/NN arrhythmias/NNS failure/NN
aminophylline/JJ agents/NNS play/VB contribute/VB incidence/NN arrhythmias/NNS ventricular/NN
aminophylline/JJ agents/NNS play/VB contribute/VB incidence/NN arrhythmias/NNS
tranexamic/JJ acid/NN containing/VBG sealants/NNS application/NN seizures/NNS Epileptic/JJ
tranexamic/JJ acid/NN containing/VBG sealants/NNS application/NN seizures/NNS
acid/NN containing/VBG sealants/NNS application/NN seizures/NNS Epileptic/JJ
acid/NN containing/VBG sealants/NNS application/NN seizures/NNS
tAMCA/NN shown/VBN cause/VB seizures/NNS epileptic/JJ
tAMCA/NN shown/VBN cause/VB seizures/NNS
octreotide/NN analog/NN function/NN patients/NNS acromegalic/JJ
octreotide/NN day/NN 2/CD 13/CD somatostatin/NN injection/NN treated/VBN acromegaly/NN
octreotide/JJ therapy/NN cholecystitis/NNS
octreotide/JJ therapy/NN patients/NNS acromegalic/JJ
octreotide/NN therapy/NN patients/NNS acromegalic/JJ
timolol/JJ 0/CD treated/CD glaucomatous/NNS
betaxolol/NN less/JJR depression/NN
Triazolam/NNP induced/VBN patient/NN depressed/JJ
triazolam/NN doses/NNS induced/VBN woman/NN depressed/JJ
atropine/JJ glycopyrrolate/JJ i/FW Comparison/NNP bradycardia/NN
suxamethonium/NN doses/NNS Comparison/NNP bradycardia/NN arrhythmias/NNS
glycopyrrolate/JJ i/FW Comparison/NNP bradycardia/NN arrhythmias/NNS
atropine/JJ glycopyrrolate/JJ i/FW Comparison/NNP bradycardia/NN arrhythmias/NNS
glycopyrrolate/JJ i/FW Comparison/NNP bradycardia/NN
atropine/JJ 1/CD administration/NN effectiveness/NN micrograms/VBZ studied/VBN prevent/VB arrhythmia/NN bradycardia/NN
suxamethonium/NN doses/NNS arrhythmia/NN
glycopyrrolate/JJ kg/NN administration/NN effectiveness/NN micrograms/VBZ studied/VBN prevent/VB arrhythmia/NN
atropine/JJ 1/CD administration/NN effectiveness/NN micrograms/VBZ studied/VBN prevent/VB arrhythmia/NN
glycopyrrolate/JJ kg/NN administration/NN effectiveness/NN micrograms/VBZ studied/VBN prevent/VB arrhythmia/NN bradycardia/NN
phenytoin/NN treatment/NN due/JJ psychosis/VBZ Acute/NNP
phenytoin/NN treatment/NN due/JJ psychosis/VBZ
phenytoin/NN treatment/NN neuralgia/NN trigeminal/JJ
phenytoin/NN treatment/NN neuralgia/NN
phenytoin/NN treatment/NN psychosis/NNS
phenytoin/NN treatment/NN occur/VBP symptoms/NNS result/NN unrelated/JJ seizures/NNS
phenytoin/NN treatment/NN patients/NNS epileptic/JJ
phenytoin/NN treatment/NN occur/VBP symptoms/NNS psychotic/JJ
phenytoin/NN treatment/NN occur/VBP symptoms/NNS
sulpiride/VB reported/VBN dyskinesia/NN parkinsonism/NN
sulpiride/VB reported/VBN dyskinesia/NN tardive/NN
sulpiride/VB reported/VBN dyskinesia/NN
chloroacetaldehyde/NN metabolite/NN indicating/VBG carried/VBN elucidate/VB development/NN cystitis/NNS hemorrhagic/JJ
chloroacetaldehyde/NN metabolite/NN indicating/VBG carried/VBN elucidate/VB development/NN cystitis/NNS
CAA/NNP chloroacetaldehyde/NN metabolite/NN indicating/VBG carried/VBN elucidate/VB development/NN cystitis/NNS hemorrhagic/JJ
CAA/NNP chloroacetaldehyde/NN metabolite/NN indicating/VBG carried/VBN elucidate/VB development/NN cystitis/NNS
CAA/NNP role/NN elucidate/VB development/NN cystitis/NNS hemorrhagic/JJ
CAA/NNP role/NN elucidate/VB development/NN cystitis/NNS
CAA/NNP contribute/VB damage/NN bladder/NN
CAA/NNP contribute/VB damage/NN
methotrexate/NN nitrogranulogen/NN drugs/NNS action/NN nephrotoxic/JJ
MTX/NNP methotrexate/NN nitrogranulogen/NN drugs/NNS action/NN nephrotoxic/JJ
MTX/NNP +/NNP or/CC administered/VBN action/NN nephrotoxic/JJ
cyclophosphamide/NN nitrogranulogen/NN drugs/NNS action/NN nephrotoxic/JJ
CY/NNP cyclophosphamide/NN nitrogranulogen/NN drugs/NNS action/NN nephrotoxic/JJ
CY/NNP -RSB-/NNP evaluated/VBN action/NN nephrotoxic/JJ
nitrogranulogen/NN drugs/NNS action/NN nephrotoxic/JJ
NG/NNP nitrogranulogen/NN drugs/NNS action/NN nephrotoxic/JJ
5/CD nitrogranulogen/NN drugs/NNS action/NN nephrotoxic/JJ
fluorouracil/JJ 5/CD nitrogranulogen/NN drugs/NNS action/NN nephrotoxic/JJ
5/CD fluorouracil/JJ 5/CD nitrogranulogen/NN drugs/NNS action/NN nephrotoxic/JJ
FU/NNP 5/CD fluorouracil/JJ 5/CD nitrogranulogen/NN drugs/NNS action/NN nephrotoxic/JJ
5/CD +/NNP or/CC administered/VBN action/NN nephrotoxic/JJ
FU/NNP -RSB-/NNP evaluated/VBN action/NN nephrotoxic/JJ
5/CD combined/VBN cause/VB caused/VBD cystitis/NNS hemorrhagic/JJ
5/CD combined/VBN cause/VB caused/VBD cystitis/NNS
FU/NNP 5/CD combined/VBN cause/VB caused/VBD cystitis/NNS hemorrhagic/JJ
FU/NNP 5/CD combined/VBN cause/VB caused/VBD cystitis/NNS
MTX/NNP FU/NNP 5/CD combined/VBN cause/VB caused/VBD cystitis/NNS hemorrhagic/JJ
MTX/NNP FU/NNP 5/CD combined/VBN cause/VB caused/VBD cystitis/NNS
CY/NNP caused/VBD cystitis/NNS hemorrhagic/JJ
CY/NNP caused/VBD cystitis/NNS
MTX/NNP +/NNP nephrotoxicity/NN
CY/NNP monotherapy/NN indicate/VBP nephrotoxicity/NN
5/CD +/NNP nephrotoxicity/NN
FU/NNP CY/NNP monotherapy/NN indicate/VBP nephrotoxicity/NN
amphotericin/NNP B/NNP coccidioidomycosis/NNS
B/NNP coccidioidomycosis/NNS
AmB/NNP B/NNP coccidioidomycosis/NNS
posaconazole/NN resolved/VBN abnormalities/NN failure/NN heart/NN
posaconazole/NN resolved/VBN abnormalities/NN failure/NN
AmB/NNP toxicity/NN
oxygen/NN increase/NN result/VB infarction/NN acute/JJ
oxygen/NN increase/NN result/VB infarction/NN myocardial/JJ
oxygen/NN increase/NN result/VB infarction/NN
cocaine/NN locus/NNS remains/VBZ circumstantial/JJ regard/NN spasm/NN
cocaine/NN effect/NN thrombotic/JJ
calcium/NN blocker/NN discontinuation/NN showed/VBD patients/NNS signs/NNS neurotoxicity/NN
methylphenidate/JJ intake/NN reported/VBN stroke/NN ischaemic/JJ
methylphenidate/JJ intake/NN reported/VBN stroke/NN
methylphenidate/JJ intake/NN reported/VBN documented/VBN vasculitis/NNS associated/VBN abuse/NN amphetamine/JJ
methylphenidate/JJ intake/NN reported/VBN documented/VBN vasculitis/NNS associated/VBN abuse/NN
methylphenidate/NN treated/VBN suffered/VBN strokes/NNS ischaemic/JJ
methylphenidate/NN treated/VBN suffered/VBN strokes/NNS
methylphenidate/NN hyperactivity/JJ
methylphenidate/JJ vasculitis/NNS
methylphenidate/JJ therapy/NN history/NN patients/NNS considered/VBN vasculitis/NNS
Antithymocyte/JJ globulin/NN induced/VBN anemia/NN aplastic/JJ
Antithymocyte/JJ globulin/NN induced/VBN anemia/NN
globulin/NN induced/VBN anemia/NN aplastic/JJ
globulin/NN induced/VBN anemia/NN
antithymocyte/JJ therapy/NN anemia/NN aplastic/JJ
antithymocyte/JJ therapy/NN anemia/NN
globulin/NN therapy/NN anemia/NN aplastic/JJ
globulin/NN therapy/NN anemia/NN
antithymocyte/JJ globulin/NN Use/NN treatment/NN D/NNP induced/VBN anemia/NN aplastic/JJ
antithymocyte/JJ globulin/NN Use/NN treatment/NN D/NNP induced/VBN anemia/NN
globulin/NN Use/NN treatment/NN D/NNP induced/VBN anemia/NN aplastic/JJ
globulin/NN Use/NN treatment/NN D/NNP induced/VBN anemia/NN
adriamycin/NN Effect/NN induced/VBN nephropathy/RB
enalapril/NN effect/NN assessed/VBN Munich/NNP rats/NNS nephrosis/NNS
enalapril/NN reduced/VBD reducing/VBG albuminuria/NN
enalapril/NN effect/NN assess/VB progression/NN injury/NN renal/JJ
enalapril/NN effect/NN assess/VB progression/NN injury/NN
enalapril/NN effect/NN assess/VB nephrosis/NNS
adriamycin/NN nephrosis/NNS assess/VB progression/NN injury/NN renal/JJ
adriamycin/NN nephrosis/NNS assess/VB progression/NN injury/NN
enalapril/JJ treatment/NN reduced/VBD reducing/VBG albuminuria/NN
sulphasalazine/NN arthritis/NN rheumatoid/JJ
sulphasalazine/NN arthritis/NN
levodopa/NN dyskinesias/NNS monkeys/NNS parkinsonian/NN
Levodopa/NNP induced/VBN present/VB problem/NN patients/NNS long/JJ management/NN disease/NN Parkinson/NNP
Levodopa/NNP induced/VBN present/VB problem/NN patients/NNS long/JJ management/NN disease/NN Parkinson/NNP '/POS
Levodopa/NNP induced/VBN present/VB problem/NN patients/NNS long/JJ management/NN disease/NN s/JJ
Levodopa/NNP induced/VBN present/VB problem/NN patients/NNS long/JJ management/NN disease/NN
Levodopa/NNP induced/VBN present/VB problem/NN patients/NNS long/JJ management/NN disease/NN PD/NNP
MPTP/NNP types/NNS Using/VBG parkinsonism/NN study/NN evaluated/VBN degree/NN involved/VBN development/NN LIDs/NNP
levodopa/NN therapy/NN duration/NN progression/NN rate/NN involved/VBN degree/NN evaluated/VBN study/NN parkinsonism/NN
MPTP/NNP exposure/NN Monkeys/NNS developed/VBD dyskinesia/NN
MPTP/NN exposure/NN monkeys/NNS resistant/JJ LIDs/NNS
MPTP/NN exposure/NN monkeys/NNS resistant/JJ LIDs/NNS e/NNP developed/VBD dyskinesia/NN
Dipyridamole/NNP induced/VBN ischemia/NN myocardial/JJ
Dipyridamole/NNP induced/VBN ischemia/NN
dipyridamole/NN therapy/NN effect/NN reported/VBN demonstrated/VBN occur/VB disease/NN coronary/JJ
dipyridamole/NN therapy/NN effect/NN reported/VBN demonstrated/VBN occur/VB disease/NN artery/NN
dipyridamole/NN therapy/NN effect/NN reported/VBN demonstrated/VBN occur/VB disease/NN
dipyridamole/NN demonstrated/VBN occur/VB disease/NN coronary/JJ
dipyridamole/NN demonstrated/VBN occur/VB disease/NN artery/NN
dipyridamole/NN demonstrated/VBN occur/VB disease/NN
dipyridamole/NN therapy/NN effect/NN reported/VBN demonstrated/VBN dipyridamole/NN ischemia/NN myocardial/JJ
dipyridamole/NN therapy/NN effect/NN reported/VBN demonstrated/VBN dipyridamole/NN ischemia/NN
dipyridamole/NN ischemia/NN myocardial/JJ
dipyridamole/NN ischemia/NN
dipyridamole/NN mechanism/NN demonstrated/VBN observed/VBD ischemia/NNP
levodopa/NN effect/NN reflect/VB incidence/NN haemorrhage/NN cause/NN death/NN
noradrenaline/NN levels/NNS reflect/VB incidence/NN haemorrhage/NN cause/NN death/NN patients/NNS disease/NN Parkinson/NNP
noradrenaline/NN levels/NNS reflect/VB incidence/NN haemorrhage/NN cause/NN death/NN patients/NNS disease/NN Parkinson/NNP '/POS
noradrenaline/NN levels/NNS reflect/VB incidence/NN haemorrhage/NN cause/NN death/NN patients/NNS disease/NN s/JJ
noradrenaline/NN levels/NNS reflect/VB incidence/NN haemorrhage/NN cause/NN death/NN patients/NNS disease/NN
noradrenaline/NN levels/NNS brain/NN parkinsonian/NN
levodopa/NN effect/NN reflect/VB incidence/NN haemorrhage/NN cause/NN death/NN patients/NNS disease/NN Parkinson/NNP
levodopa/NN effect/NN reflect/VB incidence/NN haemorrhage/NN cause/NN death/NN patients/NNS disease/NN Parkinson/NNP '/POS
levodopa/NN effect/NN reflect/VB incidence/NN haemorrhage/NN cause/NN death/NN patients/NNS disease/NN s/JJ
levodopa/NN effect/NN reflect/VB incidence/NN haemorrhage/NN cause/NN death/NN patients/NNS disease/NN
levodopa/NN effect/NN reflect/VB levels/NNS brain/NN parkinsonian/NN
noradrenaline/NN levels/NNS reflect/VB effect/NN hypotensive/JJ
noradrenaline/NN levels/NNS reflect/VB effect/NN levodopa/NN mechanism/NN hypotensive/JJ
noradrenaline/NN levels/NNS reflect/VB incidence/NN haemorrhage/NN cause/NN death/NN
levodopa/NN effect/NN reflect/VB incidence/NN haemorrhage/NN cerebral/JJ
levodopa/NN effect/NN reflect/VB incidence/NN haemorrhage/NN
noradrenaline/NN levels/NNS reflect/VB incidence/NN haemorrhage/NN cerebral/JJ
noradrenaline/NN levels/NNS reflect/VB incidence/NN haemorrhage/NN
adriamycin/NN Effect/NN combined/VBD tissues/NNS tumor/NN
adriamycin/NN Effect/NN combined/VBD hyperthermia/NN
Adriamycin/NNP enhancement/NN mediated/VBN activity/NN toxicities/NNS
Adriamycin/NNP enhancement/NN mediated/VBN hyperthermia/NN
Adriamycin/NNP enhanced/VBD hyperthermia/NN
Adriamycin/NNP enhances/VBZ increased/VBN toxicity/NN
Adriamycin/NNP enhances/VBZ hyperthermia/NN
riboflavin/NN thiamine/NN deficiency/NN nutritional/JJ
riboflavin/NN thiamine/NN deficiency/NN
thiamine/NN deficiency/NN nutritional/JJ
thiamine/NN deficiency/NN
Isoniazid/NNP agent/NN neuropathy/NN
Vitamin/NNP D/NNP toxicity/NN
D/NNP toxicity/NN
3/CD toxicity/NN
vitamin/NN D/NNP treated/VBN cows/NNS None/NN showed/VBD signs/NNS fever/NN milk/NN
vitamin/NN D/NNP treated/VBN cows/NNS None/NN showed/VBD signs/NNS fever/NN
D/NNP treated/VBN cows/NNS None/NN showed/VBD signs/NNS fever/NN milk/NN
D/NNP treated/VBN cows/NNS None/NN showed/VBD signs/NNS fever/NN
3/CD D/NNP treated/VBN cows/NNS None/NN showed/VBD signs/NNS fever/NN milk/NN
3/CD D/NNP treated/VBN cows/NNS None/NN showed/VBD signs/NNS fever/NN
vitamin/NN D/NNP treated/VBN cows/NNS None/NN showed/VBD developed/VBD signs/NNS fever/NN milk/NN
vitamin/NN D/NNP treated/VBN cows/NNS None/NN showed/VBD developed/VBD signs/NNS fever/NN
D/NNP treated/VBN cows/NNS None/NN showed/VBD developed/VBD signs/NNS fever/NN milk/NN
D/NNP treated/VBN cows/NNS None/NN showed/VBD developed/VBD signs/NNS fever/NN
3/CD D/NNP treated/VBN cows/NNS None/NN showed/VBD developed/VBD signs/NNS fever/NN milk/NN
3/CD D/NNP treated/VBN cows/NNS None/NN showed/VBD developed/VBD signs/NNS fever/NN
vitamin/NNP toxicity/NNP
D/NNP toxicity/NNP
3/NNP toxicity/NNP
vitamin/NNP toxicity/NNP Signs/NNS observed/VBN developed/VBD died/VBD signs/NNS D/NNP toxicity/NN
D/NNP toxicity/NNP Signs/NNS observed/VBN developed/VBD died/VBD signs/NNS D/NNP toxicity/NN
3/NNP toxicity/NNP Signs/NNS observed/VBN developed/VBD died/VBD signs/NNS D/NNP toxicity/NN
vitamin/NNP D/NNP signs/NNS died/VBD developed/VBD observed/VBN Signs/NNS toxicity/NNP
D/NNP signs/NNS died/VBD developed/VBD observed/VBN Signs/NNS toxicity/NNP
3/CD toxicity/NN D/NNP signs/NNS died/VBD developed/VBD observed/VBN Signs/NNS toxicity/NNP
vitamin/NNP D/NNP toxicity/NN
D/NNP toxicity/NN
3/CD toxicity/NN
vitamin/NN toxicity/NN
D/NNP toxicity/NN
3/CD D/NNP toxicity/NN
vitamin/NN D/NNP doses/NNS safety/NN margin/NN cows/NNS D/NNP toxicity/NN
D/NNP doses/NNS safety/NN margin/NN cows/NNS D/NNP toxicity/NN
3/CD D/NNP doses/NNS safety/NN margin/NN cows/NNS D/NNP toxicity/NN
vitamin/CD cannot/NN used/VBN concluded/VBD D/NNP toxicity/NN
D/NNP cannot/NN used/VBN concluded/VBD D/NNP toxicity/NN
3/CD cannot/NN used/VBN concluded/VBD D/NNP toxicity/NN
vitamin/NN toxicity/NN D/NNP cows/NNS margin/NN prevent/VBP fever/NN milk/NN
vitamin/NN toxicity/NN D/NNP cows/NNS margin/NN prevent/VBP fever/NN
D/NNP cows/NNS margin/NN prevent/VBP fever/NN milk/NN
D/NNP cows/NNS margin/NN prevent/VBP fever/NN
3/CD D/NNP cows/NNS margin/NN prevent/VBP fever/NN milk/NN
3/CD D/NNP cows/NNS margin/NN prevent/VBP fever/NN
vitamin/NN toxicity/NN D/NNP doses/NNS induce/VB fever/NN milk/NN
vitamin/NN toxicity/NN D/NNP doses/NNS induce/VB fever/NN
D/NNP doses/NNS induce/VB fever/NN milk/NN
D/NNP doses/NNS induce/VB fever/NN
3/CD D/NNP doses/NNS induce/VB fever/NN milk/NN
3/CD D/NNP doses/NNS induce/VB fever/NN
vitamin/NN toxicity/NN D/NNP concluded/VBD used/VBN prevent/VB fever/NN milk/NN
vitamin/NN toxicity/NN D/NNP concluded/VBD used/VBN prevent/VB fever/NN
D/NNP concluded/VBD used/VBN prevent/VB fever/NN milk/NN
D/NNP concluded/VBD used/VBN prevent/VB fever/NN
3/CD D/NNP concluded/VBD used/VBN prevent/VB fever/NN milk/NN
3/CD D/NNP concluded/VBD used/VBN prevent/VB fever/NN
vitamin/NN D/NNP doses/NNS safety/NN margin/NN prevent/VBP fever/NN milk/NN
vitamin/NN D/NNP doses/NNS safety/NN margin/NN prevent/VBP fever/NN
D/NNP doses/NNS safety/NN margin/NN prevent/VBP fever/NN milk/NN
D/NNP doses/NNS safety/NN margin/NN prevent/VBP fever/NN
3/CD D/NNP doses/NNS safety/NN margin/NN prevent/VBP fever/NN milk/NN
3/CD D/NNP doses/NNS safety/NN margin/NN prevent/VBP fever/NN
vitamin/NN D/NNP doses/NNS safety/NN margin/NN cows/NNS D/NNP doses/NNS induce/VB fever/NN milk/NN
vitamin/NN D/NNP doses/NNS safety/NN margin/NN cows/NNS D/NNP doses/NNS induce/VB fever/NN
D/NNP doses/NNS safety/NN margin/NN cows/NNS D/NNP doses/NNS induce/VB fever/NN milk/NN
D/NNP doses/NNS safety/NN margin/NN cows/NNS D/NNP doses/NNS induce/VB fever/NN
3/CD D/NNP doses/NNS safety/NN margin/NN cows/NNS D/NNP doses/NNS induce/VB fever/NN milk/NN
3/CD D/NNP doses/NNS safety/NN margin/NN cows/NNS D/NNP doses/NNS induce/VB fever/NN
vitamin/NN D/NNP doses/NNS safety/NN margin/NN cows/NNS D/NNP concluded/VBD used/VBN prevent/VB fever/NN milk/NN
vitamin/NN D/NNP doses/NNS safety/NN margin/NN cows/NNS D/NNP concluded/VBD used/VBN prevent/VB fever/NN
D/NNP doses/NNS safety/NN margin/NN cows/NNS D/NNP concluded/VBD used/VBN prevent/VB fever/NN milk/NN
D/NNP doses/NNS safety/NN margin/NN cows/NNS D/NNP concluded/VBD used/VBN prevent/VB fever/NN
3/CD D/NNP doses/NNS safety/NN margin/NN cows/NNS D/NNP concluded/VBD used/VBN prevent/VB fever/NN milk/NN
3/CD D/NNP doses/NNS safety/NN margin/NN cows/NNS D/NNP concluded/VBD used/VBN prevent/VB fever/NN
vitamin/CD cannot/NN used/VBN concluded/VBD D/NNP cows/NNS margin/NN prevent/VBP fever/NN milk/NN
vitamin/CD cannot/NN used/VBN concluded/VBD D/NNP cows/NNS margin/NN prevent/VBP fever/NN
D/NNP cannot/NN used/VBN concluded/VBD D/NNP cows/NNS margin/NN prevent/VBP fever/NN milk/NN
D/NNP cannot/NN used/VBN concluded/VBD D/NNP cows/NNS margin/NN prevent/VBP fever/NN
3/CD cannot/NN used/VBN concluded/VBD D/NNP cows/NNS margin/NN prevent/VBP fever/NN milk/NN
3/CD cannot/NN used/VBN concluded/VBD D/NNP cows/NNS margin/NN prevent/VBP fever/NN
vitamin/CD cannot/NN used/VBN concluded/VBD D/NNP doses/NNS induce/VB fever/NN milk/NN
vitamin/CD cannot/NN used/VBN concluded/VBD D/NNP doses/NNS induce/VB fever/NN
D/NNP cannot/NN used/VBN concluded/VBD D/NNP doses/NNS induce/VB fever/NN milk/NN
D/NNP cannot/NN used/VBN concluded/VBD D/NNP doses/NNS induce/VB fever/NN
3/CD cannot/NN used/VBN concluded/VBD D/NNP doses/NNS induce/VB fever/NN milk/NN
3/CD cannot/NN used/VBN concluded/VBD D/NNP doses/NNS induce/VB fever/NN
vitamin/CD cannot/NN used/VBN prevent/VB fever/NN milk/NN
vitamin/CD cannot/NN used/VBN prevent/VB fever/NN
D/NNP cannot/NN used/VBN prevent/VB fever/NN milk/NN
D/NNP cannot/NN used/VBN prevent/VB fever/NN
3/CD cannot/NN used/VBN prevent/VB fever/NN milk/NN
3/CD cannot/NN used/VBN prevent/VB fever/NN
atropine/NN administration/NN Pro/NNP pre/NN abolished/VBN increases/NNS
atropine/NN administration/NN Pro/NNP pre/NN abolished/VBN increases/NNS flow/NN in/IN
atropine/NN administration/NN Pro/NNP pre/NN abolished/VBN increases/NNS flow/NN dural/JJ
atropine/NN administration/NN Pro/NNP pre/NN abolished/VBN increases/NNS flow/NN blood/NN
atropine/NN administration/NN Pro/NNP pre/NN abolished/VBN increases/NNS flow/NN
thyroxine/JJ abuse/NN considered/VBN reminds/VBZ illustrates/VBZ derangements/NNS function/NN seen/VBN eating/VBG
thyroxine/JJ abuse/NN considered/VBN reminds/VBZ illustrates/VBZ derangements/NNS function/NN seen/VBN eating/VBG disorders/NNS
ketoconazole/JJ treatment/NN associated/VBN deaths/NNS
bradykinin/JJ receptors/NNS activation/NN Role/NNP barrier/NN hypertension/NN
bradykinin/NN release/NN role/NN barrier/NN hypertension/NN
Hoe/NN vehicle/NN treated/VBN rats/NNS induced/VBN hypertension/NN
140/CD microM/NN vehicle/NN treated/VBN rats/NNS induced/VBN hypertension/NN
dextran/NN labeled/VBN quantitated/VBN induced/VBN hypertension/NN
bradykinin/NN release/NN related/VBN barrier/NN hypertension/NN
ketoconazole/NN taking/VBG developed/VBD disease/NN coronary/JJ
ketoconazole/NN taking/VBG developed/VBD disease/NN artery/NN
ketoconazole/NN taking/VBG developed/VBD disease/NN
ketoconazole/NN taking/VBG treatment/NN infection/NN fungal/JJ
ketoconazole/NN taking/VBG treatment/NN infection/NN
phenylephrine/NN Reversal/VB patients/NNS infarction/NN acute/JJ
phenylephrine/NN Reversal/VB patients/NNS infarction/NN myocardial/JJ
phenylephrine/NN Reversal/VB patients/NNS infarction/NN
nitroglycerin/NN effects/NNS phenylephrine/NN Reversal/VB patients/NNS infarction/NN acute/JJ
nitroglycerin/NN effects/NNS phenylephrine/NN Reversal/VB patients/NNS infarction/NN myocardial/JJ
nitroglycerin/NN effects/NNS phenylephrine/NN Reversal/VB patients/NNS infarction/NN
Nitroglycerin/NNP shown/VBN reduce/VB ST/NNP elevation/NN infarction/NN acute/JJ
Nitroglycerin/NNP shown/VBN reduce/VB ST/NNP elevation/NN infarction/NN myocardial/JJ
Nitroglycerin/NNP shown/VBN reduce/VB ST/NNP elevation/NN infarction/NN
nitroglycerin/NN reverse/VB agents/NNS potentiated/VBN elevation/NN infarction/NN acute/JJ
nitroglycerin/NN reverse/VB agents/NNS potentiated/VBN elevation/NN infarction/NN myocardial/JJ
nitroglycerin/NN reverse/VB agents/NNS potentiated/VBN elevation/NN infarction/NN
nitroglycerin/NN received/VBD patients/NNS infarctions/NNS myocardial/NN
nitroglycerin/NN received/VBD patients/NNS infarctions/NNS
phenylephrine/NN addition/NN beneficial/JJ treatment/NN patients/NNS infarction/NN acute/JJ
phenylephrine/NN addition/NN beneficial/JJ treatment/NN patients/NNS infarction/NN myocardial/JJ
phenylephrine/NN addition/NN beneficial/JJ treatment/NN patients/NNS infarction/NN
nitroglycerin/NN phenylephrine/NN addition/NN beneficial/JJ treatment/NN patients/NNS infarction/NN acute/JJ
nitroglycerin/NN phenylephrine/NN addition/NN beneficial/JJ treatment/NN patients/NNS infarction/NN myocardial/JJ
nitroglycerin/NN phenylephrine/NN addition/NN beneficial/JJ treatment/NN patients/NNS infarction/NN
zidovudine/NN toxicity/NN
vitamin/NN B/NNP role/NN supplementation/NN preventing/VBG toxicity/NN
B/NNP role/NN supplementation/NN preventing/VBG toxicity/NN
12/CD B/NNP role/NN supplementation/NN preventing/VBG toxicity/NN
folinic/JJ supplementation/NN preventing/VBG toxicity/NN
acid/JJ supplementation/NN preventing/VBG toxicity/NN
folinic/JJ supplementation/NN preventing/VBG zidovudine/NN suppression/NN bone/NN
folinic/JJ supplementation/NN preventing/VBG zidovudine/NN suppression/NN marrow/NN
folinic/JJ supplementation/NN preventing/VBG zidovudine/NN suppression/NN
acid/JJ supplementation/NN preventing/VBG zidovudine/NN suppression/NN bone/NN
acid/JJ supplementation/NN preventing/VBG zidovudine/NN suppression/NN marrow/NN
acid/JJ supplementation/NN preventing/VBG zidovudine/NN suppression/NN
vitamin/NN B/NNP role/NN supplementation/NN preventing/VBG zidovudine/NN suppression/NN bone/NN
vitamin/NN B/NNP role/NN supplementation/NN preventing/VBG zidovudine/NN suppression/NN marrow/NN
vitamin/NN B/NNP role/NN supplementation/NN preventing/VBG zidovudine/NN suppression/NN
B/NNP role/NN supplementation/NN preventing/VBG zidovudine/NN suppression/NN bone/NN
B/NNP role/NN supplementation/NN preventing/VBG zidovudine/NN suppression/NN marrow/NN
B/NNP role/NN supplementation/NN preventing/VBG zidovudine/NN suppression/NN
12/CD B/NNP role/NN supplementation/NN preventing/VBG zidovudine/NN suppression/NN bone/NN
12/CD B/NNP role/NN supplementation/NN preventing/VBG zidovudine/NN suppression/NN marrow/NN
12/CD B/NNP role/NN supplementation/NN preventing/VBG zidovudine/NN suppression/NN
folinic/JJ acid/NN combination/NN randomized/VBN 500/CD counts/VBZ virus/NN human/JJ
folinic/JJ acid/NN combination/NN randomized/VBN 500/CD counts/VBZ virus/NN immunodeficiency/NN
folinic/JJ acid/NN combination/NN randomized/VBN 500/CD counts/VBZ virus/NN
folinic/JJ acid/NN combination/NN randomized/VBN 500/CD counts/VBZ virus/NN HIV/NNP
folinic/JJ acid/NN combination/NN randomized/VBN 500/CD counts/VBZ patients/NNS infected/JJ
acid/NN combination/NN randomized/VBN 500/CD counts/VBZ virus/NN human/JJ
acid/NN combination/NN randomized/VBN 500/CD counts/VBZ virus/NN immunodeficiency/NN
acid/NN combination/NN randomized/VBN 500/CD counts/VBZ virus/NN
acid/NN combination/NN randomized/VBN 500/CD counts/VBZ virus/NN HIV/NNP
acid/NN combination/NN randomized/VBN 500/CD counts/VBZ patients/NNS infected/JJ
ZDV/NNP receive/VB randomized/VBN 500/CD counts/VBZ virus/NN human/JJ
ZDV/NNP receive/VB randomized/VBN 500/CD counts/VBZ virus/NN immunodeficiency/NN
ZDV/NNP receive/VB randomized/VBN 500/CD counts/VBZ virus/NN
ZDV/NNP receive/VB randomized/VBN 500/CD counts/VBZ virus/NN HIV/NNP
ZDV/NNP receive/VB randomized/VBN 500/CD counts/VBZ patients/NNS infected/JJ
vitamin/NN acid/NN combination/NN randomized/VBN 500/CD counts/VBZ virus/NN human/JJ
vitamin/NN acid/NN combination/NN randomized/VBN 500/CD counts/VBZ virus/NN immunodeficiency/NN
vitamin/NN acid/NN combination/NN randomized/VBN 500/CD counts/VBZ virus/NN
vitamin/NN acid/NN combination/NN randomized/VBN 500/CD counts/VBZ virus/NN HIV/NNP
vitamin/NN acid/NN combination/NN randomized/VBN 500/CD counts/VBZ patients/NNS infected/JJ
B/NNP counts/VBZ virus/NN human/JJ
B/NNP counts/VBZ virus/NN immunodeficiency/NN
B/NNP counts/VBZ virus/NN
B/NNP counts/VBZ virus/NN HIV/NNP
B/NNP counts/VBZ patients/NNS infected/JJ
12/CD B/NNP counts/VBZ virus/NN human/JJ
12/CD B/NNP counts/VBZ virus/NN immunodeficiency/NN
12/CD B/NNP counts/VBZ virus/NN
12/CD B/NNP counts/VBZ virus/NN HIV/NNP
12/CD B/NNP counts/VBZ patients/NNS infected/JJ
folate/NN levels/NNS myelosuppression/NN
vitamin/NN B/NNP correlation/NN levels/NNS myelosuppression/NN
B/NNP correlation/NN levels/NNS myelosuppression/NN
12/CD B/NNP correlation/NN levels/NNS myelosuppression/NN
folinic/JJ supplementation/NN 12/CD seem/VB B/NNP induced/VBN myelotoxicity/RB
acid/JJ supplementation/NN 12/CD seem/VB B/NNP induced/VBN myelotoxicity/RB
Vitamin/NNP B/NNP induced/VBN myelotoxicity/RB
B/NNP induced/VBN myelotoxicity/RB
12/CD seem/VB B/NNP induced/VBN myelotoxicity/RB
phenytoin/NN patients/NNS epileptic/JJ
phenytoin/JJ medication/NN atrophy/NN cerebellar/NN
phenytoin/JJ medication/NN atrophy/NN
phenytoin/JJ levels/NNS elevation/NN duration/NN seizure/NN
phenytoin/NN overdosage/NN result/VB atrophy/NN cerebellar/NN
phenytoin/NN overdosage/NN result/VB atrophy/NN
phenytoin/NN overdosage/NN result/VB conclude/VBP unlikely/JJ cause/NN atrophy/NN cerebellar/NN
phenytoin/NN overdosage/NN result/VB conclude/VBP unlikely/JJ cause/NN atrophy/NN
phenytoin/NN medication/NN cause/NN unlikely/JJ conclude/VBP result/VB atrophy/NN cerebellar/NN
phenytoin/NN medication/NN cause/NN unlikely/JJ conclude/VBP result/VB atrophy/NN
phenytoin/NN medication/NN cause/NN atrophy/NN cerebellar/NN
phenytoin/NN medication/NN cause/NN atrophy/NN
capsaicin/NN intensity/NN pain/NN
capsaicin/NN attention/NN affected/VBN ratings/NNS pain/NN
capsaicin/JJ treatment/NN interaction/NN suggest/VBP showing/VBG affect/VB pain/NN
capsaicin/NN suggest/VBP showing/VBG affect/VB pain/NN
sirolmus/NNS lacks/VBZ effects/NNS nephrotoxic/JJ
Srl/NNP sirolmus/NNS lacks/VBZ effects/NNS nephrotoxic/JJ
Srl/NNP associated/VBN proteinuria/NN reported/VBN lacks/VBZ effects/NNS nephrotoxic/JJ
angiotensin/NN inhibitor/NN blocker/NN reduced/VBD development/NN proteinuria/NN
releasing/JJ blocker/NN reduced/VBD development/NN proteinuria/NN
blocker/NN reduced/VBD development/NN proteinuria/NN
ARB/NNP blocker/NN reduced/VBD development/NN proteinuria/NN
ACE/NNP inhibitor/NN blocker/NN reduced/VBD development/NN proteinuria/NN
inhibitor/NN blocker/NN reduced/VBD development/NN proteinuria/NN
Srl/NNP used/VBN monitored/VBD proteinuria/NN dysfunction/NN renal/JJ
Srl/NNP used/VBN monitored/VBD proteinuria/NN dysfunction/NN
ARB/NNP therapy/NN used/VBN monitored/VBD proteinuria/NN
ARB/NNP therapy/NN used/VBN monitored/VBD proteinuria/NN dysfunction/NN renal/JJ
ARB/NNP therapy/NN used/VBN monitored/VBD proteinuria/NN dysfunction/NN
ACEi/NNP therapy/NN used/VBN monitored/VBD proteinuria/NN
ACEi/NNP therapy/NN used/VBN monitored/VBD proteinuria/NN dysfunction/NN renal/JJ
ACEi/NNP therapy/NN used/VBN monitored/VBD proteinuria/NN dysfunction/NN
PG/NNP 9/CD able/JJ prevent/VB amnesia/NN
9/CD able/JJ prevent/VB amnesia/NN
PG/NNP profiles/VBN Affinity/NNP 2/CD effect/NN amnesic/JJ
9/CD shown/VBN PG/NNP profiles/VBN Affinity/NNP 2/CD effect/NN amnesic/JJ
PG/NNP 2/CD effect/NN amnesic/JJ
9/CD PG/NNP 2/CD effect/NN amnesic/JJ
acetylcholine/JJ levels/NNS increase/NN 9/CD PG/NNP 2/CD effect/NN amnesic/JJ
Sch/NNP mg/NNP exceeded/VBN was/VBD stimulation/NN tetanic/JJ
co/NN treatment/NN pneumonia/NNP Pneumocystis/NNP
co/NN treatment/NN pneumonia/NNP
trimoxazole/JJ treatment/NN pneumonia/NNP Pneumocystis/NNP
trimoxazole/JJ treatment/NN pneumonia/NNP
co/NN lasting/JJ cholestasis/JJ
trimoxazole/JJ treatment/NN co/NN lasting/JJ cholestasis/JJ
co/NN treatment/NN pneumonia/NNP HIV/NNP
co/NN patients/NNS infected/JJ
trimoxazole/JJ treatment/NN pneumonia/NNP HIV/NNP
trimoxazole/JJ treatment/NN co/NN patients/NNS infected/JJ
co/NN doses/NNS treated/VBN pneumonia/NN Pneumocystis/JJ
co/NN doses/NNS treated/VBN pneumonia/NN
trimoxazole/NN doses/NNS treated/VBN pneumonia/NN Pneumocystis/JJ
trimoxazole/NN doses/NNS treated/VBN pneumonia/NN
co/NN doses/NNS treated/VBN pneumonia/NN PCP/NNP
trimoxazole/NN doses/NNS treated/VBN pneumonia/NN PCP/NNP
co/NN doses/NNS treated/VBN pneumonia/NN infection/NN opportunistic/JJ
co/NN doses/NNS treated/VBN pneumonia/NN infection/NN
trimoxazole/NN doses/NNS treated/VBN pneumonia/NN infection/NN opportunistic/JJ
trimoxazole/NN doses/NNS treated/VBN pneumonia/NN infection/NN
co/NN doses/NNS treated/VBN pneumonia/NN infection/NN HIV/NNP
co/NN doses/NNS treated/VBN pneumonia/NN infection/NN individuals/NNS infected/JJ
trimoxazole/NN doses/NNS treated/VBN pneumonia/NN infection/NN HIV/NNP
trimoxazole/NN doses/NNS treated/VBN pneumonia/NN infection/NN individuals/NNS infected/JJ
co/NN exams/NNS formation/NN treatment/NN PCP/NNP
trimoxazole/JJ treatment/NN PCP/NNP
co/NN exams/NNS formation/NN liver/NN
co/NN exams/NNS formation/NN abscess/NN
trimoxazole/JJ treatment/NN formation/NN liver/NN
trimoxazole/JJ treatment/NN formation/NN abscess/NN
co/NN exams/NNS formation/NN cases/NNS HIV/NN
co/NN exams/NNS formation/NN cases/NNS patients/NNS infected/JJ
trimoxazole/JJ treatment/NN formation/NN cases/NNS HIV/NN
trimoxazole/JJ treatment/NN formation/NN cases/NNS patients/NNS infected/JJ
sodium/NN channel/NN subunit/VBP syndrome/NN nephrotic/JJ
sodium/NN channel/NN subunit/VBP syndrome/NN
sodium/NN excretion/NN decreased/VBN syndrome/NN nephrotic/JJ
sodium/NN excretion/NN decreased/VBN syndrome/NN
aldosterone/NN concentration/NN excretion/NN proteinuria/NN
sodium/NN excretion/NN proteinuria/NN
sodium/NN excretion/NN appearance/NN proteinuria/NN
aldosterone/NN escape/VB appears/VBZ increased/VBN phase/NN syndrome/NN nephrotic/JJ
aldosterone/NN escape/VB appears/VBZ increased/VBN phase/NN syndrome/NN
Sirolimus/NNP agent/NN used/VBN have/VB nephrotoxicity/NN
creatinine/JJ ratios/NNS samples/NNS assessed/VBN magnitude/NN proteinuria/NN
creatinine/JJ ratios/NNS samples/NNS estimate/NN grams/NNS proteinuria/NN
sirolimus/NNS initiation/NN development/NN nephrotic/NN
nifedipine/NN receiving/VBG patients/NNS hypertensive/JJ
nifedipine/NN receiving/VBG comprising/VBG other/JJ patients/NNS hypertensive/JJ
nifedipine/JJ reducing/VBG nephrotoxicity/NN
tacrolimus/NNS associated/VBN nephrotoxicity/NN
nifedipine/JJ recipients/NNS impact/NN factor/NN selecting/VBG agent/NN treat/VB hypertension/NN
fluoxetine/NN receiving/VBG treatment/NN disorder/NN depression/NN major/JJ
fluoxetine/NN receiving/VBG treatment/NN disorder/NN depression/NN
fluoxetine/NN receiving/VBG treatment/NN disorder/NN obsessive/JJ
fluoxetine/NN receiving/VBG treatment/NN disorder/NN compulsive/JJ
fluoxetine/NN receiving/VBG treatment/NN disorder/NN
fluoxetine/NN purposeless/VBZ indistinguishable/JJ anxiety/NN
propranolol/NN beta/NN responded/VBD appeared/VBD Akathisia/NNP
antidepressant/NN akathisia/NN jitteriness/NNS pathophysiology/NN identical/JJ caused/VBN fluoxetine/NN akathisia/NN
antidepressant/NN akathisia/NN
verapamil/NN ablation/NN induced/VBN syndrome/NN patient/JJ White/NNP Wolff/NNP
verapamil/NN ablation/NN induced/VBN syndrome/NN patient/JJ White/NNP Parkinson/NNP
verapamil/NN ablation/NN induced/VBN syndrome/NN patient/JJ White/NNP
verapamil/NN ablation/NN induced/VBN syndrome/NN
verapamil/NN ablation/NN induced/VBN syndrome/NN cardiomyopathy/NN idiopathic/JJ
verapamil/NN ablation/NN induced/VBN syndrome/NN cardiomyopathy/NN dilated/JJ
verapamil/NN ablation/NN induced/VBN syndrome/NN cardiomyopathy/NN
Sodium/JJ alleviates/NNS penile/VBP pain/NN induced/VBN injections/NNS dysfunction/NN erectile/JJ
Sodium/JJ alleviates/NNS penile/VBP pain/NN induced/VBN injections/NNS dysfunction/NN
bicarbonate/NN alleviates/NNS penile/VBP pain/NN induced/VBN injections/NNS dysfunction/NN erectile/JJ
bicarbonate/NN alleviates/NNS penile/VBP pain/NN induced/VBN injections/NNS dysfunction/NN
Sodium/JJ alleviates/NNS penile/VBP
Sodium/JJ alleviates/NNS penile/VBP pain/NN
bicarbonate/NN alleviates/NNS penile/VBP
bicarbonate/NN alleviates/NNS penile/VBP pain/NN
sodium/NN bicarbonate/NN addition/NN performed/VBD attempt/NN determine/VB due/JJ pain/NN penile/JJ
sodium/NN bicarbonate/NN addition/NN performed/VBD attempt/NN determine/VB due/JJ pain/NN
bicarbonate/NN addition/NN performed/VBD attempt/NN determine/VB due/JJ pain/NN penile/JJ
bicarbonate/NN addition/NN performed/VBD attempt/NN determine/VB due/JJ pain/NN
sodium/NN bicarbonate/NN addition/NN performed/VBD study/NN comparing/VBG incidence/NN pain/NN penile/JJ
sodium/NN bicarbonate/NN addition/NN performed/VBD study/NN comparing/VBG incidence/NN pain/NN
bicarbonate/NN addition/NN performed/VBD study/NN comparing/VBG incidence/NN pain/NN penile/JJ
bicarbonate/NN addition/NN performed/VBD study/NN comparing/VBG incidence/NN pain/NN
papaverine/JJ total/NN patients/NNS presented/VBN received/VBD clinic/NN impotence/NN
sodium/NN bicarbonate/NN patients/NNS complained/VBD pain/NN penile/JJ
sodium/NN bicarbonate/NN patients/NNS complained/VBD pain/NN
bicarbonate/NN patients/NNS complained/VBD pain/NN penile/JJ
bicarbonate/NN patients/NNS complained/VBD pain/NN
sodium/NN bicarbonate/NN patients/NNS complained/VBD complained/VBD pain/NN penile/JJ
sodium/NN bicarbonate/NN patients/NNS complained/VBD complained/VBD pain/NN
bicarbonate/NN patients/NNS complained/VBD complained/VBD pain/NN penile/JJ
bicarbonate/NN patients/NNS complained/VBD complained/VBD pain/NN
sodium/NN bicarbonate/NN received/VBD men/NNS 1/CD complained/VBD complained/VBD pain/NN penile/JJ
sodium/NN bicarbonate/NN received/VBD men/NNS 1/CD complained/VBD complained/VBD pain/NN
bicarbonate/NN received/VBD men/NNS 1/CD complained/VBD complained/VBD pain/NN penile/JJ
bicarbonate/NN received/VBD men/NNS 1/CD complained/VBD complained/VBD pain/NN
sodium/NN bicarbonate/NN received/VBD men/NNS 1/CD complained/VBD pain/NN penile/JJ
sodium/NN bicarbonate/NN received/VBD men/NNS 1/CD complained/VBD pain/NN
bicarbonate/NN received/VBD men/NNS 1/CD complained/VBD pain/NN penile/JJ
bicarbonate/NN received/VBD men/NNS 1/CD complained/VBD pain/NN
prochlorperazine/NN headache/NN nausea/NN
prochlorperazine/NN headache/NN
prochlorperazine/NN headache/NN vomiting/NN
prochlorperazine/NN treatment/NN headache/NN nausea/NN
prochlorperazine/NN treatment/NN headache/NN
vinorelbine/NNP Gemcitabine/NNP patients/NNS nonsmall/JJ
vinorelbine/NNP Gemcitabine/NNP patients/NNS cell/NN
vinorelbine/NNP Gemcitabine/NNP patients/NNS lung/NN
vinorelbine/NNP Gemcitabine/NNP patients/NNS carcinoma/NN
Gemcitabine/NNP patients/NNS nonsmall/JJ
Gemcitabine/NNP patients/NNS cell/NN
Gemcitabine/NNP patients/NNS lung/NN
Gemcitabine/NNP patients/NNS carcinoma/NN
cisplatin/NN receive/VB cannot/VBP patients/NNS years/NNS age/VBP Gemcitabine/NNP patients/NNS nonsmall/JJ
cisplatin/NN receive/VB cannot/VBP patients/NNS years/NNS age/VBP Gemcitabine/NNP patients/NNS cell/NN
cisplatin/NN receive/VB cannot/VBP patients/NNS years/NNS age/VBP Gemcitabine/NNP patients/NNS lung/NN
cisplatin/NN receive/VB cannot/VBP patients/NNS years/NNS age/VBP Gemcitabine/NNP patients/NNS carcinoma/NN
gemcitabine/NN vinorelbine/NN therapy/NN obtain/VB rate/NN toxicity/NN
GEM/NNP vinorelbine/NN therapy/NN obtain/VB rate/NN toxicity/NN
vinorelbine/NN therapy/NN obtain/VB rate/NN toxicity/NN
VNB/NNP vinorelbine/NN therapy/NN obtain/VB rate/NN toxicity/NN
GEM/NNP combination/NN efficacy/NN toxicity/NN
VNB/NNP GEM/NNP combination/NN efficacy/NN toxicity/NN
VNB/NNP GEM/NNP combination/NN patients/NNS NSCLC/NN
GEM/NNP combination/NN patients/NNS NSCLC/NN
cisplatin/NN contraindication/NN those/DT combination/NN efficacy/NN toxicity/NN
cisplatin/NN contraindication/NN those/DT combination/NN patients/NNS NSCLC/NN
cisplatin/NN receiving/VBG contraindication/NN had/VBD age/NN included/VBN patients/NNS NSCLC/NN
H/NNP O/NN CPAP/VBP produced/VBD increased/VBD rate/NN output/NN decreased/VBN
H/NNP O/NN CPAP/VBP produced/VBD increased/VBD rate/NN output/NN cardiac/JJ
H/NNP O/NN CPAP/VBP produced/VBD increased/VBD rate/NN output/NN
2/CD O/NN CPAP/VBP produced/VBD increased/VBD rate/NN output/NN decreased/VBN
2/CD O/NN CPAP/VBP produced/VBD increased/VBD rate/NN output/NN cardiac/JJ
2/CD O/NN CPAP/VBP produced/VBD increased/VBD rate/NN output/NN
O/NN CPAP/VBP produced/VBD increased/VBD rate/NN output/NN decreased/VBN
O/NN CPAP/VBP produced/VBD increased/VBD rate/NN output/NN cardiac/JJ
O/NN CPAP/VBP produced/VBD increased/VBD rate/NN output/NN
nitroprusside/JJ infusion/NN produced/VBD increased/VBD rate/NN output/NN decreased/VBN
nitroprusside/JJ infusion/NN produced/VBD increased/VBD rate/NN output/NN cardiac/JJ
nitroprusside/JJ infusion/NN produced/VBD increased/VBD rate/NN output/NN
H/NNP O/NN CPAP/VBP produced/VBD decrease/NN
H/NNP O/NN CPAP/VBP produced/VBD pressure/NN in/IN
H/NNP O/NN CPAP/VBP produced/VBD pressure/NN arterial/JJ
H/NNP O/NN CPAP/VBP produced/VBD pressure/NN blood/NN
H/NNP O/NN CPAP/VBP produced/VBD pressure/NN
2/CD O/NN CPAP/VBP produced/VBD decrease/NN
2/CD O/NN CPAP/VBP produced/VBD pressure/NN in/IN
2/CD O/NN CPAP/VBP produced/VBD pressure/NN arterial/JJ
2/CD O/NN CPAP/VBP produced/VBD pressure/NN blood/NN
2/CD O/NN CPAP/VBP produced/VBD pressure/NN
O/NN CPAP/VBP produced/VBD decrease/NN
O/NN CPAP/VBP produced/VBD pressure/NN in/IN
O/NN CPAP/VBP produced/VBD pressure/NN arterial/JJ
O/NN CPAP/VBP produced/VBD pressure/NN blood/NN
O/NN CPAP/VBP produced/VBD pressure/NN
H/NNP O/NNP 10/CD levels/NNS produce/VBP decreases/NNS
H/NNP O/NNP 10/CD levels/NNS produce/VBP pressure/NN in/IN
H/NNP O/NNP 10/CD levels/NNS produce/VBP pressure/NN arterial/JJ
H/NNP O/NNP 10/CD levels/NNS produce/VBP pressure/NN blood/NN
H/NNP O/NNP 10/CD levels/NNS produce/VBP pressure/NN
H/NNP O/NNP 10/CD levels/NNS produce/VBP pressure/NN and/CC
H/NNP O/NNP 10/CD levels/NNS produce/VBP pressure/NN output/NN cardiac/JJ
H/NNP O/NNP 10/CD levels/NNS produce/VBP pressure/NN output/NN
2/CD O/NNP 10/CD levels/NNS produce/VBP decreases/NNS
2/CD O/NNP 10/CD levels/NNS produce/VBP pressure/NN in/IN
2/CD O/NNP 10/CD levels/NNS produce/VBP pressure/NN arterial/JJ
2/CD O/NNP 10/CD levels/NNS produce/VBP pressure/NN blood/NN
2/CD O/NNP 10/CD levels/NNS produce/VBP pressure/NN
2/CD O/NNP 10/CD levels/NNS produce/VBP pressure/NN and/CC
2/CD O/NNP 10/CD levels/NNS produce/VBP pressure/NN output/NN cardiac/JJ
2/CD O/NNP 10/CD levels/NNS produce/VBP pressure/NN output/NN
O/NNP 10/CD levels/NNS produce/VBP decreases/NNS
O/NNP 10/CD levels/NNS produce/VBP pressure/NN in/IN
O/NNP 10/CD levels/NNS produce/VBP pressure/NN arterial/JJ
O/NNP 10/CD levels/NNS produce/VBP pressure/NN blood/NN
O/NNP 10/CD levels/NNS produce/VBP pressure/NN
O/NNP 10/CD levels/NNS produce/VBP pressure/NN and/CC
O/NNP 10/CD levels/NNS produce/VBP pressure/NN output/NN cardiac/JJ
O/NNP 10/CD levels/NNS produce/VBP pressure/NN output/NN
nitroprusside/JJ infusion/NN alter/VB produce/VBP decreases/NNS
nitroprusside/JJ infusion/NN alter/VB produce/VBP pressure/NN in/IN
nitroprusside/JJ infusion/NN alter/VB produce/VBP pressure/NN arterial/JJ
nitroprusside/JJ infusion/NN alter/VB produce/VBP pressure/NN blood/NN
nitroprusside/JJ infusion/NN alter/VB produce/VBP pressure/NN
nitroprusside/JJ infusion/NN alter/VB produce/VBP pressure/NN and/CC
nitroprusside/JJ infusion/NN alter/VB produce/VBP pressure/NN output/NN cardiac/JJ
nitroprusside/JJ infusion/NN alter/VB produce/VBP pressure/NN output/NN
ribavirin/NNP effect/NN patients/NNS fever/NN Argentine/JJ
ribavirin/NNP effect/NN patients/NNS fever/NN hemorrhagic/JJ
ribavirin/NNP effect/NN patients/NNS fever/NN
ribavirin/NNP effect/NN studied/VBN patients/NNS fever/NN Argentine/JJ
ribavirin/NNP effect/NN studied/VBN patients/NNS fever/NN hemorrhagic/JJ
ribavirin/NNP effect/NN studied/VBN patients/NNS fever/NN
ribavirin/NNP effect/NN studied/VBN patients/NNS fever/NN AHF/NNP
ribavirin/NNP Administration/NNP resulted/VBD neutralization/NN viremia/NN
ribavirin/NNP has/VBZ effect/NN cases/NNS AHF/NNP
ribavirin/NNP days/NNS AHF/NNP
bupropion/NN dysfunction/NN sexual/JJ
bupropion/NN dysfunction/NN
selective/JJ serotonin/NN induced/VBN dysfunction/NN sexual/JJ
selective/JJ serotonin/NN induced/VBN dysfunction/NN
serotonin/NN induced/VBN dysfunction/NN sexual/JJ
serotonin/NN induced/VBN dysfunction/NN
reuptake/VBP effects/NNS bupropion/NN dysfunction/NN sexual/JJ
reuptake/VBP effects/NNS bupropion/NN dysfunction/NN
inhibitor/NN reuptake/VBP effects/NNS bupropion/NN dysfunction/NN sexual/JJ
inhibitor/NN reuptake/VBP effects/NNS bupropion/NN dysfunction/NN
bupropion/NN release/NN dysfunction/NN sexual/JJ
bupropion/NN release/NN dysfunction/NN
bupropion/NN release/NN dysfunction/NN SD/NNP
bupropion/NN release/NN dysfunction/NN induced/VBN side/NN SD/NNP
selective/JJ inhibitor/NN induced/VBN dysfunction/NN sexual/JJ
selective/JJ inhibitor/NN induced/VBN dysfunction/NN
serotonin/NN inhibitor/NN induced/VBN dysfunction/NN sexual/JJ
serotonin/NN inhibitor/NN induced/VBN dysfunction/NN
reuptake/NN inhibitor/NN induced/VBN dysfunction/NN sexual/JJ
reuptake/NN inhibitor/NN induced/VBN dysfunction/NN
inhibitor/NN induced/VBN dysfunction/NN sexual/JJ
inhibitor/NN induced/VBN dysfunction/NN
selective/JJ inhibitor/NN induced/VBN dysfunction/NN SD/NNP
serotonin/NN inhibitor/NN induced/VBN dysfunction/NN SD/NNP
reuptake/NN inhibitor/NN induced/VBN dysfunction/NN SD/NNP
inhibitor/NN induced/VBN dysfunction/NN SD/NNP
selective/JJ inhibitor/NN induced/VBN side/NN SD/NNP
serotonin/NN inhibitor/NN induced/VBN side/NN SD/NNP
reuptake/NN inhibitor/NN induced/VBN side/NN SD/NNP
inhibitor/NN induced/VBN side/NN SD/NNP
SSRI/NNP inhibitor/NN induced/VBN dysfunction/NN sexual/JJ
SSRI/NNP inhibitor/NN induced/VBN dysfunction/NN
SSRI/NNP inhibitor/NN induced/VBN dysfunction/NN SD/NNP
SSRI/NNP inhibitor/NN induced/VBN side/NN SD/NNP
SSRIs/NNP effect/NN bupropion/NN release/NN dysfunction/NN sexual/JJ
SSRIs/NNP effect/NN bupropion/NN release/NN dysfunction/NN
SSRIs/NNP effect/NN bupropion/NN release/NN dysfunction/NN SD/NNP
SSRIs/NNP effect/NN bupropion/NN release/NN dysfunction/NN induced/VBN side/NN SD/NNP
SSRI/NNP type/NN used/VBD affected/VBN duration/NN SD/NNP
Bupropion/NNP treatment/NN SD/NN
SSRIs/NNP induced/VBN SD/NN
acetylcholine/NN release/NN seizure/NN
acetylcholine/NN release/NN relationship/NN seizure/NN
alcohol/NN examined/VBN sensitivity/NN METHODS/NNS Prone/NNP ve/VB Seizure/NNP
carbachol/NN nicotine/NN administered/VBN recorded/VBN latencies/NNS onset/NN tremor/NN
neostigmine/NN nicotine/NN administered/VBN recorded/VBN latencies/NNS onset/NN tremor/NN
nicotine/NN administered/VBN recorded/VBN latencies/NNS onset/NN tremor/NN
ACh/NNP measured/VBN testing/VBG handling/NN convulsions/NNS
ACh/NNP measured/VBN testing/VBG handling/NN convulsions/NNS
ACh/NNP elevated/JJ measured/VBN testing/VBG handling/NN convulsions/NNS
ethanol/NN severity/NN associated/VBN differences/NNS activity/NN convulsants/NNS
alcohol/NN withdrawal/NN implicate/VB associated/VBN differences/NNS activity/NN convulsants/NNS
bleomycin/NN cisplatin/NN treatment/NN alkaloid/VBD developed/VBD microangiopathy/NN thrombotic/JJ
bleomycin/NN cisplatin/NN treatment/NN alkaloid/VBD developed/VBD microangiopathy/NN
vinca/NN cisplatin/NN treatment/NN alkaloid/VBD developed/VBD characterized/VBN insufficiency/NN anemia/NN microangiopathic/JJ
vinca/NN cisplatin/NN treatment/NN alkaloid/VBD developed/VBD characterized/VBN insufficiency/NN anemia/NN hemolytic/JJ
vinca/NN cisplatin/NN treatment/NN alkaloid/VBD developed/VBD characterized/VBN insufficiency/NN anemia/NN
alkaloid/VBD developed/VBD characterized/VBN insufficiency/NN anemia/NN microangiopathic/JJ
alkaloid/VBD developed/VBD characterized/VBN insufficiency/NN anemia/NN hemolytic/JJ
alkaloid/VBD developed/VBD characterized/VBN insufficiency/NN anemia/NN
vinca/NN cisplatin/NN treatment/NN alkaloid/VBD developed/VBD characterized/VBN insufficiency/NN thrombocytopenia/NN
alkaloid/VBD developed/VBD characterized/VBN insufficiency/NN thrombocytopenia/NN
bleomycin/NN cisplatin/NN treatment/NN alkaloid/VBD developed/VBD characterized/VBN insufficiency/NN renal/JJ
bleomycin/NN cisplatin/NN treatment/NN alkaloid/VBD developed/VBD characterized/VBN insufficiency/NN
vinca/NN cisplatin/NN treatment/NN alkaloid/VBD developed/VBD microangiopathy/NN thrombotic/JJ
vinca/NN cisplatin/NN treatment/NN alkaloid/VBD developed/VBD microangiopathy/NN
alkaloid/VBD developed/VBD microangiopathy/NN thrombotic/JJ
alkaloid/VBD developed/VBD microangiopathy/NN
bleomycin/NN cisplatin/NN treatment/NN alkaloid/VBD developed/VBD characterized/VBN insufficiency/NN anemia/NN microangiopathic/JJ
bleomycin/NN cisplatin/NN treatment/NN alkaloid/VBD developed/VBD characterized/VBN insufficiency/NN anemia/NN hemolytic/JJ
bleomycin/NN cisplatin/NN treatment/NN alkaloid/VBD developed/VBD characterized/VBN insufficiency/NN anemia/NN
bleomycin/NN cisplatin/NN treatment/NN alkaloid/VBD developed/VBD characterized/VBN insufficiency/NN thrombocytopenia/NN
cisplatin/NN treatment/NN alkaloid/VBD developed/VBD microangiopathy/NN thrombotic/JJ
cisplatin/NN treatment/NN alkaloid/VBD developed/VBD microangiopathy/NN
cisplatin/NN treatment/NN alkaloid/VBD developed/VBD characterized/VBN insufficiency/NN renal/JJ
cisplatin/NN treatment/NN alkaloid/VBD developed/VBD characterized/VBN insufficiency/NN
vinca/NN cisplatin/NN treatment/NN alkaloid/VBD developed/VBD characterized/VBN insufficiency/NN renal/JJ
vinca/NN cisplatin/NN treatment/NN alkaloid/VBD developed/VBD characterized/VBN insufficiency/NN
alkaloid/VBD developed/VBD characterized/VBN insufficiency/NN renal/JJ
alkaloid/VBD developed/VBD characterized/VBN insufficiency/NN
bleomycin/NN cisplatin/NN treatment/NN alkaloid/VBD developed/VBD patients/NNS carcinoma/NN
vinca/NN cisplatin/NN treatment/NN alkaloid/VBD developed/VBD patients/NNS carcinoma/NN
alkaloid/VBD developed/VBD patients/NNS carcinoma/NN
cisplatin/NN treatment/NN alkaloid/VBD developed/VBD patients/NNS carcinoma/NN
cisplatin/NN treatment/NN alkaloid/VBD developed/VBD characterized/VBN insufficiency/NN anemia/NN microangiopathic/JJ
cisplatin/NN treatment/NN alkaloid/VBD developed/VBD characterized/VBN insufficiency/NN anemia/NN hemolytic/JJ
cisplatin/NN treatment/NN alkaloid/VBD developed/VBD characterized/VBN insufficiency/NN anemia/NN
cisplatin/NN treatment/NN alkaloid/VBD developed/VBD characterized/VBN insufficiency/NN thrombocytopenia/NN
cisplatin/NN nephrotoxicity/NN ascribed/VBN examined/VBN suppression/NN bone/NN
cisplatin/NN nephrotoxicity/NN ascribed/VBN examined/VBN suppression/NN marrow/NN
cisplatin/NN nephrotoxicity/NN ascribed/VBN examined/VBN suppression/NN
cisplatin/NN nephrotoxicity/NN anemia/NN
cisplatin/NN nephrotoxicity/NN ascribed/VBN failure/NN renal/JJ
cisplatin/NN nephrotoxicity/NN ascribed/VBN failure/NN
cisplatin/NN nephrotoxicity/NN anemia/NN thrombocytopenia/NN
lactate/NN infusion/NN produced/VBN injury/NN
lactate/NN infusion/NN produced/VBN injury/NN cortex/NN in/IN
lactate/NN infusion/NN produced/VBN injury/NN cortex/NN the/DT
lactate/NN infusion/NN produced/VBN injury/NN cortex/NN
creatine/JJ development/NN arrhythmia/NN
glutamate/NN supplementation/NN failed/VBN protect/VB neurotoxicity/NN peripheral/JJ
glutamate/NN supplementation/NN failed/VBN protect/VB neurotoxicity/NN
glutamate/NN claimed/VBN ameliorate/VB neurotoxicity/RB
glutamine/NN glutamate/NN claimed/VBN ameliorate/VB neurotoxicity/RB
amino/NN glutamine/NN glutamate/NN claimed/VBN ameliorate/VB neurotoxicity/RB
acid/NN glutamine/NN glutamate/NN claimed/VBN ameliorate/VB neurotoxicity/RB
glutamate/NN claimed/VBN factor/NN neuropathy/NN peripheral/JJ
glutamate/NN claimed/VBN factor/NN neuropathy/NN
glutamine/NN glutamate/NN claimed/VBN factor/NN neuropathy/NN peripheral/JJ
glutamine/NN glutamate/NN claimed/VBN factor/NN neuropathy/NN
paclitaxel/NN chemotherapy/NN factor/NN claimed/VBN ameliorate/VB neurotoxicity/RB
PAC/NNP paclitaxel/NN chemotherapy/NN factor/NN claimed/VBN ameliorate/VB neurotoxicity/RB
PAC/NNP ameliorate/VB neurotoxicity/RB
amino/NN glutamine/NN glutamate/NN claimed/VBN factor/NN neuropathy/NN peripheral/JJ
amino/NN glutamine/NN glutamate/NN claimed/VBN factor/NN neuropathy/NN
acid/NN glutamine/NN glutamate/NN claimed/VBN factor/NN neuropathy/NN peripheral/JJ
acid/NN glutamine/NN glutamate/NN claimed/VBN factor/NN neuropathy/NN
glutamate/JJ supplementation/NN role/NN evaluate/VB aimed/VBN induced/VBN neuropathy/NN peripheral/JJ
glutamate/JJ supplementation/NN role/NN evaluate/VB aimed/VBN induced/VBN neuropathy/NN
glutamate/JJ mg/NN supplemented/VBN 23/CD regimen/NN available/JJ patients/NNS ovarian/NN
glutamate/JJ mg/NN supplemented/VBN 23/CD regimen/NN available/JJ patients/NNS cancer/NN
PAC/NN cycles/NNS regimen/NN available/JJ patients/NNS ovarian/NN
PAC/NN cycles/NNS regimen/NN available/JJ patients/NNS cancer/NN
glutamate/JJ supplementation/NN fails/VBZ protect/VB neurotoxicity/NN peripheral/JJ
glutamate/JJ supplementation/NN fails/VBZ protect/VB neurotoxicity/NN
Suxamethonium/NNP induced/VBN arrest/NN death/NN
suxamethonium/NN use/NN hyperkalaemia/NN result/NN death/NN
suxamethonium/NN caused/VBN death/NN
isoproterenol/NN pretreatment/NN Effects/NNPS tachycardia/NN
isoproterenol/JJ pretreatment/NN reduced/VBN ii/NN activation/NN mediated/JJ tachycardia/NN
dopamine/JJ activation/NN mediated/JJ tachycardia/NN
isoproterenol/NN pretreatment/NN abolish/VB bromocriptine/NN tachycardia/NN
isoproterenol/JJ pretreatment/NN unaffected/JJ reversed/VBN tachycardia/NN
isoproterenol/JJ pretreatment/NN unaffected/JJ hypotension/NN
Bromocriptine/NNP induced/VBN unaffected/JJ reversed/VBN bradycardia/NN
domperidone/JJ i/FW reduced/VBN effect/NN bradycardia/NN reversed/VBN unaffected/JJ hypotension/NN
domperidone/JJ i/FW reduced/VBN effect/NN bradycardia/NN reversed/VBN tachycardia/NN
isoproterenol/NN pretreatment/NN abolished/VBD 15/CD induced/VBN tachycardia/NN
bromocriptine/NN reversed/VBD abolished/VBD 15/CD induced/VBN bradycardia/NN
dopamine/NN receptors/NNS mask/VB bradycardia/NN
bromocriptine/NN tachycardia/NN appears/VBZ predominate/VB mask/VB bradycardia/NN
dopamine/NN receptors/NNS mask/VB predominate/VB appears/VBZ tachycardia/NN
calcium/NN chloride/NN injury/NN arterial/JJ
calcium/NN chloride/NN injury/NN
chloride/NN injury/NN arterial/JJ
chloride/NN injury/NN
CaCl/NNP chloride/NN injury/NN arterial/JJ
CaCl/NNP chloride/NN injury/NN
2/CD NNS chloride/NN injury/NN arterial/JJ
2/CD NNS chloride/NN injury/NN
ribavirin/NNP associated/VBN anemia/NN hemolytic/JJ
ribavirin/NNP associated/VBN anemia/NN
ribavirin/NNP found/VBN found/VBN cause/VB hemolysis/NNS
pegylated/JJ interferon/NN treated/VBN patients/NNS infected/JJ chronically/RB
pegylated/JJ interferon/NN treated/VBN patients/NNS infected/JJ
pegylated/JJ interferon/NN treated/VBN patients/NNS infected/JJ virus/NN with/IN
pegylated/JJ interferon/NN treated/VBN patients/NNS infected/JJ virus/NN hepatitis/NNP
pegylated/JJ interferon/NN treated/VBN patients/NNS infected/JJ virus/NN C/NNP
pegylated/JJ interferon/NN treated/VBN patients/NNS infected/JJ virus/NN
interferon/NN treated/VBN patients/NNS infected/JJ chronically/RB
interferon/NN treated/VBN patients/NNS infected/JJ
interferon/NN treated/VBN patients/NNS infected/JJ virus/NN with/IN
interferon/NN treated/VBN patients/NNS infected/JJ virus/NN hepatitis/NNP
interferon/NN treated/VBN patients/NNS infected/JJ virus/NN C/NNP
interferon/NN treated/VBN patients/NNS infected/JJ virus/NN
alpha/NN interferon/NN treated/VBN patients/NNS infected/JJ chronically/RB
alpha/NN interferon/NN treated/VBN patients/NNS infected/JJ
alpha/NN interferon/NN treated/VBN patients/NNS infected/JJ virus/NN with/IN
alpha/NN interferon/NN treated/VBN patients/NNS infected/JJ virus/NN hepatitis/NNP
alpha/NN interferon/NN treated/VBN patients/NNS infected/JJ virus/NN C/NNP
alpha/NN interferon/NN treated/VBN patients/NNS infected/JJ virus/NN
2/CD alpha/NN interferon/NN treated/VBN patients/NNS infected/JJ chronically/RB
2/CD alpha/NN interferon/NN treated/VBN patients/NNS infected/JJ
2/CD alpha/NN interferon/NN treated/VBN patients/NNS infected/JJ virus/NN with/IN
2/CD alpha/NN interferon/NN treated/VBN patients/NNS infected/JJ virus/NN hepatitis/NNP
2/CD alpha/NN interferon/NN treated/VBN patients/NNS infected/JJ virus/NN C/NNP
2/CD alpha/NN interferon/NN treated/VBN patients/NNS infected/JJ virus/NN
a/DT interferon/NN treated/VBN patients/NNS infected/JJ chronically/RB
a/DT interferon/NN treated/VBN patients/NNS infected/JJ
a/DT interferon/NN treated/VBN patients/NNS infected/JJ virus/NN with/IN
a/DT interferon/NN treated/VBN patients/NNS infected/JJ virus/NN hepatitis/NNP
a/DT interferon/NN treated/VBN patients/NNS infected/JJ virus/NN C/NNP
a/DT interferon/NN treated/VBN patients/NNS infected/JJ virus/NN
ribavirin/JJ a/DT interferon/NN treated/VBN patients/NNS infected/JJ chronically/RB
ribavirin/JJ a/DT interferon/NN treated/VBN patients/NNS infected/JJ
ribavirin/JJ a/DT interferon/NN treated/VBN patients/NNS infected/JJ virus/NN with/IN
ribavirin/JJ a/DT interferon/NN treated/VBN patients/NNS infected/JJ virus/NN hepatitis/NNP
ribavirin/JJ a/DT interferon/NN treated/VBN patients/NNS infected/JJ virus/NN C/NNP
ribavirin/JJ a/DT interferon/NN treated/VBN patients/NNS infected/JJ virus/NN
ribavirin/NNP anemia/NNP patients/NNS C/NNP hepatitis/NNP
ribavirin/NNP anemia/NNP patients/NNS C/NNP
ribavirin/NNP anemia/NNP
timolol/JJ treatment/NN infarction/NN myocardial/JJ
timolol/JJ treatment/NN infarction/NN
timolol/JJ treatment/NN evaluated/VBN infarction/NN myocardial/JJ
timolol/JJ treatment/NN evaluated/VBN infarction/NN
timolol/NN placebo/NN study/NN effect/NN treatment/NN evaluated/VBN infarction/NN myocardial/JJ
timolol/NN placebo/NN study/NN effect/NN treatment/NN evaluated/VBN infarction/NN
timolol/JJ bradycardia/NN
timolol/JJ group/NN remained/VBD increased/VBD re/NN infarction/NN
BCNU/JJ chemotherapy/NN treatment/NN gliomas/NNS malignant/JJ
BCNU/JJ chemotherapy/NN treatment/NN gliomas/NNS
BCNU/NNP clearance/NN 1/CD provide/VB treatment/NN gliomas/NNS malignant/JJ
BCNU/NNP clearance/NN 1/CD provide/VB treatment/NN gliomas/NNS
1/CD BCNU/NNP clearance/NN 1/CD provide/VB treatment/NN gliomas/NNS malignant/JJ
1/CD BCNU/NNP clearance/NN 1/CD provide/VB treatment/NN gliomas/NNS
3/CD BCNU/NNP clearance/NN 1/CD provide/VB treatment/NN gliomas/NNS malignant/JJ
3/CD BCNU/NNP clearance/NN 1/CD provide/VB treatment/NN gliomas/NNS
bis/NN 3/CD BCNU/NNP clearance/NN 1/CD provide/VB treatment/NN gliomas/NNS malignant/JJ
bis/NN 3/CD BCNU/NNP clearance/NN 1/CD provide/VB treatment/NN gliomas/NNS
2/CD BCNU/NNP clearance/NN 1/CD provide/VB treatment/NN gliomas/NNS malignant/JJ
2/CD BCNU/NNP clearance/NN 1/CD provide/VB treatment/NN gliomas/NNS
chloroethyl/NN 2/CD BCNU/NNP clearance/NN 1/CD provide/VB treatment/NN gliomas/NNS malignant/JJ
chloroethyl/NN 2/CD BCNU/NNP clearance/NN 1/CD provide/VB treatment/NN gliomas/NNS
1/CD provide/VB treatment/NN gliomas/NNS malignant/JJ
1/CD provide/VB treatment/NN gliomas/NNS
nitrosourea/NN 1/CD provide/VB treatment/NN gliomas/NNS malignant/JJ
nitrosourea/NN 1/CD provide/VB treatment/NN gliomas/NNS
BCNU/JJ therapy/NN courses/NNS received/VBD Twenty/CD patients/NNS recurrent/NN Grade/VBG astrocytomas/NNS
ethanol/NN diluent/NN concentration/NN lowered/VBN decreased/VBD frequency/NN loss/NN visual/JJ
ethanol/NN diluent/NN concentration/NN lowered/VBN decreased/VBD frequency/NN loss/NN
penicillamine/JJ therapy/NN caused/VBD arthritis/NN rheumatoid/JJ
penicillamine/JJ therapy/NN caused/VBD arthritis/NN
chloroquine/JJ penicillamine/JJ therapy/NN caused/VBD arthritis/NN rheumatoid/JJ
chloroquine/JJ penicillamine/JJ therapy/NN caused/VBD arthritis/NN
penicillamine/JJ therapy/NN arthritis/NN rheumatoid/JJ
penicillamine/JJ therapy/NN arthritis/NN
chloroquine/JJ penicillamine/JJ therapy/NN arthritis/NN rheumatoid/JJ
chloroquine/JJ penicillamine/JJ therapy/NN arthritis/NN
mefloquine/NN prophylaxis/NNS malaria/NN
Ticlopidine/NNP induced/VBN hepatitis/NN cholestatic/JJ
Ticlopidine/NNP induced/VBN hepatitis/NN
ticlopidine/NN cases/NNS report/VB induced/VBN hepatitis/NN cholestatic/JJ
ticlopidine/NN cases/NNS report/VB induced/VBN hepatitis/NN
ticlopidine/JJ percutaneous/NNS receiving/VBG developed/VBN hepatitis/NN cholestatic/JJ
ticlopidine/JJ percutaneous/NNS receiving/VBG developed/VBN hepatitis/NN
ticlopidine/NN complication/NN hepatitis/NNP Cholestatic/NNP
ticlopidine/NN complication/NN hepatitis/NNP
ticlopidine/NN developed/VBD showed/VBD characteristics/NNS hepatitis/NN cholestatic/JJ
ticlopidine/NN developed/VBD showed/VBD characteristics/NNS hepatitis/NN
ticlopidine/NN effect/NN hepatitis/NNP Cholestatic/NNP
ticlopidine/NN effect/NN hepatitis/NNP
methylprednisolone/NN administration/NN assess/VB space/NN end/NN surgery/NN cataract/NN
gentamicin/NN methylprednisolone/NN administration/NN assess/VB space/NN end/NN surgery/NN cataract/NN
Ketamine/JJ sedation/NN fractures/NNS
ketamine/NN safety/NN examine/VB treatment/NN fractures/NNS
ketamine/NN manipulation/NN fracture/NN dislocation/NN
ketamine/NN manipulation/NN fracture/NN
Ketamine/VB provided/VBN sedation/NN facilitate/VB reduction/NN fractures/NNS
gabapentin/NN drug/NN patients/NNS neuropathic/JJ
gabapentin/NN drug/NN patients/NNS pain/NN
gabapentin/NN induced/VBN hyperalgesia/NN secondary/JJ
gabapentin/NN induced/VBN hyperalgesia/NN
dopamine/NN neurons/NNS induced/VBN neurotoxicity/RB
LY/NNP induced/VBN neurotoxicity/RB
274614/CD LY/NNP induced/VBN neurotoxicity/RB
amino/JJ antagonist/NN Protection/NNP induced/VBN neurotoxicity/RB
acid/NN antagonist/NN Protection/NNP induced/VBN neurotoxicity/RB
dopamine/NN neurons/NNS compounds/NNS effect/NN neurotoxic/JJ
LY/NNP 274614/NNP antagonist/NN involves/VBZ effect/NN neurotoxic/JJ
274614/NNP antagonist/NN involves/VBZ effect/NN neurotoxic/JJ
NMDA/NNP receptors/NNS involves/VBZ effect/NN neurotoxic/JJ
NMDA/NNP antagonist/NN involves/VBZ effect/NN neurotoxic/JJ
lithium/NN Rats/NNS induced/VBN nephropathy/RB
lithium/NN Rats/NNS induced/VBN feeding/NN uninephrectomy/NN combination/NN these/DT attempt/NN induce/VB hyperfiltration/JJ failure/NN renal/JJ
lithium/NN Rats/NNS induced/VBN feeding/NN uninephrectomy/NN combination/NN these/DT attempt/NN induce/VB hyperfiltration/JJ failure/NN
Lithium/NNP caused/VBD absence/NN glomerulosclerosis/NNS
lithium/NN rats/NNS decrease/VB increase/VB tended/VBN fact/NN failed/VBD' failed/VBD progression/NN failure/NN renal/JJ
lithium/NN rats/NNS decrease/VB increase/VB tended/VBN fact/NN failed/VBD' failed/VBD progression/NN failure/NN
creatinine/NN levels/NNS decrease/VB increase/VB tended/VBN fact/NN failed/VBD' failed/VBD progression/NN failure/NN renal/JJ
creatinine/NN levels/NNS decrease/VB increase/VB tended/VBN fact/NN failed/VBD' failed/VBD progression/NN failure/NN
Li/NNP nephropathy/JJ
Capsaicin/NNP induced/VBN alters/NNS muscle/NN
Capsaicin/NNP induced/VBN alters/NNS pain/NN
Busulfan/NNP induced/VBN cystitis/NNS hemorrhagic/JJ
Busulfan/NNP induced/VBN cystitis/NNS
busulfan/NN induced/VBN cystitis/NNS hemorrhage/JJ
busulfan/NN induced/VBN cystitis/NNS
cyclophosphamide/NN radiation/NN appearances/NNS cystitis/NNS
cyclophosphamide/NN radiation/NN cystitis/NNS
busulfan/NN tendency/NN induce/VB atypia/NN carcinoma/NN
sodium/NN application/NN valproate/VBP revealed/VBD disorders/NNS neurological/JJ
sodium/NN application/NN valproate/VBP revealed/VBD disorders/NNS
valproate/VBP revealed/VBD disorders/NNS neurological/JJ
valproate/VBP revealed/VBD disorders/NNS
valproate/VB revealed/VBD disorders/NNS neurological/JJ
valproate/VB revealed/VBD disorders/NNS
sodium/NN application/NN valproate/VBP revealed/VBD indicating/VBG damage/NN cerebellum/NN
sodium/NN application/NN valproate/VBP revealed/VBD indicating/VBG damage/NN
valproate/VBP revealed/VBD indicating/VBG damage/NN cerebellum/NN
valproate/VBP revealed/VBD indicating/VBG damage/NN
valproate/VB revealed/VBD indicating/VBG damage/NN cerebellum/NN
valproate/VB revealed/VBD indicating/VBG damage/NN
valproate/JJ encephalopathy/NN development/NN damage/NN hepatic/JJ
valproate/JJ encephalopathy/NN development/NN damage/NN
valproate/JJ encephalopathy/NN development/NN damage/NN hyperammonemia/NN
vincristin/NN administration/NN due/JJ myeloencephalopathy/RB
vincristine/NN instillation/NN girl/NN leucemia/NN acute/JJ
vincristine/NN instillation/NN girl/NN leucemia/NN lymphoblastic/JJ
vincristine/NN instillation/NN girl/NN leucemia/NN
vincristine/NN instillation/NN 57/CD man/NN lymphoma/NN lymphoblastic/JJ
vincristine/NN instillation/NN 57/CD man/NN lymphoma/NN
vincristine/JJ transformation/NN pseudocystic/JJ
vincristine/JJ transformation/NN
vincristine/JJ transformation/NN degeneration/NN
vincristine/JJ transformation/NN degeneration/NN myelin/NN of/IN
vincristine/JJ transformation/NN degeneration/NN myelin/NN
vincristine/JJ transformation/NN degeneration/NN myelin/NN and/CC
vincristine/JJ transformation/NN degeneration/NN myelin/NN axons/NNS
estradiol/NN dependent/JJ levels/NNS inhibition/NN hyperprolactinemic/JJ
ribonucleic/NN levels/NNS inhibition/NN hyperprolactinemic/JJ
acid/NN levels/NNS inhibition/NN hyperprolactinemic/JJ
estrogen/NN secretion/NN fertility/NN necessary/JJ induced/VBN inhibited/VBD hyperprolactinemia/NN
estradiol/NN levels/NNS presence/NN frequency/NN' frequency/NN caused/VBD hyperprolactinemia/NN
dopamine/JJ sulpiride/NN induced/VBN hyperprolactinemia/NN
steroid/JJ manner/NN hyperprolactinemia/NN
molindone/JJ administration/NN failure/NN rhabdomyolysis/NNS illustrate/VB reported/VBN case/NN patient/NN schizophrenic/JJ
epinephrine/NN overdose/NN accidental/VB due/JJ systolic/JJ left/VBD
epinephrine/NN overdose/NN accidental/VB due/JJ systolic/JJ ventricular/NN
epinephrine/NN overdose/NN accidental/VB due/JJ systolic/JJ
epinephrine/NN overdose/NN accidental/VB due/JJ systolic/JJ and/CC
epinephrine/NN overdose/NN accidental/VB due/JJ systolic/JJ dysfunction/NN diastolic/JJ
epinephrine/NN overdose/NN accidental/VB due/JJ systolic/JJ dysfunction/NN
epinephrine/NN overdose/NN
Catecholamine/NNP induced/VBN recognized/VBN catecholamines/NNS due/JJ cardiomyopathy/RB
catecholamines/NNS due/JJ cardiomyopathy/RB
epinephrine/NN mg/NN injected/VBN woman/NN year/NN left/VBD elevated/VBD markers/NNS necrosis/NNS myocardial/JJ
epinephrine/NN mg/NN injected/VBN woman/NN year/NN left/VBD elevated/VBD markers/NNS necrosis/NNS
epinephrine/NN mg/NN injected/VBN woman/NN year/NN left/VBD
epinephrine/NN mg/NN injected/VBN woman/NN year/NN left/VBD dysfunction/NN ventricular/JJ
epinephrine/NN mg/NN injected/VBN woman/NN year/NN left/VBD dysfunction/NN systolic/JJ
epinephrine/NN mg/NN injected/VBN woman/NN year/NN left/VBD dysfunction/NN systolic/JJ and/CC
epinephrine/NN mg/NN injected/VBN woman/NN year/NN left/VBD dysfunction/NN systolic/JJ diastolic/JJ
epinephrine/NN mg/NN injected/VBN woman/NN year/NN left/VBD dysfunction/NN
sevoflurane/NN effects/NNS convulsions/NNS
sevoflurane/NN influence/NN studied/VBN convulsions/NNS
sevoflurane/NN concentration/NN 0/CD end/NN lidocaine/NN //NNS was/VBD threshold/NN convulsive/JJ
sevoflurane/NN threshold/NN convulsive/JJ
enflurane/NN sevoflurane/NN threshold/NN convulsive/JJ
sevoflurane/NN concentrations/NNS administered/VBN decreased/VBD pressure/NN convulsions/NNS
sevoflurane/JJ enflurane/VBP marked/JJ administered/VBN decreased/VBD pressure/NN convulsions/NNS
enflurane/NN sevoflurane/NN concentrations/NNS administered/VBN decreased/VBD pressure/NN convulsions/NNS
enflurane/VBP marked/JJ administered/VBN decreased/VBD pressure/NN convulsions/NNS
Apamin/NNP had/VBD decrease/VB threshold/NN convulsive/JJ
lidocaine/JJ toxicity/NN
sevoflurane/NN reduces/VBZ effect/NN toxicity/NN
sevoflurane/NN reduces/VBZ effect/NN convulsive/JJ
sevoflurane/NN reduces/VBZ carries/VBZ due/JJ depression/NN
lidocaine/JJ toxicity/NN effect/NN reduces/VBZ carries/VBZ due/JJ depression/NN
vinorelbine/JJ squamous/NNS
vinorelbine/JJ cell/NN
vinorelbine/JJ cell/NN trial/NN esophageal/VBP
vinorelbine/JJ cell/NN trial/NN esophageal/VBP carcinoma/NN
vinorelbine/JJ cell/NN administered/VBN agent/NN squamous/NNS
vinorelbine/JJ cell/NN
vinorelbine/JJ cell/NN carcinoma/JJ esophageal/JJ
vinorelbine/JJ cell/NN carcinoma/JJ
VNB/NNP cell/NN administered/VBN agent/NN squamous/NNS
VNB/NNP cell/NN
VNB/NNP cell/NN carcinoma/JJ esophageal/JJ
VNB/NNP cell/NN carcinoma/JJ
cisplatin/NN pretreated/VBD assessable/JJ toxicity/NN
VNB/NNP tolerated/JJ occurred/VBD instances/NNS toxicity/NNS
VNB/NNP agent/NN carcinoma/NN esophageal/JJ
VNB/NNP agent/NN carcinoma/NN squamous/NNS
VNB/NNP agent/NN carcinoma/NN cell/NN
VNB/NNP agent/NN carcinoma/NN
VNB/NNP evaluation/NN warranted/VBN profile/NN toxicity/NN
nitroglycerin/NN effect/NN inducing/VBG seems/VBZ depend/VB stimulation/NN site/NN pain/NN
BD/NNP mice/NNS treatment/NN pre/NN induced/VBN convulsions/NNS
1063/CD BD/NNP mice/NNS treatment/NN pre/NN induced/VBN convulsions/NNS
BD/NNP mice/NNS treatment/NN pre/NN induced/VBN convulsions/NNS
1018/CD BD/NNP mice/NNS treatment/NN pre/NN induced/VBN convulsions/NNS
LR/NNP mice/NNS treatment/NN pre/NN induced/VBN convulsions/NNS
132/CD LR/NNP mice/NNS treatment/NN pre/NN induced/VBN convulsions/NNS
BD/NNP agonist/NN tolylguanidine/NN o/NN agonist/NN well/NN worsened/VBD toxicity/NN
1031/CD BD/NNP agonist/NN tolylguanidine/NN o/NN agonist/NN well/NN worsened/VBD toxicity/NN
3/CD R/NN BD/NNP agonist/NN tolylguanidine/NN o/NN agonist/NN well/NN worsened/VBD toxicity/NN
R/NN BD/NNP agonist/NN tolylguanidine/NN o/NN agonist/NN well/NN worsened/VBD toxicity/NN
1/CD R/NN BD/NNP agonist/NN tolylguanidine/NN o/NN agonist/NN well/NN worsened/VBD toxicity/NN
-LSB-/CD 2/CD 1/CD R/NN BD/NNP agonist/NN tolylguanidine/NN o/NN agonist/NN well/NN worsened/VBD toxicity/NN
2/CD 1/CD R/NN BD/NNP agonist/NN tolylguanidine/NN o/NN agonist/NN well/NN worsened/VBD toxicity/NN
3/CD 1/CD R/NN BD/NNP agonist/NN tolylguanidine/NN o/NN agonist/NN well/NN worsened/VBD toxicity/NN
4/CD 3/CD 1/CD R/NN BD/NNP agonist/NN tolylguanidine/NN o/NN agonist/NN well/NN worsened/VBD toxicity/NN
dichlorophenyl/NN 3/CD 1/CD R/NN BD/NNP agonist/NN tolylguanidine/NN o/NN agonist/NN well/NN worsened/VBD toxicity/NN
ethyl/JJ -RSB-/NNS 1/CD R/NN BD/NNP agonist/NN tolylguanidine/NN o/NN agonist/NN well/NN worsened/VBD toxicity/NN
-RSB-/NNS 1/CD R/NN BD/NNP agonist/NN tolylguanidine/NN o/NN agonist/NN well/NN worsened/VBD toxicity/NN
1/CD 1/CD R/NN BD/NNP agonist/NN tolylguanidine/NN o/NN agonist/NN well/NN worsened/VBD toxicity/NN
4/CD 1/CD 1/CD R/NN BD/NNP agonist/NN tolylguanidine/NN o/NN agonist/NN well/NN worsened/VBD toxicity/NN
diazabicyclo/JJ -LSB-/NN 1/CD R/NN BD/NNP agonist/NN tolylguanidine/NN o/NN agonist/NN well/NN worsened/VBD toxicity/NN
-LSB-/NN 1/CD R/NN BD/NNP agonist/NN tolylguanidine/NN o/NN agonist/NN well/NN worsened/VBD toxicity/NN
4/CD -LSB-/NN 1/CD R/NN BD/NNP agonist/NN tolylguanidine/NN o/NN agonist/NN well/NN worsened/VBD toxicity/NN
3/CD -LSB-/NN 1/CD R/NN BD/NNP agonist/NN tolylguanidine/NN o/NN agonist/NN well/NN worsened/VBD toxicity/NN
0/CD -RSB-/NNS nonane/JJ -LSB-/NN 1/CD R/NN BD/NNP agonist/NN tolylguanidine/NN o/NN agonist/NN well/NN worsened/VBD toxicity/NN
-RSB-/NNS nonane/JJ -LSB-/NN 1/CD R/NN BD/NNP agonist/NN tolylguanidine/NN o/NN agonist/NN well/NN worsened/VBD toxicity/NN
nonane/JJ -LSB-/NN 1/CD R/NN BD/NNP agonist/NN tolylguanidine/NN o/NN agonist/NN well/NN worsened/VBD toxicity/NN
cocaine/NN toxicity/NN
di/FW agonist/NN well/NN worsened/VBD toxicity/NN
o/NN agonist/NN well/NN worsened/VBD toxicity/NN
tolylguanidine/NN o/NN agonist/NN well/NN worsened/VBD toxicity/NN
DTG/NNP tolylguanidine/NN o/NN agonist/NN well/NN worsened/VBD toxicity/NN
oligodeoxynucleotide/NN shown/VBN attenuate/VB effects/NNS convulsive/JJ
salvianolic/JJ A/NN effect/NN infarction/NN myocardial/JJ
salvianolic/JJ A/NN effect/NN infarction/NN
acid/JJ A/NN effect/NN infarction/NN myocardial/JJ
acid/JJ A/NN effect/NN infarction/NN
A/NN effect/NN infarction/NN myocardial/JJ
A/NN effect/NN infarction/NN
salvianolic/JJ A/NN potential/NN evaluate/VB isoproterenol/NN induced/VBN infarction/NN myocardial/JJ
salvianolic/JJ A/NN potential/NN evaluate/VB isoproterenol/NN induced/VBN infarction/NN
acid/JJ A/NN potential/NN evaluate/VB isoproterenol/NN induced/VBN infarction/NN myocardial/JJ
acid/JJ A/NN potential/NN evaluate/VB isoproterenol/NN induced/VBN infarction/NN
A/NN potential/NN evaluate/VB isoproterenol/NN induced/VBN infarction/NN myocardial/JJ
A/NN potential/NN evaluate/VB isoproterenol/NN induced/VBN infarction/NN
isoproterenol/NN observed/VBN ADP/NNP ratio/NN characterized/VBN dysfunction/NN respiratory/NN
isoproterenol/NN observed/VBN ADP/NNP ratio/NN characterized/VBN dysfunction/NN
ADP/NNP ratio/NN characterized/VBN dysfunction/NN respiratory/NN
ADP/NNP ratio/NN characterized/VBN dysfunction/NN
isoproterenol/NN dysfunction/NN cardiac/JJ
isoproterenol/NN dysfunction/NN
salvianolic/JJ A/NN Administration/NNP attenuated/VBD isoproterenol/NN dysfunction/NN injury/NN myocardial/JJ
salvianolic/JJ A/NN Administration/NNP attenuated/VBD isoproterenol/NN dysfunction/NN injury/NN
acid/JJ A/NN Administration/NNP attenuated/VBD isoproterenol/NN dysfunction/NN injury/NN myocardial/JJ
acid/JJ A/NN Administration/NNP attenuated/VBD isoproterenol/NN dysfunction/NN injury/NN
A/NN Administration/NNP attenuated/VBD isoproterenol/NN dysfunction/NN injury/NN myocardial/JJ
A/NN Administration/NNP attenuated/VBD isoproterenol/NN dysfunction/NN injury/NN
salvianolic/JJ A/NN Administration/NNP attenuated/VBD isoproterenol/NN dysfunction/NN cardiac/JJ
salvianolic/JJ A/NN Administration/NNP attenuated/VBD isoproterenol/NN dysfunction/NN
acid/JJ A/NN Administration/NNP attenuated/VBD isoproterenol/NN dysfunction/NN cardiac/JJ
acid/JJ A/NN Administration/NNP attenuated/VBD isoproterenol/NN dysfunction/NN
A/NN Administration/NNP attenuated/VBD isoproterenol/NN dysfunction/NN cardiac/JJ
A/NN Administration/NNP attenuated/VBD isoproterenol/NN dysfunction/NN
isoproterenol/NN dysfunction/NN injury/NN myocardial/JJ
isoproterenol/NN dysfunction/NN injury/NN
salvianolic/JJ A/NN damage/NN myocardial/JJ
salvianolic/JJ A/NN damage/NN
acid/JJ A/NN damage/NN myocardial/JJ
acid/JJ A/NN damage/NN
A/NN damage/NN myocardial/JJ
A/NN damage/NN
isoproterenol/NN A/NN damage/NN myocardial/JJ
isoproterenol/NN A/NN damage/NN
salvianolic/JJ acid/NN has/VBZ effect/NN isoproterenol/NN induced/VBN infarction/NN myocardial/JJ
salvianolic/JJ acid/NN has/VBZ effect/NN isoproterenol/NN induced/VBN infarction/NN
acid/NN has/VBZ effect/NN isoproterenol/NN induced/VBN infarction/NN myocardial/JJ
acid/NN has/VBZ effect/NN isoproterenol/NN induced/VBN infarction/NN
A/DT activity/NN acid/NN has/VBZ effect/NN isoproterenol/NN induced/VBN infarction/NN myocardial/JJ
A/DT activity/NN acid/NN has/VBZ effect/NN isoproterenol/NN induced/VBN infarction/NN
propranolol/NN diazepam/NN effects/NNS patients/NNS disorder/NN panic/NN
propranolol/NN diazepam/NN effects/NNS patients/NNS disorder/NN
diazepam/NN effects/NNS patients/NNS disorder/NN panic/NN
diazepam/NN effects/NNS patients/NNS disorder/NN
propranolol/NN diazepam/NN effects/NNS patients/NNS disorder/NN agoraphobia/NN
diazepam/NN effects/NNS patients/NNS disorder/NN agoraphobia/NN
propranolol/NN diazepam/NN doses/NNS performance/NN patients/NNS disorders/NNS panic/NN
propranolol/NN diazepam/NN doses/NNS performance/NN patients/NNS disorders/NNS
diazepam/NN doses/NNS performance/NN patients/NNS disorders/NNS panic/NN
diazepam/NN doses/NNS performance/NN patients/NNS disorders/NNS
propranolol/NN diazepam/NN doses/NNS performance/NN patients/NNS disorders/NNS agoraphobia/NNS
diazepam/NN doses/NNS performance/NN patients/NNS disorders/NNS agoraphobia/NNS
clonidine/NN produced/VBN pressure/NN decrease/NN rats/NNS hypertensive/JJ
nalozone/NN inhibited/JJ micrograms/VBZ rats/NNS hypertensive/JJ
naloxone/NN reversed/VBN effect/NN hypotensive/JJ
clonidine/NN influence/VB membranes/NNS rats/NNS hypertensive/NN
clonidine/JJ dihydroergocryptine/NN influence/VB influence/VB membranes/NNS rats/NNS hypertensive/NN
-LSB-/NNP -RSB-/NNP stereoselective/JJ influence/VB membranes/NNS rats/NNS hypertensive/NN
3/CD -RSB-/NNP stereoselective/JJ influence/VB membranes/NNS rats/NNS hypertensive/NN
H/NNP -RSB-/NNP stereoselective/JJ influence/VB membranes/NNS rats/NNS hypertensive/NN
-RSB-/NNP stereoselective/JJ influence/VB membranes/NNS rats/NNS hypertensive/NN
naloxone/NN -RSB-/NNP stereoselective/JJ influence/VB membranes/NNS rats/NNS hypertensive/NN
-LSB-/NNP binding/NNS -RSB-/NNP clonidine/JJ dihydroergocryptine/NN influence/VB influence/VB membranes/NNS rats/NNS hypertensive/NN
3/CD -LSB-/NNP binding/NNS -RSB-/NNP clonidine/JJ dihydroergocryptine/NN influence/VB influence/VB membranes/NNS rats/NNS hypertensive/NN
H/NNP -RSB-/NNP clonidine/JJ dihydroergocryptine/NN influence/VB influence/VB membranes/NNS rats/NNS hypertensive/NN
-RSB-/NNP clonidine/JJ dihydroergocryptine/NN influence/VB influence/VB membranes/NNS rats/NNS hypertensive/NN
dihydroergocryptine/NN influence/VB influence/VB membranes/NNS rats/NNS hypertensive/NN
naloxone/NN influence/VB influence/VB membranes/NNS rats/NNS hypertensive/NN
Lamivudine/NNP antigen/NN seropositive/VBP undergoing/VBG patients/NNS cancer/NN
Lamivudine/NNP prevention/NN reactivation/NN hepatitis/NNP
Lamivudine/NNP prevention/NN reactivation/NN B/NNP
hepatitis/NN reactivation/NN prevention/NN Lamivudine/NNP antigen/NN seropositive/VBP undergoing/VBG patients/NNS cancer/NN
B/NNP antigen/NN seropositive/VBP undergoing/VBG patients/NNS cancer/NN
surface/NN antigen/NN seropositive/VBP undergoing/VBG patients/NNS cancer/NN
antigen/NN seropositive/VBP undergoing/VBG patients/NNS cancer/NN
HBSAG/NNP antigen/NN seropositive/VBP undergoing/VBG patients/NNS cancer/NN
lamivudine/NN received/VBD patients/NNS cancer/NN
lamivudine/NN receive/VB group/NN received/VBD patients/NNS cancer/NN
lamivudine/NN received/VBD patients/NNS have/VBP malignancies/NNS solid/JJ hematological/JJ
lamivudine/NN received/VBD patients/NNS have/VBP malignancies/NNS
lamivudine/NN receive/VB group/NN received/VBD patients/NNS have/VBP malignancies/NNS solid/JJ hematological/JJ
lamivudine/NN receive/VB group/NN received/VBD patients/NNS have/VBP malignancies/NNS
lamivudine/NN received/VBD patients/NNS have/VBP malignancies/NNS infection/NN HBV/NNP
lamivudine/NN received/VBD patients/NNS have/VBP malignancies/NNS infection/NN
lamivudine/NN receive/VB group/NN received/VBD patients/NNS have/VBP malignancies/NNS infection/NN HBV/NNP
lamivudine/NN receive/VB group/NN received/VBD patients/NNS have/VBP malignancies/NNS infection/NN
lamivudine/NN group/NN observed/VBN hepatitis/NN
lamivudine/NN decreases/VBZ incidence/NN morbidity/NN patients/NNS cancer/NN
methylergonovine/NN Effect/NN patients/NNS angina/NN variant/JJ
methylergonovine/NN Effect/NN patients/NNS angina/NN
methylergonovine/NN administration/NN effects/NNS studied/VBN pectoris/NNS angina/NN
methylergonovine/NN administration/NN effects/NNS studied/VBN pectoris/NNS
methylergonovine/NN administration/NN effects/NNS studied/VBN patients/NNS angina/NN variant/JJ
methylergonovine/NN administration/NN effects/NNS studied/VBN patients/NNS angina/NN
methylergonovine/NN administration/NN effects/NNS studied/VBN patients/NNS patients/NNS pain/NN chest/NN
methylergonovine/NN administration/NN effects/NNS studied/VBN patients/NNS patients/NNS pain/NN
methylergonovine/NN dose/NN injection/NN use/VBP tests/NNS spasm/NN
methylergonovine/NN dose/NN injection/NN use/VBP tests/NNS have/VBP sensitivity/NN angina/NN variant/JJ
methylergonovine/NN dose/NN injection/NN use/VBP tests/NNS have/VBP sensitivity/NN angina/NN
etoposide/NN A/NN effect/NN observed/VBN patient/NN T/NNP acute/JJ
etoposide/NN A/NN effect/NN observed/VBN patient/NN T/NNP
etoposide/NN A/NN effect/NN observed/VBN patient/NN leukemia/NN lymphocytic/JJ
etoposide/NN A/NN effect/NN observed/VBN patient/NN leukemia/NN
cyclosporin/NN etoposide/NN A/NN effect/NN observed/VBN patient/NN T/NNP acute/JJ
cyclosporin/NN etoposide/NN A/NN effect/NN observed/VBN patient/NN T/NNP
cyclosporin/NN etoposide/NN A/NN effect/NN observed/VBN patient/NN leukemia/NN lymphocytic/JJ
cyclosporin/NN etoposide/NN A/NN effect/NN observed/VBN patient/NN leukemia/NN
A/NN effect/NN observed/VBN patient/NN T/NNP acute/JJ
A/NN effect/NN observed/VBN patient/NN T/NNP
A/NN effect/NN observed/VBN patient/NN leukemia/NN lymphocytic/JJ
A/NN effect/NN observed/VBN patient/NN leukemia/NN
cyclosporin/NN etoposide/NN A/NN administration/NN resulted/VBD eradication/NN infiltration/NN leukemic/JJ
cyclosporin/NN etoposide/NN A/NN administration/NN resulted/VBD eradication/NN infiltration/NN
A/NN administration/NN resulted/VBD eradication/NN infiltration/NN leukemic/JJ
A/NN administration/NN resulted/VBD eradication/NN infiltration/NN
etoposide/NN A/NN administration/NN resulted/VBD eradication/NN infiltration/NN leukemic/JJ
etoposide/NN A/NN administration/NN resulted/VBD eradication/NN infiltration/NN
debrisoquine/JJ polymorphism/NN belonging/VBG patients/NNS experience/VB reactions/NNS adverse/JJ
debrisoquine/JJ polymorphism/NN belonging/VBG patients/NNS experience/VB reactions/NNS drug/NN
debrisoquine/JJ polymorphism/NN belonging/VBG patients/NNS experience/VB reactions/NNS
sparteine/NN phenotype/NN polymorphism/NN belonging/VBG patients/NNS experience/VB reactions/NNS adverse/JJ
sparteine/NN phenotype/NN polymorphism/NN belonging/VBG patients/NNS experience/VB reactions/NNS drug/NN
sparteine/NN phenotype/NN polymorphism/NN belonging/VBG patients/NNS experience/VB reactions/NNS
Propylthiouracil/NNP induced/VBN staining/VBG autoantibody/NN vasculitis/NNS
propylthiouracil/NN case/NN describe/VB induced/VBN vasculitis/NNS
propylthiouracil/NN treated/VBN hyperthyroidism/NN
propylthio/NN associated/VBN vasculitis/NNS
uracil/VBP pANCA/NNP vasculitis/NNS
propylthio/NN attributable/JJ vasculitis/NNS
uracil/JJ therapy/NN manifestation/NN induced/VBN attributable/JJ vasculitis/NNS
Adriamycin/NNP induced/VBN plays/VBZ death/NN
3/CD methyladenine/NN used/VBN model/NN heart/NN
3/CD methyladenine/NN used/VBN model/NN failure/NN
methyladenine/NN used/VBN model/NN heart/NN
methyladenine/NN used/VBN model/NN failure/NN
3/NNP MA/NNP methyladenine/NN used/VBN model/NN heart/NN
3/NNP MA/NNP methyladenine/NN used/VBN model/NN failure/NN
MA/NNP methyladenine/NN used/VBN model/NN heart/NN
MA/NNP methyladenine/NN used/VBN model/NN failure/NN
adriamycin/NN induced/VBN rats/NNS plays/VBZ death/NN
estrogen/NN Characterization/NNP tumors/NNS adenohypophyseal/JJ
estrogen/NN Characterization/NNP tumors/NNS
DES/NNP establishing/VBG induced/VBN tumor/NN
adriamycin/NN toxicity/NN
polyethylene/NN Effect/NN glycol/VBD toxicity/NN
glycol/VBD toxicity/NN
400/CD glycol/VBD toxicity/NN
ADR/NNP activity/NN tumor/NN L/NNP
ADR/NNP activity/NN tumor/NN leukemia/NN 1210/CD
ADR/NNP activity/NN tumor/NN leukemia/NN
ADR/NNP activity/NN tumor/NN leukemia/NN ascites/NNS Ehrlich/NNP
ADR/NNP activity/NN tumor/NN leukemia/NN ascites/NNS
ADR/NNP activity/NN tumor/NN
salt/NN angiotensinogen/NN hypertension/NN
Testosterone/NNP hypertension/NN
testosterone/NN causes/VBZ increases/NNS BP/NNP injury/NN renal/JJ
testosterone/NN causes/VBZ increases/NNS BP/NNP injury/NN
Testosterone/JJ replacement/NN increased/VBD BP/NNP injury/NN renal/JJ
Testosterone/JJ replacement/NN increased/VBD BP/NNP injury/NN
angiotensin/NN system/NN upregulation/NN contributes/VBZ development/NN hypertension/NN
angiotensin/NN system/NN upregulation/NN contributes/VBZ development/NN injury/NN renal/JJ
angiotensin/NN system/NN upregulation/NN contributes/VBZ development/NN injury/NN
Testosterone/NNP contributes/VBZ development/NN injury/NN renal/JJ
Testosterone/NNP contributes/VBZ development/NN injury/NN
Testosterone/NNP contributes/VBZ development/NN hypertension/NN
pentazocine/NN due/JJ myopathy/JJ fibrous/NNS
pentazocine/NN due/JJ myopathy/JJ
pentazocine/NN due/JJ neuropathy/NNP Compression/NNP
pentazocine/NN due/JJ neuropathy/NNP
pentazocine/NN due/JJ neuropathy/NNP nerve/NN of/IN
pentazocine/NN due/JJ neuropathy/NNP nerve/NN the/DT
pentazocine/NN due/JJ neuropathy/NNP nerve/NN radial/JJ
pentazocine/NN due/JJ neuropathy/NNP nerve/NN
pentazocine/NN injection/NN effect/NN Fibrous/NNS
pentazocine/NN injection/NN effect/NN myopathy/RB
pentazocine/NN woman/NN 37/CD fibrous/NNS
pentazocine/NN woman/NN 37/CD fibrous/NNS bilaterally/NN myopathy/RB
pentazocine/NN woman/NN 37/CD showed/VBD myopathy/NN fibrous/JJ
pentazocine/NN woman/NN 37/CD showed/VBD myopathy/NN
Paracetamol/NNP associated/VBN coma/NN
Paracetamol/NNP associated/VBN coma/NN renal/JJ
Paracetamol/NNP associated/VBN coma/NN and/CC
Paracetamol/NNP associated/VBN coma/NN failure/NN hepatic/JJ
Paracetamol/NNP associated/VBN coma/NN failure/NN
paracetamol/NNP ingestion/NNP failure/NN acidosis/NNS failure/NN acute/JJ
paracetamol/NNP ingestion/NNP failure/NN acidosis/NNS failure/NN renal/JJ
paracetamol/NNP ingestion/NNP failure/NN acidosis/NNS failure/NN
paracetamol/NNP ingestion/NNP failure/NN acidosis/NNS and/CC
paracetamol/NNP ingestion/NNP failure/NN hepatic/JJ
paracetamol/NNP ingestion/NNP failure/NN
pergolide/NN treated/VBN disease/NN disease/NN patients/NNS Parkinson/NNP
pergolide/NN treated/VBN disease/NN disease/NN patients/NNS Parkinson/NNP '/POS
pergolide/NN treated/VBN disease/NN s/VBZ
pergolide/NN treated/VBN disease/NN
pergolide/NN treated/VBN disease/NN disease/NN Valvular/JJ
pergolide/NN treated/VBN disease/NN disease/NN heart/NN
pergolide/NN treated/VBN disease/NN disease/NN
pergolide/NN treated/VBN patients/NNS disease/NN Parkinson/NNP
pergolide/NN treated/VBN patients/NNS disease/NN Parkinson/NNP '/POS
pergolide/NN treated/VBN patients/NNS disease/NN s/JJ
pergolide/NN treated/VBN patients/NNS disease/NN
pergolide/NN treated/VBN patients/NNS disease/NN PD/NNP
pergolide/NN treated/VBN patients/NNS reported/VBN abnormalities/NNS Valvular/JJ
pergolide/NN treated/VBN patients/NNS reported/VBN abnormalities/NNS heart/NN
pergolide/NN treated/VBN patients/NNS reported/VBN abnormalities/NNS
pergolide/NN treated/VBN area/NN patients/NNS PD/NNP
pergolide/NN role/NN suggestive/NN pattern/NN observed/VBN patients/NNS two/CD failure/NN heart/NN
pergolide/NN role/NN suggestive/NN pattern/NN observed/VBN patients/NNS two/CD failure/NN
pergolide/NN role/NN suggestive/NN pattern/NN regurgitation/NN valvular/NN
pergolide/NN role/NN suggestive/NN pattern/NN regurgitation/NN
Pergolide/NNP discontinued/VBN resulting/VBG failure/NN heart/NN
Pergolide/NNP discontinued/VBN resulting/VBG failure/NN
Pergolide/NNP discontinued/VBN disease/NN valvular/NN
Pergolide/NNP discontinued/VBN disease/NN heart/NN
Pergolide/NNP discontinued/VBN disease/NN
dopamine/NN agonists/NNS non/VB converted/VBN usual/JJ reveals/VBZ supports/VBZ frequency/NN regurgitation/NN valve/NN
dopamine/NN agonists/NNS non/VB converted/VBN usual/JJ reveals/VBZ supports/VBZ frequency/NN regurgitation/NN
dopamine/NN agonists/NNS non/VB converted/VBN usual/JJ reveals/VBZ supports/VBZ frequency/NN regurgitation/NN patients/NNS PD/NNP
pergolide/NN treated/VBN patients/NNS PD/NNP
pergolide/NN treated/VBN patients/NNS regurgitation/NN valve/NN
pergolide/NN treated/VBN patients/NNS regurgitation/NN
Lamivudine/NNP added/VBN infection/NN hepatitis/NNP
Lamivudine/NNP added/VBN infection/NN B/NNP
Lamivudine/NNP added/VBN infection/NN
sirolimus/NNS replaced/VBN transplant/VB acidosis/NNS
sirolimus/NNS replaced/VBN transplant/VB acidosis/VBZ
tacrolimus/NNS suspected/VBN acidosis/VBZ transplant/VB acidosis/NNS
tacrolimus/NNS suspected/VBN acidosis/VBZ
lamivudine/NN augmented/VBN triggered/VBN dysfunction/NN mitochondrial/JJ
lamivudine/NN augmented/VBN triggered/VBN dysfunction/NN
tacrolimus/NNS triggered/VBN dysfunction/NN mitochondrial/JJ
tacrolimus/NNS triggered/VBN dysfunction/NN
DCE/NNP reversed/VBD amnesia/NN
DCE/NNP prove/VB remedy/NN management/NN dysfunctions/NNS cognitive/JJ
DCE/NNP prove/VB remedy/NN management/NN dysfunctions/NNS
cholesterol/NN property/NN improving/VBG remedy/NN management/NN dysfunctions/NNS cognitive/JJ
cholesterol/NN property/NN improving/VBG remedy/NN management/NN dysfunctions/NNS
Indomethacin/NNP induced/VBN insufficiency/NN renal/JJ
Indomethacin/NNP induced/VBN insufficiency/NN
indomethacin/NN therapy/NN pulmonale/NN reported/VBN case/NN failure/NN renal/JJ
indomethacin/NN therapy/NN pulmonale/NN reported/VBN case/NN failure/NN
bicuculline/NN containing/VBG medium/NN Mg/NNP resulted/VBD pilocarpine/VBD treated/VBN mice/NNS experience/VB SE/NNP
Mg/NNP resulted/VBD pilocarpine/VBD treated/VBN mice/NNS experience/VB SE/NNP
glutamate/NN antagonists/NNS blocked/VBN duration/NN afterdischarges/NNS shifts/NNS followed/VBN spike/NN resulted/VBD survivors/NNS SE/NNP
glutamate/NN photostimulation/NN distant/VBZ duration/NN slices/NNS survivors/NNS SE/NNP
carbidopa/NN levodopa/NN point/NN normality/NN lead/VB toxicity/NN
levodopa/NN therapy/NN starting/VBG is/VBZ started/VBN carbidopa/NN levodopa/NN point/NN normality/NN lead/VB toxicity/NN
levodopa/NN point/NN normality/NN lead/VB toxicity/NN
levodopa/NN psychosis/NNS
levodopa/NN psychosis/NNS disturbances/NNS sleep/NN
levodopa/NN psychosis/NNS disturbances/NNS
nitroglycerin/NN Provocation/NNP neuropathy/NN diabetic/JJ
nitroglycerin/NN Provocation/NNP neuropathy/NN autonomic/JJ
nitroglycerin/NN Provocation/NNP neuropathy/NN
nitroglycerin/NN effect/NN compared/VBN subjects/NNS subjects/NNS neuropathy/NN autonomic/JJ
nitroglycerin/NN effect/NN compared/VBN subjects/NNS subjects/NNS neuropathy/NN
nitroglycerin/NN effect/NN compared/VBN neuropathy/NN autonomic/JJ
nitroglycerin/NN effect/NN compared/VBN neuropathy/NN
nitroglycerin/NN effect/NN compared/VBN subjects/NNS subjects/NNS diabetic/JJ
nitroglycerin/NN effect/NN compared/VBN subjects/NNS subjects/NNS diabetic/JJ
nitroglycerin/NN pressure/NN decrease/NN increase/NN course/NN similar/JJ neuropathy/NN autonomic/JJ
nitroglycerin/NN pressure/NN decrease/NN increase/NN course/NN similar/JJ neuropathy/NN
nitroglycerin/NN pressure/NN decrease/NN increase/NN course/NN similar/JJ occurred/VBD neuropathy/NN autonomic/JJ
nitroglycerin/NN pressure/NN decrease/NN increase/NN course/NN similar/JJ occurred/VBD neuropathy/NN
nitroglycerin/NN pressure/NN decrease/NN increase/NN course/NN similar/JJ subjects/NNS normal/JJ diabetic/JJ
nitroglycerin/NN pressure/NN decrease/NN increase/NN course/NN similar/JJ occurred/VBD subjects/NNS diabetic/JJ
magnesium/NN administration/NN preeclampsia/NN
magnesium/NN administration/NN became/VBD quadriplegic/JJ
magnesium/NN administration/NN became/VBD history/NN disease/NN neuromuscular/NN
magnesium/NN administration/NN became/VBD history/NN disease/NN
magnesium/NN administration/NN paralysis/NN
magnesium/NN effects/NNS sensitive/JJ Patients/NNS suspected/VBN having/VBG disorder/NN
magnesium/NN effects/NNS sensitive/JJ Patients/NNS suspected/VBN having/VBG disorder/NN transmission/NN of/IN
magnesium/NN effects/NNS sensitive/JJ Patients/NNS suspected/VBN having/VBG disorder/NN transmission/NN neuromuscular/NN
magnesium/NN effects/NNS sensitive/JJ Patients/NNS suspected/VBN having/VBG disorder/NN transmission/NN
disulfiram/NN overdose/NN
disulfiram/NN intoxication/NN axonal/NN superimposed/VBN case/NN palsy/NN
disulfiram/NN intoxication/NN axonal/NN caused/VBN polyneuropathy/RB
vitamin/NNP D/NNP growth/NN accelerated/VBN calcification/NN artery/NN
vitamin/NNP D/NNP growth/NN accelerated/VBN calcification/NN
D/NNP growth/NN accelerated/VBN calcification/NN artery/NN
D/NNP growth/NN accelerated/VBN calcification/NN
vitamin/NN treatment/NN growth/NN enhance/VB extent/NN calcification/NN artery/NN
vitamin/NN treatment/NN growth/NN enhance/VB extent/NN calcification/NN
D/NNP treatment/NN growth/NN enhance/VB extent/NN calcification/NN artery/NN
D/NNP treatment/NN growth/NN enhance/VB extent/NN calcification/NN
Warfarin/NNP doses/NNS given/VBN rats/NNS enhance/VB carboxylation/NN protein/NN inhibitor/NN calcification/NN
vitamin/NN treatment/NN growth/NN enhance/VB carboxylation/NN protein/NN inhibitor/NN calcification/NN
D/NNP treatment/NN growth/NN enhance/VB carboxylation/NN protein/NN inhibitor/NN calcification/NN
Warfarin/NNP weeks/NNS Treatment/NNP caused/VBD 20/CD rats/NNS calcification/NN
phosphate/JJ serum/NN relationship/NN was/VBD determined/VBN explanation/NN association/NN calcification/NN artery/NN
phosphate/JJ serum/NN relationship/NN was/VBD determined/VBN explanation/NN association/NN calcification/NN
phosphate/JJ serum/NN relationship/NN was/VBD calcification/NN artery/NN
phosphate/JJ serum/NN relationship/NN was/VBD calcification/NN
phosphate/JJ serum/NN relationship/NN was/VBD levels/NNS induced/VBN calcification/NN artery/NN
phosphate/JJ serum/NN relationship/NN was/VBD levels/NNS induced/VBN calcification/NN
phosphate/NN levels/NNS was/VBD determined/VBN explanation/NN association/NN calcification/NN artery/NN
phosphate/NN levels/NNS was/VBD determined/VBN explanation/NN association/NN calcification/NN
phosphate/NN levels/NNS was/VBD calcification/NN artery/NN
phosphate/NN levels/NNS was/VBD calcification/NN
phosphate/NN levels/NNS induced/VBN calcification/NN artery/NN
phosphate/NN levels/NNS induced/VBN calcification/NN
phosphate/NN levels/NNS related/VBN calcification/NN artery/NN
phosphate/NN levels/NNS related/VBN calcification/NN
vitamin/NNP D/NNP synergy/NN examined/VBD calcification/NN artery/NN
vitamin/NNP D/NNP synergy/NN examined/VBD calcification/NN
D/NNP synergy/NN examined/VBD calcification/NN artery/NN
D/NNP synergy/NN examined/VBD calcification/NN
vitamin/NNP D/NNP doses/NNS known/VBN cause/VB calcification/NN
vitamin/NNP D/NNP doses/NNS known/VBN cause/VB calcification/NN media/NNS of/IN
vitamin/NNP D/NNP doses/NNS known/VBN cause/VB calcification/NN media/NNS the/DT
vitamin/NNP D/NNP doses/NNS known/VBN cause/VB calcification/NN media/NNS artery/NN
D/NNP doses/NNS known/VBN cause/VB calcification/NN
D/NNP doses/NNS known/VBN cause/VB calcification/NN media/NNS of/IN
D/NNP doses/NNS known/VBN cause/VB calcification/NN media/NNS the/DT
D/NNP doses/NNS known/VBN cause/VB calcification/NN media/NNS artery/NN
vitamin/NNP Warfarin/NNP doses/NNS known/VBN calcification/NN
vitamin/NNP Warfarin/NNP doses/NNS known/VBN calcification/NN media/NNS of/IN
vitamin/NNP Warfarin/NNP doses/NNS known/VBN calcification/NN media/NNS the/DT
vitamin/NNP Warfarin/NNP doses/NNS known/VBN calcification/NN media/NNS artery/NN
K/NNP Warfarin/NNP doses/NNS known/VBN calcification/NN
K/NNP Warfarin/NNP doses/NNS known/VBN calcification/NN media/NNS of/IN
K/NNP Warfarin/NNP doses/NNS known/VBN calcification/NN media/NNS the/DT
K/NNP Warfarin/NNP doses/NNS known/VBN calcification/NN media/NNS artery/NN
Warfarin/JJ administration/NN increased/VBD extent/NN calcification/NN
vitamin/NNP D/NNP media/NNS increased/VBD extent/NN calcification/NN
D/NNP media/NNS increased/VBD extent/NN calcification/NN
vitamin/NNP dose/NNP calcification/NN artery/NN
vitamin/NNP dose/NNP calcification/NN
D/NNP dose/NNP calcification/NN artery/NN
D/NNP dose/NNP calcification/NN
vitamin/NNP dose/NNP effect/NN parallel/NN elevation/NN calcium/NN suggests/VBZ induce/VB calcification/NN artery/NN
vitamin/NNP dose/NNP effect/NN parallel/NN elevation/NN calcium/NN suggests/VBZ induce/VB calcification/NN
D/NNP dose/NNP effect/NN parallel/NN elevation/NN calcium/NN suggests/VBZ induce/VB calcification/NN artery/NN
D/NNP dose/NNP effect/NN parallel/NN elevation/NN calcium/NN suggests/VBZ induce/VB calcification/NN
vitamin/NNP dose/NN effect/NN dose/NNP calcification/NN artery/NN
vitamin/NNP dose/NN effect/NN dose/NNP calcification/NN
D/NNP dose/NN effect/NN dose/NNP calcification/NN artery/NN
D/NNP dose/NN effect/NN dose/NNP calcification/NN
vitamin/NNP dose/NN effect/NN dose/NNP effect/NN parallel/NN elevation/NN calcium/NN suggests/VBZ induce/VB calcification/NN artery/NN
vitamin/NNP dose/NN effect/NN dose/NNP effect/NN parallel/NN elevation/NN calcium/NN suggests/VBZ induce/VB calcification/NN
D/NNP dose/NN effect/NN dose/NNP effect/NN parallel/NN elevation/NN calcium/NN suggests/VBZ induce/VB calcification/NN artery/NN
D/NNP dose/NN effect/NN dose/NNP effect/NN parallel/NN elevation/NN calcium/NN suggests/VBZ induce/VB calcification/NN
vitamin/NNP D/NNP induce/VB suggests/VBZ calcium/NN elevation/NN parallel/NN effect/NN dose/NNP calcification/NN artery/NN
vitamin/NNP D/NNP induce/VB suggests/VBZ calcium/NN elevation/NN parallel/NN effect/NN dose/NNP calcification/NN
D/NNP induce/VB suggests/VBZ calcium/NN elevation/NN parallel/NN effect/NN dose/NNP calcification/NN artery/NN
D/NNP induce/VB suggests/VBZ calcium/NN elevation/NN parallel/NN effect/NN dose/NNP calcification/NN
vitamin/NNP D/NNP induce/VB calcification/NN artery/NN
vitamin/NNP D/NNP induce/VB calcification/NN
D/NNP induce/VB calcification/NN artery/NN
D/NNP induce/VB calcification/NN
calcium/NN elevation/NN parallel/NN effect/NN dose/NNP calcification/NN artery/NN
calcium/NN elevation/NN parallel/NN effect/NN dose/NNP calcification/NN
calcium/NN suggests/VBZ induce/VB calcification/NN artery/NN
calcium/NN suggests/VBZ induce/VB calcification/NN
calcium/NN effect/NN induce/VB suggests/VBZ calcium/NN elevation/NN parallel/NN effect/NN dose/NNP calcification/NN artery/NN
calcium/NN effect/NN induce/VB suggests/VBZ calcium/NN elevation/NN parallel/NN effect/NN dose/NNP calcification/NN
calcium/NN effect/NN induce/VB calcification/NN artery/NN
calcium/NN effect/NN induce/VB calcification/NN
calcium/NN had/VBD explained/VBN inhibits/VBZ activity/NN protein/NN inhibitor/NN calcification/NN
Warfarin/NNP treatment/NN had/VBD explained/VBN inhibits/VBZ activity/NN protein/NN inhibitor/NN calcification/NN
Warfarin/NNP D/NNP synergy/NN explained/VBN inhibits/VBZ activity/NN protein/NN inhibitor/NN calcification/NN
Warfarin/NNP inhibits/VBZ activity/NN protein/NN inhibitor/NN calcification/NN
vitamin/NNP D/NNP produced/VBN calcium/NN had/VBD explained/VBN inhibits/VBZ activity/NN protein/NN inhibitor/NN calcification/NN
D/NNP produced/VBN calcium/NN had/VBD explained/VBN inhibits/VBZ activity/NN protein/NN inhibitor/NN calcification/NN
vitamin/NNP Warfarin/NNP D/NNP synergy/NN explained/VBN inhibits/VBZ activity/NN protein/NN inhibitor/NN calcification/NN
D/NNP synergy/NN explained/VBN inhibits/VBZ activity/NN protein/NN inhibitor/NN calcification/NN
vitamin/NNP D/NNP treated/VBN rats/NNS found/VBN sites/NNS calcification/NN artery/NN
vitamin/NNP D/NNP treated/VBN rats/NNS found/VBN sites/NNS calcification/NN
D/NNP treated/VBN rats/NNS found/VBN sites/NNS calcification/NN artery/NN
D/NNP treated/VBN rats/NNS found/VBN sites/NNS calcification/NN
gamma/JJ showed/VBD found/VBN sites/NNS calcification/NN artery/NN
gamma/JJ showed/VBD found/VBN sites/NNS calcification/NN
carboxylated/JJ gamma/JJ showed/VBD found/VBN sites/NNS calcification/NN artery/NN
carboxylated/JJ gamma/JJ showed/VBD found/VBN sites/NNS calcification/NN
gamma/JJ protein/NN required/VBN inhibitor/NN calcification/NN
carboxyglutamate/JJ residues/NNS gamma/JJ protein/NN required/VBN inhibitor/NN calcification/NN
gamma/JJ protein/NN required/VBN required/VBN sites/NNS calcification/NN
carboxyglutamate/JJ residues/NNS gamma/JJ protein/NN required/VBN required/VBN sites/NNS calcification/NN
SRL/NNP treated/VBN therapy/NN sarcoma/NN cancers/NNS carsinom/NN renal/JJ
SRL/NNP treated/VBN therapy/NN sarcoma/NN cancers/NNS carsinom/NN cell/NN
SRL/NNP treated/VBN therapy/NN sarcoma/NN cancers/NNS carsinom/NN
SRL/NNP treated/VBN therapy/NN neoplasia/NN due/JJ nephropathy/NN CAN/NNP
SRL/NNP treated/VBN therapy/NN sarcoma/NN nephropathy/NN
SRL/NNP treated/VBN therapy/NN neoplasia/NN
SRL/NNP treated/VBN therapy/NN sarcoma/NN cancers/NNS tumors/NNS intestinal/JJ
SRL/NNP treated/VBN therapy/NN sarcoma/NN cancers/NNS tumors/NNS
SRL/NNP treated/VBN therapy/NN sarcoma/NN Kaposi/NNP
SRL/NNP treated/VBN therapy/NN sarcoma/NN Kaposi/NNP '/POS
SRL/NNP treated/VBN therapy/NN sarcoma/NN s/JJ
SRL/NNP treated/VBN therapy/NN sarcoma/NN
SRL/NNP treated/VBN therapy/NN sarcoma/NN cancers/NNS skin/NN
SRL/NNP treated/VBN therapy/NN sarcoma/NN cancers/NNS
SRL/NNP treated/VBN therapy/NN neoplasia/NN due/JJ nephropathy/NN chronic/JJ
SRL/NNP treated/VBN therapy/NN neoplasia/NN due/JJ nephropathy/NN allograft/NN
SRL/NNP treated/VBN therapy/NN neoplasia/NN due/JJ nephropathy/NN
DFO/NNP other/JJ factor/NN ototoxic/JJ
DFO/NNP role/NN development/NN impairment/NN hearing/NN
DFO/NNP role/NN development/NN impairment/NN
amphetamine/NN dose/NN sensitization/VBN diet/NN promoting/VBG causes/NNS sugar/NN
amphetamine/NN dose/NN sensitization/VBN diet/NN promoting/VBG causes/NNS dependency/NN
cocaine/NN revealed/VBN period/NN METHODS/NNS aneurysms/NNS
cocaine/NN patients/NNS outcome/NN predictors/NNS aneurysms/NNS
Cocaine/NNP use/NN predisposed/VBD predisposed/VBD' aneurysms/NNS
nelarabine/NN therapy/NN T/NN
nelarabine/NN therapy/NN T/NN leukaemia/NN cell/NN
nelarabine/NN therapy/NN T/NN leukaemia/NN lymphoblastic/JJ
nelarabine/NN therapy/NN T/NN leukaemia/NN
nelarabine/NN therapy/NN T/NN leukaemia/NN and/CC
nelarabine/NN therapy/NN T/NN leukaemia/NN lymphoma/NN
cyclophosphamide/NN nelarabine/NN therapy/NN T/NN
cyclophosphamide/NN nelarabine/NN therapy/NN T/NN leukaemia/NN cell/NN
cyclophosphamide/NN nelarabine/NN therapy/NN T/NN leukaemia/NN lymphoblastic/JJ
cyclophosphamide/NN nelarabine/NN therapy/NN T/NN leukaemia/NN
cyclophosphamide/NN nelarabine/NN therapy/NN T/NN leukaemia/NN and/CC
cyclophosphamide/NN nelarabine/NN therapy/NN T/NN leukaemia/NN lymphoma/NN
etoposide/NN nelarabine/NN therapy/NN T/NN
etoposide/NN nelarabine/NN therapy/NN T/NN leukaemia/NN cell/NN
etoposide/NN nelarabine/NN therapy/NN T/NN leukaemia/NN lymphoblastic/JJ
etoposide/NN nelarabine/NN therapy/NN T/NN leukaemia/NN
etoposide/NN nelarabine/NN therapy/NN T/NN leukaemia/NN and/CC
etoposide/NN nelarabine/NN therapy/NN T/NN leukaemia/NN lymphoma/NN
nelarabine/NN d/NNS combination/NN used/VBN children/NNS T/NN
nelarabine/NN d/NNS combination/NN used/VBN children/NNS leukaemia/NN cell/NN
nelarabine/NN d/NNS combination/NN used/VBN children/NNS leukaemia/NN
nelarabine/NN d/NNS combination/NN used/VBN children/NNS leukaemia/NN or/CC
nelarabine/NN d/NNS combination/NN used/VBN children/NNS leukaemia/NN lymphoma/NN
AraG/NNP nelarabine/NN d/NNS combination/NN used/VBN children/NNS T/NN
AraG/NNP nelarabine/NN d/NNS combination/NN used/VBN children/NNS leukaemia/NN cell/NN
AraG/NNP nelarabine/NN d/NNS combination/NN used/VBN children/NNS leukaemia/NN
AraG/NNP nelarabine/NN d/NNS combination/NN used/VBN children/NNS leukaemia/NN or/CC
AraG/NNP nelarabine/NN d/NNS combination/NN used/VBN children/NNS leukaemia/NN lymphoma/NN
cyclophosphamide/NN etoposide/NN d/NNS nelarabine/NN d/NNS combination/NN used/VBN children/NNS T/NN
cyclophosphamide/NN etoposide/NN d/NNS nelarabine/NN d/NNS combination/NN used/VBN children/NNS leukaemia/NN cell/NN
cyclophosphamide/NN etoposide/NN d/NNS nelarabine/NN d/NNS combination/NN used/VBN children/NNS leukaemia/NN
cyclophosphamide/NN etoposide/NN d/NNS nelarabine/NN d/NNS combination/NN used/VBN children/NNS leukaemia/NN or/CC
cyclophosphamide/NN etoposide/NN d/NNS nelarabine/NN d/NNS combination/NN used/VBN children/NNS leukaemia/NN lymphoma/NN
CPM/NNP etoposide/NN d/NNS nelarabine/NN d/NNS combination/NN used/VBN children/NNS T/NN
CPM/NNP etoposide/NN d/NNS nelarabine/NN d/NNS combination/NN used/VBN children/NNS leukaemia/NN cell/NN
CPM/NNP etoposide/NN d/NNS nelarabine/NN d/NNS combination/NN used/VBN children/NNS leukaemia/NN
CPM/NNP etoposide/NN d/NNS nelarabine/NN d/NNS combination/NN used/VBN children/NNS leukaemia/NN or/CC
CPM/NNP etoposide/NN d/NNS nelarabine/NN d/NNS combination/NN used/VBN children/NNS leukaemia/NN lymphoma/NN
etoposide/NN d/NNS nelarabine/NN d/NNS combination/NN used/VBN children/NNS T/NN
etoposide/NN d/NNS nelarabine/NN d/NNS combination/NN used/VBN children/NNS leukaemia/NN cell/NN
etoposide/NN d/NNS nelarabine/NN d/NNS combination/NN used/VBN children/NNS leukaemia/NN
etoposide/NN d/NNS nelarabine/NN d/NNS combination/NN used/VBN children/NNS leukaemia/NN or/CC
etoposide/NN d/NNS nelarabine/NN d/NNS combination/NN used/VBN children/NNS leukaemia/NN lymphoma/NN
VP/NNP etoposide/NN d/NNS nelarabine/NN d/NNS combination/NN used/VBN children/NNS T/NN
VP/NNP etoposide/NN d/NNS nelarabine/NN d/NNS combination/NN used/VBN children/NNS leukaemia/NN cell/NN
VP/NNP etoposide/NN d/NNS nelarabine/NN d/NNS combination/NN used/VBN children/NNS leukaemia/NN
VP/NNP etoposide/NN d/NNS nelarabine/NN d/NNS combination/NN used/VBN children/NNS leukaemia/NN or/CC
VP/NNP etoposide/NN d/NNS nelarabine/NN d/NNS combination/NN used/VBN children/NNS leukaemia/NN lymphoma/NN
cyclophosphamide/NN etoposide/NN giving/VBG safety/NN supports/VBZ monitored/VBN toxicity/NN neurological/JJ
cyclophosphamide/NN etoposide/NN giving/VBG safety/NN supports/VBZ monitored/VBN toxicity/NN
etoposide/NN giving/VBG safety/NN supports/VBZ monitored/VBN toxicity/NN neurological/JJ
etoposide/NN giving/VBG safety/NN supports/VBZ monitored/VBN toxicity/NN
imidazoline/NN modulation/NN hypotension/NN
estrogen/NN modulation/NN hypotension/NN
clonidine/NN effect/NN hypotensive/JJ
estrogen/NN modulates/VBZ effect/NN hypotensive/JJ
alpha/NN rats/NNS paralleled/VBN SDRR/NNP activity/NN a/DT
alpha/NN rats/NNS paralleled/VBN SDRR/NNP activity/NN reduced/VBN
alpha/NN rats/NNS paralleled/VBN SDRR/NNP activity/NN locomotor/NN
alpha/NN rats/NNS paralleled/VBN SDRR/NNP activity/NN
methyldopa/NN hypotension/NN alpha/NN rats/NNS paralleled/VBN SDRR/NNP activity/NN a/DT
methyldopa/NN hypotension/NN alpha/NN rats/NNS paralleled/VBN SDRR/NNP activity/NN reduced/VBN
methyldopa/NN hypotension/NN alpha/NN rats/NNS paralleled/VBN SDRR/NNP activity/NN locomotor/NN
methyldopa/NN hypotension/NN alpha/NN rats/NNS paralleled/VBN SDRR/NNP activity/NN
estrogen/NN downregulates/NNS mediated/VBD hypotension/VB
estrogen/NN interaction/NN hypotension/VB
rapamycin/JJ inhibitors/NNS target/NN observed/VBN recipients/NNS nephropathy/NN chronic/JJ
rapamycin/JJ inhibitors/NNS target/NN observed/VBN recipients/NNS nephropathy/NN allograft/NN
rapamycin/JJ inhibitors/NNS target/NN observed/VBN recipients/NNS nephropathy/NN
sirolimus/NNS target/NN observed/VBN recipients/NNS nephropathy/NN chronic/JJ
sirolimus/NNS target/NN observed/VBN recipients/NNS nephropathy/NN allograft/NN
sirolimus/NNS target/NN observed/VBN recipients/NNS nephropathy/NN
mipafox/NN inhibition/NN correlation/NN damage/NN neuropathic/JJ
mipafox/NN inhibition/NN correlation/NN damage/NN
mipafox/NN inhibition/NN esterase/JJ neurotoxic/JJ
organophosphate/NN Mipafox/NNP exposed/VBN rats/NNS examined/VBN correlation/NN esterase/NN neurotoxic/JJ
organophosphate/NN neurotoxic/JJ
Mipafox/NNP exposed/VBN rats/NNS examined/VBN correlation/NN damage/NN neuropathic/JJ
Mipafox/NNP exposed/VBN rats/NNS examined/VBN correlation/NN damage/NN
Mipafox/NNP exposed/VBN rats/NNS examined/VBN correlation/NN esterase/NN enzyme/NN neuropathy/NN
N/NNP Mipafox/NNP exposed/VBN rats/NNS examined/VBN correlation/NN damage/NN neuropathic/JJ
N/NNP Mipafox/NNP exposed/VBN rats/NNS examined/VBN correlation/NN damage/NN
N/NNP diisopropylphosphorodiamidofluoridate/NN N/NNP Mipafox/NNP exposed/VBN rats/NNS examined/VBN correlation/NN damage/NN neuropathic/JJ
N/NNP diisopropylphosphorodiamidofluoridate/NN N/NNP Mipafox/NNP exposed/VBN rats/NNS examined/VBN correlation/NN damage/NN
'/POS N/NNP diisopropylphosphorodiamidofluoridate/NN N/NNP Mipafox/NNP exposed/VBN rats/NNS examined/VBN correlation/NN damage/NN neuropathic/JJ
'/POS N/NNP diisopropylphosphorodiamidofluoridate/NN N/NNP Mipafox/NNP exposed/VBN rats/NNS examined/VBN correlation/NN damage/NN
-/JJ diisopropylphosphorodiamidofluoridate/NN N/NNP Mipafox/NNP exposed/VBN rats/NNS examined/VBN correlation/NN damage/NN neuropathic/JJ
-/JJ diisopropylphosphorodiamidofluoridate/NN N/NNP Mipafox/NNP exposed/VBN rats/NNS examined/VBN correlation/NN damage/NN
diisopropylphosphorodiamidofluoridate/NN N/NNP Mipafox/NNP exposed/VBN rats/NNS examined/VBN correlation/NN damage/NN neuropathic/JJ
diisopropylphosphorodiamidofluoridate/NN N/NNP Mipafox/NNP exposed/VBN rats/NNS examined/VBN correlation/NN damage/NN
N/NNP Mipafox/NNP exposed/VBN rats/NNS examined/VBN correlation/NN esterase/NN enzyme/NN neuropathy/NN
N/NNP diisopropylphosphorodiamidofluoridate/NN N/NNP Mipafox/NNP exposed/VBN rats/NNS examined/VBN correlation/NN esterase/NN enzyme/NN neuropathy/NN
'/POS N/NNP diisopropylphosphorodiamidofluoridate/NN N/NNP Mipafox/NNP exposed/VBN rats/NNS examined/VBN correlation/NN esterase/NN enzyme/NN neuropathy/NN
-/JJ diisopropylphosphorodiamidofluoridate/NN N/NNP Mipafox/NNP exposed/VBN rats/NNS examined/VBN correlation/NN esterase/NN enzyme/NN neuropathy/NN
diisopropylphosphorodiamidofluoridate/NN N/NNP Mipafox/NNP exposed/VBN rats/NNS examined/VBN correlation/NN esterase/NN enzyme/NN neuropathy/NN
Mipafox/NNP exposed/VBN rats/NNS examined/VBN correlation/NN esterase/NN neurotoxic/JJ
Mipafox/NNP organophosphate/NN neurotoxic/JJ
N/NNP Mipafox/NNP exposed/VBN rats/NNS examined/VBN correlation/NN esterase/NN neurotoxic/JJ
N/NNP diisopropylphosphorodiamidofluoridate/NN N/NNP Mipafox/NNP exposed/VBN rats/NNS examined/VBN correlation/NN esterase/NN neurotoxic/JJ
'/POS N/NNP diisopropylphosphorodiamidofluoridate/NN N/NNP Mipafox/NNP exposed/VBN rats/NNS examined/VBN correlation/NN esterase/NN neurotoxic/JJ
-/JJ diisopropylphosphorodiamidofluoridate/NN N/NNP Mipafox/NNP exposed/VBN rats/NNS examined/VBN correlation/NN esterase/NN neurotoxic/JJ
diisopropylphosphorodiamidofluoridate/NN N/NNP Mipafox/NNP exposed/VBN rats/NNS examined/VBN correlation/NN esterase/NN neurotoxic/JJ
N/NNP Mipafox/NNP organophosphate/NN neurotoxic/JJ
N/NNP diisopropylphosphorodiamidofluoridate/NN N/NNP Mipafox/NNP organophosphate/NN neurotoxic/JJ
'/POS N/NNP diisopropylphosphorodiamidofluoridate/NN N/NNP Mipafox/NNP organophosphate/NN neurotoxic/JJ
-/JJ diisopropylphosphorodiamidofluoridate/NN N/NNP Mipafox/NNP organophosphate/NN neurotoxic/JJ
diisopropylphosphorodiamidofluoridate/NN N/NNP Mipafox/NNP organophosphate/NN neurotoxic/JJ
organophosphate/NN Mipafox/NNP exposed/VBN rats/NNS examined/VBN correlation/NN damage/NN neuropathic/JJ
organophosphate/NN Mipafox/NNP exposed/VBN rats/NNS examined/VBN correlation/NN damage/NN
organophosphate/NN Mipafox/NNP exposed/VBN rats/NNS examined/VBN correlation/NN esterase/NN enzyme/NN neuropathy/NN
Mipafox/NNP exposure/NN sampled/VBN cord/NN inhibition/NNP percentage/NN predict/VB damage/NN neuropathic/JJ
Mipafox/NNP exposure/NN sampled/VBN cord/NN inhibition/NNP percentage/NN predict/VB damage/NN
dopamine/JJ receptors/NNS induced/VBN hyperactivity/RB
SCH/NN blocked/VBN hyperactivity/RB
23390/CD SCH/NN blocked/VBN hyperactivity/RB
fluphenazine/NN SCH/NN blocked/VBN hyperactivity/RB
raclopride/NN SCH/NN blocked/VBN hyperactivity/RB
SKF/NNP agonist/NN had/VBD induced/VBN hyperactivity/RB
38393/CD SKF/NNP agonist/NN had/VBD induced/VBN hyperactivity/RB
PHNO/NNP induced/VBN hyperactivity/RB
isoflurane/NN metabolism/NNS flow/NN aneurysms/NNS cerebral/JJ
isoflurane/NN metabolism/NNS flow/NN aneurysms/NNS
oxygen/NN flow/NN measured/VBN isoflurane/NN hypotension/NN
oxygen/NN flow/NN measured/VBN isoflurane/NN hypotension/NN patients/NNS subjected/VBN craniotomy/VB clipping/VBG aneurysm/NN cerebral/JJ
oxygen/NN flow/NN measured/VBN isoflurane/NN hypotension/NN patients/NNS subjected/VBN craniotomy/VB clipping/VBG aneurysm/NN
isoflurane/NN hypotension/NN patients/NNS subjected/VBN craniotomy/VB clipping/VBG aneurysm/NN cerebral/JJ
isoflurane/NN hypotension/NN patients/NNS subjected/VBN craniotomy/VB clipping/VBG aneurysm/NN
xenon/NN Schmidt/VBN 5/CD days/NNS haemorrhage/NN subarachnoid/JJ
xenon/NN Schmidt/VBN 5/CD days/NNS haemorrhage/NN
Hg/NN induced/VBN MAP/NN hypotension/NN
isoflurane/JJ concentration/NN reduced/VBN clipping/NN aneurysm/NN
Spironolactone/NNP induced/VBN patients/NNS failure/NN heart/NN
Spironolactone/NNP induced/VBN patients/NNS failure/NN
spironolactone/NN use/NN evaluating/VBG patients/NNS heart/NN
spironolactone/NN use/NN evaluating/VBG patients/NNS failure/NN
spironolactone/NN benefits/NNS reported/VBN changed/VBN treatments/NNS failure/NN heart/NN
spironolactone/NN benefits/NNS reported/VBN changed/VBN treatments/NNS failure/NN
spironolactone/NN treated/VBN patients/NNS heart/NN
spironolactone/NN treated/VBN patients/NNS failure/NN
spironolactone/NN treated/VBN patients/NNS heart/NN
spironolactone/NN treated/VBN patients/NNS failure/NN
K/NNP >/NNP mg/NN dL/NN developed/VBD hyperkalemia/NN
K/NNP >/NNP insufficiency/NN renal/JJ
K/NNP >/NNP insufficiency/NN
Cr/NNP >/NNP insufficiency/NN renal/JJ
Cr/NNP >/NNP insufficiency/NN
Cr/NNP >/NNP insufficiency/NN >/NNP mg/NN dL/NN developed/VBD hyperkalemia/NN
potassium/NN levels/NNS had/VBD Patients/NNS developed/VBD older/JJR hyperkalemia/NN
potassium/NN doses/NNS levels/NNS had/VBD Patients/NNS developed/VBD older/JJR hyperkalemia/NN
potassium/NN levels/NNS had/VBD Patients/NNS developed/VBD older/JJR likely/JJ have/VB diabetes/NN
potassium/NN doses/NNS levels/NNS had/VBD Patients/NNS developed/VBD older/JJR likely/JJ have/VB diabetes/NN
thiazide/JJ diuretics/NNS treated/VBN likely/JJ had/VBD Patients/NNS developed/VBD insufficiency/NN renal/JJ
thiazide/JJ diuretics/NNS treated/VBN likely/JJ had/VBD Patients/NNS developed/VBD insufficiency/NN
creatinine/NN weight/NN had/VBD Patients/NNS developed/VBD insufficiency/NN renal/JJ
creatinine/NN weight/NN had/VBD Patients/NNS developed/VBD insufficiency/NN
MDMA/NNP users/NNS reported/VBN deficits/NNS memory/NN
MDMA/NNP users/NNS reported/VBN deficits/NNS
3/CD MDMA/NNP users/NNS reported/VBN deficits/NNS memory/NN
3/CD MDMA/NNP users/NNS reported/VBN deficits/NNS
4/CD 3/CD MDMA/NNP users/NNS reported/VBN deficits/NNS memory/NN
4/CD 3/CD MDMA/NNP users/NNS reported/VBN deficits/NNS
methylenedioxymethamphetamine/NN 3/CD MDMA/NNP users/NNS reported/VBN deficits/NNS memory/NN
methylenedioxymethamphetamine/NN 3/CD MDMA/NNP users/NNS reported/VBN deficits/NNS
ecstasy/NN methylenedioxymethamphetamine/NN 3/CD MDMA/NNP users/NNS reported/VBN deficits/NNS memory/NN
ecstasy/NN methylenedioxymethamphetamine/NN 3/CD MDMA/NNP users/NNS reported/VBN deficits/NNS
diclofenac/JJ therapy/NN associated/VBN hepatitis/NN Chronic/JJ
diclofenac/JJ therapy/NN associated/VBN hepatitis/NN active/JJ
diclofenac/JJ therapy/NN associated/VBN hepatitis/NN
sodium/NN therapy/NN associated/VBN hepatitis/NN Chronic/JJ
sodium/NN therapy/NN associated/VBN hepatitis/NN active/JJ
sodium/NN therapy/NN associated/VBN hepatitis/NN
diclofenac/JJ sodium/NN therapy/NN developed/VBD hepatitis/NN chronic/JJ
diclofenac/JJ sodium/NN therapy/NN developed/VBD hepatitis/NN active/JJ
diclofenac/JJ sodium/NN therapy/NN developed/VBD hepatitis/NN
sodium/NN therapy/NN developed/VBD hepatitis/NN chronic/JJ
sodium/NN therapy/NN developed/VBD hepatitis/NN active/JJ
sodium/NN therapy/NN developed/VBD hepatitis/NN
neurotensin/NN Effects/NNPS catalepsy/NN parkinsonian/NN
neurotensin/NN Effects/NNPS catalepsy/NN
haloperidol/NN induced/VBN symptoms/NNS parkinsonian/NN
haloperidol/NN induced/VBN symptoms/NNS
neurotensin/NN effects/NNS investigate/VB haloperidol/NN induced/VBN symptoms/NNS parkinsonian/NN
neurotensin/NN effects/NNS investigate/VB haloperidol/NN induced/VBN symptoms/NNS
neurotensin/JJ pallidus/NNS infusions/NNS RESULTS/NNS catalepsy/NN parkinsonian/NN
neurotensin/JJ pallidus/NNS infusions/NNS RESULTS/NNS catalepsy/NN
citalopram/NN adolescent/NN depressed/JJ
citalopram/NNP boy/NN treatment/NN report/VBP depression/NN major/JJ
citalopram/NNP boy/NN treatment/NN report/VBP depression/NN
GNC/VBP H/NNP immunotherapy/NN overdose/NN cocaine/NN
GNC/VBP H/NNP immunotherapy/NN overdose/NN
92/CD H/NNP immunotherapy/NN overdose/NN cocaine/NN
92/CD H/NNP immunotherapy/NN overdose/NN
H/NNP immunotherapy/NN overdose/NN cocaine/NN
H/NNP immunotherapy/NN overdose/NN
2/CD H/NNP immunotherapy/NN overdose/NN cocaine/NN
2/CD H/NNP immunotherapy/NN overdose/NN
cocaine/NN use/NN continues/VBZ remains/VBZ treatment/NN overdose/NN cocaine/NN
cocaine/NN use/NN continues/VBZ remains/VBZ treatment/NN overdose/NN
GNC/NNP H/NNP potential/NN examined/VBN using/VBG model/NN overdose/NN cocaine/NN
GNC/NNP H/NNP potential/NN examined/VBN using/VBG model/NN overdose/NN
92/NNP H/NNP potential/NN examined/VBN using/VBG model/NN overdose/NN cocaine/NN
92/NNP H/NNP potential/NN examined/VBN using/VBG model/NN overdose/NN
H/NNP potential/NN examined/VBN using/VBG model/NN overdose/NN cocaine/NN
H/NNP potential/NN examined/VBN using/VBG model/NN overdose/NN
2/CD H/NNP potential/NN examined/VBN using/VBG model/NN overdose/NN cocaine/NN
2/CD H/NNP potential/NN examined/VBN using/VBG model/NN overdose/NN
cocaine/NN toxicity/NN blockade/NN observed/VBN H/NNP reduced/VBN up/RB %/NN death/NN
GNC/NNP dose/NN observed/VBN blockade/NN toxicity/NN
92/CD GNC/NNP dose/NN observed/VBN blockade/NN toxicity/NN
H/NNP observed/VBN blockade/NN toxicity/NN
2/CD H/NNP observed/VBN blockade/NN toxicity/NN
GNC/NNP dose/NN observed/VBN H/NNP reduced/VBN up/RB seizures/VBD
92/CD GNC/NNP dose/NN observed/VBN H/NNP reduced/VBN up/RB seizures/VBD
H/NNP reduced/VBN up/RB seizures/VBD
2/CD H/NNP reduced/VBN up/RB seizures/VBD
cocaine/NN toxicity/NN
GNC/NNP dose/NN observed/VBN H/NNP reduced/VBN up/RB %/NN death/NN
92/CD GNC/NNP dose/NN observed/VBN H/NNP reduced/VBN up/RB %/NN death/NN
H/NNP reduced/VBN up/RB %/NN death/NN
2/CD H/NNP reduced/VBN up/RB %/NN death/NN
cocaine/NN injection/NN post/NN prevented/VBD death/NN
GNC/NNP H/NNP prevented/VBD death/NN
92/NNP H/NNP prevented/VBD death/NN
H/NNP prevented/VBD death/NN
2/CD H/NNP prevented/VBD death/NN
GNC/NNP potential/NN support/VBP H/NNP tool/NN overdose/NN cocaine/NN
GNC/NNP potential/NN support/VBP H/NNP tool/NN overdose/NN
92/CD GNC/NNP potential/NN support/VBP H/NNP tool/NN overdose/NN cocaine/NN
92/CD GNC/NNP potential/NN support/VBP H/NNP tool/NN overdose/NN
H/NNP tool/NN overdose/NN cocaine/NN
H/NNP tool/NN overdose/NN
2/CD H/NNP tool/NN overdose/NN cocaine/NN
2/CD H/NNP tool/NN overdose/NN
naloxone/JJ administered/VBN animals/NNS facilitated/VBD reversed/VBN Amnesia/NNP
morphine/JJ min/NNS reversed/VBN Amnesia/NNP
morphine/NN facilitated/VBD reversed/VBN Amnesia/NNP
morphine/NN infusion/NN patients/NNS compared/VBN incidence/NN apnoea/NN
bupivacaine/NN patients/NNS patients/NNS compared/VBN incidence/NN apnoea/NN
morphine/JJ infusion/NN had/VBD patients/NNS occurred/VBD obstructive/NN
morphine/JJ infusion/NN had/VBD patients/NNS occurred/VBD obstructive/NN 05/NNP less/RBR P/NNP
morphine/JJ infusion/NN had/VBD patients/NNS occurred/VBD obstructive/NN 05/NNP less/RBR
morphine/JJ infusion/NN had/VBD patients/NNS occurred/VBD obstructive/NN 05/NNP than/IN
morphine/JJ infusion/NN had/VBD patients/NNS occurred/VBD obstructive/NN 05/NNP 0/NNP
morphine/JJ infusion/NN had/VBD patients/NNS occurred/VBD obstructive/NN 05/NNP
morphine/JJ infusion/NN had/VBD patients/NNS occurred/VBD obstructive/NN and/CC
morphine/JJ infusion/NN had/VBD patients/NNS occurred/VBD obstructive/NN apnoea/NN central/JJ
morphine/JJ infusion/NN had/VBD patients/NNS occurred/VBD obstructive/NN apnoea/NN
morphine/JJ group/NN incidence/NN tachyarrhythmias/NNS
Dup/NNP 753/NNP prevents/VBZ development/NN nephrosis/NNS
753/NNP prevents/VBZ development/NN nephrosis/NNS
puromycin/NN aminonucleoside/NN development/NN nephrosis/NNS
aminonucleoside/NN development/NN nephrosis/NNS
blood/NN urea/NN syndromes/NNS proteinuria/NN
nitrogen/NN urea/NN syndromes/NNS proteinuria/NN
urea/NN syndromes/NNS proteinuria/NN
angiotensin/NNP II/NNP antagonist/NN administration/NN inhibited/JJ appearance/NN syndromes/NNS nephrotic/JJ
angiotensin/NNP II/NNP antagonist/NN administration/NN inhibited/JJ appearance/NN syndromes/NNS
II/NNP antagonist/NN administration/NN inhibited/JJ appearance/NN syndromes/NNS nephrotic/JJ
II/NNP antagonist/NN administration/NN inhibited/JJ appearance/NN syndromes/NNS
blood/NN urea/NN syndromes/NNS nephrotic/JJ
blood/NN urea/NN syndromes/NNS
nitrogen/NN urea/NN syndromes/NNS nephrotic/JJ
nitrogen/NN urea/NN syndromes/NNS
urea/NN syndromes/NNS nephrotic/JJ
urea/NN syndromes/NNS
Dup/NNP administration/NN inhibited/JJ appearance/NN syndromes/NNS proteinuria/NN hypoalbuminemia/NN
753/CD Dup/NNP administration/NN inhibited/JJ appearance/NN syndromes/NNS proteinuria/NN hypoalbuminemia/NN
losartan/NN administration/NN inhibited/JJ appearance/NN syndromes/NNS proteinuria/NN hypoalbuminemia/NN
angiotensin/NNP II/NNP antagonist/NN administration/NN inhibited/JJ appearance/NN syndromes/NNS proteinuria/NN
II/NNP antagonist/NN administration/NN inhibited/JJ appearance/NN syndromes/NNS proteinuria/NN
angiotensin/NNP II/NNP antagonist/NN administration/NN inhibited/JJ appearance/NN syndromes/NNS proteinuria/NN hypercholesterolemia/NN
II/NNP antagonist/NN administration/NN inhibited/JJ appearance/NN syndromes/NNS proteinuria/NN hypercholesterolemia/NN
blood/NN urea/NN syndromes/NNS proteinuria/NN hypoalbuminemia/NN
nitrogen/NN urea/NN syndromes/NNS proteinuria/NN hypoalbuminemia/NN
urea/NN syndromes/NNS proteinuria/NN hypoalbuminemia/NN
Dup/NNP administration/NN inhibited/JJ appearance/NN syndromes/NNS nephrotic/JJ
Dup/NNP administration/NN inhibited/JJ appearance/NN syndromes/NNS
753/CD Dup/NNP administration/NN inhibited/JJ appearance/NN syndromes/NNS nephrotic/JJ
753/CD Dup/NNP administration/NN inhibited/JJ appearance/NN syndromes/NNS
losartan/NN administration/NN inhibited/JJ appearance/NN syndromes/NNS nephrotic/JJ
losartan/NN administration/NN inhibited/JJ appearance/NN syndromes/NNS
angiotensin/NNP II/NNP antagonist/NN administration/NN inhibited/JJ appearance/NN syndromes/NNS proteinuria/NN hypoalbuminemia/NN
II/NNP antagonist/NN administration/NN inhibited/JJ appearance/NN syndromes/NNS proteinuria/NN hypoalbuminemia/NN
blood/NN urea/NN syndromes/NNS proteinuria/NN hypercholesterolemia/NN
nitrogen/NN urea/NN syndromes/NNS proteinuria/NN hypercholesterolemia/NN
urea/NN syndromes/NNS proteinuria/NN hypercholesterolemia/NN
Dup/NNP administration/NN inhibited/JJ appearance/NN syndromes/NNS proteinuria/NN
753/CD Dup/NNP administration/NN inhibited/JJ appearance/NN syndromes/NNS proteinuria/NN
losartan/NN administration/NN inhibited/JJ appearance/NN syndromes/NNS proteinuria/NN
Dup/NNP administration/NN inhibited/JJ appearance/NN syndromes/NNS proteinuria/NN hypercholesterolemia/NN
753/CD Dup/NNP administration/NN inhibited/JJ appearance/NN syndromes/NNS proteinuria/NN hypercholesterolemia/NN
losartan/NN administration/NN inhibited/JJ appearance/NN syndromes/NNS proteinuria/NN hypercholesterolemia/NN
puromycin/NN aminonucleoside/NN development/NN system/NN renin/NN induced/VBN nephrosis/NNS
aminonucleoside/NN development/NN system/NN renin/NN induced/VBN nephrosis/NNS
angiotensin/NN system/NN renin/NN induced/VBN nephrosis/NNS
amikacin/NN toxicity/VBZ
aminoglycosides/NNS improved/VBN impair/VB infarction/NN
aminoglycosides/NNS improved/VBN endophthalmitis/NNS
vancomycin/NN amikacin/NN treatment/NN toxicity/NN retinal/JJ
vancomycin/NN amikacin/NN treatment/NN toxicity/NN
amikacin/NN toxicity/NN treatment/NN endophthalmitis/NNS streptococcal/JJ
amikacin/NN toxicity/NN treatment/NN endophthalmitis/NNS
amikacin/NN treatment/NN endophthalmitis/NNS streptococcal/JJ
amikacin/NN treatment/NN endophthalmitis/NNS
vancomycin/NN amikacin/NN treatment/NN endophthalmitis/NNS streptococcal/JJ
vancomycin/NN amikacin/NN treatment/NN endophthalmitis/NNS
fluorescein/NN confirmed/VBD telangiectasis/VBZ
lamivudine/NN use/VBP therapy/NN disorders/NNS rheumatologic/JJ
lamivudine/NN use/VBP therapy/NN disorders/NNS
lamivudine/JJ patients/NNS disease/NN rheumatologic/JJ
lamivudine/JJ patients/NNS disease/NN
hepatitis/NN antigen/NN lamivudine/JJ patients/NNS disease/NN rheumatologic/JJ
hepatitis/NN antigen/NN lamivudine/JJ patients/NNS disease/NN
B/NN antigen/NN lamivudine/JJ patients/NNS disease/NN rheumatologic/JJ
B/NN antigen/NN lamivudine/JJ patients/NNS disease/NN
virus/NN antigen/NN lamivudine/JJ patients/NNS disease/NN rheumatologic/JJ
virus/NN antigen/NN lamivudine/JJ patients/NNS disease/NN
surface/NN antigen/NN lamivudine/JJ patients/NNS disease/NN rheumatologic/JJ
surface/NN antigen/NN lamivudine/JJ patients/NNS disease/NN
antigen/NN lamivudine/JJ patients/NNS disease/NN rheumatologic/JJ
antigen/NN lamivudine/JJ patients/NNS disease/NN
HBs/NNP Ag/NNP antigen/NN lamivudine/JJ patients/NNS disease/NN rheumatologic/JJ
HBs/NNP Ag/NNP antigen/NN lamivudine/JJ patients/NNS disease/NN
Ag/NNP antigen/NN lamivudine/JJ patients/NNS disease/NN rheumatologic/JJ
Ag/NNP antigen/NN lamivudine/JJ patients/NNS disease/NN
lamivudine/NN therapies/NNS patients/NNS diseases/NNS rheumatologic/JJ
lamivudine/NN therapies/NNS patients/NNS diseases/NNS
HBs/NNP patients/NNS diseases/NNS rheumatologic/JJ
HBs/NNP patients/NNS diseases/NNS
Ag/NNP patients/NNS diseases/NNS rheumatologic/JJ
Ag/NNP patients/NNS diseases/NNS
ecstasy/JJ users/NNS deficits/NNS Learning/NNP
ecstasy/JJ users/NNS deficits/NNS Learning/NNP and/CC
ecstasy/JJ users/NNS deficits/NNS memory/NN
ecstasy/JJ users/NNS deficits/NNS
ecstasy/JJ users/NNS display/VBP impairments/NNS
ecstasy/JJ users/NNS display/VBP impairments/NNS performance/NN in/IN
ecstasy/JJ users/NNS display/VBP impairments/NNS performance/NN learning/NN
ecstasy/JJ users/NNS display/VBP impairments/NNS performance/NN learning/NN and/CC
ecstasy/JJ users/NNS display/VBP impairments/NNS performance/NN learning/NN memory/NN
cannabis/NN users/NNS hyperactivity/NN Deficits/NNS
cannabis/NN users/NNS hyperactivity/NN Deficits/NNS learning/NN in/IN
cannabis/NN users/NNS hyperactivity/NN Deficits/NNS learning/NN
cannabis/NN users/NNS hyperactivity/NN Deficits/NNS learning/NN and/CC
cannabis/NN users/NNS hyperactivity/NN Deficits/NNS learning/NN memory/NN
cannabis/NN users/NNS hyperactivity/NN
ecstasy/RB revealed/VBN task/NN phases/NNS analysis/NN hyperactivity/NN
ecstasy/NN related/VBN effects/NNS neurotoxic/JJ
ecstasy/NN effects/NNS neurotoxic/JJ
minoxidil/NN use/NN Pseudoacromegaly/NNP
minoxidil/NN resulted/VBD patient/NN pseudoacromegaly/NN
minoxidil/JJ use/NN effect/NN pseudoacromegaly/NN
WR/NNP cisplatin/NNP trial/NN amifostine/NN carcinoma/NN breast/NN
WR/NNP cisplatin/NNP trial/NN amifostine/NN carcinoma/NN
2721/CD amifostine/NN carcinoma/NN breast/NN
2721/CD amifostine/NN carcinoma/NN
amifostine/NN carcinoma/NN breast/NN
amifostine/NN carcinoma/NN
cisplatin/NNP trial/NN amifostine/NN carcinoma/NN breast/NN
cisplatin/NNP trial/NN amifostine/NN carcinoma/NN
Cisplatin/NNP has/VBZ activity/NN line/VBP treatment/NN carcinoma/NN breast/NN
Cisplatin/NNP has/VBZ activity/NN line/VBP treatment/NN carcinoma/NN
cisplatin/NN observed/VBN limited/VBN dose/NN e/NNP g/NNP nephrotoxicity/NN neurotoxicity/NN
cisplatin/NN associated/VBN toxicities/NNS dose/NN e/NNP g/NNP nephrotoxicity/NN neurotoxicity/NN
cisplatin/NN observed/VBN limited/VBN treatment/NN carcinoma/NN breast/NN
cisplatin/NN observed/VBN limited/VBN treatment/NN carcinoma/NN
cisplatin/NN associated/VBN toxicities/NNS dose/NN limited/VBN treatment/NN carcinoma/NN breast/NN
cisplatin/NN associated/VBN toxicities/NNS dose/NN limited/VBN treatment/NN carcinoma/NN
cisplatin/NN observed/VBN limited/VBN dose/NN toxicities/NNS
cisplatin/NN associated/VBN toxicities/NNS
amifostine/NN cisplatin/NN trials/NNS suggested/VBD reduced/VBN incidence/NN cisplatin/NN induced/VBN nephrotoxicity/NN neuropathy/NN
amifostine/NN cisplatin/NN trials/NNS suggested/VBD reduced/VBN incidence/NN cisplatin/NN induced/VBN nephrotoxicity/NN ototoxicity/NN
amifostine/NN cisplatin/NN trials/NNS suggested/VBD reduced/VBN incidence/NN cisplatin/NN induced/VBN nephrotoxicity/NN
amifostine/NNP cisplatin/NNP conducted/VBN carcinoma/NN breast/NN
amifostine/NNP cisplatin/NNP conducted/VBN carcinoma/NN
cisplatin/NNP conducted/VBN carcinoma/NN breast/NN
cisplatin/NNP conducted/VBN carcinoma/NN
amifostine/NN addition/NN observed/VBN tumor/NN
cisplatin/VB observed/VBN tumor/NN effect/NN toxicity/NN
cisplatin/VB observed/VBN tumor/NN
amifostine/NN addition/NN observed/VBN tumor/NN effect/NN toxicity/NN
phenobarbital/JJ containing/VBG diet/NN fed/VBN rats/NNS developed/VBD fed/VBN rats/NNS developed/VBD nodules/NNS carcinomas/NNS hepatocellular/NN
phenobarbital/JJ containing/VBG diet/NN fed/VBN rats/NNS developed/VBD fed/VBN rats/NNS developed/VBD nodules/NNS carcinomas/NNS
phenobarbital/JJ containing/VBG diet/NN fed/VBN rats/NNS developed/VBD nodule/NN carcinoma/NN hepatocellular/NN
phenobarbital/JJ containing/VBG diet/NN fed/VBN rats/NNS developed/VBD nodule/NN carcinoma/NN
phenobarbital/JJ diet/NN fed/VBN rats/NNS fed/VBN rats/NNS %/NN carcinomas/NNS incidence/NN hepatocellular/NN
phenobarbital/JJ diet/NN fed/VBN rats/NNS fed/VBN rats/NNS %/NN carcinomas/NNS
dothiepin/NN hydrochloride/NN treatment/NN disorder/NN depressive/NN
dothiepin/NN hydrochloride/NN treatment/NN disorder/NN
hydrochloride/NN treatment/NN disorder/NN depressive/NN
hydrochloride/NN treatment/NN disorder/NN
amitriptyline/NNP study/NN placebo/NN treatment/NN outpatients/NNS depressed/JJ
dothiepin/NN study/NN placebo/NN treatment/NN outpatients/NNS depressed/JJ
amitriptyline/NNP Dothiepin/NNP effective/JJ alleviating/VBG symptoms/NNS illness/NN depressive/JJ
amitriptyline/NNP Dothiepin/NNP effective/JJ alleviating/VBG symptoms/NNS illness/NN
Dothiepin/NNP effective/JJ alleviating/VBG symptoms/NNS illness/NN depressive/JJ
Dothiepin/NNP effective/JJ alleviating/VBG symptoms/NNS illness/NN
dothiepin/NN less/JJR incidence/NN frequency/NN vision/NN blurred/JJ
dothiepin/NN less/JJR incidence/NN frequency/NN vision/NN
dothiepin/NN less/JJR incidence/NN frequency/NN vision/NN mouth/NN dry/JJ
dothiepin/NN less/JJR incidence/NN frequency/NN vision/NN mouth/NN
antidepressant/NN drug/NN associated/VBN treatment/NN outpatients/NNS depressed/JJ
amitriptyline/NNP effects/NNS associated/VBN treatment/NN outpatients/NNS depressed/JJ
Dothiepin/NNP found/VBN drug/NN associated/VBN treatment/NN outpatients/NNS depressed/JJ
propylthiouracil/NN caused/VBD disease/NN Liver/JJ
propylthiouracil/NN caused/VBD disease/NN
gamma/NN transmitted/VBD part/NN neurophysiology/NN epilepsy/NN absence/NN
gamma/NN transmitted/VBD part/NN neurophysiology/NN epilepsy/NN
aminobutyric/JJ acid/NN gamma/NN transmitted/VBD part/NN neurophysiology/NN epilepsy/NN absence/NN
aminobutyric/JJ acid/NN gamma/NN transmitted/VBD part/NN neurophysiology/NN epilepsy/NN
acid/NN gamma/NN transmitted/VBD part/NN neurophysiology/NN epilepsy/NN absence/NN
acid/NN gamma/NN transmitted/VBD part/NN neurophysiology/NN epilepsy/NN
saralasin/NN prevented/VBD hypertensive/VBP
sodium/NN nitroprusside/NN prevented/VBD hypertensive/VBP
nitroprusside/NN prevented/VBD hypertensive/VBP
angiotensin/NN system/NN hypotension/NN
saralasin/NN treated/VBD demonstrated/VBD increase/NN
saralasin/NN treated/VBD demonstrated/VBD pressure/NN in/IN
saralasin/NN treated/VBD demonstrated/VBD pressure/NN blood/NN
saralasin/NN treated/VBD demonstrated/VBD pressure/NN
SNP/NNP infusion/NN demonstrated/VBD increase/NN
SNP/NNP infusion/NN demonstrated/VBD pressure/NN in/IN
SNP/NNP infusion/NN demonstrated/VBD pressure/NN blood/NN
SNP/NNP infusion/NN demonstrated/VBD pressure/NN
angiotensin/NN system/NN antagonizing/VBG effects/NNS hypotensive/JJ
bilirubin/NN mortality/NN predicted/VBD presentation/NN encephalopathy/RB
fentanyl/NN reduces/VBZ pain/NN
fentanyl/NN reduces/VBZ nausea/NNS
fentanyl/NN reduces/VBZ nausea/NNS vomiting/VBG
sevoflurane/NN reduces/VBZ pain/NN
sevoflurane/NN reduces/VBZ nausea/NNS
sevoflurane/NN reduces/VBZ nausea/NNS vomiting/VBG
sevoflurane/NN anaesthesia/NN induction/NN advantages/NNS occurs/VBZ nausea/NN postoperative/JJ
sevoflurane/NN anaesthesia/NN induction/NN advantages/NNS occurs/VBZ nausea/NN
sevoflurane/NN anaesthesia/NN induction/NN advantages/NNS occurs/VBZ nausea/NN and/CC
sevoflurane/NN anaesthesia/NN induction/NN advantages/NNS occurs/VBZ nausea/NN vomiting/VBG
sevoflurane/JJ anaesthesia/NN vomiting/VBG study/NN examined/VBN incidence/NN nausea/NN postoperative/JJ
sevoflurane/JJ anaesthesia/NN vomiting/VBG study/NN examined/VBN incidence/NN nausea/NN
sevoflurane/JJ anaesthesia/NN vomiting/VBG study/NN and/CC
sevoflurane/JJ anaesthesia/NN vomiting/VBG
sevoflurane/JJ anaesthesia/NN vomiting/VBG pain/NN
fentanyl/NN Omission/NNP reduce/VB did/VBD reduce/VB moderate/JJ nausea/NN
fentanyl/NN %/NN discharge/NN moderate/JJ nausea/NN
fentanyl/NN fentanyl/NN %/NN discharge/NN moderate/JJ nausea/NN
fentanyl/NN Omission/NNP reduce/VB did/VBD reduce/VB incidence/NN vomiting/VBG
fentanyl/NN %/NN discharge/NN moderate/JJ reduce/VB incidence/NN vomiting/VBG
fentanyl/NN fentanyl/NN %/NN discharge/NN moderate/JJ reduce/VB incidence/NN vomiting/VBG
dexamethasone/VB reduce/VB did/VBD reduce/VB incidence/NN nausea/NN postoperative/JJ
dexamethasone/VB reduce/VB did/VBD reduce/VB incidence/NN nausea/NN
dexamethasone/VB reduce/VB did/VBD reduce/VB incidence/NN nausea/NN and/CC
dexamethasone/VB reduce/VB did/VBD reduce/VB incidence/NN nausea/NN vomiting/NN
dexamethasone/VB reduce/VB incidence/NN vomiting/VBG
dexamethasone/VB reduce/VB moderate/JJ nausea/NN
Dexamethasone/NNP had/VBD effect/NN incidence/NN nausea/NN postoperative/JJ
Dexamethasone/NNP had/VBD effect/NN incidence/NN nausea/NN
Dexamethasone/NNP had/VBD effect/NN incidence/NN nausea/NN and/CC
Dexamethasone/NNP had/VBD effect/NN incidence/NN nausea/NN vomiting/NN
fentanyl/JJ groups/NNS Combining/VBG revealed/VBD reducing/VBG nausea/VBG
fentanyl/JJ groups/NNS Combining/VBG revealed/VBD reducing/VBG nausea/VBG prior/RB discharge/VB decreased/VBN nausea/NN
fentanyl/NN omission/NN unaffected/JJ severity/NN Pain/NN
sevoflurane/NN had/VBD reduce/VB increased/VBD respiratory/RB
sevoflurane/NN had/VBD reduce/VB increased/VBD depression/NN
sevoflurane/NN had/VBD reduce/VB increased/VBD depression/NN hypotension/NN
sevoflurane/NN had/VBD reduce/VB increased/VBD depression/NN bradycardia/NN
sevoflurane/VB supplement/NN appears/VBZ exacerbated/VBD nausea/NN postoperative/JJ
sevoflurane/VB supplement/NN appears/VBZ exacerbated/VBD nausea/NN
sevoflurane/VB supplement/NN appears/VBZ exacerbated/VBD nausea/NN and/CC
sevoflurane/VB supplement/NN appears/VBZ exacerbated/VBD nausea/NN vomiting/NN
sevoflurane/VB supplement/NN appears/VBZ exacerbated/VBD improvement/NN pain/NN postoperative/JJ
sevoflurane/VB supplement/NN appears/VBZ exacerbated/VBD improvement/NN pain/NN
fentanyl/NN exacerbated/VBD improvement/NN pain/NN postoperative/JJ
fentanyl/NN exacerbated/VBD improvement/NN pain/NN
iopamidol/JJ patients/NNS disease/NN chronic/JJ
iopamidol/JJ patients/NNS disease/NN kidney/NN
iopamidol/JJ patients/NNS disease/NN
iodixanol/JJ iopamidol/JJ patients/NNS disease/NN chronic/JJ
iodixanol/JJ iopamidol/JJ patients/NNS disease/NN kidney/NN
iodixanol/JJ iopamidol/JJ patients/NNS disease/NN
N/NNP use/NN mellitus/NNS diabetes/NN
N/NNP use/NN mellitus/NNS
acetylcysteine/NN use/NN mellitus/NNS diabetes/NN
acetylcysteine/NN use/NN mellitus/NNS
iopamidol/NN %/NN mg/NN increases/VBZ patients/NNS diabetes/NN
iodixanol/NN %/NN mg/NN increases/VBZ patients/NNS diabetes/NN
iopamidol/NN less/JJR all/DT 0/NNP patients/NNS diabetes/NN
iopamidol/JJ patients/NNS administration/NN different/JJ mellitus/NNS diabetes/NN
iopamidol/JJ patients/NNS administration/NN different/JJ mellitus/NNS
iodixanol/JJ high/JJ iopamidol/JJ patients/NNS administration/NN different/JJ mellitus/NNS diabetes/NN
iodixanol/JJ high/JJ iopamidol/JJ patients/NNS administration/NN different/JJ mellitus/NNS
methotrexate/NN dose/NN induction/NN leukemia/NN meningeal/JJ
methotrexate/NN dose/NN induction/NN leukemia/NN
methotrexate/JJ regimen/NN high/NN treated/VBN developed/VBD leukemia/NN acute/JJ
methotrexate/JJ regimen/NN high/NN treated/VBN developed/VBD leukemia/NN lymphoblastic/JJ
methotrexate/JJ regimen/NN high/NN treated/VBN developed/VBD leukemia/NN
methotrexate/NN concentrations/NNS achieve/VB designed/VBN regimen/NN high/NN treated/VBN developed/VBD leukemia/NN acute/JJ
methotrexate/NN concentrations/NNS achieve/VB designed/VBN regimen/NN high/NN treated/VBN developed/VBD leukemia/NN lymphoblastic/JJ
methotrexate/NN concentrations/NNS achieve/VB designed/VBN regimen/NN high/NN treated/VBN developed/VBD leukemia/NN
methotrexate/JJ regimen/NN high/NN treated/VBN disease/NN meningeal/JJ
methotrexate/JJ regimen/NN high/NN treated/VBN disease/NN
methotrexate/NN concentrations/NNS achieve/VB designed/VBN regimen/NN high/NN treated/VBN disease/NN meningeal/JJ
methotrexate/NN concentrations/NNS achieve/VB designed/VBN regimen/NN high/NN treated/VBN disease/NN
bilirubin/NN elevations/NNS transaminase/NN neutropenia/NN
bilirubin/NN elevations/NNS transaminase/NN encountered/VBD toxicities/NNS
bilirubin/NN elevations/NNS transaminase/NN mucositis/NNS
methotrexate/NN treatment/NN induction/NN remission/NN relapse/NN leukemia/NN acute/JJ
methotrexate/NN treatment/NN induction/NN remission/NN relapse/NN leukemia/NN lymphoblastic/JJ
methotrexate/NN treatment/NN induction/NN remission/NN relapse/NN leukemia/NN
